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Abstract 
According to the scanning model of eukaryotic translation initiation, ribosomes bind near 
the 5’ cap of an mRNA and then initiate translation at the first start codon they encounter 
as they progress down the mRNA. Upstream open reading frames (uORFs) can regulate 
translation initiation at downstream start codons. Recently, a uORF in the GDP-L-galactose 
phosphorylase (GGP) mRNA was reported to mediate autoregulation of ascorbate, or 
Vitamin C, production. Ascorbate is an essential enzymatic cofactor and antioxidant in 
plants and animals. Ascorbate concentrations are tightly regulated in plants through post-
transcriptional repression of GGP, the major enzyme controlling ascorbate biosynthesis. 
Key attributes of the noncanonical GGP uORF include: (1) initiation at either a near-
cognate start codon or an AUG codon in poor context; (2) it encodes a 32-65 residue 
peptide containing conserved motifs; and (3) ribosome profiling indicates the presence of 
an elongation pause at the uORF C-terminus. These attributes suggest that the GGP uORF 
is a novel upstream Conserved Coding region (uCC), a new paradigm of translational 
control involving a uORF whose initiation at a weak start site is triggered by queuing of 
scanning ribosomes behind an elongating ribosome paused at a conserved amino acid motif 
within the uCC. We hypothesize that ascorbate promotes pausing of translation elongation 
in the uORF to enhance uORF translation and to repress translation of GGP. To assess 
ascorbate mediated GGP repression by the uORF, we examined reporter constructs in 
mammalian cell lines and in rabbit reticulocyte lysate in vitro translation systems. 
Alignment of 20 algae species’ GGP uORFs shows absolute conservation of five amino 
acid motifs. Consistent with the GGP uORF being a uCC, conservation of all five motifs 
and their spacing is essential for regulation of GGP mRNA translation by ascorbate in vivo 
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and in vitro, and the elongation pause is specific to ascorbate. Ribosome profiling from 
Chlamydomonas reinhardtii and Solanum lycopersicum showed an elongation pause at the 
C-terminal glycine repeat. In support of the queuing model, reducing ribosome loading by 
inserting a cap-proximal stem-loop in the GGP mRNA abolished ascorbate specific 
regulation of GGP expression. Taken together, these data indicate that the GGP uORF is a 
uCC. We propose that ascorbate interacts with conserved residues of the uCC nascent 
peptide within the ribosome exit tunnel, causing an elongation pause that regulates GGP 
mRNA translation. 
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1.1. Regulation of gene expression 
Eukaryotic genomes contain tens of thousands of protein coding genes. Humans 
are estimated to have 20,000-25,000 protein coding genes and ten times as many total 
mRNA transcripts (Salzberg, 2018). Gene regulation allows cells to control which genes 
in the cell’s DNA are expressed, at what time, and at what level. Regulation of gene 
expression is essential for cells to adapt to changing stresses and for the development of 
different cell types in complex organisms. In eukaryotes, gene expression involves many 
steps and regulation can occur at any of these steps. Some of the steps that can be regulated 
are at the level of chromatin accessibility and transcription, at RNA processing, RNA 
stability, translation, and at protein activity and stability.  
In eukaryotes, DNA is packaged into chromatin inside the cell nucleus (Kornberg, 
1974). Transcription of DNA into RNA is a key regulatory point for many genes. Sets of 
transcription factor proteins bind to specific DNA elements in or near a gene and promote 
or repress its transcription in response to cellular signals (Matsui et al., 1980). The number 
of promoters targeted by any given sequence-specific regulator ranges from just a few to 
several hundred, or even several thousand in complex organisms like metazoans (Venters 
and Pugh, 2009). The transcriptional activators then recruit transcriptional coactivators to 
modify the local chromatin environment and promote the assembly of the transcription pre-
initiation complex, which is composed of general transcription factors and RNA 
Polymerase II (Pol II) (Roeder, 1996). After Pol II is recruited to a promoter, transcription 
proceeds through initiation, elongation, and termination. Unlike bacterial mRNAs, 
eukaryotic mRNAs require processing in the nucleus before they are fully translatable. The 
mRNAs are capped, introns are spliced out, and the 3’ end is modified (Proudfoot et al., 
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2002). mRNA nuclear export is directed and coordinated with processing and assembly 
into messenger ribonucleoprotein particles (mRNPs). During capping, splicing, and 
polyadenylation, many RNA-binding and modifying proteins are recruited to the 
transcripts including the transcription-export (TREX) complex, which is essential for 
mRNA export (Carmody and Wente, 2009; Cheng et al., 2006; Kohler and Hurt, 2007; 
Masuda et al., 2005). TREX acts as a quality control mechanism and also appears to have 
gene regulatory effects (Kohler and Hurt, 2007). In higher eukaryotes the TREX complex 
is poorly recruited to mRNAs that lack splicing components or the 5’ cap (Carmody and 
Wente, 2009; Cheng et al., 2006). mRNA export utilizes Nxf1-Nxt1, which is not 
dependent on the Ran-GTP gradient (Herold et al., 2000), and is recruited to the mRNP 
through TREX (Carmody and Wente, 2009). After export from the nucleus, the mRNA can 
be translated in the cytosol or directed to the endoplasmic reticulum (ER) if the encoded 
protein is destined for secretion.  
The stability of an mRNA molecule in the cytosol affects how many times it can be 
translated and thus how many proteins will be produced per mRNA. The steady-state level 
of any mRNA in a cell is a balance between its synthesis via transcription and its 
degradation by the mRNA decay machinery. Multiple decay pathways have been 
characterized for mRNAs and different mRNAs can be degraded by different distinct 
pathways, but the same mRNA can also be degraded by different pathways depending on 
cellular conditions (Guhaniyogi and Brewer, 2001). The rate at which an mRNA is decayed 
is dependent on cis-acting elements within the mRNA and trans-acting factors that bind 
the elements. mRNA stability is also regulated through translation to modulate gene 
expression and as a quality control mechanism (Shoemaker and Green, 2012; Stoecklin 
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and Muhlemann, 2013). The role of mRNA features and translation in mRNA stability will 
be discussed in more detail in the next section.  
 Protein synthesis is an essential component of the gene expression pathway and is 
a key element in its control. Regulation of translation is essential to most cellular processes 
and is critical to maintain homeostasis in the cell and the organism. In general, the synthesis 
rate of a protein is proportional to the concentration and translational efficiency of its 
mRNA (Hershey et al., 2012). The majority of eukaryotic mRNAs have long half-lives 
(>two hours) (Raghavan et al., 2002), so rapid regulation of the cellular levels of the 
proteins they encode is achieved by controlling mRNA translational efficiency and protein 
degradation rates rather than the mRNA level. Translational control is the only way to 
regulate gene expression under some conditions such as during early viral infection, before 
viral transcription has started and the RNAs packaged in the virus are the sole source of 
viral protein synthesis (Walsh et al., 2013), and in cells lacking active transcription such as 
oocytes and reticulocytes (Richter and Lasko, 2011). Protein synthesis also accounts for a 
large proportion of a cells’ energy budget, especially for cells that are growing or are 
biosynthetically active. In addition, because protein synthesis is integrated with all aspects 
of cellular metabolism, dysregulation of translation contributes to a variety of disease states 
including cancers and neurological diseases (Le Quesne et al., 2010). Translation and 
translational control will be discussed in more detail in a later section.  
 After synthesis, proteins are still subject to regulation. Proteins can undergo 
regulated modifications that affect the activity or behavior of the protein, some proteins are 
regulated by small molecules or protein-protein interactions, and proteins undergo 
degradation. Post-translational modifications (PTMs) are mostly catalyzed by enzymes that 
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recognize specific target sequences in specific proteins. The most common post-
translational modifications are cleavage of precursor proteins, formation of disulfide 
bonds, or covalent addition or removal of low-molecular-weight groups, such as a 
phosphoryl group. As of 2015, over 200 different types of post-translational modifications 
have been identified (Duan and Walther, 2015). Post-translational modifications are 
fundamental in regulating protein folding, interactions, and the functional state of the 
protein. Post-translational modifications, such as phosphorylation, are reversible by the 
action of specific deconjugating enzymes. In the case of phosphorylation by phosphatases. 
The balance between modifying and reversing the modification allows for rapid and energy 
efficient control of protein function; control by protein degradation and de novo synthesis 
are much more time and energy intensive.  
 Many enzymes are controlled by conformational changes that alter catalytic 
activity. Frequently, the conformational change is the result of small molecule binding. 
This type of regulation is common in biosynthetic pathways, where the end product of the 
pathway inhibits the enzyme that catalyzes the first step in its synthesis by feedback 
inhibition (Alves and Savageau, 2000). This ensures an adequate supply of the end product 
while preventing synthesis of excess product.  
 Finally, protein expression can be regulated through proteolysis, or protein 
degradation. A common means of regulated protein degradation involves post-translational 
conjugation of ubiquitin to select Lys residues on target proteins (Hershko et al., 1983). 
Degradation signals within the protein are referred to as degrons and can be activated or 
inactivated via covalent modifications or sequestration (Ravid and Hochstrasser, 2008). 
Ubiquitination involves three main steps and types of enzymes: ubiquitin activation by 
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ubiquitin-activating enzymes (E1s); conjugation , or transfer of ubiquitin from E1 to E2, 
by ubiquitin-conjugating enzymes (E2s); and ligation by ubiquitin ligases (E3s). 
Degradation is also regulated by the activity, expression, and localization of the E3 ligases 
that recognize substrates of the ubiquitin system and conjugate ubiquitin to them 
(Varshavsky, 2005). There are over 500 distinct E3 ligases in the average mammal 
(Varshavsky, 2005). After ubiquitination, the protein is processively degraded into short 
peptides by the ATP-dependent 26S proteasome. 
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1.2. mRNA features and RNA stability 
Eukaryotic genomes encode large numbers of RNases, many with overlapping 
activities, making redundancy a general feature of RNA degradation pathways (Houseley 
and Tollervey, 2009). With a few exceptions, mutating a single RNA degradation enzyme 
does not result in a complete block to RNA degradation, indicating that multiple enzymes 
are capable of targeting the same RNAs. In a wild-type cell, different mRNAs can be 
degraded by distinct pathways while a given mRNA can also be degraded by different, 
seemingly redundant pathways, depending on cellular conditions (Guhaniyogi and Brewer, 
2001).  
As discussed above, the processing of pre-mRNAs includes the addition of a 5’ cap 
and the modification of the 3’ end by the addition of a non-templated poly(A) tail. In 
addition to being required for efficient translation, the 5’ cap and poly(A)-tail confer 
resistance to non-specific degradation in the cytoplasm by exonucleases (Stoecklin and 
Muhlemann, 2013). Regulated decay of mRNAs is influenced by components of the 
mRNA including the 5’-cap, the 5’-untranslated region (5’-UTR), the protein coding 
region, 3’-UTR, and the 3’-poly(A) tail, and trans-acting factors that target these specific 
features (Guhaniyogi and Brewer, 2001).  
Transcripts generated by RNA Pol II can be degraded in the nucleus or in the 
cytosol. In the nucleus, capping, transcription termination, and mRNA export act as a 
quality control mechanism. During transcription, pre-mRNAs are capped with an N7-
methylated guanosine linked to the first nucleotide of the RNA by a reverse 5’ to 5’ 
triphosphate linkage (Ramanathan et al., 2016). The m7G cap is necessary for cap-
dependent initiation of protein synthesis and also acts as a quality control mechanism. The 
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mRNA cap protects against 5’ to 3’ exonuclease cleavage and is an identifier for recruiting 
protein factors for pre-mRNA splicing (Fresco and Buratowski, 1996; Inoue et al., 1989), 
polyadenylation (Flaherty et al., 1997), and nuclear export (Nojima et al., 2007; 
Ramanathan et al., 2016). In mammalian cells, a trifunctional enzyme, DXO/Dom3Z, 
specifically de-caps an unmethylated cap and degrades the 5’ monophosphate-terminated 
RNA with its 5’ to 3’ exonuclease activity (Jiao et al., 2013).  
Pol II transcription termination involves multiple steps and features: the poly(A) 
signal, pre-mRNA cleavage (at the poly(A) site or downstream), pre-mRNA degradation, 
and specific terminator elements (Porrua et al., 2016; West et al., 2008). Utilizing the 
human ß-globin gene, West et al. found that transcription of the poly(A) signal renders Pol 
II termination competent. As Pol II synthesizes the ß-globin transcript through and beyond 
the terminator element, the mRNA is cotranscriptionally cleaved, and the 3’ portion is 
degraded by a 5’-3’ exonuclease that releases PolII from the DNA template (West et al., 
2008). Termination can occur hundreds or thousands of nucleotides downstream from the 
poly(A) signal, so cleavage of the mRNA occurs near the poly(A) signal. Nearly every 
known mRNA contains a polyadenylation signal sequence AAUAAA, or variants, 10-30 
bases upstream of the cleavage/polyadenylation site (Colgan and Manley, 1997). Cleavage 
of the 3’end is coupled to poly(A) addition by a large complex of multisubunit proteins. In 
yeast, the processes are mediated by the cleavage and polyadenylation factor (CTF) that is 
organized into three modules that each mediate a key function: a nuclease module that 
cleaves the transcript; a polymerase module that binds other components including poly(A) 
polymerase; and a phosphatase that regulates 3’ end processing (Stewart, 2019).  
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 At steady state, the length of the poly(A) tail on a cytoplasmic mRNA varies 
between approximately 70 nt in Saccharomyces cerevisiae and over 200 nt in mammalian 
cells (Wahle and Winkler, 2013). The poly(A) tail serves as a binding site for poly(A)-
binding protein (PABP). PABP has four RNA recognition motifs (RRM1-4) and the first 
RRMs (1-2) bind the poly(A) tail and are thought to enhance translation by binding the 
eukaryotic initiation factor (eIF) eIF4G (Machida et al., 2018; Safaee et al., 2012). PABP 
also has binding sites for other molecules important for translation and metabolism of RNA 
including for Paip2, which inhibits translation by competing with poly(A) RNA and eIF4G 
for binding to PABP (Karim et al., 2006).   
Correct nuclear processing and recruitment of export factors target an mRNA for 
export to the cytosol. Defects in mRNP assembly prevent the association of export factors, 
and capping and splicing are important for the recruitment of the TREX complex (Carmody 
and Wente, 2009; Cheng et al., 2006; Zhou et al., 2000). Export failure leads to degradation 
of the mRNA by 5’ and/or 3’ exonucleases (Houseley and Tollervey, 2009).  
After export to the cytosol the mRNA can be degraded as part of translation quality 
control or by 3’-5’ decay or 5’-3’ decay. mRNA stability is regulated through translation 
to modulate gene expression and as a quality control mechanism (Shoemaker and Green, 
2012; Stoecklin and Muhlemann, 2013). Ribosomes that arrest during translation, usually 
on aberrant mRNAs, trigger mRNA quality control pathways that lead to mRNA decay. In 
eukaryotes, examples of aberrant translation events include premature stop codons in the 
middle of an open reading frame (ORF) that trigger nonsense-mediated decay (NMD) 
(Amrani et al., 2004); translation of the poly(A) tail at the end of the mRNA due to lack of 
a stop codon triggers non-stop decay (Frischmeyer et al., 2002); and kinetic traps, such as 
   27 
hairpins or truncations that prevent further translation, trigger no-go decay (Doma and 
Parker, 2006). In each case, the ribosome and associated factors are thought to ‘sense’ the 
defect in the mRNA and recruit machinery to begin the process of mRNA decay, 
proteolysis of the nascent peptide (NC), and recycling of the stalled ribosome 
(Radhakrishnan and Green, 2016). 
In the cytoplasm, mRNAs undergo progressive deadenylation at rates that are 
specific for each mRNA species (Houseley and Tollervey, 2009). The mRNP contains 
information that defines its lifespan. The best characterized stability/instability elements 
are AU-rich elements (AREs), which are bound by proteins that extend or shorten mRNA 
lifespan in response to cellular signals (Houseley and Tollervey, 2009), and miRNA 
recognition sites (Wahle and Winkler, 2013). Stoeklin et al. found that ARE-mediated 
mRNA decay occurs in a 5’-3’ direction in a processing body that includes decapping 
enzymes, the 5’-3’ exonuclease Xrn1, and Lsm1-7 (Stoecklin et al., 2006). The majority of 
cytoplasmic deadenylation is associated with the Ccr4-Not and Pan2-Pan3 complexes 
(Wahle and Winkler, 2013). Following deadenylation, the mRNA can be degraded in a 3’-
5’ direction by the exosome. Deadenylation is a trigger for mRNAs decapping, shutting 
down mRNA translation and activating mRNA degradation by Xrn1 (Franks and Lykke-
Andersen, 2008). Cytoplasmic decapping is catalyzed by Dcp2 in conjunction with a 
coactivator Dcp1 and is stimulated by decapping enhancer proteins. The Edc family of 
enhancers recruit Dcp2 cap-binding and catalysis (Franks and Lykke-Andersen, 2008). 
Pat1 and Dhh1 appear to activate decapping at least partly by repressing translation. Dhh1 
is hypothesized to promote destabilization of the eIF4F-mRNA cap complex (Coller and 
Parker, 2005; Franks and Lykke-Andersen, 2008). Dhh1 is also proposed to be a sensor of 
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ribosome speed, targeting mRNAs with slow moving ribosomes for degradation 
(Radhakrishnan et al., 2016).  
The eukaryotic RNA exosome has nuclear and cytoplasmic forms that are defined 
by unique subunit compositions that interact with factors in these compartments (Zinder 
and Lima, 2017). In S. cerevisiae the cytoplasmic exosome includes a nine-subunit core 
(Exo9) that interacts with Dis3 to form a 10-subunit complex. The Exo9 core lacks catalytic 
activity, while Dis3 catalyzes endoribonuclease and processive 3’-5’ exoribonuclease 
activities (Dziembowski et al., 2007; Lebreton et al., 2008; Liu et al., 2006; Zinder and 
Lima, 2017). Despite appearing redundant with the 5’-3’ decay pathways, the cytoplasmic 
exosome contributes to translation-dependent mRNA surveillance. 
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1.3. Protein biosynthesis 
 Translation of a eukaryotic mRNA to produce a protein consists of four steps: 
initiation, mediated by initiation factors; elongation, mediated by elongation factors; 
termination, mediated by release factors; and recycling. Protein synthesis is largely 
regulated at the initiation stage rather than during elongation or termination (Jackson et al., 
2010). Regulation of initiation allows rapid and reversible control of gene expression, 
along with spatial control. During translation initiation, an elongation-competent 80S 
ribosome is assembled on an mRNA at the initiation codon, which is base paired with the 
anticodon loop of an initiator transfer RNA (Met-tRNAMeti) in the ribosomal peptidyl (P) 
site. Initiation requires at least twelve eukaryotic initiation factors and has three main steps 
(Hinnebusch, 2014; Hussain et al., 2014; Jackson et al., 2010). The first step is the 
formation of a 43S pre-initiation complex (PIC); the second step is binding of the PIC to 
an mRNA - forming a 48S PIC - and selection of the start codon; and the third step is the 
joining of a 60S subunit to the 48S PIC to form an elongation competent 80S ribosome.  
Marilyn Kozak lists five structural features of an mRNA that influence translation 
initiation: the m7G cap; the context nucleotides flanking the start codon; the position of the 
start codon relative to the 5’ end of the mRNA (whether it is the first start codon) (discussed 
in a later section); secondary structure upstream and downstream from the start codon; and 
the length of the leader (Kozak, 1991b). As discussed above, the m7G cap is ubiquitous 
and serves as a determinant of mRNA quality control as well as increasing translation 
efficiency (Kozak, 1991b; Ramanathan et al., 2016). Interestingly, a guanylated, 
unmethylated cap is sufficient to protect an mRNA from 5’-exonuclease but N-7 
methylation is essential for efficient translation (Horikami et al., 1984; Kozak, 1991b). The 
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m7G cap facilitates translation and scanning by recruiting the cap-binding complex eIF4F, 
which attaches to the cap to activate the mRNA for 43S PIC attachment (Hinnebusch, 
2014). The cap binding complex eIF4F is comprised of  the cap binding protein eIF4E, 
eIF4G, and the RNA helicase eIF4A. eIF4G is a scaffold with binding domains for mRNA, 
eIF4E, eIF4A, PABP, eIF3 (mammals), and eIF1 and -5 (budding yeast) (Hinnebusch, 
2014; Hinton et al., 2007). The eIF4G scaffold allows assembly of a stable circular mRNA-
protein complex through interactions with eIF4E and PABP, which bind the 5’ and 3’ ends, 
respectively, of the mRNA (Hinton et al., 2007). eIF4G allosterically activates eIF4A and 
recruits it to the cap, where eIF4A locally unwinds secondary structure in the mRNA 
(Hinnebusch, 2014). mRNA unwinding along with eIF4G interactions with eIF3, eIF5, or 
eIF1 promote 43S PIC attachment to the 5’ end of the mRNA (Hinnebusch, 2014).  
Kozak proposed the scanning model of eukaryotic translation initiation in 1978 
(Kozak, 1978). In this model, the 40S subunit, along with initiation factors, binds the 
mRNA near the 7-methyl guanosine cap at the 5’ end and moves primarily in a 5’ to 3’ 
direction until it encounters an AUG codon (Fig. 1.1) (Kozak, 1978). Particular sequences 
immediately surrounding the AUG codon (the context nucleotides) enhance selection of 
the AUG codon by the scanning PIC, but a 5’ proximal AUG codon that deviates 
sufficiently from the optimum context will be bypassed in an event referred to as leaky 
scanning (Hinnebusch, 2014). In her 1984 paper, Kozak proposed the ‘Kozak consensus 
sequence’, CC(A/G)CCAUGG (A/G represents A or G and AUG represents the initiating 
codon) (Kozak, 1984). Kozak examined the effects of point mutations in the nucleotides 
flanking the AUG codon by measuring the yield of a cloned preproinsulin gene in 
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Figure 1.1. Scanning model of eukaryotic translation initiation 
A 43S pre-initiation complex consisting of a 40S ribosomal subunit with bound eIF2–
GTP–Met-tRNAiMet ternary complex and other initiation factors binds near the 5’ m7G 
cap of an mRNA and then scans down the mRNA in search of a start codon. Selection of 
the start codon is mediated by base-pairing interactions between the anticodon of the 
tRNAiMet in the preinitiation complex and an AUG codon in the mRNA. Typically, the 
ribosome initiates translation at the most 5’ proximal start codon it encounters during 
scanning; however, the sequence context of the start codon influences the efficiency of 
start codon selection with a purine at the -3 position and a G at +4 relative to the A of the 
AUG codon having the greatest impact on start codon selection.  
 
expression over a 20-fold range (Kozak, 1986b). A purine at the -3 position and a G at the 
+4 position were found to be the most important for AUG codon selection, and Kozak 
confirmed that ACCAUGG is the optimal sequence for initiation by eukaryotic ribosomes 
(Fig. 1.1) (Kozak, 1986b). However, only 0.2% of vertebrate genes contain the precise 
‘Kozak consensus sequence’ (Cavener and Ray, 1991), and the preferred nucleotide 
sequence around the start codon varies among different species (Nakagawa et al., 2008). 
For example, an early study performed prior to completion of plant genome sequences, 
identified the most common sequences for monocots as 
GCGGC(A/C)(A/G)(A/C)CAUGGCG and AAAAAAA(A/C)AAUGGCU for dicots 
(Joshi et al., 1997). More recent studies reveal that, while preferred nucleotide sequences 
are diverse among species, patterns of nucleotide bias roughly reflect evolutionary 
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relationships between species; and there are strong biases for particular nucleotides at 
certain positions (Nakagawa et al., 2008). There is a strong bias for A/G at position -3, A/C 
at position -2, and C at position +5 across all species. Nakagawa et al. also found that the 
signal for these particular nucleotides at the -3, -2, and +5 positions was especially high in 
genes with high expression levels, suggesting that the nucleotides are responsible for 
regulating translation initiation (Nakagawa et al., 2008). 
In the past, protein coding sequences were traditionally defined as open reading 
frames that begin with a universal AUG start codon and terminate with one of three stop 
codons; however, it has been known since the 1980s that translation can initiate at codons 
other than AUG, although at lower efficiency (Clements et al., 1988; Kearse and Wilusz, 
2017; Peabody, 1987, 1989; Zitomer et al., 1984). Most cases of alternate initiation occur 
at near-cognate codons that differ from AUG by only one nucleotide. The prevalence of 
near-cognate initiation was revealed by ribosome profiling when thousands of novel 
potential non-AUG initiation events were identified (Ingolia et al., 2009). The efficiency 
of initiation varies by codon, with CUG generally being the most efficient, followed by 
GUG, ACG, and AUU (Clements et al., 1988; Ivanov et al., 2010b; Kearse and Wilusz, 
2017; Peabody, 1989; Wei et al., 2013); however, efficiency varies especially in in vitro 
assays where the method of preparation and ionic concentrations vary (Kearse and Wilusz, 
2017). In a study of near-cognate initiation efficiency using luciferase reporters in 
HEK293T cells, CUG has an initiation efficiency of about 19%, GUG of 9%, UUG of 2%, 
ACG of 7%, and AUU of 3% compared to an AUG codon (Ivanov et al., 2010b).  
The length and structure of the 5’-UTR also influence translation initiation 
efficiency (Hinnebusch, 2014; Kozak, 1991a, b). Very short 5’-UTRs increase leaky 
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scanning and reduce translational efficiency. In yeast, shortening the 5’-UTR of PGK1 
from 45 to 21 nucleotides reduced translational efficiency by 50% (Hinnebusch, 2011; van 
den Heuvel et al., 1989). Using wheat germ extract and mRNAs containing two AUG 
codons in-frame with the chloramphenicol acetyltransferase (CAT) coding sequence, 
Kozak demonstrated that as the distance of the first AUG codon from the m7G cap was 
decreased from 32 to 3 nucleotides, the yield of protein from the first AUG codon 
decreased, with a corresponding increase in production from the second AUG codon 
(Kozak, 1991a). When the leader length was only three nucleotides to the first AUG codon, 
the majority of protein was produced from AUG #2, at six nucleotides similar levels of 
protein were produced from AUG #1 and AUG #2, and at 12 nucleotides about twice as 
much protein was produced from AUG #1 compared to AUG #2. At 32 nucleotides, leaky 
scanning was almost completely absent and only trace amounts of protein were initiated at 
AUG #2 (Kozak, 1991a). Similar effects are exploited in yeast to permit translation of 
multiple proteins from the same MOD5 mRNA initiated either inefficiently at a cap-
proximal AUG codon or at the second AUG codon by ribosomes that skip the first AUG 
codon (Hinnebusch, 2011; Slusher et al., 1991). The MOD5 isoform initiated from the first 
AUG codon is imported into the mitochondria, while protein initiated from the second 
AUG codon functions in the cytoplasm (Gillman et al., 1991; Najarian et al., 1987; Slusher 
et al., 1991).  
Stable secondary structures impede the progression of the PIC along the 5’-UTR, 
possibly because RNA hairpins cannot thread through the 40S mRNA entry channel 
(Hinnebusch, 2011). Kozak studied the effect of RNA hairpins on translation initiation 
using plasmids encoding preproinsulin in mammalian cell culture (Kozak, 1986a). Hairpin 
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structures of varying stability were inserted upstream of the AUG initiator codon and 
protein production was monitored. Kozak found that a stable hairpin (DG = -50 kcal/mol) 
reduced protein yield by 85-95% and that the hairpin inhibited translation even when it was 
placed in the middle of the 5’-UTR where it did not involve the cap or the AUG codon 
(Kozak, 1986a). In summary, in yeast and mammals, mRNAs with high translational 
efficiencies are expected to contain a 5’-UTR of about 32 nucleotides or greater; lack stable 
secondary structure, extra AUG codons and near-cognate codons in an optimum context; 
and to contain the functional AUG start codon in an optimum context (Hinnebusch, 2011).  
 Beginning translation requires a pool of separated ribosomal subunits generated by 
recycling post-termination ribosomal complexes (post-TCs) (Jackson et al., 2010). 
Recycling begins with termination upon recognition of a stop codon in the aminoacyl (A) 
site of the 80S ribosome by eukaryotic release factors (eRF) eRF1 and GTP-bound eRF3. 
GTP is hydrolyzed and eRF3 dissociates, leaving eRF1in the A site ready to hydrolyze the 
peptidyl-tRNA in the P site (Pisarev et al., 2007; Pisarev et al., 2010). Termination and 
recycling are coupled through ABCE1 (mammals)/Rli1 (yeast), which participates in 
peptide release and separating the 80S ribosome into a free 60S subunit and a 40S subunit 
bound to deacylated tRNA and mRNA (Dong et al., 2004; Pisarev et al., 2007; Young et 
al., 2015a). Next, the deacylated tRNA is removed from the ribosome with dissociation of 
the 40S-mRNA complex in a process mediated by Ligatin and MCT-1/DENR (Jackson et 
al., 2012; Skabkin et al., 2010).  
Before translation of an mRNA can begin, multiple complexes are assembled on 
and off the mRNA. The ternary complex (TC) is essential for initiation and is composed 
of eIF2, GTP, and Met-tRNAiMet. Scanning requires an open 43S PIC conformation that is 
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stabilized by eIF1 and eIF1A binding to the small ribosomal (40S) subunit along with eIF5 
and eIF3 (Hinnebusch, 2014). The open PIC is preloaded with Met-tRNAiMet by binding 
the ternary complex and forming the 43S PIC. As described above, attachment of the PIC 
to the mRNA is facilitated by the eIF4F complex, comprised of the cap-binding protein 
eIF4E, eIF4G, the RNA helicase eIF4A, and PABP (Hinnebusch, 2011).  
After attachment to an mRNA, the 43S PIC scans the mRNA in search of an AUG 
codon, or less frequently a near-cognate codon, in a suitable context. Scanning by the PIC 
involves two linked processes: the first is unwinding of 5’-UTR secondary structures, and 
the second is ribosomal movement along the mRNA. Scanning a 5’-UTR with even weak 
secondary structures requires ATP and the factors eIF4A, eIF4G, and eIF4B along with 
additional DEAD box helicases (Hinnebusch, 2011, 2014; Jackson et al., 2010). Using in 
vitro translation of mRNAs with different 5’-UTR lengths, Berthelot et al. estimated that 
that scanning occurs at about eight bases per second (Berthelot et al., 2004). Using the 
same method, Bethelot et al. and Vassilenko et al. also found that scanning exhibits a strong 
5’ to 3’ directional bias (Berthelot et al., 2004; Hinnebusch, 2014; Jackson et al., 2010; 
Vassilenko et al., 2011). 
 An essential part of the scanning process is the capacity for the 43S PIC to bypass 
AUG codons in poor sequence contexts, as well as near-cognate triplets, in the 5’ leader, 
so that the correct AUG start codon on the mRNA is selected. The PIC scans until it 
encounters an AUG codon in a proper sequence context, using complementarity with the 
anticodon of the initiator tRNA to select an AUG codon when it enters the P site of the 40S 
subunit (Hinnebusch, 2011). Base pairing of the Met-tRNAiMet anticodon with the AUG 
start codon triggers a halt to scanning and initiates selection of the translation start site 
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(Cigan et al., 1988a; Hinnebusch, 2014). In yeast in vitro assays, single-base substitutions 
at the second and third position of the AUG triplet reduce ternary complex affinity for the 
PIC/unstructured-mRNA complex by 10-50 fold (Kolitz et al., 2009). The reduction in 
affinity is attributed to a slower conformational change of the PIC to a more stable complex 
following the initial association between the ternary complex and the PIC. The 
conformational change corresponds to the switch from the open (scanning) PIC to the 
closed (non-scanning) PIC conformation, which increases the stability of ternary complex 
binding to reconstituted 43S/mRNA complexes upon AUG codon recognition 
(Hinnebusch, 2014; Kolitz et al., 2009; Passmore et al., 2007).  
Studies by Hussain et al. and Llacer et al. give insight into how structural changes 
allow start codon selection through a change from the open to the closed PIC conformation 
(Hussain et al., 2014; Llacer et al., 2015). The binding of eIF1 and the eIF1A C-terminal 
tail to the 40S subunit stabilize the open PIC conformation that allows codon sampling 
during scanning (Hussain et al., 2014; Llacer et al., 2015; Saini et al., 2010). Llacer et al. 
found that eIF2 connects eIF1 and eIF1A with the Met-tRNAiMet on the 40S head, and that 
eIF3 appears to form connections between the mRNA entry and exit channels of the 40S 
subunit and the P site (Llacer et al., 2015). Hussain et al. found that eIF1 and eIF1A binding 
rotates the 40S head, likely facilitating ternary complex binding in the open PIC position 
where the initiator Met-tRNAiMet is not fully inserted into the 40S P site (Hussain et al., 
2014). During scanning, eIF5 stimulates GTP hydrolysis by eIF2, but completion of the 
reaction with release of inorganic phosphate (Pi) is blocked by the presence of eIF1 in the 
complex. AUG codon specificity is ensured by an energetic penalty imposed by movement 
of the tRNA anticodon stem loop (ASL) to permit codon recognition that can normally 
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only be fully compensated for by a perfect codon:anticodon duplex (Hussain et al., 2014). 
In addition to moving the anticodon stem-loop, base pairing between the tRNAiMet and an 
AUG codon causes conformational changes in the PIC that likely weaken eIF1 association 
with the 40S subunit and trigger eIF1 release from the PIC. The disassociation of eIF1 from 
the 40S subunit leads to a closed, scanning-arrested conformation of the 40S subunit and 
to Pi release from eIF2-GDP (Algire et al., 2005; Hussain et al., 2014). eIF2-GDP and eIF5 
leave the PIC and eIF5B-GTP binds to the 40S subunit and accelerates the rate of 60S 
subunit joining forming an 80S initiation complex (Hinnebusch, 2014). The 80S initiation 
complex contains Met-tRNAiMet in the P site with its anticodon based paired to the AUG  
start codon of the mRNA, and the ribosome is ready to begin the elongation phase of 
protein synthesis. 
 Following initiation, an 80S ribosome is poised on an mRNA ready to begin 
elongation, with the anticodon of Met-tRNAiMet in the P site base-paired with the start 
codon (Dever and Green, 2012). The second codon of the open reading frame is in the A 
site of the ribosome waiting for the cognate aminoacyl-tRNA to bind. Eukaryotic 
elongation factor (eEF) eEF1A binds aminoacyl-tRNA in a GTP-dependent manner and 
directs the tRNA to the ribosome A site. Codon recognition by the tRNA triggers GTP 
hydrolysis by eEF1A, which releases the factor and enables the aminoacyl-tRNA to be 
accommodated into the A site. Following accommodation of the aminoacyl-tRNA into the 
A site, peptide bond formation with the P-site peptidyl-tRNA occurs. The ribosomal 
peptidyl transferase center (PTC) consists primarily of conserved ribosomal RNA (rRNA) 
elements on the large ribosomal subunit that position the aminoacyl-tRNA substrates for 
catalysis. 
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 During peptide bond formation, ratcheting of the ribosomal subunits triggers 
movement of the acceptor end of the P and A site tRNAs into the exit (E) and P sites, 
respectively, while the anticodon loops remain bound in the P and A sites such that the 
tRNAs adopt hybrid P/E and A/P states (Behrmann et al., 2015; Budkevich et al., 2011; 
Dever et al., 2018; Dever and Green, 2012; Korostelev et al., 2008; Laurberg et al., 2008; 
Moazed and Noller, 1989). Translocation of the tRNAs into the E and P sites is facilitated 
by the GTPase eEF2. Binding of eEF2-GTP stabilizes the hybrid state and promotes 
translocation. Hydrolysis of GTP enables the release of eEF2 from the post-translocation 
complex (Dever and Green, 2012). In the post-translocation state, a deacylated tRNA 
occupies the E site and the peptidyl-tRNA is in the P site. The A site is empty and is 
available for the next aminoacyl-tRNA in complex with eEF1A. Following GTP 
hydrolysis, eEF1A-GDP is released from the ribosome. The eukaryotic factor eEF1B acts 
as a guanine exchange factor (GEF) and catalyzes the displacement of GDP from eEF1A 
enabling GTP to bind, re-forming active eEF1A-GTP.  
In addition to the elongation factors described above, the factor eIF5A is required 
for translation elongation. eIF5A was originally denoted as an initiation factor because it 
was characterized as stimulating the transfer of methionine from Met-tRNAiMet in the 80S 
initiation complex to the aminoacyl-tRNA analog puromycin, an assay that monitors the 
formation of the first peptide bond (Dever and Green, 2012; Kemper et al., 1976). eIF5A 
contains a conserved post-translational modification, where a conserved lysine reside is 
modified to hypusine in a two-step process. First, an N-butylamine moiety is transferred 
from spermidine to the e-amino group of a specific lysine side chain to form 
deoxyhypusine, then a hydroxylation reaction completes the modification. eIF5A promotes 
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translation elongation, and by utilizing hydroxyl radical probing experiments, Gutierrez et 
al. localized eIF5A near the E site of the ribosome with the hypusine residue next to the 
acceptor stem of the P-site tRNA (Gutierrez et al., 2013). It is proposed that eIF5A 
stimulates the peptidyl transferase activity of the ribosome and facilitates the reactivity of 
poor substrates like proline (Gutierrez et al., 2013).   
Codon optimality can determine elongation rates because of the non-uniform 
decoding rate of each of the 61 codons that encode a pool of 20 amino acids (Hanson and 
Coller, 2018; Sabi and Tuller, 2014). Multiple codons code for a single amino acid and 
these codons are recognized distinctly by the ribosome; therefore, individual codons can 
be optimal or non-optimal depending how efficiently the appropriate cognate tRNA can be 
selected from the cytoplasmic pool of tRNAs. Highly expressed genes show codon bias, 
disproportionately utilizing codons that are overrepresented in the transcriptome, that 
correlates with high tRNA levels, but codon optimality can also influence protein folding 
and translation fidelity (Hanson and Coller, 2018; Roth, 2012).  
Sørensen and Pederson used radio-labelled amino acid incorporation assays to show 
that codon identity affects the translation elongation rate (Hanson and Coller, 2018; 
Sorensen and Pedersen, 1991). The elongation rate for a particular codon is dependent on 
the tRNA pool because a ribosome will wait longer for a rare cognate tRNA to enter the 
ribosomal A-site. The kinetic cost to elongation is particularly high when the cognate tRNA 
species is rare compared with near-cognate tRNAs (Chu et al., 2011; Koutmou et al., 2015). 
Yu et al. used ribosome profiling and biochemistry experiments in Neurospora crassa, an 
organism that shows an unusually strong codon preference, to compare the overall rates of 
luciferase mRNA translation in a cell-free translation system to demonstrate that the rate 
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of ribosome elongation is impacted by codon choice (Koutmou et al., 2015; Yu et al., 
2015). The luciferase mRNAs containing primarily optimized or de-optimized codons 
were translated, and the differences in the time until the first luciferase signal was detected 
was used as a metric of the ribosome elongation rate (Yu et al., 2015). Using ribosome 
profiling, they observed differential ribosome occupancy on luciferase reporter mRNA 
regions that were optimized or de-optimized for codon usage (Yu et al., 2015). Elongation 
rate also plays an important role in co-translational protein folding (Harding et al., 1999; 
Koutmou et al., 2015; Purvis et al., 1987; Thanaraj and Argos, 1996). Optimizing codons 
(Yu et al., 2015) or increasing rare tRNA abundance (Zhang et al., 2009) increases protein 
production, but in some cases decreases the production of functional protein. In addition to 
directly influencing elongation rates, codon usage can influence mRNA stability by 
targeting degradation factors to slow moving ribosomes (Radhakrishnan et al., 2016).  
Changes in tRNA pools help maintain cellular homeostasis. tRNAs are 
aminoacylated by aminoacyl-tRNA synthetases that attach the appropriate amino acid to 
the correct tRNAs by catalyzing the esterification of the specific cognate amino acid or its 
precursor to its compatible cognate tRNAs. Twenty different aminoacyl tRNA synthetases, 
one for each natural amino acid, catalyze the aminoacylation of tRNAs (Ibba and Soll, 
2004). Changes in the levels of tRNA pools and abundance of non-optimal codons in an 
mRNA play critical roles in promoting selective mRNA translation during amino acid 
starvation (Koutmou et al., 2015; Saikia et al., 2016). Selective aminoacylation of rare 
tRNA isoacceptors was first shown in Escherichia coli (Dittmar et al., 2005; Elf et al., 
2003), and Saikia et al. demonstrated the same effect in human cell culture (Saikia et al., 
2016). Using ribosome profiling, global codon usage analysis, quantitative tRNA arrays, 
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and luciferase reporter assays Saikia et al. studied differential mRNA translation in amino 
acid starved cells (Saikia et al., 2016). They found that the pools of aminoacylated tRNAs 
are altered in response to amino acid starvation to favor the translation of mRNAs involved 
in protein recycling.  
 Translation termination occurs upon recognition of a  stop codon in the ribosomal 
A-site, followed by hydrolysis of the ester bond of the peptidyl-tRNA located in the P site, 
and release the nascent chain (Jackson et al., 2012). The stop codons (UAA, UGA, or UAG) 
are recognized by eukaryotic release factor eRF1, which binds to the A site in complex 
with GTP-bound eRF3. eRF1, a tRNA shaped protein with three domains (Dever and 
Green, 2012; Song et al., 2000), is responsible for high-fidelity stop codon recognition and 
peptidyl-tRNA hydrolysis, and its function is enhanced by the translational GTPase eRF3 
(Dever and Green, 2012). The eRF1 N-terminal domain recognizes all three stop codons, 
the middle domain is functionally analogous to the acceptor stem of a tRNA and extends 
into the PTC to promote peptide release, and the C-terminal domain facilitates interactions 
with eRF3 (Song et al., 2000).  
During termination, eRF1 and eRF3 bind to the A-site of a pre-termination complex 
as an eRF1-eRF3-GTP ternary complex. GTP is hydrolyzed and eRF3 dissociates, leaving 
eRF1in the A site ready to hydrolyze the peptidyl-tRNA in the P site (Pisarev et al., 2007; 
Pisarev et al., 2010). Conformational changes enable the eRF1 middle domain to enter the 
PTC, and the peptidyl-tRNA is hydrolyzed following a nucleophilic attack of water on the 
ester carbonyl group of peptidyl-tRNA (Jackson et al., 2012). Termination and recycling 
are temporally coupled though the action of ABCE1 (mammals)/Rli1 (yeast), a member of 
the ATP-binding cassette protein family, that participates in peptide release and separating 
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the 80S ribosome into a free 60S subunit and a 40S subunit bound to deacylated tRNA and 
mRNA (Dong et al., 2004; Pisarev et al., 2007; Young et al., 2015a). ABCE1/Rli1 is critical 
for release and contributes to peptide release independently of eRF3 through eRF1 
(Shoemaker and Green, 2011).  
  Following peptide release, the 80S ribosome is still bound to the mRNA along with 
the now deacylated tRNA in the P site, and likely eRF1. The presence of eRF1 accounts 
for a 2-nt toe-print shift in post-termination complexes (Jackson et al., 2012; Pisarev et al., 
2007; Pisarev et al., 2010). ABCE1/Rli1 stimulates efficient dissociation of the 60S 
subunit, leaving mRNA and deacylated tRNA bound to the 40S subunit (Shoemaker and 
Green, 2011; Young et al., 2015a). The deacylated tRNA is removed from the ribosome 
with dissociation of the 40S-mRNA complex in a process mediated by Ligatin and MCT-
1/DENR (Jackson et al., 2012; Skabkin et al., 2010). In some cases, the partial dissolution 
of the complex can allow for “re-initiation” under the correct circumstances, enabling the 
translation of more than one open reading frame on an mRNA. Reinitiation is discussed in 
more detail below, but Dong et al. found that affinity-tagged Rli1 copurifies with eIF2, 
eIF3, and eIF5, perhaps linking ribosome recycling with initiation (Dong et al., 2004; 
Nurenberg and Tampe, 2013). 
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1.4. Upstream open reading frames and translation of main open reading frames 
 Many genes contain at least one short upstream open reading frame (uORF) that is 
less than about 30 codons long. Approximately 50% of mammalian genes and 13% of yeast 
genes contain a uORF (Calvo et al., 2009; Lawless et al., 2009; Resch et al., 2009). 
Estimates of plant genes containing uORFs range from 11% to 60% (Hayden and 
Jorgensen, 2007; Pesole et al., 2000). After translating the uORF, some ribosomes resume 
scanning and are capable of reinitiating at downstream sites. The process is not well 
understood, but termination at uORF stop codons probably proceeds conventionally, and 
the 60S subunit is released followed by deacylated tRNA, but some 40S subunits remain 
on the mRNA and resume scanning (Jackson et al., 2010).  
Multiple factors influence reinitiation efficiency including the time to translate the 
uORF, the distance between the uORF termination codon and the main open reading frame 
(mORF) start site, and the availability of ternary complex. The probability of rescanning 
and re-initiation decreases rapidly with increasing uORF length or if the uORF includes 
stable RNA secondary structures that cause pausing during elongation (Jackson et al., 
2010; Kozak, 2001). Luukkonen et al. used the HIV type 1 tat mRNA, which contains the 
tat open reading frame followed by rev and nef open reading frames, to examine how open 
reading frame length impacts reinitiation at a second open reading frame (Luukkonen et 
al., 1995). With the native mRNA, only Tat is produced due to lack of reinitiation at the 
rev and nef open reading frames (Luukkonen et al., 1995; Schwartz et al., 1990; Schwartz 
et al., 1992). Normalizing to Rev expression from an mRNA lacking the tat uORF, 
Luukkonen et al. showed that a uORF length of 75 nt (25 codons) reduced Rev expression 
to 60%. Increasing the nt length from 102 nt (34 codons) to 111 nt (37 codons) decreased 
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expression from 40% to 20% and at 120 nt (40 codons) Rev expression was undetectable. 
In a similar study, Kozak used an in vitro translation system to study how uORF length 
impacts downstream CAT expression. When normalized to an mRNA without a uORF, 
even a 39-nt (13 codon) uORF reduced CAT expression to 30% (Kozak, 2001). In results 
mirroring Lukkonen, at 99 nt (33 codons) CAT expression was reduced to about 20% 
(Kozak, 2001; Luukkonen et al., 1995). In addition to examining uORF length, Kozak also 
examined the effect of elongation time on reinitiation (Kozak, 2001). A viral pseudoknot 
that had been shown to cause a transient delay in elongation was inserted into the uORF or 
into the mORF. Inserting the pseudoknot into the CAT mORF had little effect on CAT 
expression, but inserting it into the uORF strongly inhibited downstream translation of 
CAT (Kozak, 2001). The control uORF, a 17 codon uORF without secondary structure, 
allowed expression of CAT (Kozak, 2001). The fact that both increased uORF length and 
impeding elongation with RNA secondary structure reduces the efficiency of rescanning 
indicates that the time taken to translate the uORF is crucial.  
The inverse relationship between reinitiation and length of the uORF/translation 
time could be related to the loss of initiation factors (Kozak, 1987, 1992, 2001; Luukkonen 
et al., 1995). Some of the initiation factors which promoted initiation at the uORF might 
remain after subunit joining, and could be stochastically released during the elongation and 
termination phases (Jackson et al., 2012; Kozak, 1987). At the time Kozak proposed the 
loss of initiation factors, there was no obvious way to identify which factors might be 
essential for reinitiation; however, alternate mechanisms of initiation were discovered later, 
such as IRES-dependent initiation, that require only a subset of initiation factors. By 
examining mRNAs with alternate initiation mechanisms and systems lacking specific 
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initiation factors, researchers have been able to deduce which factors contribute to 
reinitiation after translating a uORF. Pöyry et al. used a series of mRNAs based on triose 
phosphate isomerase-CAT (TPI-CAT) (Poyry et al., 2004). The reporter consists of a 5’-
UTR and the first 38 codons of TPI placed immediately upstream of the CAT coding 
sequence. A termination codon was introduced at codon 2 and reinitiation could occur at 
codon 14 (Met14) (Poyry et al., 2004). In an in vitro coupled transcription-translation 
system, the reinitiation efficiency was approximately 40% of the primary initiation at 
codon Met1 (Poyry et al., 2004). Efficient reinitiation was only seen when the mRNA was 
translated by a scanning-dependent mechanism or by initiation dependent on the 
encephalomyocarditis virus IRES (Jackson et al., 2012; Poyry et al., 2004). No reinitiation 
was observed when the primary initiation event was dependent on the classical swine fever 
virus IRES, which initiates independently of eIFs 4A, 4B, 4E, and 4G; or the cricket 
paralysis virus IRES, which is completely independent of all eIFs (Jackson et al., 2012; 
Poyry et al., 2004). Pestova and Kolupaeva used an mRNA with an unstructured 5’-UTR 
consisting of CAA repeats that can be translated at lower efficiency in the absence of any 
of the members of the eIF4 group of initiation factors (Pestova and Kolupaeva, 2002). 
Reinitiation was observed when the mRNA was translated using rabbit reticulocyte lysate 
(RRL) containing all of the initiation factors, but not in an eIF4G-depeleted system 
(Pestova and Kolupaeva, 2002); however, reinitiation did occur when a recombinant eIF4G 
p50 fragment that interacts with both eIF3 and eIF4A was added (Poyry et al., 2004), These 
observations led to the proposal that reinitiation requires the persistence of the eIF4G-eIF3-
40S subunit chain of interactions (Jackson et al., 2012; Poyry et al., 2004). This model was 
initially met with skepticism because the prevailing view was that all factors dissociated 
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from the ribosome at or just before subunit joining. The notion of factor dissociation was 
based on the observation that no initiation factors could be detected co-sedimenting with 
80S initiation complexes (Benne and Hershey, 1978; Unbehaun et al., 2004); however, the 
length of time required for these experiments and the stringent conditions might have 
caused factor dissociation. With this caveat, the results cannot rule out a brief persistence 
of the factor-ribosome interactions for the length of time it would take to translate a short 
uORF (Jackson et al., 2012). Bohlen et al. developed a technique that they term selective 
40S footprinting to visualize initiating 40S ribosomes on endogenous mRNAs in vivo 
(Bohlen et al., 2019). They discovered that eIF3B, eIF4G1, and eIF4E remain on 
elongating ribosomes with a decay half-life of about 12 codons. Bohlen et al.’s findings 
provide a rationale for how ribosomes can reinitiate translation after translating small 
uORFs.  
 The efficiency of re-initiation increases with increasing distance between the 
upstream stop codon and the downstream AUG codon, with a maximum efficiency reached 
around a distance of 80 nt in mammalian cells (Kozak, 1987). This led to the hypothesis 
that the re-scanning 40S subunits are incompetent for re-initiation because they lack ternary 
complex, but a new ternary complex can be acquired during scanning. Accordingly, this 
means that the critical distance between the stop codon and the reinitiation site is dependent 
on the availability of eIF2-ternary complex, which is a regulatory target (Dever et al., 1992; 
Dever et al., 1995; Hinnebusch, 2005; Jackson et al., 2012; Sonenberg and Hinnebusch, 
2009). Two well-studied examples of uORFs regulating mORF translation through the 
availability of eIF2-ternary complex are the genes GCN4 in yeast and ATF4 in mammals  
(Abastado et al., 1991; Dever et al., 1995; Hinnebusch, 2005; Vattem and Wek, 2004).  
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Both the GCN4 and ATF4 mRNAs are regulated through reversible phosphorylation 
of eIF2 in response to environmental stressors, in particular in response to amino acid 
starvation or endoplasmic reticulum stress (Fig. 1.2) (Harding et al., 1999; Hinnebusch, 
2005). As discussed in more detail above, eIF2 is responsible for binding Met-tRNAiMet to 
the 40S ribosomal subunit in an early step in the translation initiation pathway, as part of 
the ternary complex formed by eIF2, Met-tRNAiMet, and GTP. During translation initiation 
the GTP is hydrolyzed to GDP, and an eIF2-GDP binary complex is released. eIF2 has a 
100-400-fold higher affinity for GDP than GTP making the GEF eIF2B essential for 
recycling eIF2-GDP back to active eIF2-GTP (Dever et al., 1995; Pain, 1986). 
Phosphorylation of the eIF2a subunit at serine 51 inhibits the exchange of GDP for GTP 
(Dever et al., 1995; Nika et al., 2001; Rowlands et al., 1988). In addition, due to competitive 
inhibition of eIF2B, phosphorylated eIF2 also prevents eIF2B from exchanging GDP for 
GTP on unphosphorylated eIF2 (Rowlands et al., 1988). In all cells examined, eIF2 is 
present at higher levels than eIF2B; therefore, substoichiometric phosphorylation of eIF2 
is sufficient to abolish eIF2B activity (Dever et al., 1995). Without eIF2B, eIF2 cannot be 
returned to its active GTP bound state, and initiation rates are decreased because of the lack 
of available ternary complex (Sonenberg and Hinnebusch, 2009). A reduction in ternary 
complex decreases global translation, but increases the translation of a select number of 
mRNAs containing short uORFs including the mRNAs encoding the stress response 
factors yeast GCN4 and mammalian ATF4, GADD34, and CHOP  (Abastado et al., 1991; 
Dever et al., 1995; Hinnebusch, 2005; Lee et al., 2009; Palam et al., 2011; Vattem and 














Figure 1.2. Regulated translation reinitiation controls GCN4 and ATF4 expression 
(A) Translation of the S. cerevisiae GCN4 mRNA is regulated by reversible 
phosphorylation of eIF2 in response to amino acid stress. Four short uORFs regulate the 
flow of ribosomes to the GCN4 open reading frame and control GCN4 expression in 
response to ternary complex levels. Under normal growth conditions, eIF2 is not 
phosphorylated and ternary complex levels are high. Scanning ribosomes translate uORF1 
and then resume scanning. These ribosomes readily reacquire a ternary complex and then 
reinitiate translation at the inhibitory uORFs 3 or 4. Translation of these latter uORFs 
causes ribosomes to disengage from the mRNA and GCN4 is not expressed. Under stress 
conditions, eIF2 is phosphorylated leading to decreased levels of ternary complex. 
Following translation of uORF1, ribosomes scan a longer time, and thus a longer distance, 
before reacquiring a ternary complex. The ribosomes scan past uORFs 2-4 without 
reinitiating and then reinitiate translation at the GCN4 open reading frame leading to 
increased GCN4 expression. (B) Translation of metazoan ATF4 mRNA is also regulated 
by reversible phosphorylation of eIF2 as part of the integrated stress response. Two uORFs 
regulate ATF4 expression, with uORF2 overlapping out-of-frame with ATF4. Under 
normal conditions, eIF2 is not phosphorylated and ternary complex levels are high. 
Scanning ribosomes translate uORF1 and then resume scanning. The ribosomes readily 
reacquire a ternary complex and then translate uORF2, preventing initiation at the ATF4 
start site. Under stress conditions, phosphorylation of eIF2 leads to reduced ternary 
complex levels. After translating uORF1, ribosomes scan a longer time before reacquiring 
a ternary complex. The ribosomes scan past the uORF2 start codon without initiating, then 
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reacquire a ternary complex and reinitiate translation at the  ATF4 start codon, leading to 
increased ATF4 expression. 
 
Yeast GCN4 is a transcriptional activator that allows S. cerevisiae to respond to 
amino acid starvation through the general amino acid control (GAAC) response (Fig. 
1.2A). As part of GAAC, GCN4 stimulates the transcription of more than 30 amino acid 
biosynthetic genes in 12 pathways, as well as genes encoding aminoacyl-tRNA synthetases 
and pathway specific activators (Hinnebusch, 2005). Because yeast can synthesize all 20 
amino acids, GAAC is not triggered by growth in minimal medium, but GAAC is triggered 
by antimetabolites, mutations of a biosynthetic enzyme, or by media containing amino acid 
imbalances that elicit starvation by feedback inhibition of enzymes in shared pathways 
(Hinnebusch, 2005; Niederberger et al., 1981). During GAAC, the protein kinase (PK) 
GCN2 is activated by a buildup in uncharged tRNA and then phosphorylates eIF2a to 
enhance translation of GCN4 (Hinnebusch, 2005; Lanker et al., 1992; Wek et al., 1995). 
The GCN4 mRNA contains four uORFs in the 5’ leader. The uORFs are very short with 
uORFs 1, 3 and 4 containing four codons and uORF2 containing three codons (Fig. 1.2A) 
(Hinnebusch, 1984; Mueller and Hinnebusch, 1986). The first and fourth uORFs are 
sufficient for nearly wild-type regulation and have different effects on GCN4 expression 
(Hinnebusch, 1997). If uORF1 is left intact but the other uORFs are mutated, GCN4 
translation is reduced by 50%; however, if only uORF4 is left intact, GCN4 translation is 
reduced to about 1% under both amino acid starvation and non-starvation conditions 
(Hinnebusch, 1997; Mueller and Hinnebusch, 1986). This indicates that uORF1 is 
necessary to overcome the translational barrier imposed by uORF4 through reinitiation 
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(Hinnebusch, 1997). During translation of the GCN4 mRNA, the 43S PIC binds near the 
cap, scans the mRNA, and initiates translation at the 5’ proximal uORF1 (Abastado et al., 
1991; Cigan et al., 1988b; Hinnebusch, 1997). After synthesis of the short uORF1 peptide, 
some 40S subunits, along with essential initiation factors, retain association with the 
mRNA and can reinitiate translation downstream if they acquire ternary complex. 
Translation re-initiation on the GCN4 mRNA is regulated by the availability of eIF2-
ternary complexes (Dever et al., 1995). In unstressed cells, ternary complexes are readily 
available and a scanning ribosome will rapidly reacquire a ternary complex following 
termination at uORF1. The scanning ribosome with bound ternary complex will reinitiate 
translation at uORF2, 3, or 4 and then dissociate from the mRNA, failing to translate GCN4 
(Hinnebusch, 1997). In contrast, under amino acid starvation conditions, phosphorylation 
eIF2a reduces available ternary complex. The scanning 40S ribosomal subunits fail to 
acquire Met-tRNAiMet as part of the ternary complex and bypass uORFs 2-4. Many of these 
subunits will acquire a ternary complex while scanning between uORF4 and GCN4, 
allowing them to initiate translation at the GCN4 start site (Dever et al., 1992; Hinnebusch, 
1997). As part of  the GAAC, increased eIF2a phosphorylation and GCN4 levels 
contribute to a program of gene expression that coordinates amino acid and purine 
metabolism, salvages nutrients, represses general protein synthesis, and extends yeast 
lifespan (Hinnebusch, 2005; Mittal et al., 2017; Vattem and Wek, 2004).  
ATF4 is a master regulator in metazoan cells that is crucial for the adaptation to 
stresses by increasing expression of genes involved in metabolism, nutrient import, and 
countering oxidative stress as a key mediator of the Integrated Stress Response (ISR) (Fig 
1.2B) (Harding et al., 2000; Harding et al., 2003; Jiang et al., 2004; Young and Wek, 2016). 
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In mammals, four protein kinases are known to link distinct upstream stress signals to 
eIF2a phosphorylation (Taniuchi et al., 2016). The four kinases respond to different 
stresses: PKR-like eukaryotic initiation factor 2a kinase (PERK) is activated by misfolded 
proteins in the endoplasmic reticulum (Bertolotti et al., 2000; Harding et al., 1999); general 
control nonderepressible 2 (GCN2) is activated by uncharged tRNAs, allowing cells to 
adapt to amino acid starvation (Dever et al., 1992; Zhang et al., 2002); heme-regulated 
inhibitor (HRI) is activated during heme deficiency (Chen and London, 1995; Chen et al., 
1991); and protein kinase R (PKR) is activated during viral infection (Levin et al., 1980; 
Meurs et al., 1990). Harding et al. studied the ATF4-mediated integrated stress response 
by treating mouse fibroblasts with or without Atf4 or Perk with the drug tunicamycin to 
induce ER stress (Harding et al., 2003). Some of the genes most affected by ER stress that 
were dependent on ATF4 include Herp, an ER stress inducible member of a secretory 
pathway; Atf3, a stress response transcription factor; Cpo, important for mitochondrial 
function and redox/detoxification; many genes involved in translation, amino acid import, 
and metabolism including tRNA synthetases (Harding et al., 2003).  
The ATF4 mRNA contains two uORFs (Fig. 1.2B). The 5’ proximal uORF1 is only 
three codons while uORF2 is 59 codons and overlaps out-of-frame (OF) with the ATF4 
coding region (Lu et al., 2004; Vattem and Wek, 2004). Like GCN4 uORF1, the ATF4 
uORF1 promotes downstream translation reinitiation (Lu et al., 2004; Vattem and Wek, 
2004). In unstressed cells, eIF2-GTP is abundant and ribosomes scanning downstream of 
uORF1 efficiently reinitiate at the uORF2 start codon and are thus unable to translate the 
ATF4 coding region because the ATF4 start codon is a considerable distance upstream of 
the uORF2 stop codon. During cell stress, eIF2a phosphorylation results in inhibition of 
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eIF2B and reduced recycling of eIF2-GDP leading to reduced levels of eIF2-GTP and 
ternary complexes. The increased time required for scanning ribosomes to acquire a ternary 
complex allows the scanning ribosome to bypass the uORF2 start codon, acquire a ternary 
complex, and reinitiate translation at the ATF4 start codon (Vattem and Wek, 2004).  
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1.5. uORF-encoded nascent polypeptide-mediated translational stalling 
Interactions between the nascent chain and the ribosome exit tunnel can modulate 
the translation rate and induce translational stalling to regulate gene expression. The active 
site for peptide bond formation is the PTC located in a cleft on the intersubunit side of the 
large ribosomal subunit (Hussain et al., 2014; Llacer et al., 2015; Rodnina, 2013; 
Simonovic and Steitz, 2009). As the nascent chain is synthesized, it traverses a tunnel 
within the large subunit and exits at the solvent side. Mounting evidence has revealed that 
instead of being a passive channel for the nascent chain, the ribosomal tunnel plays a role 
in early protein folding events as well as regulation of translation (Wilson and Beckmann, 
2011). Proteolytic and early cryogenic electron microscopy (cryo-EM) studies show that, 
in an extended conformation, nascent chains require approximately 30 amino acids to span 
the ribosomal exit tunnel (Malkin and Rich, 1967; Sabatini and Blobel, 1970); however, 
subsequent cryo-EM studies of ribosome-nascent chain complexes have revealed more 
compacted or a-helical-like nascent chain conformations within distinct regions of the 
ribosome exit tunnel (Bhushan et al., 2010).  
As described in more detail in the previous section, peptide bond formation at the 
PTC involves the accurate placement of the substrates to allow nucleophilic attack of the 
a-amino group of the aminoacyl-tRNA in the A site onto the carbonyl-carbon of the 
peptidyl-tRNA in the P site (Rodnina, 2013; Simonovic and Steitz, 2009). The rate of this 
nucleophilic attack varies for each amino acid (Wohlgemuth et al., 2008) with some amino 
acids or combinations of amino acids disfavoring peptide bond formation to such an extent 
that they can slow translation or promote translational arrest. In eukaryotes, consecutive 
stretches of positively charged amino acids have been shown to induce translational arrest 
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(Chiabudini et al., 2014; Lu and Deutsch, 2008; Wilson et al., 2016). Proline-containing 
motifs also promote ribosome stalling during translation elongation and termination 
(Gutierrez et al., 2013) because proline is both a poor A-site acceptor of the peptidyl moiety 
(Johansson et al., 2011; Pavlov et al., 2009) as well as a poor donor when located in the P 
site (Wohlgemuth et al., 2008).  
Due to differences in bacterial and eukaryotic translation, the mechanism of 
regulation by ribosome stalling differs in bacteria versus eukaryotes. Bacteria have coupled 
transcription and translation that is not possible in eukaryotes because in eukaryotes 
transcription occurs in the nucleus while translation occurs in the cytoplasm. In addition, 
unlike eukaryotic mRNAs, bacterial mRNAs can be polycistronic and contain multiple 
open reading frames on a single mRNA. Instead of having a uORF that represses mORF 
translation, bacteria utilize ribosome stalling to mask (del Valle et al., 2019; Gong and 
Yanofsky, 2002a) or unmask (Arenz et al., 2014; Sarker and Oliver, 2002) regulatory 
domains or binding sites within the mRNA. One such regulator is Rho, a bacterial protein 
that terminates transcription by binding to transcription terminator pause sites on exposed 
sections of RNA. 
Regulatory nascent chain mediated translational stalling can be categorized into 
three types: bacterial transcription antitermination via translational stalling, bacterial 
translation induction via translation elongation stalling, and eukaryotic translation 
repression via translation stalling (Wilson et al., 2016). TnaC is an example of induction 
via transcription antitermination mediated by translation termination stalling. TnaC is a 
peptide with an arrest sequence that stalls the ribosome dependent on the presence of L-
tryptophan. The stalling leads to upregulation of the expression of tryptophanase (TnaA) 
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and a tryptophan-specific permease (TnaB) (Gong and Yanofsky, 2002b) that are encoded 
together with the TnaC peptide in the tna operon in the order TnaC-TnaA-TnaB. A spacer 
between tnaC and tnaA contains Rho binding sites that are no longer accessible upon L-
tryptophan dependent stalling, resulting in anti-termination of transcription and induction 
of tnaA and tnaB in the presence of free L-tryptophan. Cryo-EM analysis of a TnaC-stalled 
ribosome confirmed that the nascent TnaC peptide and the ribosome exit tunnel cooperate 
to monitor free L-tryptophan levels (Bischoff et al., 2014; Wilson et al., 2016). Critical 
residues of the nascent chain were found in a defined conformation in the ribosome exit 
tunnel establishing multiple contacts to the tunnel wall from the PTC all the way down to 
the uL22/uL4 constriction (Bischoff et al., 2014). Along with the peptide, two L-tryptophan 
molecules were present in the tunnel, in binding pockets formed by the ribosome exit tunnel 
and the nascent chain (Bischoff et al., 2014). Stabilization of the nascent chain in the 
presence of L-tryptophan is communicated allosterically to the PTC, where a C-terminal 
proline residues together with induction of an unfavorable geometry of the PTC for release 
factor binding and peptide transfer results in stalling (Bischoff et al., 2014; Wilson et al., 
2016).  
Two examples of translation induction via translation elongation stalling are SecM 
and ErmCL. SecM (secretion monitor) is a peptide that stalls ribosomes during synthesis, 
upregulating the SecA-dependent pathway in E. coli (McNicholas et al., 1997). SecA is an 
ATPase-dependent motor the helps secretory and outer membrane proteins cross the 
bacterial cytoplasmic membrane. SecM is encoded by the 5’-end of the bicistronic secM-
secA mRNA that also encodes SecA. The intergenic region of the secM-secA mRNA can 
form a stem-loop (SL) secondary structure, masking the translation initiation Shine-
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Dalgarno sequence of SecA and limiting its expression (Kiser and Schmidt, 1999; Zhang 
et al., 2015). Impairment of SecM secretion increases the duration of the SecM stall (Sarker 
and Oliver, 2002), allowing the bacterium to sense secretion defects. Increasing the SecM 
stall destabilizes the secM-secA mRNA stem-loop structure and increases the exposure of 
the SecA Shine-Dalgarno, enabling ribosomes to bind and translate SecA. Unlike 
eukaryotic uORFs, SecM is large, 170 amino acids in length, and contains a 17-amino-acid 
arrest sequence that interacts with components of the ribosome exit tunnel. Interactions 
between the arrest sequence and the ribosome exit tunnel lead to an inhibitory conformation 
of the PTC (Zhang et al., 2015), slowing peptide bond formation, especially because a 
proline-tRNA is in the A-site of the PTC and proline has a naturally slow peptide bond 
formation rate (Pavlov et al., 2009).  
The Staphylococcus aureus ErmCL leader peptide senses macrolide antibiotics and 
induces expression of a downstream resistance gene ErmC, encoding a macrolide 
resistance methyltransferase . Similar to the SecM-SecA mRNA, the ErmCL-ErmC mRNA 
has a stem-loop secondary structure that sequesters the ribosome-binding site and the AUG 
start codon of the ErmC open reading frame (Arenz et al., 2014; Horinouchi and Weisblum, 
1980). In the presence of subinhibitory concentrations of erythromycin, ribosomes 
translating ErmCL stall, leading to a change in the mRNA secondary structure. The change 
in mRNA secondary structure exposes the ribosome-binding site and the start codon of the 
ermC gene, allowing expression of ErmC. Cryo-EM structures show that erythromycin 
binds in the ribosome exit tunnel and that the ErmCL nascent chain directly senses the drug 
in the tunnel (Arenz et al., 2014). The interaction between the ErmCL nascent chain and 
erythromycin in the ribosome exit tunnel induces allosteric conformational changes at the 
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PTC, preventing the stable binding and accommodation of the A-site tRNA and inducing 
translational arrest. 
 Unlike in bacteria where stalling can induce expression of a mORF, in eukaryotes 
mORF translation is repressed via translation stalling in a uORF. A well-studied example 
of uORF-mediated translational control is from human cytomegalovirus (hCMV) (Chang 
et al., 1989; Degnin et al., 1993; Schleiss et al., 1991). The 5’ leader of the hCMV UL4 
mRNA encoding the glycoprotein gp48 contains three upstream AUG (uAUG) codons that 
initiate uORF1,  uORF2, and uORF3 (Schleiss et al., 1991). Mutational studies revealed 
that the 22-residue uORF2 represses gp48 translation during early stage hCMV infection 
(Janzen et al., 2002; Schleiss et al., 1991). The uORF2 start codon is in poor context 
(GUGaugC) suggesting that ribosomes will frequently leaky scan past the AUG codon 
without initiating translation. Even with leaky scanning, uORF2 is repressive (Cao and 
Geballe, 1995). Putting uORF2 upstream of b-galactosidase (b-gal) reduced b-gal 
expression 10-fold (Cao and Geballe, 1995). When the uORF2 start codon context was 
optimized, expression of b-gal dropped to background levels (Cao and Geballe, 1995). 
Mutational analysis of uORF2 identified residues 21 and 22 as critical for the inhibitory 
activity of the uORF with the PP-stop motif impairing translation termination and leading 
to persistence of the uORF2 peptidyl-tRNA linkage with the proline-tRNA in the P site 
and the termination codon is in the A site. (Bhushan et al., 2010; Degnin et al., 1993; Janzen 
et al., 2002). In a cryo-EM structure, the hCMV stalling peptide was essentially extended, 
but there were interactions with the ribosome exit tunnel constriction that appeared to alter 
the PTC (Bhushan et al., 2010). The repressive nature of uORF2 despite the poor context 
of the AUG start codon suggests that either the stall is very long preventing subsequent 
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scanning ribosomes from leaky scanning to the UL4 start codon or that there are additional 
factors that increase initiation at uAUG2.  
 An additional well described stalling uORF-encoded peptide is the fungal arginine 
attenuator peptide (AAP). The N. crassa arg-2 mRNA, and the related S. cerevisiae CPA1 
mRNA, encode a 23-residue and 24-residue peptide, respectively, upstream of an arginine 
biosynthetic enzyme subunit (Luo et al., 1995; Werner et al., 1987). The mORF encodes 
the small subunit of carbamoyl-phosphate synthetase A (CPSase A) that binds glutamine, 
the physiological nitrogen donor of the CPSase, and transfers its amide nitrogen group to 
a larger subunit that catalyzes the synthesis of carbamoyl phosphate from ammonia 
(Pierard and Schroter, 1978; Werner et al., 1987; Werner et al., 1985). Expression of CPA1 
and arg-2 is repressed by arginine at the translation level in a manner dependent on the cis 
action of the leader peptide encoded in the 5’ region of the mRNA (Delbecq et al., 1994; 
Luo et al., 1995; Werner et al., 1987). The CPA1 and arg-2 uORFs initiate at an AUG 
codon in poor context allowing frequent leaky scanning. In fact, removing the uORF 
abolishes repression of CPA1 expression, but does not increase the level of CPA1 
expression (Wang et al., 1999; Werner et al., 1987). Mutating a single highly conserved 
aspartate residue, D12 in arg-2, abolishes arginine specific repression of the downstream 
gene (Freitag et al., 1996; Werner et al., 1987). In the presence of high arginine 
concentrations, ribosomes translating the AAP stall at the stop codon; however, the stop 
codon is not a prerequisite for stalling, suggesting that the stall is due to impaired 
elongation (Fang et al., 2000; Wang et al., 1998; Wei et al., 2012). In a cryo-EM study, the 
C terminus of the AAP appears to compact adjacent to the PTC. At the tunnel constriction, 
 61 
the AAP nascent chain appears to be stabilized and interacts with ribosomal proteins L4 
and L17 altering the PTC, which could lead to stalling (Bhushan et al., 2010).  
 There are several features that most nascent chain stallers have in common. First, 
in all the cases described above, the geometry of the PTC is perturbed in order to achieve 
the stall. Three residues of the PTC, large rRNA nucleotides A2602, U2585, and U2506 
(numbered according to E. coli) are particularly prone to be affected due to critical 
contributions to peptide bond formation and/or termination (Wilson et al., 2016). Second, 
proline residues are critical in many, but not all arrest sequences presumably due to their 
already poor reaction kinetics and restricted geometry (Johansson et al., 2011; Wilson et 
al., 2016). Third, all described stallers establish specific contacts to the wall of the ribosome 
tunnel; however, the critical regions appear to be concentrated on the upper half of the 
tunnel extending from the PTC to the uL22/uL4 constriction (Wilson et al., 2016). Finally, 
allosteric relay systems are proposed to transmit the molecular recognition events from the 
tunnel to the PTC through the nascent chain or via rRNA nucleotides comprising the tunnel 
(Wilson et al., 2016).  
 There are also variations in arrest sequences that allow versatility. First, different 
arrest sequences stall elongation or termination with the critical amino acid stretch ranging 
from as short as three amino acids (Sothiselvam et al., 2014) to as long as 99 amino acids 
(Ishii et al., 2015)(Wilson, 2016). Second, stalling during elongation can occur at a distinct 
single site, as in TnaC or ErmCL (Arenz et al., 2014; Bischoff et al., 2014; Gong and 
Yanofsky, 2002a, b), or over an entire stretch of amino acids as for SecM (Sarker and 
Oliver, 2002; Zhang et al., 2015). Third, there is no consensus and no common contact 
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pattern between the nascent chain and the ribosome tunnel with some arrest sequences 
developing secondary structure within the tunnel (Wilson et al., 2016).  
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1.6. Polyamines and uORF mediated autoregulatory circuits  
Polyamines are small organic polycations that interact with negatively charged 
molecules such as RNA and DNA through their linearly distributed positive charges. In 
addition to binding nucleic acids, the polyamine spermidine is essential for the post-
translational hypusine modification of eIF5A (Park et al., 1981) and for maintaining the 
inward rectification of potassium ion channels  (Lopatin et al., 1995). Polyamines are 
required for cell growth, survival, and proliferation (Minois et al., 2011), and their elevated 
levels in cancer cells make them a therapeutic target (Wang and Casero, 2006). 
Polyamines are synthesized in a highly regulated multistep process (Fig. 1.3). The 
first step is the production of putrescine from ornithine by ornithine decarboxylase (ODC) 
(Fig. 1.3A). ODC is regulated by the inhibitory protein ODC antizyme (OAZ), which is 
itself regulated by antizyme inhibitor (AZIN) (Ivanov et al., 2010a). Interestingly, AZIN is 
a non-functional paralog of ODC (Murakami et al., 1996). Spermidine is generated from 
putrescine by the addition of an aminopropyl group transferred from decarboxylated S-
adenosylmethionine (dcAdoMet) by spermidine synthase (Pegg, 2009). Spermine is 
generated in the same way by the addition of an aminopropyl group to spermidine by 
spermine synthase (Fig. 1.3A). The dcAdoMet is generated by S-AdoMet decarboxylase 
(AdoMetDC). Spermine and spermidine can be acetylated by spermine/spermidine 
acetyltransferases leading to catabolism and/or cellular export (Pegg, 2009).  
The ability of uORFs to act as sensors for regulatory circuits and to amplify signals 
probably explains why they are common in most polyamine biosynthetic pathway mRNAs 
(Fig. 1.3B) (Ivanov et al., 2010a). As an essential biochemical, polyamine biosynthesis is 





























































































































































Figure 1.3. Polyamines and uORF-mediated autoregulatory circuits  
(A) Cartoon representation of polyamine biosynthesis in vertebrates and (B) the 
accompanying translational regulation through uORFs. ODC, ornithine decarboxylase; 
OAZ, ornithine decarboxylase antizyme; AZIN, antizyme inhibitor; AdoMetDC, S-
adenosylmethionine decarboxylase; SpmSyn, spermine synthase. Putrescine, spermidine, 
and spermine are polyamines that promote OAZ expression by stimulating programmed 
ribosomal frameshifting. The polyamines cause elongating ribosomes to pause during 
translation of uORFs in the AZIN and AdoMetDC mRNAs to repress their expression.  
 
pathway and AdoMetDC is feedback-controlled at translation by spermidine and spermine 
by a uORF (Law et al., 2001). The uORF encodes a short peptide of the sequence 
MAGDIS; the aspartic acid residue at position 4 is essential, the isoleucine at position 5 
can only be substituted for valine, and the peptide must have an amino acid at position 6, 
so length is important (Law et al., 2001). In the model proposed by Law et al., a ribosome 
binds the AdoMetDC mRNA at the 5’cap and begins scanning. The AdoMetDC uORF has 
a high rate of leaky scanning because the uORF AUG start codon is only 14 nucleotides 
from the 5’ cap (Ruan et al., 1996). Very short leader sequences of less than 32 nucleotides 
increase the rate of leaky scanning with a 50% increase in leaky scanning seen at a distance 
of 12 nucleotides compared to 32 nucleotides (Kozak, 1991a). In the case of the 
AdoMetDC uORF, most scanning ribosomes skip over the uORF start codon without 
initiating. Occasionally, the scanning ribosomal complex recognizes the start codon of the 
uORF and initiates translation. At low polyamine levels, the ribosome translates the uORF, 
 67 
terminates, and then presumably either disengages from the mRNA or resumes scanning 
allowing subsequent ribosomes to access the AdoMetDC reading frame. In the presence of 
high polyamine levels, the ribosome translating the MAGDIS uORF fails to terminate 
properly and instead stalls at the stop codon. Ribosome stalling only 35-nts from the cap 
prevents additional ribosomes from loading onto the AdoMetDC mRNA and thus inhibits 
AdoMetDC expression (Law et al., 2001).  
AdoMetDC is just one example of translational control regulating polyamine levels 
in cells. In most species, the OAZ mRNA contains an open reading frame that is regulated 
via a programmed frame-shift (Ivanov et al., 2010a). OAZ is a negative regulator of 
polyamines that functions by binding to ODC monomers, preventing the formation of 
functional ODC homodimers (Matsufuji et al., 1990). The bound OAZ presents ODC for 
ubiquitin-independent degradation by the 26S proteasome (Li and Coffino, 1992; 
Murakami et al., 1992). In most cases, OAZ is encoded by two partially overlapping open 
reading frames, orf1 and orf2. The important biochemical properties are encoded by the 
downstream orf2 that can only be translated after initiation at the upstream orf1. A 
proportion of ribosomes that initiate translation at the orf1 start site switch to the +1 reading 
frame when the orf1 stop codon is in the A site and then proceed to decode orf2 to 
synthesize functional antizyme (Matsufuji et al., 1995). The ribosomal frameshift is 
controlled by polyamine levels in the cell; at low polyamine levels, few ribosomes change 
frame, decreasing the synthesis of the negative regulator. Elevated polyamine levels 
increase the proportion of ribosomes that switch frame and synthesize functional OAZ.  
OAZ, in turn, promotes ODC turnover leading to a reduction in polyamine levels in the 
cell.  
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In addition to translational control of AdoMetDC and antizyme, a third regulator of 
polyamine biosynthesis is regulated by a type of uORF that we classify as an upstream 
conserved coding region (uCC). AZIN positively regulates polyamine levels by negatively 
regulating OAZ. AZIN is a homolog of ODC that has a higher affinity for antizyme than 
ODC. Thus, AZIN can sequester the intracellular pool of antizyme, leading to increased 
levels of ODC, higher ODC activity, and higher polyamine levels. A uCC is a uORF-like 
element that encodes a peptide with high amino acid sequence conservation. The uCC 
typically lacks an AUG start codon and instead initiates with a near-cognate start codon or 
an AUG codon in poor sequence context. In most cases, the AZIN uCC starts at a AUU 
codon, but UUG and ACG initiation codons have also identified (Ivanov et al., 2010a).  
 Bioinformatic analysis identified uCCs in the 5’ leaders of AZIN homologs in 
animals, and ODC homologs in mushrooms, Zygomycota, and the Pezizomycota 
subphylum of Ascomycota (Ivanov et al., 2010a). A distinguishing feature of this uCC is 
that in nearly all cases, translation appears to initiate at a non-AUG codon. There is little 
amino acid sequence conservation across the uCC from different phyla, except that almost 
all AZIN uCCs encode two adjacent proline residues at or very close to the C terminus.  
The AZIN uCC represses expression of the mORF (Ivanov et al., 2008). Ivanov et 
al. generated RLuc reporters where the mouse AZIN 5’ leader was upstream of RLuc and 
transfected the reporters into cells with low polyamines, due to pre-treatment with the ODC 
inhibitor difluoromethylornithine (DFMO), or with high polyamines, supplemented with 
spermidine. Experiments using reporters with the wild-type uCC sequence showed that 
spermidine enhanced repression. Ivanov et al. saw a 6.5-fold repression of RLuc in cells 
treated with spermidine compared to polyamine-depleted cells (Ivanov et al., 2008). In the 
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mouse AZIN based reporter, the initiation codon was experimentally verified to be an 
absolutely conserved AUU codon present in good sequence context (Ivanov et al., 2008). 
Mutating the AUU initiation codon to a non-initiating UUU codon abolished polyamine-
induced repression of the mORF (Ivanov et al., 2008).  
The ability of the uCC to repress AZIN expression is dependent on the uCC C-
terminal amino acid sequence. A mutant where the last 10 codons of the uCC were out-of-
frame led to a complete loss of polyamine-dependent repression (Ivanov et al., 2008). 
Interestingly, spermidine enhanced initiation at the uCC AUU start codon (Ivanov et al., 
2008). In polyamine depleted cells, an AUU initiation codon was 18% as efficient as an 
AUG codon in directing expression of a uCC-FLuc fusion, while in polyamine 
supplemented cells the AUU initiation codon was 54% as efficient as the AUG codon 
(Ivanov et al., 2008). Taken together, the loss of polyamine regulation by the out-of-frame 
control and the enhanced uCC translation by polyamines, suggest that both the non-AUG 
initiation and the C-terminal amino acid sequence of the uCC are key regulatory 
components of the system.  
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1.7. Regulation of protein expression by upstream conserved coding motifs 
At the time this project was begun, the only described uCC was, as described above, 
in the AZIN mRNA (Fig. 1.4). In a paper describing the regulation of AZIN expression, 
Ivanov et al. (2018) proposed that uCCs have three key characteristics that make them 
regulatory: they have a weak start site; the uCCs are conserved at the amino acid level, not 
at the nucleotide level, and contain highly conserved motifs that are essential for their 
regulatory effect through ribosomal pausing; and finally, that the ribosomal pause leads to 
ribosome queuing that both blocks downstream scanning, and enhances initiation at the 
weak start site of the uCC (Ivanov et al., 2018).  
The uCC weak start site is essential because it allows ‘leaky scanning’, which is 
necessary for downstream mORF translation. During ‘leaky scanning’, scanning ribosomes 
skip potential weak start sites and instead initiate downstream at an AUG codon in good 
context. A weak start site can be a near-cognate codon that differs from AUG by a single 
nucleotide change as in the AUU codon of the AZIN uCC (Fig. 1.4) (Ivanov et al., 2010b). 
Finally, proximity of the start codon to the 5’ cap can affect initiation efficiency, which is 
the case with the AdoMetDC uORF encoding the MAGDIS peptide.  
In addition to the poor initiation site, the AZIN uCC is conserved at the amino acid 
level not at the nucleotide level and contains a very highly conserved amino acid sequence 
motif that is essential for its regulatory effect. The AZIN uCC contains a PPW motif that 
requires eIF5A for its synthesis (Fig. 1.4) (Ivanov et al., 2018). High polyamine levels 
interfere with eIF5A activity, causing an elongation defect and the translating ribosome 
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Figure 1.4. A conserved uCC regulates AZIN expression through eIF5A 
The AZIN uCC regulates AZIN expression in response to polyamine concentrations. The 
uCC initiates at a near-cognate AUU start codon that allows leaky scanning. A conserved 
PPW motif near the 3’ end of the uCC controls translation elongation in response to 
polyamine levels. Under low polyamine conditions, most ribosomes leaky scan over the 
uCC without translating and initiate translation at the AZIN start codon. Any ribosomes 
that initiate translation at the uCC start codon will efficiently translate the PPW motif with 
the assistance of eIF5A. Following termination at the uCC stop codon, these ribosomes 
disengage from the mRNA, enabling subsequent ribosomes to leaky scan the uCC and 
synthesize AZIN. Under high polyamine conditions, eIF5A activity is inhibited. Any 
ribosomes that initiate translation at the uCC start codon pause at the PPW motif. 
Subsequent scanning ribosomes, most of which leaky scan past the AUU codon at the start 
of the uCC, form a queue behind the paused elongating ribosome. When the queue reaches 
the AUU start codon of the uCC, the scanning ribosome will spend a longer time over the 
near cognate start site, providing greater opportunity for initiation at this weak start codon. 
The increased initiation at the uCC start codon will provide more elongating ribosomes to 
reinforce the elongation pause on the PPW motif, resulting in enhanced uCC translation 
and decreased translation of the AZIN open reading frame. 
 
A unique feature of uCCs is that part of the regulatory effect is via an elongation or 
termination defect that generates a ribosome queue. In their 2018 paper, Ivanov et al. show 
enhancement of initiation at the weak AZIN uCC AUU start site in the presence of 
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polyamines is dependent on ribosome queuing (Fig. 1.4) (Ivanov et al., 2018). Ribosome 
profiling using HEK293T cells grown under low polyamine conditions (treated with 
DFMO) or high polyamines (supplemented with 2 mM spermidine), showed that in the 
presence of high polyamines, elongating ribosomes pause at the PPW motif with the Trp 
codon in the A site. Reporter assays demonstrated that the initiation enhancement in the 
presence of high polyamines was dependent on the conserved motifs within the uCC. 
Queuing of scanning ribosomes has not been determined directly, but queuing has been 
deduced experimentally. Ivanov et al. reduced queuing potential using the drug 
eIF4E/eIF4G interaction inhibitor 1 (4EGI-1). The drug impairs ribosome loading on 
mRNAs by disrupting the association of eIF4G with eIF4E (Sekiyama et al., 2015). 
HEK293T cells were transfected with reporters containing the AUU initiated AZIN uCC 
or an out-of-frame control uCC upstream of Renilla luciferase (RLuc). The cells were 
supplemented with spermidine and the effect of reducing ribosome loading was observed 
by normalizing to the out-of-frame control. Reducing queuing potential with 4EGI-1 de-
repressed RLuc expression (Ivanov et al., 2018). The observation that impairing ribosome 
loading leads to reduced uCC translation and derepression of AZIN synthesis is consistent 
with a model in which the elongation pause leads to a queue of subsequent scanning and 
translating ribosomes. The ribosome queue could increase the time that a scanning 
ribosome spends in the vicinity of the weak start site, increasing the probability of initiation 
on the uCC.  
In the uCC model, under permissive conditions leaky scanning allows the majority 
of ribosomes to scan past the weak uCC start site and initiate translation downstream at the 
mORF start site. Thus, the mORF is translated under ‘standard’ conditions. Occasionally a 
 74 
scanning ribosome will initiate at the weak start site of the uCC, the frequency of initiation 
will depend, in part, on the strength of the start codon and context nucleotides. Ribosomes 
that translate the uCC will likely disengage from the mRNA after termination due to the 
length of the uCC coding region. When the concentration of polyamines is elevated, the 
occasional ribosome that initiates translation of the uCC will pause on the PPW motif 
because high polyamines interfere with eIF5A function. Biochemical studies showed that 
polyamines competitively inhibit eIF5A function on the ribosome. The paused ribosome 
in the uCC prompts queuing of subsequent translating and scanning ribosomes (many of 
which scan past the uCC start codon without initiating). When the queue builds to a 
sufficient length, a scanning 40S subunit will be poised in the vicinity of the uCC start 
codon and will thus spend more time traversing over the start codon, increasing the chances 
for initiation at the weak start site of the uCC. In this way, the elongation pause generates 
a feedback loop which increases translation of the uCC to reinforce the pause, leading to 
decreased translation of the mORF (Fig. 1.4).  
We believe that the AZIN uCC is just one example of a uCC that regulates a 
biosynthetic pathway. Current research indicates that the AAP in the N. crassa arg-2 and 
S. cerevisiae CPA1 mRNAs also has the characteristics of a uCC rather than a uORF. 
Moreover, in reviewing the literature we found that a uORF present in the plant GDP-L-
galactose phosphorylase (GGP) mRNA, encoding an enzyme in the ascorbic acid 
biosynthesis pathway, has similarities to a uCC. As first described by Laing et al., the uORF 




1.8. Plant L-ascorbic acid biosynthesis and GDP-L-galactose phosphorylase  
L-ascorbic acid, or vitamin C, is an essential biochemical in plants and animals, 
and a similar compound, D-erythroascorbic acid, is found in yeast (Hancock et al., 2000). 
In plants and animals, ascorbate is an important electron donor, acting as an antioxidant 
and an enzymatic co-factor for fifteen mammalian enzymes (Padayatty and Levine, 2016). 
ascorbate is a co-factor for two monooxygenases, 12 dioxygenases, and one amine oxidase. 
These enzymes are essential for the synthesis of collagen, carnitine, and neurotransmitters 
among other functions (Naidu, 2003).  
Most plants and animals synthesize ascorbate from D-glucose or D-galactose; 
however, a small number of animal species have lost the ability to synthesize ascorbate. 
These species include guinea pigs, fruit eating bats, and apes, including humans, because 
of the absence of L-gulonolactone oxidase (Burns, 1957; Nishikimi and Yagi, 1991). L-
gulonolactone oxidase is the last enzyme in the animal ascorbate biosynthetic pathway and 
catalyzes the reaction of L-gulono-1,4-lactone with oxygen to generate L-xylo-hex-3-
gulonolactone and hydrogen peroxide (Linster and Van Schaftingen, 2007) (Fig. 1.5). L-
xylo-hex-3-gulonolactone then spontaneously converts to ascorbate. Animals that cannot 
produce their own ascorbate, must acquire ascorbate through their diet. Ascorbate is widely 
available in fresh fruits and vegetables, in particular in fruits such as oranges, lemons, 
watermelon, strawberries, and in vegetables such as broccoli and cabbage. Ascorbate is 
also the mostly widely used vitamin supplement throughout the world (Naidu, 2003).  
A severe ascorbate deficiency produces the fatal disease scurvy, which can only be 
cured by ascorbate. Scurvy was a severe problem for large armies, Northern European 
cities, and sea voyages. Victims typically died after two to three months of a diet lacking 
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ascorbate. In 1753, James Lind showed that scurvy could be cured by citrus fruits in the 
first controlled clinical trial (Lind, 1953; Padayatty and Levine, 2016). Ascorbic acid was 
isolated by Albert Szent-Gyorgyi in 1928 and shown to be the antiscorbutic factor by 
Szent-Gyorgyi and King in 1932 (King and Waugh, 1932; Svirbely and Szent-Gyorgyi, 
1932, 1933), for which Szent-Gyorgyi was awarded the 1937 Nobel Prize in Physiology or 
Medicine.  
In humans, ascorbate is absorbed through the small intestine and transported via 
SVCT1, while the oxidized form of ascorbic acid, dehydroascorbic acid (DHAA), is likely 
transported via GLUT2 and then reduced to ascorbic acid within the cell (Padayatty and 
Levine, 2016). Ascorbate is water soluble and accumulates against a concentration gradient 
to millimolar concentrations gradient in tissues. The majority of ascorbate is found in the 
liver, brain, and skeletal muscle of humans. In the human liver, ascorbate is present in the 
600-900 µM range but specialized cells like lymphocytes have ascorbic acid concentrations 
exceeding 3.8 mM (Padayatty and Levine, 2016).  
 Ascorbate is found in all the cell compartments of higher plants and the average 
ascorbate concentration is 2-25 mM, with concentrations being highest in chloroplasts 
(Zhang, 2013). In plant photosynthetic tissues, ascorbate concentrations are regulated 
according to demand. Leaf ascorbate concentrations increase under high light intensity 
when photosynthesis drives the production of reactive oxygen species (Bartoli et al., 2006; 
Dowdle et al., 2007; Gao et al., 2011; Yabuta et al., 2007). The response to light is driven 
by changes in gene expression for several L-galactose pathway genes. Ascorbate 
concentrations are tightly regulated in green tissues such as leaves because of the 
maintenance of the redox state; however, fruits can act as skin organs and accumulate 
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ascorbate at much higher levels (Cruz-Rus et al., 2012). In non-photosynthetic tissues such 
as fruit, ascorbate concentrations are relatively stable but can vary between cultivars due 
to changes in gene expression (Bulley et al., 2009). Studies of ascorbate concentrations in 
fruits over time indicate that ascorbate is synthesized in the green tissues and is then 
transported to, and stored in, the fruits (Rasanu, 2005). In the strawberry plant, the roots 
have the lowest ascorbate concentrations (1 µmol/ (gram formula weight gFW)), followed 
by stems (3.5 µmol/gFW), leaf (5.5 µmol/gFW), flower (6 µmol/gFW), and fruit (10 
µmol/gFW) (Cruz-Rus et al., 2011). The acerola fruit accumulates ascorbate in 
concentrations as high as 1400 mg/100 g fresh fruit. In strawberries, ascorbate 
concentrations increased from 20 mg/100 g fresh fruit in green fruits to 300 mg/100 g fresh 
ripe fruit (Cruz-Rus et al., 2011).  
In animals only one pathway for ascorbate biosynthesis has been described (Fig. 
1.5); however, several alternative pathways for ascorbate biosynthesis and metabolism 
have been discovered in plants (Wheeler et al., 1998; Zhang, 2013). The Smirnoff or D-
mannitol/L-galactose pathway was proposed in 1998 (Wheeler et al., 1998), and appears 
to be the predominant pathway used by plants (Zhang, 2013) (Fig. 1.5). The other pathways 
include galacturonate pathway (Agius et al., 2003), the myoinositol pathway (Lorence et 
al., 2004), and a pathway utilizing gulose is also proposed to function in plants although it 
has not been experimentally validated (Wolucka and Van Montagu, 2003; Zhang, 2013) 
(Fig. 1.5). The myoinositol pathway and proposed gulose pathway indicate that parts of the 
animal pathway could also operate in plants, as the pathways all converge on L-gulono-































































































































































































































































































































Figure 1.5. The L-ascorbate biosynthetic pathways in plants and animals 
The ascorbic acid biosynthetic pathways in plants and animals converge on L-ascorbic acid 
through L-guolono-1,4-lactone (animals and possibly plants) and L-galactono-1,4-lactone 
(plants). The animal pathway is shown in purple with the enzyme L-gulonolactone oxidase 
highlighted in orange. The proposed plant myoinositol pathway is shown in blue. The 
predominant plant biosynthetic pathway, the Smirnoff pathway, is shown in green and the 
secondary plant galacturonate pathway is shown in pink. The plant enzymes GME and 
GGP are shown in orange. 
 
pathway and galacturonate pathway converge on L-galactono-1,4-lactone, which is not 
present in animals. 
In the D-mannitol/L-galactose pathway, ascorbate is synthesized from the precursor 
of D-glucose over more than ten enzymatic reaction steps (Zhang, 2013). The first six steps 
are responsible for the biosynthesis of the nucleotide sugar GDP-D-mannose, which is a 
precursor for cell wall polysaccharides and glycoproteins as well as the substrate for 
ascorbate biosynthesis. The last four enzymatic steps after synthesis of GDP-L-galactose 
are unique to ascorbate biosynthesis. GDP-L-galactose phosphorylase (GGP) is the first 
enzyme in this latter half of the pathway; and converting GDP-L-galactose to L-galactose 
1-P is the first committed step in the D-mannitol/L-galactose ascorbate biosynthetic 
pathway.  
 The enzyme GGP, encoded by the gene GGP or VTC2, is the control point of 
ascorbate biosynthesis in plants, and overexpression of the kiwifruit GGP gene resulted in 
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a four-fold increase in ascorbate accumulation (Bulley et al., 2009; Dowdle et al., 2007; 
Zhang, 2013). No other single gene in the L-galactose pathways has a significant effect on 
ascorbate levels (Bulley et al., 2012), but simultaneously increasing the expression of GDP 
mannose epimerase (GME) and GGP in Arabidopsis leads to a synergistic seven-fold 
increase in ascorbate (Bulley et al., 2009; Zhang, 2013). During fruit development, GGP 
and GME transcript levels parallel ascorbate concentration (Bulley et al., 2009). Consistent 
with the rate controlling effects of GGP, GGP transcript levels show a strong circadian 
rhythm in leaves, with peak expression before dawn, likely in preparation for 
photosynthesis (Dowdle et al., 2007).  
 GGP (VCT2) is of great interest to plant biologists because of its role in directly 
influencing ascorbate concentration in plant tissues. GGP was hypothesized to possibly 
control gene transcription because a GGP-YFP fusion protein was detected in the nucleus 
as well as the cytosol (Muller-Moule, 2008). In 2015, Laing et al. published that ascorbate, 
or a metabolite closely connected to ascorbate, downregulated the translation of the GGP 
mRNA (Laing et al., 2015). High concentrations of ascorbate reduced GGP expression via 
a feedback loop, reducing ascorbate concentrations (Fig. 1.6). The regulation of GGP 
expression occurred at the translational level and was mediated by a conserved 
noncanonical uORF in the 5’UTR of the GGP mRNA. Alignment of uORFs from diverse 
plant species showed that the amino acid sequence was more highly conserved than the 
nucleotide sequence. Consistent with this observation, synonymous mutations of codons 
within the uORF did not affect regulation of the downstream mORF (Laing et al., 2015).  
For the synonymous mutation study, Laing et al. synthesized a GGP uORF fragment from 
















Figure 1.3. The L-AA biosynthetic enzyme GGP is negatively regulated by L-AA 
via a proposed uCC
Figure 1.6. The L-ascorbic acid biosynthetic enzyme GGP is negatively 




Figure 1.6. The L-ascorbic acid biosynthetic enzyme GGP is negatively regulated by 
L-ascorbic acid via a proposed uCC 
In plants, the GGP enzyme is the control point in the ascorbate biosynthetic pathway. GGP 
expression is negatively regulated by ascorbate (L-AA) through a conserved non-canonical 
uORF that we propose is a uCC.  
 
codon. This altered 38% of the uORF nucleotides. The synthesized fragment was cloned 
into a GGP-LUC reporter and then transiently transfected into Nicotiana benthamiana; 
luciferase activity was measured after 7 days. To generate high ascorbate conditions, the 
leaf was transfected with a plasmid containing GGP under the control of the strong 35S 
promoter; to lower ascorbate concentrations, the native GGP mRNA was targeted by 
RNAi. Laing et al. also reported that analysis of previously published ribosome profiling 
studies by Liu et al. (2013) and Juntawong et al. (2014) showed evidence of a higher than 
average ribosome density on the uORF and stalling during translation of the uORF 
(Juntawong et al., 2014; Laing et al., 2015; Liu et al., 2013). Two possible mechanisms 
were proposed for how the GGP uORF regulates GGP mORF translation: first, ascorbate 
was proposed to interact directly with the uORF peptide causing the ribosome to stall and 
thus impairing ribosome scanning to the downstream mORF AUG start site (Laing et al., 
2015); second, ascorbate was proposed to directly enhance noncanonical initiation at the 
near cognate start codon of the GGP uORF, and then the uORF-encoded peptide was 
proposed to cause the ribosome to stall constitutively (Laing et al., 2015). The authors 
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preferred the later model where ascorbate directly promotes initiation at the ACG start 
codon of the uORF and then the uORF peptide causes ribosome stalling.  
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1.9. Is the GGP motif a uCC that regulates ascorbate biosynthesis? 
 We hypothesize that the noncanonical uORF discovered by Laing et al. (2015) is 
actually a uCC. Based on the Laing et al. data, the GGP uCC exhibits the three hallmark 
features of a uCC. First, the uORF sequences published by Laing et al. (2015) show 
conservation of a near-cognate ACG codon, located upstream of the conserved region of 
the uORF, that could serve as a translation start site for the uORF. Recall that the AZIN 
uCC utilizes an AUU start site that allows leaky scanning through the uCC and translation 
of the downstream mORF; perhaps the ACG codon in the GGP uORF is functioning in a 
similar manner. Second, there is absolute conservation of amino acid sequence motifs 
within the uORF-encoded peptide, but the nucleotide sequence varies. In particular, 
nucleotide substitutions at the third position of codons, the wobble nucleotide, indicate that 
the uORF peptide sequence is conserved, but not the mRNA sequence. This conservation 
is consistent with the conservation of the PPW motif in the AZIN uCC. Finally, Laing et 
al. (2015) showed evidence of high ribosome density in the GGP uORF, consistent with 
translation of the uORF. Moreover, a prominent ribosome footprint was noted towards the 
3’ end of the uORF, indicating the presence of a translation stall site. Similarly, Ivanov et 
al. showed that ribosomes accumulate on the PPW and PS-stop motifs on the AZIN uCC 
in the presence of higher polyamine concentrations (Ivanov et al., 2018). In the case of the 
AZIN uCC, the ribosome pausing leads to queuing of subsequent scanning ribosomes and 
enhanced initiaton at the weak upstream start site of the uCC. We propose that a similar 
mechanism might control translation of the GGP uORF in response to ascorbate levels.  
 The goal of my project was to test our hypothesis that the GGP noncanonical uORF 
is in fact a uCC that regulates GGP expression in response to ascorbate. In support of our 
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hypothesis, I show that translation of the GGP mRNA is regulated by ascorbate in a uORF-
dependent manner and that the conserved motifs in the uORF are essential for regulation. 
I also provide evidence that the spacing between the conserved motifs in the uORF is 
critical for ascorbate regulation of GGP mRNA translation. Finally, by manipulating 
ribosome loading on the mRNA, I provide evidence that ribosome queuing is necessary for 















































2.1. Plasmid constructs 
2.1.1. Molecular techniques for cloning the reporters 
Unless otherwise specified, polymerase chain reactions (PCRs) were performed 
using Invitrogen Platinum SuperFi DNA Polymerase (ThermoFisher Scientific). For a 25 
µl reaction: 5 µl of SuperFi 5X buffer, 0.5 µl 10 mM dNTP mix, 1.25 µl forward primer, 
1.25 µl reverse primer, 1 µl template DNA diluted 1:500 in water, 0.25 µl Platinum SuperFi 
DNA Polymerase, and water to 25 µl. A 3-step thermocycler protocol was used: initial 
denaturation at 98°C for 30 s, 30 cycles of denaturing at 98°C for 5 s, annealing at a varying 
temperature for 10 s, extension at 72°C for varying time, and finally a final extension at 
72°C for 5 minutes and a hold at 4°C. The annealing temperature was determined for each 
primer pair using the Tm calculator at www.thermofisher.com/tmcalculator and the 
extension time was calculated based on product size using 15s/kb.  
For plasmid and PCR digests, 1 µg of plasmid, or the full PCR reaction, was 
digested in 50 µl according to New England Biolabs’ (NEB) recommendations: 5 µl of the 
appropriate buffer, 1 µg of plasmid or the PCR reaction, 2 µl of each restriction enzyme, 
and water to 50 µl. The reaction was incubated at 37°C for 30 minutes to overnight. 
Plasmids were gel purified using the Qiagen QiaexII Gel Extraction Kit. PCR product 
digestions were heat-inactivated at the appropriate temperature or were column purified 
with the Roche High Pure PCR Purification Kit if the enzymes could not be heat-
inactivated. For plasmid digests with only one restriction enzyme, 1 µl of Shrimp Alkaline 
Phosphatase (rSAP) (NEB) was added during the digestion.  
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For gel purifications using the QiaexII Gel Extraction Kit, the plasmid was run on 
an 1-2% agarose gel and the band of interest was cut out of the gel and placed in a 1.5 ml 
microcentrifuge tube. Depending on the size of the DNA fragment, QX1 buffer and water 
were added. For fragments under 4 kb 750 µl of QX1 was added, for fragments over 4 kb 
an additional 500 µl of water was also added. QIAEXII was resuspended by vortexing and 
10 or 30 µl was added to the DNA. The solution was incubated at 50°C for 10 minutes with 
shaking. The sample was sedimented by centrifugation at 17,900xg for 30 s and the 
supernatant removed. The pellet was washed with 500 µl of QX1 and the pellet was 
resuspended by mixing on a vortex. The sample was sedimented again as above. After 
removing the supernatant, the pellet was washed by resuspending in 500 µl Buffer PE 
twice. The pellet was air-dried for 15 minutes and resuspended in water or tris-EDTA (TE) 
buffer. The resuspended pellet was centrifuged and the supernatant containing the purified 
DNA was transferred to a clean tube.  
For Roche High Pure PCR Purification, the PCR reaction volume was adjusted to 
100 µl with water, then 500 µl of Binding Buffer was added. The solution was transferred 
to a column and centrifuged at max for 1 minute. The flow through was discarded and 500 
µl of Wash buffer was added, and the column was centrifuged again. The flow through was 
discarded and 200 µl of Wash buffer was added, and the column was centrifuged again. 
The column was transferred to a clean tube and 50 µl of Elution Buffer was added to the 
column. The column was centrifuged at max for 1 minute to elute the DNA.  
Site-directed mutagenesis was done using the QuikChange II XL Site-Directed 
Mutagenesis kit from Agilent. For a 50 µl reaction: 5 µl of 10x reaction buffer, 1 µl of 
plasmid template, 1.25 µl of primer 1, 1.25 µl of primer 2, 1 µl of dNTP mix, 3 µl of 
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QuikSolution, and water to 50 µl. Then 1 µl of PfuUltra HF DNA polymerase was added. 
The following thermocycler parameters were used: initial denaturation at 95°C for 1 min, 
16 cycles of denaturation at 95°C for 50 s, annealing at 60°C for 50 s, and extension at 
68°C for 1 minute per kb of plasmid size. After cycling, the reaction was placed on ice for 
2 minutes and then treated with 1 µl of DpnI and digested at 37°C for 1 hour. The DNA 
was used to transform XL10-Gold Supercompetent cells by thawing the cells on ice. For 
each transformation, 45 µl of cells were transferred to a prechilled 14 ml Falcon tube and 
2 µl of b-ME was added. The cells were incubated on ice for 10 minutes with swirling and 
then 2 µl of the DpnI treated DNA was added. The reactions were incubated on ice for 30 
minutes and then heat shocked in a 42°C water bath for 30 s. The cells were incubated on 
ice for 2 minutes and then 0.5 ml of SOC outgrowth medium (NEB) was added to each 
tube and the tubes were incubated at 37°C with shaking at 250 rpm for 1 hour. The 
transformants were plated on Luria Broth Agar-Ampicillin (100 mg/ml) (LB-Amp) plates 
using 250 µl on each of two plates and incubated overnight at 37°C.  
For NEBuilder HiFi Assembly reactions, PCR products or synthesized inserts were 
designed according to NEB’s recommendations. The inserts were designed to have a 20-
40-nt overlap with either the second insert or the vector with a Tm equal to or greater than 
48°C. PCR products generated from plasmids were digested with DpnI by adding 1 µl of 
10X CutSmart Buffer (NEB), 1 µl of DpnI (NEB), and 8 µl of PCR reaction and then 
incubating at 37°C for 30 minutes. The DpnI was heat-inactivated by incubating at 80°C 
for 20 minutes. PCR products generated from synthesized DNA were not treated with 
DpnI. To quantify the amount of DNA in each sample, 1µl of insert and 1 µl of prepared 
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vector was run on an agarose gel. The band intensity and relative size of each fragment 
were used to determine the volume of each to add to the assembly reaction to achieve the 
recommended ratio for the assembly reaction, for 2-3 fragment assembly a vector: insert 
ratio of 1:2, or for 4-6 fragment assembly a vector to insert ratio of 1:1. In the reactions, 
0.5 µl of vector was used for a 10 µl reaction volume and 5 µl of NEBuilder HiFi DNA 
Assembly Master Mix was added to the DNA. The volume was adjusted to 10 µl with 
water and the reaction was incubated at 50°C for 15 minutes for a 2-3 fragment assembly 
or 60 minutes for a 4-6 fragment assembly. After incubation the samples were placed on 
ice for transformation. To transform NEB 5-alpha competent E. coli (C2987I/H), the 
chemically competent cells were thawed on ice and then 2 µl of the chilled assembly 
product was added to the cells and mixed in by gentle flicking. The mixture was placed in 
ice for 30 minutes then heated shocked at 42°C for 30 s. The tube was transferred back 
onto ice for 2 minutes. Then 950 µl of SOC media was added to the tube and the tube was 
incubated at 37°C for 1 hour with shaking at 250 rpm. The LB-Amp (100 mg/ml) plates 
were warmed to 37°C and 100 µl of the cells was plated, and the plates were incubated 
overnight at 37°C or for 2-3 days at room temperature (RT).  
The NEB Quick Ligation Kit was used for ligation if HiFi Assembly was not used. 
The relative amounts of DNA were determined as above, and a molar ratio of 1:3 vector to 
insert was used. For a 20 µl reaction, 1 µl of vector was used, and the insert was scaled 
accordingly. For a 20 µl reaction, 10 µl of Quick Ligase Reaction Buffer was added to the 
DNA fragments and water was added to 20 µl, then 1 µl of Quick Ligase was added. The 
reaction was mixed and incubated at RT for 5 minutes. The reaction was then placed on 
ice before 2 µl was used to transform 50 µl of competent cells as above for HiFi Assembly.  
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Plasmids used for sequencing or as templates for PCR were prepared using the 
Zyppy Plasmid Miniprep Kit (Zymo). A 3 ml E. coli culture was grown overnight in LB-
Amp (100 mg/ml). After growing overnight, the culture was transferred to a 1.5 ml tube 
and centrifuged for 1 minute to pellet the cells. The supernatant was removed, and the pellet 
was resuspended in 500 µl of water. After resuspending the cell pellet, 100 µl of 7X Lysis 
Buffer was added and the cells were mixed by inverting 4-6 times until the solution was 
blue. Then 350 µl of cold Neutralization Buffer was added, and the solution was mixed 
until it was white. The tube was centrifuged at 11,000-16,000 xg for 2 minutes. The clear 
supernatant was transferred into the Zymo-Spin IIN column and centrifuged at max for 15 
s. The flow through was discarded and 200 µl of Endo-Wash Buffer was added to the 
column. The column was centrifuged at max for 15 s and 400 µl of Zyppy Wash Buffer 
was added to the column. The column was centrifuged for 30 s and then transferred to a 
clean 1.5 ml tube. After transferring to a clean tube, 30 µl of Zyppy Elution Buffer was 
added to the column, or 30 µl of water was added if the plasmid would be used for 
sequencing. The column was incubated for 1 minute at RT and then centrifuged at max for 
15 s to elute the DNA. The plasmid concentration was determined using a NanoDrop ND-
1000 Spectrophotometer.  
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2.1.2. Table 2.1. Primers used in the study 
ID  Name Sequence 













P5 NheIStopACGuCC_F 5’-GGCTAGCTAGGTGATCGGAATCACGGCTATACACGGGATATCACG-3’ 








P9 FSuCC_R2 5’-CTAAAAACCTAAAGGAAAAGAAG-3’ 
P10 FSuCC_F2 5’-ACTTCTTTTCCTTTAGGTTTTTAGGAGTTAGGGTTTGTTAGTG-3’ 
P11 phRL_hifi_AvaI_R 5’-GTGATCATGCGTTTGCGTTGCTCGGGGTCGTACACCTTGG-3’ 
P12 Trip12AAAAAA_F 5’-AGGCTAGCTAGTTAAAAAAACCGAGTAAAACTGGTGGCTC-3’ 
P13 modAAAAAAuCC_R 5’-GCTTTTTTTCCGGTCGACCTGCGTTTCTTGGTGGACTTTC-3’ 
P14 Trip12ATCACG_F 5’-AGGCTAGCTAGTTAATCACGCCGAGTAAAACTGGTGGCTC-3’ 
P15 modATCACGuCC_R 5’-GCCGTGATTCCGGTCGACCTGCGTTTCTTGGTGGACTTTC-3’ 
P16 modAAAAAAuCC_F 5’- CAGGTCGACCGGAAAAAAAGCTATACACGGGATATCACGG-3’ 
P17 modATCACGuCC_F 5’- CAGGTCGACCGGAATCACGGCTATACACGGGATATCACGG-3’ 











P21 uCCSubs_R 5'-CCTAAAGGAAAAGAAGTTAAAGCTGG-3' 
P22 uCC5UTR_F 5'-CCAGCTTTAACTTCTTTTCCTTTAGG-3' 
P23 phRL_Hifi_NheI_F 5'-CTTAATACGACTCACTATAGGCTAGCTAGGTGATCGGAAT-3' 
P24 uCC_ACG_ATG_F 5’- GAACAGGTGATCGGAATCATGGCTATACACGGGATATC-3’ 
P25 uCC_ACG_ATG_R 5’- GATATCCCGTGTATAGCCATGATTCCGATCACCTGTTC-3’ 
P26 uCCint_ATG_AAG_F 5’- GGGTGTTAGCTCACAAGTCCATATTGTCCGACAG-3’ 
P27 uCCint_ATG_AAG_R 5’- CTGTCGGACAATATGGACTTGTGAGCTAACACCC-3’ 
P28 Frag1_F 5’- CGAGCTCGGTACCTAATACG-3’ 












P32 FSDel_R 5’-CCACGTCCTCCTGCGGCAAAG-3’ 
P33 FS_Del_F 5’-CTTTGCCGCAGGAGGACGTGG-3’ 
P34 FSInsertion_R 5’-CCTTTCTTTATGTTTTTGGCGTCTTCGTCGACAAAACCTAAAGG-3’ 
P35 CPA1AmpF 5’- CGACTCACTATAGCAAGAAG-3’ 
P36 CPA1_D13N_R 5’- GATATGTAGTTTTGGCAGGTG-3’ 
P37 CPA1_D13N_F 5’- CACCTGCCAAAACTACATATC-3’ 
P38 uCCAmpR 5’- CCTTTCTTTATGTTTTTGGCGTCTTC-3’ 
P39 uCC_ATC_TTC_ACG_TCG_F 5'-GGGAACAGGTGATCGGATTCTCGGCTATACACGGGATATC-3' 
P40 uCC_ATC_TTC_ACG_TCG_R 5'-GATATCCCGTGTATAGCCGAGAATCCGATCACCTGTTCCC-3' 
P41 FSuCC_R2 5’-CTAAAAACCTAAAGGAAAAGAAG-3’ 










P45 FSuCC_R3 5’- CTAAAAACCTAAAGGAAAAGAAG-3’ 
P46 FSuCC_F3 5’- ACTTCTTTTCCTTTAGGTTTTTAGGAGTTAGGGTTTGTTAGTG-3’ 
P47 phRL_hifi_AvaI_R 5’- GTGATCATGCGTTTGCGTTGCTCGGGGTCGTACACCTTGG-3’ 
P48 Trip12AAAAAA_F 5’-AGGCTAGCTAGTTAAAAAAACCGAGTAAAACTGGTGGCTC-3’ 
P49 modAAAAAAuCC_R 5’-GCTTTTTTTCCGGTCGACCTGCGTTTCTTGGTGGACTTTC-3’ 
P50 gp48_F 5'-CCCCGCTAGCCGCCGTAATAC-3' 
P51 gp48_R 5'-ATGCGGATCCGAAGTCCAAATTTTAAG-3' 
P52 uCCStall_R 5'-ATGCGGATCCGAAGTCCAAATTC-3' 
P53 EcoRI_uCC_F  5'-GACTCGAATTCCGCCGTAATACGACTCAC-3' 
















P58 occ1096 5'-GCTATTCCAGAAGTAGTGAGGAGGC-3' 
P59 occ1098 5'-GTTGACGCAAATGGGCGGTAGGCGTGT-3' 
P60 uCCseq_F 5'-GATCGGTGCGGGCCTCTTCGC-3' 
P61 uCCseq_R 5'-GTTCACCTCGATATGTGCATCTG-3' 
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P62 SLseq_F 5'-CCAGTTCCGCCCATTCTCCG-3' 












2.1.3. The synthesized G-blocks 
The Arabidopsis thaliana GGP uCC contains an out-of-frame internal uORF that 
is not conserved in ancient plants (Fig. 2.1A). The internal uORF was disrupted changing 
the ATG start codon to AAG, creating an H13Q amino acid substitution in the uCC 
sequence (Fig. 2.1B).  
G-block 1: GGP uCC wild-type sequence with GGP uCC 5’leader for insertion into 
pUC19. KpnI, NheI, and SalI restriction sites are indicated in red. The T7 promoter is 
highlighted in yellow, the GGP uCC is underlined, the internal uORF start site is shown in 








G-block 2: GGP uCC wild-type sequence with GGP uCC 5’leader, the uCC, and the 
region between the uCC stop codon and the GGP start site for the uORF reporter in pUC19. 
KpnI, NheI, and SalI restriction sites are indicated in red. The T7 promoter is highlighted 
in yellow, the GGP uCC is underlined, the internal uORF start site is shown in cyan, and 











G-block 3: GGP uCC with an AUG start and alanine substitutions G52A, G53A, G54A 
(GGG/3A). KpnI, NheI, and the SalI restriction sites are indicated in red, the T7 promoter 
is highlighted in yellow, the uCC is underlined, and modifications to the uCC are shown in 








G-block 4: GGP uCC with an AUG start and alanine substitutions P44A, S45A, D46A 
(PSD/3A). KpnI, NheI, and SalI are indicated in red, the T7 promoter is highlighted in 
yellow, the uCC is underlined, and modifications to the uCC are shown in fuchsia. FLuc is 

































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.1. Sequence information for the A. thaliana GGP uCC 
The A. thaliana GGP uCC was used to generate the reporters used in this study. (A) The 
uCC contains an internal out-of-frame uORF that is not highly conserved shown in orange. 
(B) The internal out-of-frame uORF was disrupted by a nucleotide substitution in the 
underlined His codon of the uCC, generating an H13Q substitution. (C) The control out-
of-frame uCC (referred to as OF) was generated by removing one nucleotide from the CAC 
codon at H31 (underlined) generating a frameshift. The reading frame was restored by 
inserting a T (purple) immediately upstream of the stop codon. The start codons are shown 
in green (either AUG or ACG depending on the reporter), changes to the sequence are 
shown in purple, and the stop codon is shown in red. 
 
G-block 5: GGP uCC with an AUG start and alanine substitutions G41A, G42A (GG/2A). 
KpnI, NheI, and SalI are indicated in red, the T7 promoter is highlighted in yellow, the 









G-block 6: GGP uCC with an AUG start and alanine substitutions P38A, S39A (PS/2A). 
KpnI, NheI, and SalI are indicated in red, the T7 promoter is highlighted in yellow, the 
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G-block 7: GGP uCC with an AUG start and alanine substitutions G32A, G33A, R34A, 
G35A (GGRG/4A). KpnI, NheI, and SalI are indicated in red, the T7 promoter is 
highlighted in yellow, the uCC is underlined, and modifications to the uCC are shown in 








G-block 8: GGP uCC with an AUG start and alanine substitution R34A. KpnI, NheI, and 
SalI are indicated in red, the T7 promoter is highlighted in yellow, the uCC is underlined, 









G-block 9: GGP uCC with an AUG start and alanine substitutions P38A, S39A, E40A, 
G41A, G42A, S43A, P44A, S45A, D46A (9A). KpnI, NheI, and SalI are indicated in red, 
the T7 promoter is highlighted in yellow, the uCC is underlined, and modifications to the 








 G-block 11: GGP uCC with S11A substitution highlighted in cyan for insertion into p2luc. 







G-block 12: GGP uCC with an ACG start and an alanine insertion three codons upstream 
of the GGRG motif (1A@P28) for insertion into p2luc. The alanine codon insertion is 
shown in cyan. HindIII and BamHI are indicated in red, the uCC is underlined, and FLuc 






G-block 13: GGP uCC with an ACG start and three alanine codons inserted three codons 
upstream of the GGRG motif (3A@P28) for insertion into p2luc. The alanine codon 
insertions are shown in cyan. HindIII and BamHI are indicated in red, the uCC is 





G-block 14: GGP uCC with an ACG start and alanine insertion between P and D 
(1A@p44) for insertion into p2luc. The alanine insertion is shown in cyan. HindIII and 





G-block 15: GGP uCC with an ACG start and three alanine codons inserted between P 
and D (3A@p44) for insertion into p2luc. The alanine codon insertions are shown in cyan. 







G-block 16: GGP uCC tagged with FLAG. The T7 promoter is highlighted in yellow, 
FLAG is highlighted in green, a linker region added to increase the protein molecular 
weight is highlighted in cyan.  The uCC is underlined, and modifications to the uCC are 












G-block 17: Out-of-frame (OF) GGP uCC tagged with FLAG. The T7 promoter is 
highlighted in yellow, FLAG is highlighted in green, a linker region added to increase the 
protein molecular weight is highlighted in cyan. The uCC is underlined, and modifications 
to the uCC are shown in fuchsia. One nucleotide was removed from the CAC codon to 
change the codon to CAG and shift the frame of the conserved region. One codon was 














G-block 18: hCMV uORF2 UL4/gp48 stall control tagged with FLAG. The T7 promoter 
is highlighted in yellow, FLAG is highlighted in green, a linker region added to increase 
the protein molecular weight is highlighted in cyan. UL4 is underlined. NheI and BamHI 











2.1.4. Generation of the uCC-FLuc fusion in vitro translation reporters (Table 2.2) 
To generate plasmid pC5568 for in vitro transcription (Fig. 2.2A), a gene fragment 
was synthesized and cloned into the plasmid pCR2.1 vector backbone, G-block #1 
(Eurofins Genomics) (Fig. 2.1B). G-block #1 was sub-cloned into the pUC19 backbone 
vector between KpnI and HindIII using a rapid ligation, as described above, and correct 











































































































































































































Figure 2.2. Templates used for in vitro transcription of mRNAs used in RRL assays 
Plasmid or synthesized dsDNA G-block fragments were used as templates for in vitro 
transcription of mRNAs used in the in vitro translation assays. GGP uCC specific 
sequences are indicated in blue and all templates include a T7 promoter for transcription. 
(A) To test the GGP uCC response to ascorbate, the uCC was fused in-frame to the FLuc 
coding region followed by 22 nts and a template encoded poly(A) tail. (B) For the peptidyl-
tRNA release assay templates, FLAG was fused upstream of a 390-bp linker fragment 
encoding residues 21-81 from the human chorionic gonadotropin beta subunit and fused to 
the GGP uCC. (C) The reporter FLAG-linker-uCC fusion was fused in-frame to FLuc. (D) 
The same FLAG-linker element was fused in frame to the sequence of uORF2 from the 
hCMV UL4/gp48 mRNA, which is known to cause stalling at translation termination. 
 
M13R(-40). The resulting plasmid was named pC5560. To generate a uCC AUG start site 
(ATG), site-directed mutagenesis, as described above, was performed on plasmid pC5560 
using primers uCC_ACG_ATG_F and uCC_ACG_ATG_R. Mutagenesis was confirmed 
by sequencing using M13 universal primers M13F(-40) and M13R(-40) and the plasmid 
was named pC5563. Because A. thaliana contains an internal out-of-frame non-conserved 
uORF (Fig. 2.1A), site-directed mutagenesis was used to change the internal start site from 
ATG to AAG using primers uCCint_ATG_AAG_F and uCCint_ATG_AAG_R. 
Mutagenesis was confirmed by sequencing using M13 universal primers M13F(-40) and 
M13R(-40).  
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The resulting plasmid was used as a template for PCR amplification of the uCC. 
The insert was generated with homology to pUC19 and a KpnI site upstream of the T7 
promoter to generate a homologous 5’ end for HiFi Assembly. At the 3’ end, the uCC stop 
codon was replaced by a SalI site, followed by homology to FLuc with the start site 
removed. The PCR was performed as described above using primers Frag1_F and 
uCCAmpR to generate the uCC fragment including homology to pUC19, a KpnI site, the 
T7 promoter, the uCC with no stop codon followed by a SalI site, and FLuc without a start 
codon.  
The FLuc fragment with a polyA tail was generated from plasmid pC365 
(LucPolyA50) by PCR as described above. Primers were used to add a SalI site and to 
remove the FLuc start codon and to add pUC19 homology to the 5’ end after the HindIII 
site. The primers used for the PCR reaction were Fusion_SalI_LucF and 
LucPolyA50_HindIII_puc19_R.  
For the HiFi Assembly reaction, the fragments were treated as described above, and 
pUC19 was digested with KpnI and HindIII and gel purified. The three fragments were 
assembled as described above and correct insertion was confirmed by sequencing using 
M13 universal primers M13F(-40) and M13R(-40) and the plasmid was named pC5568 
(Fig. 2.2A).  
The AUG uCC OF reporter pC5867 was generated using fusion PCR (Fig. 2.1C, 
Fig. 2.2A). Using primers Frag1_F and FSDel_R and plasmid pC5568 as a template, one 
nucleotide was deleted in the codon H31Q, CAC to CA shown in purple, directly upstream 
of the first conserved motif. This shifted the reading from +0 to +1. The second fragment 
was generated using primers FS_Del_F and FSInsertion_R. Primer FS_Del_F added 21 
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bases of homology to the first fragment and FSInsertion_R added a single T nucleotide, 
shown in purple, at the end of the uCC coding region to restore the FLuc reading frame 
before the SalI restriction site (Fig. 2.1C). The fragments were mixed 1:1and fused by PCR 
using primers Frag1_F and FSInsertion_R. The resulting PCR product was cloned into 
digested plasmid pC5568 using HiFi Assembly as described above. Correct assembly was 
confirmed by sequencing with uCCseq_F and uCCseq_R.  
The reporters containing amino acid substitutions were generated using synthesized 
G-blocks #3-9 (LifeSct). The fragments were designed with homology for insertion 
between NheI and SalI in the existing plasmid pC5568 vector. Plasmid pC5568 was 
digested with NheI and SalI and gel purified. The synthesized fragments were inserted into 
the vector using NEBuilder HiFi DNA Assembly Master Mix (NEB). Correct insertion was 
confirmed by sequencing with primers uCCseq_F and uCCseq_R.  
The reporters containing amino acid substitutions were generated using synthesized 
G-blocks #3-9 (LifeSct). The fragments were designed with homology for insertion 
between NheI and SalI in the existing pC5568 vector (Fig. 2.2A). Plasmid pC5568 was 
digested with NheI and SalI and gel purified. The synthesized fragments were resuspended 
in water to 50 ng/µl and inserted into the digested vector by HiFi Assembly as described 
above. Correct insertion was confirmed by sequencing using primers uCCseq_F and 
uCCseq_R.
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Table 2.2. The in vitro translation uCC-FLuc fusion reporters used in the study 
uCC-FLuc substitutions Stock ID Source 
uCC  pC5568 This study 
OF pC5867 This study 
GGG/3A pC5731 This study 
PSD/3A pC5733 This study 
GG/2A pC5734 This study 
PS/2A pC5736 This study 
GGRG/4A pC5737 This study 
R34A pC5738 This study 
9A pC5740 This study 
 
Table 2.2. The uCC-FLuc fusions for in vitro translation all initiate at an AUG codon.  
 
2.1.5. Generation of the uORF in vitro translation reporters (Table 2.3) 
To generate the uORF reporters for in vitro transcription, a gene fragment was 
synthesized as G-block #2 and cloned into the pCR2.1 vector backbone (Eurofins 
Genomics). G-block #2 was sub-cloned into the pUC19 backbone vector between KpnI 
and HindIII using Quick Ligation, as described above, and correct insertion was verified 
by sequencing using M13 primers and the plasmid was named pC5559.  
To generate an AUG uCC reporter, the ACG start site was mutated to ATG by site-
directed mutagenesis, as described above, using plasmid pC5559 and primers 
uCC_ACG_ATG_F and uCC_ACG_ATG_R. Mutagenesis was confirmed by sequencing 
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using M13 universal primers M13F(-40) and M13R(-40). Because A. thaliana contains an 
internal out-of-frame non-conserved uORF, site-directed mutagenesis was used to change 
the internal start site from ATG to AAG using primers uCCint_ATG_AAG_F and 
uCCint_ATG_AAG_R (Fig. 2.1B). Mutagenesis was confirmed by sequencing using M13 
universal primers M13F(-40) and M13R(-40) and the plasmid was named pC5566. To 
generate the ACG uCC reporter, the internal start site was changed from ATG to AAG for 
the pC5559 plasmid, using the primer pair described above for plasmid pC5566 resulting 
in plasmid pC5570. To generate a uORF reporter without a start codon, the adjacent ATC 
and ACG codons were changed to TTC and TCG, respectively, using site directed 
mutagenesis as described above. Plasmid pC5559 was used as a template with primers 
uCC_ATC_TTC_ACG_TCG_F and uCC_ATC_TTC_ACG_TCG_R for plasmid 
pC5574. Mutagenesis was confirmed by sequencing using M13 primers and the plasmid 
was used as a template for mutagenesis of the internal start site as described for the other 
reporters.  
The AUG uCC OF reporter was generated by fusion PCR using the existing plasmid 
pC5867 as a template. The first fragment was generated using plasmid pC5867 as a 
template and Frag1_F and FSuCC_R2 to add a T nucleotide and restore the uCC stop codon 
frame (Fig. 2.1C). The reporter ACG uCC OF, pC5954, was generated using fusion PCR 
with plasmid pC5570 as the template and to generate NS uCC OF, plasmid pC5955, 
plasmid pC5574 was used as the template. The second fragment contained the 5’UTR of 
the GGP uCC and was amplified by PCR using plasmid pC5570 as a template and primers 
FSuCC_F2 and uCCAmp_R. The 5’UTR fragment had 23 bases of homology to the uCC 
fragment and they were mixed 1:1 and amplified by PCR with primers Frag1_F and 
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uCCAmp_R. The product was cloned into plasmid pC5570 that was digested at KpnI and 
SalI using HiFi Assembly. Correct assembly was confirmed by sequencing with uCCseq_F 
and uCCseq_R primers.  
Table 2.3. In vitro translation uORF reporters generated for study 
In vitro translation uORF reporters Stock ID Source 
AUG uCC pC5566 This study 
ACG uCC pC5570 This study 
NS uCC pC5574 This study 
AUG uCC OF pC5953 This study 
ACG uCC OF pC5954 This study 
NS uCC OF pC5955 This study 
 
Table 2.3. The in vitro translation uORF reporters were used as templates to generate in 
vivo reporters 
 
2.1.6. Generation of the in vitro translation FLuc controls (Table 2.4)  
In order to test start site fidelity in the in vitro translation system, FLuc reporters 
were generated with a GGP 5’leader containing stop codons in each of the three reading 
frames just upstream of the FLuc start site (Fig. 2.3). The pC5568 reporter was digested 
with NheI and SalI and gel purified to remove the uCC and uCC leader sequence. PCR was 
used to generate DNA fragments where the FLuc start codon was varied: ATG, ACG, ATT, 
or AAA. The Frag1_F primer was used as the forward primer for all four reactions while 






































































































































































Figure 2.3. Templates used for in vitro transcription of FLuc mRNAs used to 
optimize RRL assays 
Plasmids were generated as templates for in vitro transcription of FLuc. The reporters 
contained a T7 promoter upstream of a 200-nt segment of the GGP leader located 
immediately upstream of the uCC start codon (blue). The leader sequence was altered 
(lowercase nts) to introduce stop codons in all three reading frames (black). To optimize 
initiation fidelity, three alternate start codons were substituted for ATG (green).  
 
site ACCAUG_R2 was used, for an ACG start ACCACG_R2 was used, for an AUU start 
ACCAUU_R2 was used, and for a AAA start ACCAAA_R2 was used. The PCR products 
were cloned into plasmid pC5568 using HiFi Assembly as described above. Correct 
insertion was verified by sequencing using uCCseq_F and uCCseq_R primers.  
Table 2.4. The in vitro translation FLuc controls used for RRL optimization 
FLuc controls  Stock ID Source 
3 stops ACC ATG FLuc pC5851 This study 
3 stops ACC ACG FLuc pC5852 This study 
3 stops ACC ATT FLuc pC5853 This study 
3 stops ACC AAA FLuc pC5854 This study 
 




2.1.7. Generation of the uCC-regulated Renilla reporters for mammalian 
transfection experiments (Table 2.5) 
To study whether the GGP uCC will regulate a downstream mORF, the phRL 
plasmid (Promega) was used as a vector (Fig. 2.4A). The phRL vector contains the CMV 
immediate early enhancer/promoter followed by a T7 promoter for in vitro transcription. 
A NheI restriction site is between the T7 promoter and the RLuc start codon and an AvaI 
site is 9 codons into RLuc. The simian virus 40 (SV40) late polyadenylation signal is 
downstream of RLuc. 
To generate the phRL based plasmids for mammalian transfection, fragments were 
generated by PCR using plasmid pC5566 as a template and primer pairs that encoded the 
uCC with the appropriate start codon (Fig. 2.1B). For an ACG start codon, primers 
NheIStopACGuCC_F and UTRrenAvaI_R were used to generate a DNA fragment with 
NheI and AvaI restriction sites. phRL was digested with NheI and AvaI and gel purified. 
The DNA fragment was digested with NheI and AvaI and heat-inactivated at 80°C. The 
DNA fragment was cloned into phRL using Quick Ligase, as described above. Correct 
insertion was confirmed by sequencing using primers occ1098 and phRLuCC_R. The 
plasmid was named pC5914. To generate a uCC reporter with an AUG start codon, primers 
NheIStopATGuCC_F and UTRrenAvaI_R were used to generate the DNA fragment for 
insertion by ligation, as described above, and the plasmid was named pC5915. To generate 
a reporter with no start codon, primers NheIStopNoStartuCC_F and UTRrenAvaI_R were 
used to generate the DNA fragment that was cloned into phRL as described above. The 











































































































































































































Figure 2.4. Plasmid reporters used in mammalian cell assays 
Luciferase reporters were generated to observe ascorbate specific effects on GGP uCC 
translation. (A) To observe regulation of GGP expression in mammalian cells, a phRL 
based vector was generated with the CMV promoter/transcription start site (TSS) where 
GGP was replaced with RLuc. The reporter contained 12-nts of the A. thaliana GGP uCC 
leader sequence, the 195-nt uCC, and the 111-nt region between the uCC stop codon and 
the GGP start site (GGP specific regions depicted in blue). Restriction sites used for cloning 
are indicated with red arrows. (B) To observe translation of the GGP uCC in mammalian 
cells, a p2luc uCC-FLuc fusion was generated with the SV40 promoter/transcription start 
site. The reporter contained 12-nts of the A. thaliana GGP uCC leader sequence, the 195-
nt uCC, a 24-bp linker region with restriction sites, and FLuc fused in-frame. (C) To reduce 
ribosome loading, a stem-loop (SL) was inserted upstream of the uCC in a p2luc based 
reporter with the SV40 promoter/transcription start site. The reporter contained 12-nts of 
the A. thaliana GGP uCC leader sequence, the 195-nt uCC, the 105-nt region between the 
uCC stop codon and the GGP start site, and FLuc in place of GGP. (D)  In order to test 
specificity to ascorbate and Arg, AZIN-AAP fusion reporters previously generated by 
Ivanov were used. The reporters were generated from phRL with the CMV 
promoter/transcription start site. The reporters contain 285-nt of the mouse AZIN1 uCC 
leader sequence upstream of 108-nt of the AZIN1 uCC fused to 51-nt of the N. crassa arg-
2 AAP, followed by 96-nt of the AZIN1 5’UTR between the AZIN1 uCC stop codon and 
the AZIN1 start codon. The AZIN1 uCC- arg-2 AAP fusion has the AZIN1 uCC start site 
(AUU) but the polyamine sensing region is replaced by the Arg sensing arg-2 AAP. Mouse 
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AZIN1 specific regions are depicted in green and N. crassa arg-2 specific regions are 
depicted in purple. N. crassa arg-2 AAP D12 (shown in red) is essential for Arg sensing 
and a D12N mutation abolishes regulation of AAP translation in the presence of excess 
Arg. 
 
To generate the phRL reporters containing the OF uCC control (Fig. 2.1C), two 
fragments were used to generate a DNA insert. The first fragment contained the OF uCC 
with either an ACG, AUG or AAA start codon, and the second contained the GGP 5’UTR 
between the uCC and the GGP start codon. The first fragments were generated by PCR, as 
described above, using plasmid pC5867 as the template. For the fragment with an ACG 
start site, primers NheIStopACGuCC_F and FSuCC_R2 were used.  For the fragment with 
an AUG start site, primers NheIStopATGuCC_F and FSuCC_R2 were used. The 5’UTR 
fragment was generated by PCR using plasmid pC5570 as a template and FSuCC_F2 and 
phRL_hifi_AvaI_R. After generating the separate fragments, they were fused by PCR after 
combining 1:1 ratios of the first fragment with the 5’UTR fragment and using the forward 
primer from fragment one with primer phRL_hifi_AvaI_R. The fused PCR product was 









Table 2.5. The RLuc reporters used in in vivo assays to study uCC regulation  
GGP uCC reporters Stock ID Source 
phRL  pC5906 Ivanov et al., 2008. 
ACG uCC pC5914 This study 
AUG uCC pC5915 This study 
AAA uCC pC5916 This study 
ACG OF  pC5956 This study 
AUG OF  pC5957 This study 
 
2.1.8. Generation of the uCC-FLuc fusions for mammalian transfection 
experiments (Table 2.6 and Table 2.7) 
The p2luc backbone was used for construction of mammalian GGP-uCC FLuc 
fusion reporters (Fig. 2.4B) (Grentzmann et al., 1998). The p2luc plasmid contains the 
SV40 early enhancer/promoter upstream of a HindIII restriction site, rluc, and a polylinker 
with the following sites: SalI, BamHI, and a SacI site. Following the polylinker SacI site, 
the FLuc coding sequence lacks its own start codon. The SV40 late polyadenylation signal 
is downstream of FLuc.  
p2Luc was digested with HindIII and BamHI to and then gel purified to remove 
rluc. To generate DNA fragments for HiFi Assembly into p2luc, fragments encoding the 
GGP uCC plus an extra 12 nucleotides of the GGP 5’UTR upstream of the uCC start codon 
were generated by PCR (Fig. B). Because they were designed for HiFi Assembly, 
appropriate homology to p2luc upstream of HindIII and downstream of BamHI was added 
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using the primer sets.  The existing in vitro transcription plasmids were used as templates 
for PCR for each uCC except the S11A substitution (Table 2.2). To generate uCC 
fragments with an AUG start site primers p2lucATG_F and p2lucBamHI_uCC_R were 
used. To generate uCC fragments with an ACG start, primer p2lucACG_F and 
p2lucBamHI_uCC_R were used. For the OF uCC reporters (Fig. 2.1C), primer 
p2lucBamHI_FS_R was used to add a T nucleotide and restore the reading frame 5’ of 
FLuc. After PCR amplification the fragments and digested p2luc were assembled using 
HiFi assembly as described above. Correct incorporation of the DNA fragments was 
confirmed by sequencing using primers occ1096 and uccSeq_R.  
To generate the reporters with the S11A substitution, a 300-bp DNA fragment 
encoding the uCC with the Ser11 codon (AGC) mutated to Ala (GCC) was synthesized (G-
block #11). The synthesized block was directly assembled into HindIII and BamHI digested 
p2luc to generate plasmid pC5980. To generate the AUG initiated S11A reporter pC6045, 
the G-block fragment was used as a template for PCR using the primers p2lucATG_F and 
p2lucBamHI_uCC_R. The fragment was cloned into p2luc as described above.   
Table 2.6. The p2Luc based uCC-FLuc fusions used in in vivo assays 
uCC-FLuc fusions Stock ID Source 
p2luc  pC5150 Grentzmann et al., 1998 
ACG uCC  pC5946 This study 
AUG uCC  pC5947 This study 
ACG OF  pC5949 This study 




Table 2.7. The p2Luc based uCC substitution-FLuc fusions used in in vivo assays 
uCC-FLuc fusion substitutions Stock ID Source 
GGG/3A AUG pC5958 This study 
PSD/3A AUG pC5960 This study 
GG/2A AUG pC5961 This study 
PS/2A AUG pC5963 This study 
GGRG/4A AUG pC5964 This study 
R34A AUG pC5965 This study 
9A AUG pC5967 This study 
S11A AUG  pC6045 This study 
GGG/3A ACG pC5969 This study 
PSD/3A ACG pC5971 This study 
GG/2A ACG pC5972 This study 
PS/2A ACG pC5974 This study 
GGRG/4A ACG pC5975 This study 
R34A ACG pC5976 This study 
9A ACG pC5978 This study 
S11A ACG pC5980 This study 
 
2.1.9. Generation of the phRL based reporters containing alanine substitutions 
within the uCC (Table 2.8) 
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To generate the phRL plasmids containing alanine substitutions within the uCC, 
two fragments were used to generate a DNA insert. The first fragment contained the ACG 
initiated uCC with the alanine substitution based on the template used. The second 
fragment contained the GGP 5’UTR between the uCC and the GGP start codon. Three 
different fragments were generated for the uCC: for plasmid pC6119 template plasmid 
pC5958 was used with primers ACGSubsAmpHiFi_F and uCCSubs_R, for plasmid 
pC6121 template plasmid pC5964 was used with the same primer pair, and for plasmid 
pC6123 template plasmid pC6045 was used. The 5’UTR fragment was generated by PCR 
using plasmid pC5914 as a template and uCC5UTR_F phRL_hifi_AvaI_R primers. After 
generating the separate fragments, they were fused by PCR after combining 1:1 ratios of 
the first fragment with the 5’UTR fragment and using the forward primer 
ACGSubsAmpHiFi_F with primer phRL_hifi_AvaI_R. The fragments were used in HiFi 
assembly with NheI and AvaI digested phRL plasmid as described above. Correct assembly 
was verified by sequencing using primers occ1098 and phRLuCC_R. 
Table 2.8. The phRL reporters containing uCC substitutions 
uCC substitutions Stock ID Source 
GGG/3A pC6119 This study 
GGRG/4A pC6121 This study 
S11A pC6123 This study 
 





2.1.10. Generation of the alanine insertions within the uCC for the uCC-FLuc fusion 
reporters used in mammalian transfection experiments (Table 2.9) 
To generate the reporters with the alanine insertions within the uCC, four G-blocks 
were synthesized (Blocks #12-15) (LifeSct). All four blocks were synthesized for insertion 
in p2luc between HindIII and BamHI using HiFi Assembly. The synthesized blocks had 
regions of homology to the p2luc vector upstream of HindIII and downstream of BamHI. 
All four blocks were synthesized with an ACG uCC start site. p2luc was digested with 
HindIII and BamHI and gel purified. To generate the reporters with an ACG start site 
Blocks #12-15 were amplified by PCR using p2lucACG_F and p2lucBamHI_uCC_R. The 
DNA fragments were cloned in digested p2luc by HiFi Assembly as described above. To 
change the start site to an AUG, Blocks #12-15 were amplified by PCR using p2lucATG_F 
and p2lucBamHI_uCC_R. The DNA fragments were cloned in digested p2luc by HiFi 
Assembly as described above. Correct assembly was confirmed by sequencing using 










Table 2.9. The p2Luc based FLuc reporters containing alanine insertions within the 
uCC 
uCC-FLuc alanine insertions Stock ID Source 
+1A@P28 AUG pC6198 This study 
+1A@P28 ACG pC6194 This study 
+3A@P28 AUG pC6199 This study 
+3A@P28 ACG pC6195 This study 
+1A@P44 AUG pC6200 This study 
+1A@P44 ACG pC6196 This study 
+3A@P44 AUG pC6201 This study 
+3A@P44 ACG pC6197 This study 
 
2.1.11. Generation of the stem-loop uCC FLuc reporters for mammalian 
transfection experiments (Table 2.10) 
To generate the p2Luc reporters containing the GGP leader sequence between the 
uCC and FLuc (Fig. 2.4C), DNA fragments containing uCC sequence followed by the 
sequence 5’ of the GGP coding region were generated by PCR as described above. To 
generate a reporter with an ACG initiated uCC followed by the 5’UTR of GGP, plasmid 
pC6240, reporter pC5915 was used as a template for primers HindIIIled_ACG_uCC_F and 
BamHI_AUG_ledR. To generate plasmid pC6241, an ACG initiated OF uCC, primers 
HindIIIled_ACG_uCC_F and BamHI_AUG_ledR were used with plasmid pC5956 as the 
template. To generate the AAA initiated OF reporter pC6242, primer 
HindIII_led_NS_uCC_F and primer BamHI_AUG_ledR were used with plasmid pC5956 
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as the template. The p2Luc backbone was digested with HindIII and BamHI and gel 
purified, as described above. The PCR products were also digested with HindIII and 
BamHI but purified using the High Pure PCR Product Purification Kit (Roche) as described 
above. The vectors and inserts were ligated together using Quick Ligase (NEB) as 
described previously.  The colonies were screened by PCR using occ1096 and uCCseqR 
and the LiTaq 2X PCR mix (LifeSct) and positive colonies were further screened by 
confirmation by sequencing using primers occ1096 and uccSeq_R. 
To generate the reporters containing a stem-loop structure 17-bases from the start 
of transcription and 29-bases upstream of the uCC start site, two primers containing an 89 
base stem loop with a DG= -41.3 kcal/mol were designed to generate HindIII compatible 
sticky ends. To anneal the primers into a double stranded insert, the primers were diluted 
to 100 µM in duplex buffer (100 mM potassium acetate, 30 mM HEPES pH 7.5). Equal 
volumes of each primer were added to a microcentrifuge tube, and the primers were heated 
to 94°C for 2 minutes. The block was turned off and the solution was allowed to slowly 
cool to RT. The annealed primers were stored at -20°C.  
The reporters, pC6240, pC6241, and pC6242 were digested with HindIII and rSAP 
and then gel purified. The annealed primers fragment was ligated into the HindIII digested 
pC6240, pC6241, and pC6242 vectors using Quick Ligase as described above. Colonies 
were screened by PCR using occ1096 and trunc3_R and the LiTaq 2X PCR mix (LifeSct). 




Table 2.10. The p2Luc based FLuc reporters containing the GGP uCC regulating 
FLuc and a stem-loop to reduce ribosome loading 
uCC FLuc reporters Stock ID Source 
ACG uCC  pC6240 This study 
ACG OF  
 
pC6241 This study 
AAA OF  pC6242 This study 
SL-ACG uCC  pC6243 This study 
SL-ACG OF  pC6244 This study 
SL-AAA OF  pC6245 This study 
 
2.1.12. Generation of the phRL based stem-loop uCC RLuc reporters for 
mammalian transfection experiments (Table 2.11) 
To generate the reporters containing a stem-loop structure 49-bases from the start 
of transcription and 325-bases upstream of the uCC start site, two primers containing an 
89 base stem loop with a DG= -41.3 kcal/mol were designed to generate HindIII compatible 
sticky ends. The primers were annealed as described above for the p2luc plasmid. For 
assembly, plasmids pC5914 and pC5956 were digested with HindIII and rSAP and then 
gel purified. The annealed primers fragment was ligated into the HindIII digested pC5914 
and pC5956 vectors using Quick Ligase as described above. Colonies were screened by 
PCR using occ1096 and trunc3_R and the LiTaq 2X PCR mix (LifeSct). Positive colonies 
further screened by sequencing using occ1096 or SLseqF and uCCseqR or SLseqR. 
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Table 2.11. The phRL based RLuc reporters containing the GGP uCC regulating 
RLuc and a stem-loop to reduce ribosome loading  
uCC RLuc reporters with SL  Stock ID Source 
SL- ACG uCC  pC6215 This study 
SL- ACG OF  pC6216 This study 
 
2.1.13. Generation of the phRL based Trip12-extended uCC reporters for 
mammalian transfection experiments (Table 2.12) 
To generate a 65-codon extension of the uCC, two fragments were generated for 
fusion by PCR. The first fragment was amplified using plasmid pC5802 (Ivanov et al., 
2018) as the Trip12 template. Three different combinations of primers were used to 
generate the Trip12 fragments with the appropriate combination of start sites for Trip12 
and for the uCC. To generate the Trip12 fragment with no start site for Trip12 and no start 
site for the uCC (AAA AAA, AAA AAA) primer Trip12AAAAAA_F and primer 
modAAAAAAuCC_R were used. To generate the Trip12 fragment with no start site for 
Trip12 but an ACG start site for the uCC (AAA AAA, ATC ACG) primer 
Trip12AAAAAA_F and primer modATCACGuCC_R were used. To generate the 
extended uCC fragment with the Trip12 ACG start site and no start site in the uCC (ATC 
ACG, AAA AAA), primer Trip12ATCACG_F and primer modAAAAAAuCC_R were 
used.  
For the second fragment, containing the majority of the uCC, two different 
fragments were generated using plasmid pC5914 as the template. To keep the ACG start 
site intact, a fragment was amplified using primers modATCACGuCC_F and 
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phRL_hifi_AvaI_R. Primers modAAAAAAuCC_F and phRL_hifi_AvaI_R were used to 
remove the start site.  
To generate the Trip12-uCC extensions combinations of fragment 1 and fragment 
2 were combined 1:1 with the appropriate primers and fused by PCR. To generate the uCC 
extension without start sites, the fragments amplified with Trip12AAAAAA_F and 
modAAAAAAuCC_R for the Trip12 extension, and modAAAAAAuCC_F and 
phRL_hifi_AvaI_R for the uCC were combined and fused using primers 
HF_NheI_Trip12_F and phRL_hifi_AvaI_R. To generate the a Trip12-uCC fusion where 
Trip12 lacked a start site and the uCC start site was left intact, the fragments amplified with 
Trip12AAAAAA_F and modATCACGuCC_R for the extension, and 
modATCACGuCC_F and phRL_hifi_AvaI_R for the uCC were combined and fused by 
PCR using primers HF_NheI_Trip12_F and phRL_hifi_AvaI_R. To generate the Trip12 
extended uCC, the fragments amplified with Trip12ATCACG_F and 
modAAAAAAuCC_R for the extension, and modAAAAAAuCC_F and 
phRL_hifi_AvaI_R for the uCC were combined and fused by PCR using primers 
HF_NheI_Trip12_F and phRL_hifi_AvaI_R.  
After generating the three inserts, phRL was digested with NheI and AvaI and gel 
purified as described above. The three inserts were cloned into the digested vector using 
HiFi Assembly as described above. Correct insertion was confirmed by sequencing with 





Table 2.12. The phRL based Trip12-uCC extensions used in in vivo assays 
Mammalian phRL Trip12-uCC 
extensions 
Stock ID Source 
AAA AAA pC5982 This study 
AAA ACG pC5983 This study 
ACG AAA pC5984 This study 
  
2.1.14. Generation of the Trip12-extended uCC FLuc fusion reporter for 
mammalian transfection experiments (Table 2.13) 
To generate the Trip12-uCC-FLuc fusion, p2luc was digested with HindIII and 
BamHI as described above. Plasmid pC5982 was used as a template for PCR with primers 
HindIIIp2lucTrip12_F and p2lucBamHI-uCC_R to generate a 441 bp product with a 
HindIII restriction site, an AUG start site at Trip12, no start site at the beginning of the 
uCC, and a direct fusion to FLuc at the BamHI site. The fragment was digested with HindIII 
and BamHI as described above and cloned into p2luc using Quick Ligase. Correct insertion 
into p2luc was confirmed by sequencing using occ1096 and uCCseqR.  
Table 2.13. The p2Luc-based Trip12-uCC-FLuc fusion control 
Mammalian p2Luc Trip12-uCC FLuc 
fusion 
Stock ID Source 
Trip12-uCC pC6202 This study 
 




2.1.15.  Other reporters for mammalian transfection experiments 
Table 2.14. The phRL based AZIN-AAP controls used in in vivo assays (Fig. 2.4D) 
Previously published phRL reporters Stock ID Source 
AAP  IV2475 Ivanov, 2018 
AAP D12N IV2478 Ivanov, 2018 
 
 
2.1.16. Peptidyl-tRNA release assay templates (Table 2.15) 
The templates for the peptidyl-tRNA release assay were generated as G-blocks #16, 
#17, and #18. Each block contains the T7 promoter for in vitro transcription and a 
transcription unit encoding a FLAG-epitope tag fused in-frame with a 390-bp linker 
fragment encoding residues 21-81 from the human chorionic gonadotropin beta subunit 
with other amino acids, followed by the GGP uCC or hCMV uORF2 gp48/UL4 peptide 
coding region (Fig. 2.2B,D). G-block #16 encodes the FLAG-linker-GGP uCC peptide, G-
block #17 encodes the FLAG-linker-GGP [OF] peptide, and G-block #18 encodes the 
FLAG-linker-gp48/UL4 control peptide. 
Plasmids pC6301 and pC6302 were made by cloning into pUC19. G-block #16 was 
resuspended in water to a concentration of 5 ng/µl. For PCR, the resuspended G-block was 
diluted 1:100 in water and amplified using primers EcoRI_uCC_F and HindIII_pramod_R 
as described above. G-block #18 was diluted as described above but amplified with primers 
EcoRI_uCC_F and gp48_R. The G-block #16 fragment was digested with EcoRI and 
HindIII, as described above, and the G-block #18 fragment was digested with EcoRI and 
BamHI. pUC19 was digested with EcoRI and BamHI with rSAP, or EcoRI and HindIII 
 129 
with rSAP, and gel purified as described above. The fragments were cloned into pUC19 
using Quick Ligase as described above. 
To generate the FLAG tagged uCC FLuc fusion plasmid pC6217 (Fig. 2.2C), G-
block #15 was amplified by PCR with primers Pramod_FLUC_F and uCC_SalI_FLUC_R 
as described above. To generate the FLAG tagged OF FLuc fusion pC6218, G-block #16 
was amplified with primers Pramod_FLUC_F and OF_SalI_FLUC_R. Plasmid pC5568 
was digested with NheI and SalI and gel purified. The fragments were cloned into the 
purified pC5568 vector using HiFi DNA Assembly as described above. Correct insertion 
was confirmed by sequencing using uCCseq_F and uCCseq_R. 
Table 2.15. The FLAG tagged peptidyl-tRNA stalling assay templates 
In vitro translation stalling templates Stock ID Source 
uCC pC6301 This study 
OF None Not in vector-block #17 
uCC-FLuc pC6217 This study 
OF-FLuc pC6218 This study 
UL4/gp48 pC6302 This study 
 






2.2. Mammalian cell transfection procedures 
Human osteosarcoma U2OS (Nancy Kedersha, Harvard University) cell lines were 
maintained in Dulbecco’s Modified Eagle Medium (DMEM) with 4.5 g/L glucose and L-
glutamine without sodium pyruvate (Corning) supplemented with 10 % fetal bovine serum 
(FBS) (Gibco), 1 mM sodium pyruvate (Corning), and penicillin/streptomycin (Quality 
Biological). Cells were maintained in 100 mm plates at 37°C and 5% CO2 and split at least 
once per week using 0.25% trypsin- ethylenediaminotetraacetic acid (EDTA) (Gibco).  
L-ascorbate for cell culture was prepared by dissolving L-ascorbic acid 2-phosphate 
sesquimagnesium salt hydrate (Sigma-Aldrich) in supplemented DMEM  to a 
concentration of 200 mM. The stock solution was filter sterilized and stored at 4°C.  
 Plasmids for transfection were prepared using the QIAprep Spin Miniprep Kit 
(Qiagen). For a miniprep, 3 mls of E. coli containing the plasmid of interest were grown 
overnight in LB-Amp (100 mg/ml). The cells were pelleted in a 1.5 ml tube by 
centrifugation at 6800 xg for 3 minutes at RT. The pellet was resuspended in 250 µl Buffer 
P1 and then 250 µl of Buffer P2 was added and the solution was mixed by inverting 4-6 
times. After mixing, 350 µl Buffer N3 was added and the solution was mixed by inverting 
4-6 times. The sample was spun for 10 minutes at 17,900 xg. After clarifying the cell lysate, 
800 µl of supernatant was added to the QIAprep 2.0 spin column. The column was spun 
for 30 s and the flow-through was discarded. The column was washed with 0.5 ml Buffer 
PB and centrifuged for 30 s and the flow-through was discarded. The column was washed 
a second time with 0.75 ml Buffer PE and centrifuged for 30 s and the flow-through was 
discarded. The column was transferred to a new collection tube and spun for 1 minute to 
remove residual buffer. The column was then placed in a clean 1.5 ml tube and 50 µl of 
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Buffer EB was added to the column. The column was incubated for 1 minute and then spun 
for 1 minute to elute the DNA. The plasmid concentration was determined using a 
NanoDrop ND-1000 Spectrophotometer and diluted to 10 ng/µl before use in transfection 
experiments.  
To introduce the reporter plasmids into the U2OS cells, reverse transfection was 
used. For transfections utilizing FLuc (p2Luc plasmids), each transfection contained 5 ng 
of reporter plasmid and 1 ng of RLuc plasmid as a transfection control. For transfections 
utilizing the RLuc (phRL plasmids), each transfection contained 2 ng of reporter plasmid 
and 5 ng of FLuc plasmid as a transfection control. For each transfection, a master mix was 
made containing 0.2 µl of Lipofectamine 2000 Reagent (Invitrogen) per well and 25 µl  per 
well of Opti-MEM I Reduced-Serum Medium (Gibco). The master mix was mixed gently 
by inversion and incubated for five minutes while the reporters were aliquoted into 
individual 1.5 ml microcentrifuge tubes. After five minutes, the control plasmid was added 
to the master mix and gently mixed. The master mix was then added to the aliquoted 
reporters and gently mixed. Before the transfection, 25 µl of the reporter transfection mix 
was added to each well of a 96-well half area white tissue culture treated plate (Corning).  
After transferring the transfection reagent, the cells were prepared. To achieve a 
final concentration of 50 mM L-ascorbate in a final volume of 50 µl per well, 12.5 µl of 
200 mM L-ascorbate was added for each well to a 1.5 ml tube. As a control, 1.5 ml tubes 
containing the same volume of DMEM were used. 70-80% confluent cells were removed 
from the plate using 0.25% trypsin-EDTA (Gibco) and resuspended in supplemented 
DMEM. The cells were counted, and the volume adjusted to achieve a cell/µl count of 800 
cells/µl so 12.5 µl would contain approximately 10,000 cells. The cells were added to either 
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the 200 mM L-ascorbate in the 1.5 ml tube or the DMEM control at a volume of 12.5 µl 
per well. This ensured that 10,000 cells were seeded in each well. The cell master mix was 
gently mixed by inverting and 25 µl of the mix was added to each well achieving a cell 
count of 10,000 per well in 50 mM L-ascorbate or DMEM. The cells were incubated for 
20-22 hours.  
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2.3. Dual luciferase assay 
Buffers used for assays of FLuc (Table 2.16) and RLuc (Table 2.17) activity were 
made in the lab. All stock solutions were prepared by dissolving the indicated reagent in 
water except for coelentrerazine, used for the RLuc assay buffer, which was dissolved in 
methanol.  
After incubation, the Centro XS3 LB 960 luminometer (Berthold Technologies) 
was prepared by soaking the buffer pump lines in 80% ethanol for 10-15 minutes. After 
soaking, the lines were washed for 40 wash cycles 80% ethanol and then for 40 wash cycles 
with deionized (DI) water. After washing, the pumps were primed with the assay buffers 
and the appropriate assay and wells were selected. While the luminometer lines were 
soaking, 1X passive lysis buffer was prepared (Promega). The tissue culture plates were 
removed from the incubator one at a time and the medium was removed using a 
multichannel pipet and 25 µl of 1X passive lysis buffer was added to each well. The plate 
was placed on a shaker for 10 minutes. The plates were analyzed on the luminometer using 
the dual luciferase settings: firefly dispense 50 µl middle speed, delay duration 2.0, firefly 
counting time 10.00, Renilla dispense 50 µl middle speed, delay duration 2.0, Renilla 
counting time 10.00.  
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Table 2.16. Components of the FLuc Assay Buffer 
FLuc Assay Buffer 
Reagent Stock 
Concentration 
Final Concentration Volume (500 mls) 
Glycylglycine 250 mM 25 mM 50 ml 
K2PO4 pH 8.0 1 M 15 mM 7.5 ml 
EGTA 200 mM 4 mM 10 ml 
MgSO4 500 mM 15 mM 15 ml 
Coenzyme A (CoA) 10 mM 0.1 mM 5 ml 
Luciferin 7.5 mM 75 µM 5 ml 
Dithiothreitrol (DTT) 500 mM 1 mM 1 ml 
ATP 200 mM 2 mM 5 ml 
Commercial Firefly reagent (Promega) 5 % 25 ml 
DI water (add after adjusting pH of assay buffer to 8.0 using NaOH) 
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Table 2.17. Components of the RLuc Assay Buffer 
RLuc Assay Buffer 
Reagent Stock Concentration Final Concentration Volume (500 mls) 
NaCl 2.5 M 1.1 M 220 ml 
EDTA 500 mM 2.2 mM 2200 µl 
K2PO4 pH 5.1 1 M 220 mM 111.1 ml 
Bovine serum 
albumin (BSA) 
100 mg/ml 0.44 mg/ml 2200 µl 
NaN3 1 M 1.3 mM 650 µl 
Coelentrerazine 1.43 mM 1.43 µM 500 µl 
Commercial Renilla reagent (Promega) 5 % 25 ml 




2.4. Detection of eIF2a phosphorylation 
To monitor eIF2a phosphorylation, U2OS cells were transfected with plasmid 
pC5914 and 600,000 cells per well were plated in 6-well plates. Cells were left untreated 
(negative control), or 23 hours after transfection cells were treated with 50 mM L-ascorbic 
acid 2-phosphate sesquimagnesium salt hydrate (+ L-AA) or with 100 mM sodium arsenite 
(positive control) and then incubated for an additional 1 hour before harvesting.  
To begin harvesting, the plates were placed on ice. The cells were washed one time 
with chilled phosphate buffered saline (PBS) and then harvested by adding 30 µl of chilled 
radioimmunoprecipitation assay (RIPA) buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% 
sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 25 mM Tris pH 7.4, DI water 
to volume) with Complete Protease Inhibitor (Roche). The cells were scraped off the plate 
and the resuspended cells were transferred to 1.5 ml microcentrifuge tubes on ice. The cells 
were sonicated 10 times with one second pulses and then spun at 17,949 xg for 10 minutes 
at 4°C. The cleared cell lysates were transferred to clean microcentrifuge tubes and 
Bradford assays were used to quantify the protein concentration for each sample. The 
samples were diluted to 10 and 20 µg per 15 µl in RIPA buffer and 4X NuPAGE lithium 
dodecyl sulfate (LDS) Sample Buffer (Invitrogen) was added along with 1 mM DTT to a 
final volume of 33 µl. The samples were heated to 70°C for 10 minutes and then 15 µl was 
loaded into each well of a 4-20% Criterion TGX Precast Gel (BIO-RAD).  
After running the gel (200 V for 1 hour), the proteins were transferred using the 
BIO-RAD TGX system (50 V for 30 minutes at 4°C) to a nitrocellulose membrane. The 
membrane was stained with Ponceau-S stain to visualize proteins and then trimmed. The 
Ponceau S stain was removed by washing the membrane with water and TBS-T (Tris-
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buffered saline, 0.1% Tween 20) and the membrane was then incubated with blocking 
solution (5% non-fat milk in TBS-T) for one hour on a nutator at RT. The membrane was 
probed overnight with rabbit anti-eIF2a-(Phospho-Ser51) (Abcam ab32157) primary 
antibody (diluted 1:1,000 in blocking solution) at 4°C on a nutator. The membrane was 
then washed three times for five minutes with X-ml TBS-T and then incubated for 1 hour 
with a 1:10,000 dilution of enhanced chemiluminescence (ECL) Anti-Rabbit IgG HRP 
conjugated antibody (GE Healthcare) in blocking solution on a nutator at RT. After probing 
with this secondary antibody, the membrane was washed six times for five minutes with 
TBS-T. Immunoconjugates were detected by incubating the membrane for 5 minutes in 
Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare). The 
membrane was then exposed to film, which was developed using an SRX-101A medical 
film processor (Konica Minolta).  
After developing the Western blot, the membrane was stripped using the harsh 
stripping method. The stripping buffer (For 100 ml: 20 ml 10% SDS, 12.5 ml Tris-HCl pH 
6.8 0.5 M, 67.5 ml DI water, 0.8 ml 2-mercaptoethanol (BME)) for 30 minutes at 50 °C 
with agitation. After stripping the membrane was rinsed with tap water for 1 minute, then 
washed 5 times for 1 minute in TBS-T. The membrane was re-blocked in blocking solution, 
as above, for one hour and then probed overnight with a 1:1,000 dilution of rabbit anti-
eIF2a total (Bethyl) primary antibody in 5% non-fat milk. The membrane was then washed 
with TBS-T three times for five minutes and then incubated for 1 hour with 1:10,000 
dilution of ECL Anti-Rabbit IgG HRP conjugated antibody (GE Healthcare). After probing 
with the secondary antibody, the membrane was washed six times for five minutes each 
with TBS-T and then incubated for 5 minutes with Amersham ECL Prime Western Blotting 
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Detection Reagent (GE Healthcare). The membrane was then exposed to film, which was 
developed as described above. 
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2.5. qPCR quantification of luciferase mRNA levels 
To validate the luciferase assays, RLuc and FLuc mRNA levels were quantified 
using quantitative reverse transcription polymerase chain reaction (RT-qPCR). U2OS cells 
were transfected as described but volumes were increased 40X for 6-well plates. 
Transfected cells were grown for approximately 24 hours and then the RNA was extracted. 
The 6-well plates were placed on ice, the growth medium was removed, and the wells were 
washed with 2 mls of PBS. The cells were resuspended in 1 ml of Trizol (ThermoFisher) 
using a cell scraper and pipetting. The resuspended cells were stored at -80 °C or processed 
immediately. For processing, the sample was incubated for 5 minutes at RT then 0.2 mL 
of chloroform was added to the sample and it was mixed by hand for 15 seconds. The 
sample was incubated for 2 minutes at RT and then the sample was spun at 12,000 xg for 
15 minutes at 4 °C. The upper aqueous phase was removed and transferred to a new 
microcentrifuge tube and 1.5 µl of glycoblue (ThermoFisher) was added along with  0.5 
mL of 100% isopropanol. The sample was incubated at RT for 10 minutes and then the 
RNA was pelleted by centrifugation at 12,000 xg for 10 minutes at 4 °C. The supernatant 
was removed, and the pellet was washed with 1 mL of 75% ethanol by vortexing. The 
pellet was preserved by centrifugation at 7500 xg for 5 minutes at 4 °C. The supernatant 
was removed, and the pellet was dried for 5-10 minutes. The pellet was resuspended in 44 
µl of water and the RNA concentration was quantified using a nanodrop.  
To remove plasmid contamination up to 10 µg of nucleotide was treated with 
TURBO DNase in a 50 µl reaction. For each reaction, the extracted RNA was added at a 
maximum volume of 43.5 µl or 10 µg with water added to adjust the volume to 43.5 µl, 5 
µl of 10X TURBO DNase Buffer was added and then 2.5 µl of TURBO DNase was added 
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and the sample was gently mixed. The sample was incubated at 37 °C for 30 minutes and 
then 10 µl of resuspended DNase Inactivation Reagent was added. The sample was 
incubated at RT for 5 minutes with occasional mixing. The DNase was removed by 
centrifugation at 10,000 xg for 1.5 min and the RNA was transferred to a fresh tube. RNA 
was used immediately for RT-qPCR or stored at -80 °C. 
Multiplexed TaqMan one-step RT-qPCR was performed using TaqMan assays with 
HEX, FAM, and ROX as a reference dye. For each reaction, 5 µl of 4X TaqMan Fast Virus 
1-Step Master Mix (ThermoFisher) was combined with 0.25 µl of ActB probe mix, 0.25 
µl of either FLuc assay or RLuc assay, 4.5 µl of water, and 5 µl of purified RNA. The 
assays were run on a Stratagene Mx3000P (Agilent) using the fast cycling mode. Reverse 
transcription at 50 °C for 5 minutes followed by RT inactivation/denaturation at 95 °C for 
20 seconds. This was followed by 40 cycles of denaturation at 95 °C for 3 seconds and 
annealing/extension at 60 °C for 30 seconds.  
For the TaqMan assays PrimeTime Std qPCR Assays were designed and purchased 
from IDT. Each assay contained two primers (5.0 nmoles) and a probe (2.5 nmoles) and 
they were diluted in 500 µl IDTE buffer (10 mM Tris, 0.1 mM EDTA, pH 8.0) to 20X.  
FLuc assay set:  
Primer 1: 5’-GTGTTGGGCGCGTTATTTATC-3’ 
Primer 2: 5’-TAGGCTGCGAAATGTTCATACT-3’ 
Probe: /56-FAM/TTGCGCCCG/ZEN/CGAACGACATTTATA/3IABkFQ/ 
RLuc assay set:  
Primer 1: 5’- CTGATCTGATCGGAATGGGTAAG -3’ 
Primer 2: 5’- CAAGCGGTGAGGTACTTGTAG -3’ 
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Probe: /56-FAM/AAGAGCGGG/ZEN/AATGGCTCATATCGC/3IABkFQ/ 
N001101.1.pt.ACTB set:  
 
Primer 1: 5’- ACCTTCTACAATGAGCTGCG-3’ 
Primer 2: 5’- CCTGGATAGCAACGTACATGG-3’ 
Probe: /5HEX/ATCTGGGTC/ZEN/ATCTTCTCGCGGTTG/3IABkFQ/ 
 For analysis, DCt was calculated as the ActB Ct minus the luciferase Ct. Outliers 
were identified and removed using 1.5 times the interquartile range (IQR) as the cut-off for 
each replicate. After removing the outliers, DDCt was calculated by calculating the average 
DCt of the control (untreated 0 mM) for each reporter and subtracting it from the DCt for 
each value. Fold gene expression was calculated for each well using 2^-DDCt.  
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2.6. In vitro transcription of mRNAs 
To transcribe the mRNAs for in vitro translation assays, large amounts of 
concentrated plasmid were needed so a ZymoPure II Plasmid Maxiprep Kit (Zymo) was 
used. For each plasmid preparation, a 3 ml preculture of E. coli containing the plasmid of 
interest were grown overnight in LB + Amp (100 mg/ml) at 37°C with shaking at 250 rpm. 
One ml of the preculture was used to inoculate 100 ml of LB + Amp in a 500 ml flask and 
the culture was grown for 3 hours at 37°C with shaking at 250 rpm. The bacterial culture 
was transferred to a 500 ml tube and spun at 3,400 xg for 10 minutes to pellet the cells. 
The supernatant was discarded, and the pellet was resuspended in 14 ml of ZymoPure P1. 
After resuspending the pellet, 14 ml of ZymoPure P2 was added and mixed by inversion 6 
times. After mixing, 14 ml of ZymoPure P3 was added and the solution was mixed by 
inversion. The ZymoPure Syringe Filter was placed in a tube rack and the Luer Lock was 
plugged. The cell lysate was added to the filter and allowed to sit for 5 minutes. The Luer 
Lock plug was removed from the syringe and the syringe was placed in a 50 ml conical 
tube. The plunger was placed into the syringe and used to push the solution through the 
filter until 33-35 ml of the cleared lysate was in the conical tube. Then 14 ml of ZymoPure 
Binding Buffer was added to the cleared lysate and mixed by inversion at least 10 times. 
The 50 ml reservoir was moved from the top of the Zymo-Spin V-P Column Assembly and 
the assembly was placed in a 50 ml conical tube, and then 14 ml of the binding buffer-
lysate was added to the assembly. The column was spun at 500 xg for 2 minutes and the 
flow-through was discarded. This was repeated until all the lysate had passed through the 
column. After binding the plasmid to the filter, the filter was washed with 5 ml of 
ZymoPure Wash 1 and centrifuging the assembly at 500 xg for 2 minutes and the flow-
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through was discarded. Then 5 ml of ZymoPure Wash 2 and centrifuging the assembly at 
500 xg for 2 minutes and the flow-through was discarded. The wash step was repeated once 
and then 15 ml conical reservoir was discarded and the Zymo-Spin V-P column was placed 
in a collection tube and spun at 10,000 xg for 1 minute. The column was transferred to a 
clean 1.5 ml tube and 400 µl of ZymoPure Elution Buffer was added. The column was 
incubated for 2 minutes and then spun at 10,000 xg for 1 minute. The plasmid concentration 
was determined using a NanoDrop ND-1000 Spectrophotometer.  
For each transcription reaction, 20 µg of purified plasmid was digested in a 50 µl 
digestion with 5 µl of DraI (NEB) overnight at 37°C. After digestion, mRNAs were 
transcribed in a 500 µl reaction with T7 RNA polymerase overnight at 37°C (Table 2.18 
and Table 2.19). 
Table 2.18. Composition of the in vitro transcription reaction  
In vitro Transcription Reaction 
Reagent Stock Concentration Final Concentration Volume for 500 µl 
Ribomax buffer 5X 1X 80 µl 
DTT 1 M (5X) 1X 20 µl 
NTPs 25 mM each 5 mM each 100 µl 
Ribolock  40U/µl 0.4U/µl 5 µl 
T7 RNAP (His6) 100X 1X 5 µl 
YIPP (NEB) 100X 1X 5 µl 
Digested DNA 10X 1X 50 µl 
Water   235 µl 
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Table 2.18. For the ribomax buffer see Table 2.19. The NTPs (ThermoFisher) were 
purchased as a four nucleotide kits at 100 mM each and mixed in equal parts to achieve a 
final concentration of 25 mM of each nucleotide. Ribolock RNase Inhibitor 
(ThermoFisher) works best in the reaction mix. The T7 RNA polymerase was purified in 
the lab. Yeast Pyrophosphatase, Inorganic (YIPP) was purchased from NEB. All reagents 
and plastics from the plasmid preparation on were RNase Free. 
 
Table 2.19. Composition of the ribomax buffer  
5X Ribomax Buffer 
Reagent Stock 
Concentration 
Final Concentration Volume 5 ml 
HEPES-KOH pH 7.4 1 M 400 mM 2000 µl 
MgCl2 1 M 120 mM 600 µl 
Spermidine 1 M 10 mM 50 µl 
DTT 1 M 200 mM 1000 µl 
Water   1350 µl 
 
Table 2.19. The 5X ribomax buffer was aliquoted into 500 µl aliquots and stored at -20°C. 
All reagents and plastics from the plasmid preparation on were RNase Free.  
 
 After transcribing the mRNAs overnight, 133 µl (the maximum volume) of the 
transcription product was purified with the RNA Clean & Concentrator Kit-25 (Zymo 
Research). After transferring 133 µl of the transcription reaction to a clean 1.5 ml tube, 2 
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volumes of RNA Binding Buffer (267 µl) were added and then an equal volume of 100% 
ethanol was added (400 µl). The solution was mixed and transferred to the Zymo-Spin IIC 
Column in a collection tube and spun for 30 s at 14,000 xg. The flow-through was discarded 
and 400 µl of RNA Prep Buffer was added to the column and spun for 30 s. The flow-
through was discarded and 700 µl of RNA Wash Buffer was added to the column and spun 
for 30 s. The flow-through was discarded and 400 µl of RNA Wash Buffer was added to 
the column and the column was spun for 2 minutes. The column was transferred to a clean 
1.5 ml tube and 80 µl of RNase-Free Water was added to the column matrix and incubated 
for 1 minute before spinning for 30 s.  
The mRNAs were capped using the Vaccinia Capping System (NEB) scaled up 
four times (58 µl of purified mRNA in a total volume of 80 µl). The mRNA was added to 
a clean 1.5 ml tube and heated at 65°C for 5 minutes then placed on ice for 5 minutes. After 
denaturing the mRNA, 2 µl of RNasin (Promega) added followed by 8 µl 10X Capping 
Buffer, 4 µl GTP (10 mM), 4 µl S-adenosyl methionine (SAM) (2 mM, diluted from 32 
mM stock), and 4 µl Vaccinia Capping Enzyme. The capping reaction was incubated at 
37°C for 30 minutes. After capping, the entire capping reaction was purified again using 
the RNA Clean & Concentrator Kit-25 (Zymo Research), with the RNA Binding Buffer 
adjusted to the correct volume (160 µl) were added and then an equal volume of 100% 
ethanol was added (240 µl). The purified capped mRNAs were eluted in 50 µl. The mRNAs 
were quantified using a Bioanalzyer and an RNA Pico Chip (Agilent Technologies).  
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2.7. In vitro translation of mRNAs 
Purified mRNAs were translated using Promega’s Flexi Rabbit Reticulocyte Lysate 
System (RRL) (Promega) (Table 2.20). The total concentration of mRNA added varied to 
keep translation in the linear range but unless noted was 25 ng per reaction. Magnesium 
concentration of the Flexi Rabbit Reticulocyte Lysate varies by lot, so the amount of 
magnesium acetate added varies by lot but unless noted the magnesium concentration for 
the assay was 1.88 mM. L-ascorbic acid was buffered in 750 mM HEPES buffer at a 5X 
concentration was added to the translation reaction immediately before mRNA was added. 
Reactions were incubated at 30°C for 30 minutes and then flash frozen in liquid nitrogen. 
The reactions were thawed and Luciferase Assay System (Promega) was used to measure 
FLuc activity with a luminometer as described above but for a single luciferase.  
Table 2.20. Composition of a Promega Flexi RRL reaction 
Standard Translation Reaction (25 µl reaction volume) 
Component Volume (µl) 
Flexi Rabbit Reticulocyte Lysate  16.5 
Amino Acid Mixture, Minus Leucine, 1 mM 0.25 
Amino Acid Mixture, Minus Methionine, 1mM 0.25 
Magnesium Acetate, 25 mM To 1.88 mM 
Potassium Chloride, 2.5 M 0.7 
RNasin Plus (Promega) 0.5 
mRNA 0.5 
HEPES Buffered Ascorbate or HEPES 5 
RNase Free Water To 25 
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2.8. Western blot detection of translation products 
In vitro transcribed capped and purified mRNA from plasmids pC5568 (uCC-FLuc) 
and pC5867 (OF-FLuc) was translated as described above with or without 5 mM ascorbate 
but the reactions were allowed to proceed for 1 hour. The reactions were flash frozen in 
liquid nitrogen and then thawed. The in vitro translation reactions were mixed so that 15 
µl of loaded reaction would contain either 5 µg or 10 µg of total protein by diluting the 
translation reaction with water and adding 4X NuPAGE LDS Sample Buffer (Invitrogen), 
10X NuPAGE Sample Reducing Agent (Invitrogen), and 10X BME. Previous Bradford 
assays on RRL reactions show that the protein concentration is approximately 181 µg 
protein/µl. The samples were incubated at 70°C for 10 minutes, centrifuged at max RT for 
1 minute, and then placed back at 70°C.  
After preparing the samples, 15 µl of each was loaded onto a 4-12% Bis-Tris 
NuPAGE gel (Invitrogen) and run with NuPAGE MOPS buffer plus NuPAGE Antioxidant 
(Invitrogen) at 180 V for about 1 hour. The proteins were transferred to a 0.45-micron 
nitrocellulose membrane (Invitrogen) with NuPAGE transfer buffer and 20% methanol at 
30 V for 1 hour 10 minutes. The membrane was rinsed with DI water and then Ponceau 
stained for several minutes.  
The blot was trimmed and cut at the 39 kDa marker and then washed once with 
TBS-T. The blots were blocked in 5% BSA in TBS-T for the lower part of the blot that 
contained GAPDH and the upper blot that contained uCC-FLuc was blocked with 3% non-
fat milk in TBS-T for 1 hour at RT on a nutator. The lower part of the membrane was 
incubated with anti-GAPDH (Abcam) at 1:5,000 in 5% BSA in TBS-T at 4°C overnight 
and the upper part of the blot was incubated with anti-Luci17 (Abcam) at 1:500 in 3% non-
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fat milk in TBS-T at 4°C overnight on a nutator. After incubation, the blots were washed 
3 times for 5 minutes in TBS-T then ECL-anti-mouse IgG, Horseradish Peroxidase linked 
whole antibody (GE Healthcare) at 1:10,000 was added. For the lower blot the secondary 
antibody was diluted in 5% BSA in TBS-T, and for the upper blot the secondary antibody 
was diluted in 3% non-fat milk in TBS-T. The blots were incubated with secondary 
antibody for 1 hour at RT on a nutator and then washed 5 times for 5 minutes with TBS-T. 
After washing, SuperSignal West Femto Maximum Sensitivity Substrate (Thermo 
Scientific) was added to the blots for 5 minutes. Amersham Hyperfilm MP (GE Healthcare) 
was used for 15-minute exposures to the FLuc blot. GAPDH required a shorter exposure 
time of 15 seconds. The films were developed as described above.  
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2.9. Peptidyl-tRNA release assay 
The templates for the peptidyl-tRNA release assay were generated as G-blocks. 
Each block contains the T7 promoter for in vitro transcription, FLAG tag for peptide 
detection, a linker fragment from human chorionic gonadotropin beta subunit, and the 
peptide of interest is fused in-frame to the tag and linker (Fig. 2.B-D). FLAG-tagged uCC 
template was generated by PCR using 2X LiSpark Max SuFi PCR Master Mix (LifeSct), 
G-block #16, and the primers gp48_F and uCCStall_R. The OF FLAG-tagged uCC was 
generated using the same primers but with G-block #17 as a template. The stalling control 
gp48 template was generated using G-block #18 and the primers gp48_F and gp48_R. The 
PCR reactions were scaled up 4X for a final total volume of 100 µl. The PCR products 
were pooled and purified using the High Pure PCR Purification Kit (Roche) and eluted in 
50 µl elution buffer, as described above. DNA concentration was determined using a 
NanoDrop ND-1000 Spectrophotometer. 
The purified PCR product was used downstream in the T7 RiboMAX Express 
Large Scale RNA Production System (Promega). The reactions were scaled up 2X: 40 µl 
RiboMAX Express T7 2X Buffer, 32 µl purified PCR product (~4 µg), 8 µl T7 Express 
Enzyme Mix. The reactions were incubated at 37°C for 30 minutes. After in vitro 
transcription, the mRNAs were purified with the RNA Clean & Concentrator Kit (Zymo), 
as described after capping, and quantified using a NanoDrop ND-1000 Spectrophotometer.  
In vitro translation was done as described above except for two modifications. The 
mRNAs were denatured at 65°C for 5 minutes then placed in an ice bath and translation of 
the mRNAs was done at 25°C for 90 minutes for all five mRNAs at 0 mM or 5 mM L-
ascorbate. The reactions were stopped using liquid nitrogen. After the samples thawed, 20 
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µl was aliquoted into two tubes of 10 µl each. One tube was treated with 2 µl of RNase 
free water, the other tube was treated with 2 µl of RNase A at 0.1 mg/ml (Qiagen). The 
samples were mixed and incubated at RT for 20 minutes.  
After incubation, the samples were diluted 1:10 in water and prepared for Western 
blot so that 15 µl of prepared sample would contain 1 µg of total protein, which was 
calculated to be 3 µl of diluted sample in 30 µl of sample buffer mix. Each preparation 
contained treated sample, 2X Laemmli buffer (BIO-RAD), 10X NuPAGE Sample 
Reducing Agent (Invitrogen), 10X BME, and water to adjust the volume to 33 µl per 
sample. The samples were heated to 70°C for 10 minutes, centrifuged at max RT for 1 
minute, placed back at 70l, and 15 µl of each sample was loaded onto a 10% NuPAGE Bis-
Tris gel (Invitrogen). The gel was run with NuPAGE MOPS buffer with antioxidant 
(Invitrogen) at 140 V until the dye front reached the bottom of the gel. The proteins were 
transferred to a 0.45-micron nitrocellulose membrane (Invitrogen) with NuPAGE transfer 
buffer and 20% methanol at 30 V for 1 hour 15 minutes. The membrane was rinsed with 
DI water and then Ponceau stained for several minutes.  
After Ponceau staining, the membrane was trimmed, washed with TBS-T, and 
blocked at RT for 1 hour in 3% non-fat milk in TBS-T on a nutator. The blocked blot was 
incubated at 4°C overnight on a nutator with mouse monoclonal anti-FLAG M2 antibody 
(Sigma F3165) at 1:2,000 in 3% non-fat milk in TBS-T. After incubating overnight, the 
blot was washed 3 times for 5 minutes with TBS-T. ECL-anti-mouse IgG, Horseradish 
Peroxidase linked whole antibody (GE Healthcare) was used for incubation at 1:10,000 in 
3% non-fat milk in TBS-T for 1 hour at RT on a nutator. After incubation, the blot was 
washed 5 times for 5 minutes with TBS-T. After washing, Amersham ECL Western 
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Blotting Detection Reagent (GE Healthcare) was added to the blot for 5 minutes. 
Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare) was used for 
the blots if a 15-minute exposure was not sufficient. Amersham Hyperfilm MP (GE 
Healthcare) was used for exposures and the film was developed as described above. 
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3.1. A noncanonical uORF in the plant GGP mRNA contains highly conserved 
amino acid motifs 
3.1.1. Significance and rationale for study 
We propose that the GGP uORF, also referred to as a uCC for simplicity in the text, 
regulates GGP expression through translational control in response to L-ascorbate because 
it has the three hallmark features of a uCC: conservation of a near-cognate initiation codon 
upstream of the conserved region; absolute conservation of amino acid motifs within the 
uORF-encoded peptide; and evidence of high ribosome density within the uORF including 
a peak indicating a translation pause site. 
A key feature of the AZIN uCC is the sequence conservation at the amino acid level 
rather than at the nucleotide level, indicating that the encoded peptide has a function rather 
than the RNA. As first described by Laing et al., alignment of sequences of the uORF-like 
element in the 5’-UTR of the GGP mRNA from multiple plant species revealed strong 
amino acid sequence conservation near the C-terminus in dicotyledonous plants. 
Importantly, the codons encoding the conserved amino acid residues varied at the wobble 
position in the aligned sequences, indicating that the amino acid sequence was conserved, 
not the nucleotide sequence (Laing et al., 2015). Of note, the sequence alignments used by 
Laing et al. did not include many single-celled algae species. The inclusion of additional 
sequences from more genetically diverse species is expected to enhance the usefulness of 
the alignment as an aid to identify which amino acid residues are critical for regulation of 
GGP mRNA translation.  
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To broaden the diversity of species included in the sequence alignment, I compiled 
the sequences of the  5’UTRs from a highly diverse set of GGP mRNAs. The NCBI 
transcriptome shotgun assembly (TSA) and expressed sequence tag (EST) databases were 
searched using A. thaliana GGP as a reference sequence and I specifically searched for 
algae species. The ancestors of land plants diverged from green algae between 450 and 500 
million years ago (MYA) (Ulvskov et al., 2013), maximizing the diversity in the sequence 
alignment. The sequences were translated in all six reading frames, and the text was 
searched for amino acid motifs highlighted by Laing et al., specifically the GGRG motif 
and the C-terminal glycine repeat (Laing et al., 2015).  
3.1.2. The GGP uORF contains highly conserved motifs 
Newly identified sequences were compiled with the sequences previously 
identified by Laing et al. to generate a 21 species alignment using CLUSTALW (3.1A). 
The alignment showed that there are five perfectly conserved motifs, but that the length of 
the uORF varies. The shortest GGP uORF is only 32 codons and the longest could be as 
long as 103 codons; however, the longest uORFs contain multiple potential in-frame near-
cognate start codons, so the translated uORF might be shorter than 103 codons. In ribosome 
profiling studies of A. thaliana, ribosome footprints extended to a potential near-cognate 
ACG start codon suggesting that the GGP uORF could be at least 65 codons long (Laing 
et al., 2015). As discussed below, the greatest amino acid sequence conservation in the 
uORF includes a nearly 30 amino acid span near the C-terminus. There is no conservation 
in the N-terminal region of the uORF, which ranges in size from at least six codons to 
around 30 codons before the first conserved motif. There is also no conservation in the 
length of the C-terminal region between the last conserved polyglycine motif and the stop 
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codon with the distance ranging from one to 16 codons between the last glycine residue 
and the stop codon. In addition to the lack of conservation within the C-terminal region of 
the uORF, there is also no conservation in  the distance between the uORF stop codon and 
the AUG start codon of the GGP coding sequence (CDS) (data not shown). In some species 
the GGP coding sequence start codon was over 100 nucleotides downstream of the uCC 
stop codon, while in other cases the 3’ end of the uORF overlapped the beginning of the 
GGP coding sequence. In these latter cases, the GGP start codon was always located 3’ of 
the last conserved motif in the uORF.  
The most striking feature of the GGP uCC is the near perfect conservation of five 
motifs or single residues (Fig 3.1A, B) within a fixed span of 23 amino acids. Starting at 
the N-terminus of this conserved region, the first motif, GGRG, shows 100% conservation. 
Five codons after the GGRG motif, the sequence GGxPxD (x = any residue) is also 100% 
conserved. A hydrophobic residue often follows the aspartate and then after a four-codon 
gap, there is a C-terminal glycine repeat. In most cases, the repeat consists of three 
consecutive glycine residues; however, in at least two organisms, only the C-terminal two 
glycines are conserved. As noted above, another striking feature is the perfect conservation 
of the length (23 amino acids) of the conserved region from the start of the first conserved 
motif to the last glycine residue in the C-terminal glycine repeat.
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Figure 3.1. The GGP uCC is highly conserved across plants 
(A) The predicted amino acid sequences of the GGP uCC from 20 algae species and A. 
thaliana (red), representing approximately 450 million years of divergence, were aligned 
using Clustal Omega. Absolutely conserved amino acids are shown in orange, while 
residues conserved in >90% of the sequences are shown in blue. (B) WebLogo logogram 
of the alignment from panel A.  
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3.2. GDP-L galactose phosphorylase (GGP) mRNA translation is regulated by 
ascorbic acid in a uORF-dependent manner in mammalian cells 
3.2.1. Significance and rationale for study 
 We propose that the GGP uORF, referred to as a uCC for simplicity in the text, 
regulates GGP expression through translational control in response to L-ascorbate. Ivanov 
et al. used reporters containing the AZIN1 uCC upstream of the luciferase coding sequence 
to examine polyamine and AZIN1 uCC regulation of AZIN1 expression in mammalian cell 
culture (Ivanov et al., 2018). Increased translation of the upstream uCC inhibited luciferase 
expression and polyamines regulated downstream luciferase reporter expression in an 
AZIN uCC-specific manner. If the hypothesized GGP uCC regulates GGP expression in 
response to L-ascorbate, replacing GGP with luciferase should lead to regulation of 
luciferase expression by the GGP uCC in response to high levels of L-ascorbate. 
 Laing et al. (2015) used plants for their studies but had to deal with the challenge 
of manipulating ascorbate levels indirectly by knocking down or overexpressing GGP, 
which is an essential gene (Laing et al., 2015). GGP and the GGP uORF are specific to 
plants, so it was conceivable that regulation would not work in a mammalian cell culture 
system; however, as human cells do not make ascorbate and it is not present in cell culture 
medium or FBS, ascorbate concentrations can be controlled in the mammalian cell culture 
system by simply adding ascorbate to the culture medium (Hata and Senoo, 1989; 
Takamizawa et al., 2004).  
 As addition of ascorbate to cell culture medium can change the pH of the medium 
and cause cell death, alternative methods have been developed to increase ascorbate 
concentrations in mammalian cells. Addition of ascorbate sesquimagnesium phosphate to 
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culture medium does not alter the pH or cause cell death (data not shown), and upon uptake 
into cells ascorbate sesquimagnesium phosphate is dephosphorylated by intracellular 
phosphatases and converted to biologically active dephosphorylated L-ascorbate. 
3.2.2. GDP-L galactose phosphorylase (GGP) mRNA translation is regulated by 
ascorbic acid in a uORF-dependent manner 
 To monitor translational control conferred by the GGP uCC in the presence of 
ascorbate, reporters were generated containing the A. thaliana GGP uCC upstream of RLuc 
in place of GGP (Fig 2.4A, Fig. 3.2A). A CMV promoter was used to ensure high mRNA 
levels and boost the potential luciferase signal. The A. thaliana GGP uORF contains a non-
conserved internal OF uORF that was disrupted by changing the AUG start codon to AAG 
(Fig 2.1A, B). Disrupting the internal uORF changes the uCC amino acid sequence His13 
(CAT) to Gln13 (CAA), but the amino acid change is upstream of the conserved region. In 
order to keep the putative uCC near-cognate initiation site (ACG) in its native context, 12 
nucleotides of the A. thaliana 5’UTR upstream of the uCC was included (Fig 2.4A). An 
OF control was generated where one nucleotide was removed to shift the frame directly 
upstream of the first conserved GGRG motif (Fig 2.1C). The stop codon was put back in-
frame with the insertion of one nucleotide upstream of the stop codon. Downstream of the 
uCC stop codon, the 111 nucleotides between the uCC stop codon and the GGP start codon 
were left intact before the RLuc AUG initiation site.  
 To examine whether the GGP uCC regulates GGP expression in mammalian cells 
in response to 50 mM ascorbate, GGP-RLuc reporters were transfected into U2OS cells 
and the cells were incubated in the presence or absence of 50 mM ascorbate (Fig 3.2A). To 








0 50 100 150
50 mM L-AA
0 mM L-AA
ACG uCC % ACG OF








Figure 3.2. GGP mRNA translation is regulated by L-AA in a uCC-specific manner 
in vivo
Figure 3.2. GP mRNA translation is regulated by ascorbate in a uCC-
specific manner in vivo 
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Figure 3.2. GGP mRNA translation is regulated by ascorbate in a uCC-specific 
manner in vivo 
(A) GGP-Rluc reporters containing the A. thaliana GGP 5’ leader with either the wild-type 
or OF control uCC. (ACG-initiated), OF, or  uCC. (B) U2OS cells were transfected with 
the GGP-Rluc reporters from panel A containing the wild-type uCC, the OF control uCC, 
or the wild-type uCC lacking a start codon (ACG mutated to AAA). Cells were incubated 
24 h in DMEM in the absence of presence of 50 mM ascorbate-P (L-AA). Rluc activity 
was normalized to the activity of an FLuc reporter transfection control. (C) wild-type 
reporter (ACG uCC) activity was calculated as a percentage of the OF reporter (ACG uCC 
% ACG OF) was calculated at 0 mM and 50 mM ascorbate-P. Error bars represent standard 
deviation (SD), * p < 0.005 (Student’s two-tailed t-test; n=6, assayed in duplicate).  
 
control for differences in transfection efficiency, an FLuc reporter was used for 
normalization. The FLuc reporter was plasmid p2luc which contains the SV40 promoter 
and terminator and no uCC upstream of FLuc. GGP-RLuc expression without translation 
of the uCC was monitored using a reporter with the uCC initiation site disrupted (AAA 
codon).  
 In the absence of ascorbate, highest luciferase expression was obtained with the 
AAA reporter lacking a uCC start codon. Both the wild-type and OF reporters yielded 
lower levels of luciferase, indicating the translation of the uCC (even at low levels from 
the near cognate start codon) impairs downstream translation (Fig. 3.2B). There is no uCC- 
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Table 3.1. Relative reporter mRNA levels – related to Fig. 3.2.  
 
 
Table 3.1. Relative RLuc mRNA levels for experiments in Fig. 3.2 determined by qPCR. 
Standard deviation based on three biological replicates.  
 
specific translational control in the absence of ascorbate as GGP-RLuc levels are the same 
for the wild-type and OF reporters. Upon addition of 50 mM ascorbate, GGP-RLuc 
expression was repressed to a greater extent by the wild-type, but not the OF.   
In order to quantify the uCC-specific repression of GGP-RLuc expression in 
response to ascorbate, the data were normalized to the OF (Fig. 3.2C). At 0 mM ascorbate, 
no uCC-specific repression was observed and comparing the expression of the ACG uCC  
reporter as a percentage of the ACG OF reporter (ACG uCC % ACG OF) was nearly 100%. 
However, at 50 mM ascorbate, a dramatic uCC-specific decrease in GGP-RLuc expression 
was observed. Addition of ascorbate caused a 60% decrease (p<0.005) in GGP-RLuc 
expression with the reporter containing an intact uORF (ACG initiation codon). These 
results allow two important conclusions: first, ascorbate can regulate GGP mRNA 
translation in mammalian cells; and second, ascorbate regulation of GGP mRNA 
translation is dependent on the amino acid sequence of the uCC (regulation is lost with the 
OF mutant).  
Reporter Description Treatment RLuc mRNA SD RLuc mRNA SD RLuc activity
pC5914 ACG uCC 0 mM L-AA 1.00 0.51
pC5914 ACG uCC 50 mM L-AA 0.19 0.30 0.19 0.30 0.21
pC5956 ACG OF 0 mM L-AA 0.98 0.41
pC5956 ACG OF 50 mM L-AA 0.05 0.02 0.05 0.02 0.52
Fold induction
 (0 mM L-AA / 50 mM L-AA)
Relative mRNA level
(ACG uCC 0 mM set at 1)
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To quantify how treatment with 50 mM ascorbate affects RLuc mRNA levels, RT-
qPCR was performed. Human U2OS cells were transfected with the reporters used in Fig. 
3.2 in the manner used for luciferase assays but scaled up 40X and using 6-well cell culture 
plates. After incubation in the presence or absence of 50 mM ascorbate, total RNA was 
isolated using Trizol Reagent and treated with TURBO DNase to remove plasmid 
contamination. Multiplexed TaqMan one-step RT-qPCR assays were performed. In short, 
cDNA was generated using random priming in the same tube as the qPCR assay. After 
cDNA generation, RLuc and ActB levels were quantified simultaneously using TaqMan 
assays targeting RLuc or ActB. In a TaqMan assay, two primers amplify a portion of the 
target cDNA and a probe that is specific to the amplified region anneals to the ssDNA. The 
probe contains a dye at one end and a quencher at the other. During the amplification 
process the dye is displaced by polymerase generating a fluorescent signal specific to the 
dye. RLuc was detected using a probe with FAM dye while ActB was detected using a 
probe with HEX dye. Relative RLuc mRNA levels were calculated using 2^-DDCt utilizing 
ActB as a control housekeeping gene. 
For the experiment in Fig. 3.2, relative GGP-RLuc mRNA levels were normalized 
to the relative GGP-RLuc mRNA level for the untreated ACG-initiated uCC (Table 3.1). 
The fold-induction in GGP-RLuc mRNA levels in response to 50 mM ascorbate was then 
calculated for each reporter. The fold-induction in RLuc activity in response to 50 mM 
ascorbate from Fig. 3.2 is also shown in Table 3.1. Treatment with 50 mM ascorbate 
reduces GGP-RLuc mRNA levels by about 5-fold for the reporter containing the wild-type 
GGP uCC and luciferase activity decreased to the same extent. In contrast, treatment with 
50 mM ascorbate reduced GGP-RLuc mRNA levels by about 20-fold for the reporter 
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containing the OF, but luciferase activity only decreased 2-fold. The lack of correlation in 
relative mRNA levels and RLuc activity indicates that the changes in RLuc activity upon 
addition of ascorbate are not simply due to changes in mRNA levels. 
3.2.3. Conservation of the motifs is essential for regulation 
In order to examine whether the GGRG motif and the C-terminal glycine repeat 
(GGG) were necessary for ascorbate regulation of GGP, the conserved residues were 
replaced by alanine residues in reporters where GGP was replaced by RLuc as described 
above (Fig. 3.3A). As an additional control to test whether any alanine substitution in the 
uORF impaired regulation, the non-conserved residue Ser11 was also substituted by Ala. 
The S11A reporter was expected to show wild-type regulation of RLuc.  
To determine whether alanine substitutions of the GGRG motif and C-terminal 
glycine repeat would derepress GGP-RLuc expression in response to 50 mM ascorbate, the 
alanine substitution reporters along with reporters containing the wild-type uCC or the OF 
control were transfected into U2OS cells. As shown in Fig. 3.3B, after normalization to the 
FLuc transfection control, expression of the GGP-RLuc reporters containing a wild-type 
uCC or the S11A mutant uCC showed substantial repression in the presence of ascorbate. 
In order to quantify the impact of the motif mutations on the ascorbate-specific regulation 
of GGP-RLuc expression, the normalized RLuc/FLuc levels for each reporter in the 
presence of ascorbate were normalized to values obtained in the absence of ascorbate (Fig. 
3.3C). As expected, the reporters containing the wild-type uCC and S11A mutant uCC 
showed a greater than 60% reduction in GGP-RLuc expression upon addition of ascorbate. 




    uCC: PLPHGGRGALPSEGGSPSDLLFLAGGGSSFNFFSFRF* 
GGRG/4A: PLPHAAAAALPSEGGSPSDLLFLAGGGSSFNFFSFRF*
 GGG/3A: PLPHGGRGALPSEGGSPSDLLFLAAAASSFNFFSFRF*
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Figure 3.3. Conservation of the uCC amino acid motifs is essential for L-AA
regulation
Figure 3.3. Conservation of the uCC amino acid motifs is essential for 
ascorbate regulation  
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Figure 3.3. Conservation of the uCC amino acid motifs is essential for ascorbate 
regulation  
(A) GGP-Rluc reporters containing the A. thaliana GGP 5’ leader with the wild-type or the 
indicated mutant uCCs (mutated residues in red). (B) U2OS cells were transfected with the 
indicated GGP-RLuc reporters and incubated for 24 hr in DMEM in the absence or 
presence of 50 mM ascorbate-P (L-AA). RLuc activity was normalized to a co-transfected 
FLuc reporter (RLuc/FLuc). (C) The response of each reporter to ascorbate-P was 
calculated by dividing reporter activity in the presence versus absence of ascorbate (50 mM 
% 0 mM L-AA). Error bars represent SD, * p < 0.005 (Student’s two-tailed t-test; n=6, 
assayed in duplicate). 
 
In contrast, the alanine substitutions for both the GGRG and GGG motifs, like the OF 
mutation in the uCC,  severely impaired ascorbate-dependent repression of GGP-RLuc 
expression with at least a two-fold decrease in the repression ratio compared to a reporter 
with a wild-type uCC (p<0.005). These results indicate that both the GGRG and GGG 
motifs are necessary for uCC regulation of GGP in response to ascorbate.  
 To quantify how treatment with 50 mM ascorbate affects GGP-RLuc mRNA levels, 
RT-qPCR was performed. Human U2OS cells were transfected with the reporters used in 
Fig. 3.3 in the manner used for luciferase assays but scaled up 40X and using 6-well cell 
culture plates. After incubation in the presence or absence of 50 mM ascorbate, total RNA 
was isolated using Trizol Reagent and treated with TURBO DNase to remove plasmid 
contamination. Multiplexed TaqMan one-step RT-qPCR assays were performed to  
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Table 3.2. Relative reporter mRNA levels – related to Fig. 3.3.  
 
 
Table 3.2. Relative RLuc mRNA levels for experiments in Fig. 3.3 determined by qPCR. 
Standard deviation based on three biological replicates.  
 
quantify RLuc and ActB mRNA levels. Relative RLuc mRNA levels were calculated using 
2^-DDCt utilizing ActB as a control housekeeping gene. 
 For the experiment, relative RLuc mRNA levels for the mutants were normalized 
to the relative RLuc mRNA level for the untreated wild-type (ACG-initiated uCC) control 
(Table 3.2). The fold induction in RLuc mRNA levels in response to 50 mM ascorbate was 
then calculated for each reporter and displayed along with the fold induction in RLuc 
activity (from Fig. 3.3). 
Treatment with 50 mM ascorbate reduced GGP-RLuc mRNA levels by about 5-
fold for the wild-type reporter (ACG uCC) and luciferase activity decreased by about the 
same amount; however, whereas treatment with 50 mM ascorbate reduced GGP-Rluc 
Reporter Description Treatment RLuc mRNA SD RLuc mRNA SD RLuc activity
pC5914 ACG uCC 0 mM L-AA 1.00 0.51
pC5914 ACG uCC 50 mM L-AA 0.19 0.30 0.19 0.30 0.27
pC6123 S11A 0 mM L-AA 0.93 0.18
pC6123 S11A 50 mM L-AA 0.43 0.09 0.46 0.10 0.26
pC6121 GGRG/4A 0 mM L-AA 3.53 7.71
pC6121 GGRG/4A 50 mM L-AA 0.16 0.05 0.05 0.02 0.52
pC6119 GGG/3A 0 mM L-AA 2.53 4.75
pC6119 GGG/3A 50 mM L-AA 0.17 0.08 0.07 0.03 0.65
pC5956 OF 0 mM L-AA 0.98 0.41
pC5956 OF 50 mM L-AA 0.05 0.02 0.05 0.02 0.72
Relative mRNA level Fold induction
(ACG uCC 0 mM set at 1)  (0 mM L-AA / 50 mM L-AA)
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mRNA levels by about 20-fold for the OF, GGRG/4A, and GGG/3A substitutions, the 
luciferase activity decreased only 2-fold or less. Thus, the reduced repression of these 
three mutants by ascorbate is not due to higher mRNA levels. For the S11A mutant, 
treatment with ascorbate reduced GGP-RLuc mRNA levels by only about 2-fold while 
luciferase activity decreased almost 5-fold, consistent with the conclusion that the S11A 
mutation did not impair regulation.  
3.2.4. The GGP uORF is specifically sensitive to ascorbic acid in vivo 
To examine the specificity of the GGP uCC to ascorbate and determine whether 
ascorbate can affect regulation of a different uCC, the GGP wild-type uCC and GGP OF 
were used alongside the AAP reporter and its control, AAP D12N (Fig. 3.4A). The AAP 
is a well-described uORF that regulates production of CPAase A, an arginine biosynthetic 
enzyme subunit, in response to arginine (Luo et al., 1995; Werner et al., 1987). Mutating a 
single highly conserved aspartate residue, D12, in the AAP abolishes arginine-specific 
repression of CPAase A production (Freitag et al., 1996; Werner et al., 1987). Reporter 
constructs containing the AAP and the D12N control were developed by Ivaylo Ivanov and 
shown to respond to the addition of 25 mM Arg in mammalian cell culture (Ivanov et al., 
2018). The reporters contain the mouse azin1 uCC with the last 10 residues replaced by the 
C-terminal two-thirds of the N. crassa AAP sequence (Fig. 2.4D) . The essential D12 
residue is included in the wild-type AAP sequence but substituted for Asn (D12N) in the 
AAP control. Similar to the GGP-RLuc reporters, the AAP and AAP-D12N sequences are 
inserted in the 5’ leader of an RLuc reporter. Addition of 25 mM Arg represses RLuc 
synthesis from the AAP, but not the AAP-D12N reporter (Ivanov, data not published).  



































































































Figure 3.4. Regulation of GGP is specific to L-AA and L-AA does not regulate AAPFigure 3.4. Regulation of GP is specific to ascorbate and ascorbate does not 
regulate AAP 
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Figure 3.4. Regulation of GGP is specific to ascorbate and ascorbate does not 
regulate AAP 
(A) GGP-RLuc reporters containing the A. thaliana GGP 5’ leader or an AZIN-AAP fusion 
(mutated residues in red). (B) U2OS cells were transfected with the indicated GGP-RLuc 
reporters and incubated for 24 hr in DMEM in the absence or presence of 50 mM ascorbate-
P (L-AA) or in medium supplemented with an additional 25 mM arginine. RLuc activity 
was normalized to a co-transfected FLuc reporter (RLuc/FLuc). (C) The response of each 
reporter to ascorbate-P was calculated by dividing reporter activity in the presence versus 
absence of ascorbate (50 mM % 0 mM L-AA) and the significance of the response was 
calculated against the GGP OF reporter. (D) The response of each reporter to the addition 
of 25 mM arginine was calculated by dividing reporter activity in the presence versus 
absence of arginine (+25 mM % 0 mM Arg) and the significance of the response was 
calculated against the AAP-D12N reporter. Error bars represent SD, * p < 0.005 (Student’s 
two-tailed t-test; n=6, assayed in duplicate).  
 
U2OS cells were transfected with the wild-type and OF GGP-RLuc reporters, as 
well as the AAP and AAP-D12N RLuc reporters, and the cells were grown in DMEM 
medium containing no additions, 50 mM ascorbate, or 25 mM Arg. In DMEM, RLuc 
expression was high for all four reporters (Fig. 3.4B). The addition of 50 mM ascorbate 
repressed expression from the wild-type GGP-RLuc reporter more substantially than any 
of the other three reporters (Fig. 3.4B). As expected, addition of 25 mM Arg repressed 
RLuc expression for the reporter containing the AAP, but not the AAP-D12N 
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Table 3.3. Relative reporter mRNA levels – related to Fig. 3.4.  
 
 
Table 3.3. Relative RLuc mRNA levels for experiments in Fig. 3.4 determined by qPCR. 
Standard deviation based on three biological replicates.  
 
mutant (Fig. 3.4B). The addition of 25 mM Arg did not repress GGP-RLuc repression for 
either the wild-type uCC or OF control reporters. 
To examine the magnitude of each reporters' response to ascorbate and Arg, the 
normalized RLuc levels were further normalized to the levels obtained in the absence of 
additions (Fig. 3.4C). After normalization, only the wild-type GGP uCC showed a 
significant inhibition in response to ascorbate (p<0.005) with RLuc levels dropping nearly 
50% compared to the other reporters. As expected, the AAP, known to respond to Arg, did 
not respond to ascorbate. Addition of Arg reduced expression from the AAP reporter by 3-
fold (p<0.005), whereas expression from the AAP-D12N, wild-type uCC and OF was not 
affected by the addition of Arg (Fig. 3.4D). Thus, the different uCC elements exhibit 
specificity for their effector, with the AAP specifically responding to Arg and the GGP 
Reporter Description Treatment RLuc mRNA SD RLuc mRNA SD RLuc activity RLuc mRNA SD RLuc activity
IV2475 AAP No addition 1.00 0.15
IV2475 AAP 50 mM L-AA 0.05 0.02 0.05 0.02 0.53
IV2475 AAP 25 mM Arg 0.59 0.03 0.59 0.03 0.58
IV2478 AAP-D12N No addition 1.05 0.36
IV2478 AAP-D12N 50 mM L-AA 0.17 0.06 0.16 0.05 0.44
IV2478 AAP-D12N 25 mM Arg 1.33 0.93 1.26 0.88 1.39
pC5914 GGP uCC No addition 1.00 0.51
pC5914 GGP uCC 50 mM L-AA 0.19 0.30 0.18 0.28 0.30
pC5914 GGP uCC 25 mM Arg 1.77 1.54 1.62 1.41 1.21
pC5956 GGP uCC-OF No addition 0.98 0.41
pC5956 GGP uCC-OF 50 mM L-AA 0.05 0.02 0.05 0.02 0.56
pC5956 GGP uCC-OF 25 mM Arg 12.02 22.22 12.25 22.63 1.12
Fold induction
 (0 mM L-AA / +25 mM Arg)
Relative mRNA level Fold induction
(ACG uCC 0 mM set at 1)  (0 mM L-AA / 50 mM L-AA)
  172 
uCC specifically responding to ascorbate. Presumably, this metabolite specificity is 
dictated by the encoded amino acid sequence of the respective uCCs.  
To quantify how treatment with 50 mM ascorbate or 25 mM Arg affects RLuc 
mRNA levels, RT-qPCR was performed as described previously. Relative RLuc (to ActB 
control) mRNA levels for each reporter in presence of ascorbate or Arg were normalized 
to the relative RLuc mRNA levels in the untreated samples. As shown in Table 3.3, the 
fold induction in RLuc mRNA levels in response to 50 mM ascorbate or 25 mM arginine 
was calculated and displayed along with the fold induction in RLuc activity. Treatment 
with 50 mM ascorbate lead to a greater than 10-fold reduction in RLuc mRNA levels for 
the AAP and AAP-D12N reporters, but RLuc activity was reduced only 2-fold. RLuc 
mRNA levels were also reduced for the GGP uCC and GGP OF reporters; however, the 
GGP uCC reporter showed the least response to 50 mM ascorbate at the mRNA level (only 
5-fold reduction) but the greatest decrease in RLuc activity (over 3-fold). The lack of 
correlation in relative mRNA levels and RLuc activity in samples treated with 50 mM 
ascorbate indicates that the changes in RLuc activity are not simply due to changes in 
mRNA levels. Analysis of arginine regulation in cells transfected with AAP and AAP-
D12N reporters showed that luciferase activity correlated with mRNA levels, so we cannot 
draw a strong conclusion regarding arginine regulation of the AAP and AAP-D12N 
reporters in these experiments. Of note, the reduced mRNA levels of the AAP reporter in 
the presence of Arg is consistent with previous reports that addition of Arg triggers 
nonsense-mediated decay (Gaba et al., 2005). The GGP reporters showed a similar 
response to Arg as observed for the AAP-D12N reporter with elevated mRNA levels 
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compared to the wild-type AAP reporter, and for unknown reasons the OF GGP-RLuc 
reporter showed a massive increase mRNA levels in the presence of Arg.  
3.2.5. Treatment of mammalian cells with ascorbic acid does not trigger 
phosphorylation of eIF2a 
Cellular stress responses are known to downregulate global translation and 
upregulate translation of specific mRNAs through phosphorylation of the translation factor 
eIF2a (Abastado et al., 1991; Dever et al., 1995; Hinnebusch, 2005; Lee et al., 2009; Palam 
et al., 2011; Vattem and Wek, 2004; Young and Wek, 2016; Young et al., 2015b). In 
mammalian cells, four distinct protein kinases transduce different stress signals resulting 
in phosphorylation of eIF2a (Taniuchi et al., 2016). This phosphorylation impairs the 
function of eIF2 and thereby inhibits general translation. However, the translation of 
certain uORF-containing mRNAs can be upregulated under conditions of eIF2a 
phosphorylation (Dever et al., 1995). While this latter mechanism does not appear relevant 
to the GGP mRNA, as its translation is repressed by ascorbate, we wondered if translation 
of the GGP mRNA was hypersensitive to induction of a general stress response. To test 
whether ascorbate treatment induces a general stress response, we used immunoblot 
analyses to examine eIF2a phosphorylation in U2OS cells expressing the wild-type GGP-
RLuc reporter and grown in the presence or absence of 50 mM ascorbate or of 100 µM 
arsenite, an inducer of oxidative stress that activates the eIF2a kinase HRI (McEwen et al., 
2005). Whole cell extracts were subjected to immunoblot analysis using antibodies that 
specifically detected phosphorylation of eIF2a on Ser51 or that detect eIF2a independent 
of Ser51 phosphorylation (Fig. 3.5A). Normalizing the levels of eIF2a–P to total eIF2a 
(Fig. 3.5B) revealed that addition of ascorbate does not lead to increased levels of eIF2a–
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P, indicating that ascorbate regulation of GGP mRNA translation is likely not mediated by 
activation of a general cellular stress response. 
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Figure 3.5. L-AA-P does not regulate GGP mRNA translation through eIF2α 
phosphorylation
Figure 3.5. Ascorbate-P does not regulate GGP mRNA translation through 
eIF2a phosphorylation 
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Figure 3.5. Ascorbate-P does not regulate GGP mRNA translation through eIF2a 
phosphorylation 
(A) U2OS cells were grown in medium containing 0 mM or 50 mM ascorbate-P (L-AA) 
or with the addition of 100 µM arsenite and harvested for Western blotting. The membrane 
was probed for eIF2a-P then stripped and probed for total eIF2a. The blot shown is 
representative of three experimental replicates. (B) eIF2a-P % eIF2a total was calculated 
for each of the three experiments. Error bars represent SD, * p < 0.005 (Student’s two-
tailed t-test; n=3).  
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3.3. L-ascorbic acid enhances translation of the ACG-initiated GGP uORF in 
mammalian cell culture (in vivo) 
3.3.1. Significance and rationale for study 
The studies using the GGP-Luc reporters revealed that ascorbate regulation of GGP 
mRNA translation is dependent on the conserved uCC that initiates at a near cognate ACG 
codon. In previous studies to assess whether polyamines affected AZIN1 uCC translation, 
pairs of AZIN-Luc fusion reporters with the native AUU start codon or with an AUG start 
codon to monitor maximal initiation were utilized by Ivanov et al. (2018). With the native 
near-cognate start codon, enhanced initiation can be more easily detected after normalizing 
to the AUG-initiated reporter. Expression from the AUG-initiated uCC-luciferase reporters 
was inhibited upon addition of polyamines, due to the elongation defect in the uCC. 
Expression of the reporter with the near cognate start codon will suffer the same elongation 
defect as the AUG-initiated reporter but might also show enhanced initiation. Accordingly, 
normalizing the expression of the near-cognate initiated uCC-luciferase reporter to the 
AUG-initiated reporter will normalize the elongation defect and reveal the enhancement of 
near-cognate initiation. For the AZIN1 uCC, addition of spermidine triggered a 2-fold 
increase in AUU-initiated reporter activity following normalization to the corresponding 
AUG-initiated reporter (Ivanov et al., 2018). 
To examine whether ascorbate controls translation of the GGP uCC, uCC-Luc 
reporters were generated by fusing an eight-codon linker containing a BamHI site between 
the last sense codon of the uCC and a Firefly luciferase reporter. The reporters were under 
control of the SV40 promoter and also contained an SV40 terminator (Fig. 2.4B). Like the 
GGP-RLuc reporter described above, the uCC start site context was maintained by 
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including 12 nucleotides of the A. thaliana 5’UTR upstream of the uCC start codon (Fig 
2.4B). An OF control was generated by deleting one nucleotide directly upstream of the 
first conserved GGRG motif (Fig 2.1C) and then inserting one nucleotide immediately 
upstream of the linker to put FLuc back in-frame. As described above, the reporters were 
generated in pairs with either the native start site (ACG) or an AUG start site.  
3.3.2. Ascorbic acid controls GGP uCC translation in vivo 
In order to determine whether ascorbate affects GGP uCC translation, sets of FLuc 
reporters were transfected into U2OS cells and the cells were incubated in the presence or 
absence of 50 mM ascorbate (Fig 3.6A). To control for differences in transfection 
efficiency, an RLuc reporter was used for normalization. As expected, in the absence of 50 
mM ascorbate, the ACG-initiated fusions show much lower uCC-FLuc expression than 
AUG-initiated fusions (Fig. 3.6B). The addition of 50 mM ascorbate lead to enhanced 
expression from the ACG-initiated uCC-FLuc fusion that was so great that it was visible 
even before normalization (Fig. 3.6B). In contrast, 50 mM ascorbate decreased expression 
from the AUG-initiated uCC-FLuc fusion, likely due to impaired translation elongation on 
the uCC. Both of these effects were lost with the OF-FLuc reporter. Likewise, expression 
of FLuc reporters lacking the uCC sequences and initiating with either an ACG or AUG 
codon did not respond to 50 mM ascorbate, indicating that ascorbate does not simply (or 
directly) affect the translation start codon selection (Fig. 3.6B).   
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Figure 3.6. Ascorbate controls GGP uCC translation in vivo 
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Figure 3.6. Ascorbate controls GGP uCC translation in vivo 
(A) GGP uCC-FLuc fusion reporters containing the A. thaliana GGP uCC fused in-frame 
to FLuc (mutated residues in red). (B) U2OS cells were transfected with the indicated FLuc 
reporters and incubated for 24 hr in DMEM in the absence or presence of 50 mM ascorbate-
P. FLuc activity was normalized to a co-transfected RLuc reporter (FLuc/RLuc). (C-D) 
Enhancement of initiation for the wild-type or OF-FLuc fusion was calculated by dividing 
the expression of the ACG-initiated reporter by the expression of the AUG-initiated 
reporter (ACG % AUG uCC-FLuc or ACG % AUG OF-FLuc). Error bars represent SD, * 
p < 0.005 (Student’s two-tailed t-test; n=6, assayed in duplicate).  
 
The ability of ascorbate to enhance uCC-FLuc expression was calculated by 
comparing the expression from the ACG- and AUG-initiated wild-type and OF-FLuc 
reporters (Fig 3.6C, D). After normalization to the expression of the AUG-initiated 
reporter, the addition of 50 mM ascorbate was found to increase synthesis of the ACG-
initiated reporter by 3-fold (p<0.005). This enhancement of uCC-FLuc expression is 
dependent on the wild-type uCC sequence as no enhancement was seen with the OF-FLuc 
fusion (Fig. 3.6D). Taken together, these results show that ascorbate enhances initiation at 
the ACG near-cognate start codon of the GGP uCC and that this enhancement is dependent 
on the encoded amino acid sequence of the uCC. 
To quantify how treatment with 50 mM ascorbate affects FLuc mRNA levels, RT-
qPCR was performed as described above except that FLuc specific primers were used in 
place of RLuc primers for the RT-PCR reactions.  
  181 
Table 3.4. Relative reporter mRNA levels – related to Fig. 3.6.  
 
 
Table 3.4. Relative FLuc mRNA levels for experiments in Fig. 3.6 determined by qPCR. 
Standard deviation based on three biological replicates.  
 
The relative FLuc mRNA levels were all normalized to the levels of the wild-type 
untreated ACG-initiated uCC-FLuc fusion. As shown in Table 3.4, the fold induction of 
FLuc mRNA levels in response to 50 mM ascorbate was then calculated for each reporter 
and displayed along with the fold induction in FLuc activity from Fig. 3.6. Treatment with 
50 mM ascorbate lead to a reduction in FLuc mRNA levels for the in-frame uCC-FLuc 
fusions, but the reduction in mRNA levels was not correlated with FLuc activity. In fact, 
the ACG-initiated uCC-FLuc fusion had a nearly 2-fold decrease in mRNA levels but there 
was an increase in FLuc activity. Therefore, the ability of ascorbate to increase expression 
from the ACG-initiated uCC-FLuc reporter is not due to an increase in FLuc mRNA levels.  
3.3.3. Conservation of the GGP uCC motifs is essential for initiation regulation 
The GGP uCC contains five perfectly conserved amino acid sequence motifs in 
addition to a well, though not perfectly, conserved PS motif (Fig 3.1A, B). In order to 
Reporter Description Treatment FLuc mRNA SD FLuc mRNA SD FLuc activity
pC5946 ACG uCC 0 mM L-AA 1.00 0.26
pC5946 ACG uCC 50 mM L-AA 0.67 0.26 0.67 0.26 1.35
pC5947 AUG uCC 0 mM L-AA 1.22 1.01
pC5947 AUG uCC 50 mM L-AA 0.42 0.14 0.34 0.11 0.43
pC5949 ACG OF 0 mM L-AA 1.02 0.37
pC5949 ACG OF 50 mM L-AA 2.08 1.26 2.04 1.23 0.78
pC5950 AUG OF 0 mM L-AA 1.00 0.25
pC5950 AUG OF 50 mM L-AA 1.21 0.92 1.21 0.92 0.88
Relative mRNA level Fold induction
(ACG uCC 0 mM set at 1)  (0 mM L-AA / 50 mM L-AA)
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determine which motifs are essential for ascorbate control of uCC translation, the 
conserved motifs were individually substituted with alanine residues in the native ACG-
initiated and the mutant AUG-initiated uCC-Luc fusion constructs (Fig. 3.7A). As a 
control, the non-conserved residue Ser11, upstream of the highly conserved region, was 
also mutated to alanine.  
Following transfection into U2OS cells, and growth in the absence or presence of 
50 mM ascorbate, reporter expression was measured and normalized to a co-transfected 
RLuc transfection control. As expected, the S11A substitution did not affect the response 
of the ACG-initiated or AUG-initiated fusions to 50 mM ascorbate, and the uCC-FLuc / 
RLuc levels responded like the wild-type uCC-FLuc fusion (Fig. 3.7B). For both the wild-
type and S11A mutant, expression from the ACG-initiated fusion remained the same or 
increased in presence of ascorbate while the expression of the AUG-initiated fusion 
decreased. In contrast, alanine substitutions of any of the seven conserved motifs impaired 
the ability of ascorbate to enhance initiation of the ACG reporter and to repress expression 
from the AUG-initiated reporter, comparable to what was observed with the OF-FLuc 
fusion. 
Normalization of the ACG-initiated uCC-FLuc reporter activities to the activity 
observed with the respective AUG-initiated reporter, revealed that ascorbate stimulated 
initiation for the wild-type and S11A mutant uCCs, but not for the OF reporter or any of 
the reporters in which a conserved uCC motif was substituted by alanine residues (Fig. 
3.7C). This impact of the motif mutations blunting the effect of ascorbate to stimulate uCC 
translation is most easily observed by normalizing the ACG % AUG uCC-FLuc levels at 
50 mM ascorbate to the same ratio in the absence of ascorbate (Fig. 3.7D). Interestingly, 
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uCC FLuc
      uCC: PLPHGGRGALPSEGGSPSDLLFLAGGGSSFNFFSFRF
  GGRG/4A: PLPHAAAAALPSEGGSPSDLLFLAGGGSSFNFFSFRF
     R34A: PLPHGGAGALPSEGGSPSDLLFLAGGGSSFNFFSFRF
    PS/2A: PLPHGGRGALAAEGGSPSDLLFLAGGGSSFNFFSFRF
    GG/2A: PLPHGGRGALPSEAASPSDLLFLAGGGSSFNFFSFRF
   PSD/3A: PLPHGGRGALPSEGGSAAALLFLAGGGSSFNFFSFRF
       9A: PLPHGGRGALAAAAAAAAALLFLAGGGSSFNFFSFRF
   GGG/3A: PLPHGGRGALPSEGGSPSDLLFLAAAASSFNFFSFRF





































Figure 3.7. Conservation of the motifs is essential for L-AA control of GGP uCC 
translation in vivo
Figure 3.7. Conservation of the motifs is essential for ascorbate control of GGP 
uCC translation in vivo 
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Figure 3.7. Conservation of the motifs is essential for ascorbate control of GGP uCC 
translation in vivo 
(A) GGP uCC-FLuc fusion reporters containing the A. thaliana GGP uCC fused in-frame 
to FLuc (mutated residues in red). (B) U2OS cells were transfected with the indicated FLuc 
reporters and incubated for 24 hr in DMEM in the absence or presence of 50 mM ascorbate-
P (L-AA). FLuc activity was normalized to a co-transfected RLuc reporter (FLuc/RLuc). 
(C) Enhancement of initiation for the uCC-FLuc fusion was calculated by dividing the 
expression from the ACG-initiated reporter by the expression from the corresponding 
AUG-initiated reporter (ACG % AUG uCC-FLuc). (D) The induction by 50 mM L-AA 
was calculated by normalizing the ACG % AUG uCC-FLuc levels at 50 mM L-AA by the 
values at 0 mM L-AA for each mutant (0 mM to 50 mM L-AA fold change). The 
significance of induction was calculated compared to the wild-type uCC. Error bars 
represent SD, * p < 0.005 (Student’s two-tailed t-test; n=6, assayed in duplicate). 
 
the single R34A substitution had the same effect as mutating the entire GGRG motif. In 
both cases the fold change upon addition of ascorbate was reduced from over 4-fold to less 
than 2-fold. Though the PS motif is not perfectly conserved (Fig. 3.1), alanine substitution 
for this motif abolished the ascorbate-specific effect on uCC-FLuc translation (Fig. 3.7D). 
Substitutions of the GG and PSD motifs in the middle of the uCC had the same effect as 
substituting the whole nine-amino acid region with alanines or disrupting the entire 
conserved region with the OF mutation. Finally, substituting the C-terminal glycine 
residues with three alanine residues also abolished the ascorbate-specific induction of uCC-
FLuc translation (Fig. 3.7D). Thus, all of the conserved motifs contribute to the ascorbate-
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induced regulation of initiation at the uCC near-cognate (ACG) start site and translational 
control of GGP synthesis. 
 To quantify how treatment with 50 mM ascorbate affects uCC-FLuc mRNA levels, 
RT-qPCR was performed as described previously. The FLuc mRNA levels were first 
normalized to the levels of ActB mRNA and then these relative uCC-FLuc mRNA levels 
were all normalized to the level of the wild-type uCC-FLuc reporter mRNA from the 
untreated sample (no ascorbate) (Table 3.5). Finally, as shown in Table 3.5, the fold 
induction of each uCC-FLuc mRNA in response to 50 mM ascorbate was then calculated 
and displayed along with fold induction in FLuc activity obtained from Fig. 3.7. Treatment 
with 50 mM ascorbate did not lead to a consistent increase or decrease in uCC-FLuc mRNA 
levels across all the reporters. For the wild-type uCC and S11A substitution, the uCC-FLuc 
mRNA levels did not correlate with FLuc activity, consistent with the conclusion that 
ascorbate was controlling translation of these mRNAs. Likewise, for the constructs 
containing alanine substitutions at the conserved motifs, the diminished impact of 
ascorbate on FLuc activity cannot be accounted for by systematic changes in FLuc mRNA 
levels. This lack of correlation in relative mRNA levels and uCC-RLuc activity is 
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Table 3.5. Relative reporter mRNA levels – related to Fig. 3.7.  
 
Reporter Description Treatment FLuc mRNA SD FLuc mRNA SD FLuc activity
pC5946 uCC ACG 0 mM L-AA 1.00 0.26
pC5946 uCC ACG 50 mM L-AA 0.67 0.26 0.67 0.26 0.95
pC5947 UCC AUG 0 mM L-AA 1.22 1.01
pC5947 UCC AUG 50 mM L-AA 0.42 0.14 0.34 0.11 0.23
pC5980 S11A ACG 0 mM L-AA 1.04 0.40
pC5980 S11A ACG 50 mM L-AA 1.15 0.38 1.11 0.37 1.56
pC6045 S11A AUG 0 mM L-AA 1.26 1.12
pC6045 S11A AUG 50 mM L-AA 0.92 0.25 0.74 0.20 0.37
pC5975 GGRG/4A ACG 0 mM L-AA 1.13 0.70
pC5975 GGRG/4A ACG 50 mM L-AA 0.51 0.21 0.46 0.19 0.78
pC5964 GGRG/4A AUG 0 mM L-AA 0.98 0.18
pC5964 GGRG/4A AUG 50 mM L-AA 0.54 0.17 0.55 0.18 0.59
pC5976 R344 ACG 0 mM L-AA 1.45 1.56
pC5976 R344 ACG 50 mM L-AA 1.12 0.71 0.78 0.49 0.76
pC5965 R34A AUG 0 mM L-AA 1.33 1.14
pC5965 R34A AUG 50 mM L-AA 1.74 2.05 1.30 1.53 0.69
pC5974 PS/2A ACG 0 mM L-AA 1.09 0.57
pC5974 PS/2A ACG 50 mM L-AA 0.99 0.84 0.90 0.77 0.75
pC5963 PS/2A AUG 0 mM L-AA 1.04 0.43
pC5963 PS/2A AUG 50 mM L-AA 0.81 0.63 0.77 0.60 0.63
pC5972 GG/2A ACG 0 mM L-AA 1.25 1.10
pC5972 GG/2A ACG 50 mM L-AA 0.37 0.25 0.29 0.20 0.67
pC5961 GG/2A AUG 0 mM L-AA 1.02 0.33
pC5961 GG/2A AUG 50 mM L-AA 0.66 0.32 0.64 0.31 0.55
pC5971 PSD/3A ACG 0 mM L-AA 1.09 0.59
pC5971 PSD/3A ACG 50 mM L-AA 0.69 0.32 0.63 0.30 0.73
pC5960 PSD/3A AUG 0 mM L-AA 1.17 0.83
pC5960 PSD/3A AUG 50 mM L-AA 0.79 0.29 0.68 0.25 0.50
pC5978 9A ACG 0 mM L-AA 1.05 0.48
pC5978 9A ACG 50 mM L-AA 1.96 1.30 1.87 1.24 1.00
pC5967 9A AUG 0 mM L-AA 1.02 0.35
pC5967 9A AUG 50 mM L-AA 1.01 0.90 0.99 0.88 0.60
pC5969 GGG/3A ACG 0 mM L-AA 1.03 0.35
pC5969 GGG/3A ACG 50 mM L-AA 0.65 0.19 0.63 0.18 0.59
pC5958 GGG/3A AUG 0 mM L-AA 1.07 0.46
pC5958 GGG/3A AUG 50 mM L-AA 1.14 0.67 1.07 0.63 0.48
pC5949 OF ACG 0 mM L-AA 1.02 0.37
pC5949 OF ACG 50 mM L-AA 2.08 1.26 2.04 1.23 0.71
pC5950 OF AUG 0 mM L-AA 1.00 0.25
pC5950 OF AUG 50 mM L-AA 1.21 0.92 1.21 0.92 0.76
(ACG uCC 0 mM set at 1)  (0 mM L-AA / 50 mM L-AA)
Relative mRNA level Fold induction
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Table 3.5. Relative FLuc mRNA levels for experiments in Fig. 3.7 determined by qPCR. 
Standard deviation based on three biological replicates.  
 
3.3.4. Conservation of the motif spacing is essential for regulation of uCC 
translation 
The multiple sequence alignments of plant GGP uCC elements revealed that the 
spacing between the conserved motifs in the uCCs is perfectly maintained across all the 
plant species (Fig. 3.1A). To assess whether the spacing between the conserved motifs is 
important, we examined the effect of inserting residues between conserved motifs within 
the uCC (Fig. 3.8A). One or three alanine residues were inserted upstream of the first 
conserved motif or between the conserved proline and aspartic acid residues in the middle 
of the conserved uCC motifs. As described for the previous uCC-FLuc reporters, the 
alanine insertion reporters were generated in pairs with the native (ACG) or AUG start 
sites. The reporters, along with the RLuc transfection control plasmid, were transfected 
into U2OS cells grown in the presence or absence of 50 mM ascorbate.  
FLuc activity was normalized to RLuc activity from the co-transfected control 
plasmid (Fig. 3.8B). The reporters with one or three alanine residues inserted after Pro28 
behaved the same as the wild-type uCC-FLuc fusion: the ACG-initiated fusion expression 
increased and AUG-initiated fusion expression decreased with the addition of 50 mM 
ascorbate. Thus, inserting alanine residues upstream of the conserved region did not affect 
translation of the ACG- or AUG-initiated uCC-RLuc fusions. In contrast, inserting one or 
three alanine residues after Pro44, thus changing the spacing between the conserved Pro44 
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and Asp46 residues, caused the fusions to behave like the OF control with modest 
reductions in uCC-FLuc expression upon addition of 50 mM ascorbate.  
To quantify the enhancement of initiation in the presence of ascorbate, luciferase 
activity obtained with the ACG-initiated uCC-FLuc reporter was normalized to the levels 
observed with the AUG-initiated control (Fig. 3.8C). After normalization, the reporters 
with the alanine residues inserted upstream of the conserved region showed a noticeable 
increase in ACG-initiated uCC-FLuc expression at 50 mM compared to 0 mM ascorbate. 
This was not true for the insertions within the conserved region.  
To more clearly reveal the impacts of the insertions on uCC translation, the data 
were normalized again comparing the levels observed in the presence versus the absence 
of ascorbate. As shown in Fig. 3.8D), the native uCC, as well as the mutants containing 
one or three alanine residues upstream of the conserved motifs, showed a 2–4-fold increase 
in uCC translation in the presence of ascorbate. In contrast, adding even a single alanine 
residue in the middle of the conserved region, like the OF mutation, abolished the ability 
of ascorbate to induce initiation at the ACG start site of the native uCC (Fig. 3.8D) and to 
inhibit translation elongation on the AUG-initiated uCC (Fig. 3.7D). As a single amino 
acid insertion within the middle of the conserved region abolished regulation, these results 
provide a rationale for the perfect conservation of spacing between the conserved motifs in 
the amino acid sequence alignment (Fig. 3.1A, B). 
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uCC FLuc
    uCC:    PLPHGGRGALPSEGGSPSDLLFLAGGGSSFNFFSFRF
+1A@P28:   PALPHGGRGALPSEGGSPSDLLFLAGGGSSFNFFSFRF
+3A@P28: PAAALPHGGRGALPSEGGSPSDLLFLAGGGSSFNFFSFRF 
+1A@P44:    PLPHGGRGALPSEGGSPASDLLFLAGGGSSFNFFSFRF 
+3A@P44:    PLPHGGRGALPSEGGSPAAASDLLFLAGGGSSFNFFSFRF
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Figure 3.8. Conservation of motif spacing is essential for regulation by ascorbate 
(A) GGP uCC-FLuc fusion reporters containing the A. thaliana GGP uCC fused in-frame 
to FLuc (inserted and mutated residues in red). (B) U2OS cells were transfected with the 
indicated FLuc reporters and incubated for 24 hr in DMEM in the absence or presence of 
50 mM ascorbate-P (L-AA). FLuc activity was normalized to a co-transfected RLuc 
reporter (FLuc/RLuc). (C) Enhancement of initiation for the uCC-FLuc fusion was 
calculated by normalizing the activity from the ACG-initiated reporter to the activity from 
the corresponding AUG-initiated reporter (ACG % AUG uCC-FLuc). (D) The induction 
of uCC translation by 50 mM L-AA was calculated by dividing the normalized ACG % 
AUG uCC-FLuc levels at 50 mM L-AA by the ACG % AUG uCC-FLuc at 0 mM L-AA 
for each mutant (0 mM to 50 mM L-AA fold change). The significance of induction was 
calculated in comparison to the wild-type uCC. Error bars represent SD, * p < 0.005 
(Student’s two-tailed t-test; n=6, assayed in duplicate). 
 
To quantify how treatment with 50 mM ascorbate affects FLuc mRNA levels, RT-
qPCR was performed. Human U2OS cells were transfected with the reporters used in Fig. 
3.8 in the manner used for luciferase assays but scaled up 40X and using 6-well cell  
culture plates. After incubation in the presence or absence of 50 mM ascorbate, total RNA 
was isolated and relative FLuc mRNA levels were determined as described previously. 
The relative FLuc mRNA levels were determined in comparison to the 
endogenous ActB mRNA and then these ratios were normalized to the relative FLuc 
mRNA level obtained for the untreated ACG-initiated uCC-FLuc reporter. As shown in  
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Table 3.6. Relative reporter mRNA levels – related to Fig. 3.8. 
 
 
Table 3.6. Relative FLuc mRNA levels for experiments in Fig. 3.8 determined by qPCR; 
standard deviation based on three biological replicates.  
 
Table 3.6, the fold induction in FLuc mRNA levels in response to 50 mM ascorbate was 
then calculated for each reporter and displayed along with the fold induction in FLuc 
activity obtained from Fig. 3.8. Treatment with 50 mM ascorbate did not lead to a 
Reporter Description Treatment FLuc mRNA SD FLuc mRNA SD FLuc activity
pC5946 uCC ACG 0 mM L-AA 1.00 0.26
pC5946 uCC ACG 50 mM L-AA 0.67 0.26 0.67 0.26 1.21
pC5947 UCC AUG 0 mM L-AA 1.22 1.01
pC5947 UCC AUG 50 mM L-AA 0.42 0.14 0.34 0.11 0.33
pC6194 +1A@P28 ACG 0 mM L-AA 0.98 0.19
pC6194 +1A@P28 ACG 50 mM L-AA 0.80 0.71 0.82 0.73 1.23
pC6198 +1A@P28 AUG 0 mM L-AA 1.18 0.73
pC6198 +1A@P28 AUG 50 mM L-AA 0.24 0.09 0.20 0.08 0.41
pC6195 +3A@P28 ACG 0 mM L-AA 1.08 0.53
pC6195 +3A@P28 ACG 50 mM L-AA 17.12 43.16 15.86 39.99 1.09
pC6199 +3A@P28 AUG 0 mM L-AA 1.01 0.32
pC6199 +3A@P28 AUG 50 mM L-AA 1.06 0.28 1.05 0.27 0.48
pC6196 +1A@P44 ACG 0 mM L-AA 1.12 0.66
pC6196 +1A@P44 ACG 50 mM L-AA 0.31 0.10 0.28 0.09 0.58
pC6200 +1A@P44 AUG 0 mM L-AA 1.11 0.62
pC6200 +1A@P44 AUG 50 mM L-AA 0.46 0.08 0.41 0.07 0.85
pC6197 +3A@P44 ACG 0 mM L-AA 1.00 0.29
pC6197 +3A@P44 ACG 50 mM L-AA 1.33 0.95 1.33 0.95 0.82
pC6201 +3A@P44 AUG 0 mM L-AA 1.46 1.56
pC6201 +3A@P44 AUG 50 mM L-AA 3.18 4.58 2.17 3.13 0.73
pC5949 OF ACG 0 mM L-AA 1.02 0.37
pC5949 OF ACG 50 mM L-AA 2.08 1.26 2.04 1.23 0.88
pC5950 OF AUG 0 mM L-AA 1.00 0.25
pC5950 OF AUG 50 mM L-AA 1.21 0.92 1.21 0.92 1.07
Relative mRNA level Fold induction
(ACG uCC 0 mM set at 1)  (0 mM L-AA / 50 mM L-AA)
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consistent increase or decrease in FLuc mRNA levels across all the sets of reporters. In 
cells transfected with the uCC ACG reporter, FLuc mRNA levels decreased while FLuc 
activity increased. This was also true for the +1A@P28 ACG reporter, confirming that 
ascorbate induced translation of these mRNAs. While the +1A@P44 reporter showed 
decreases in both mRNA levels and Luc activity, which might indicate that the reduced 
mRNA levels contributed to the reduced uCC-Luc activity, the +3A@P44 reporter with 
native ACG start codon showed elevated mRNA levels but not FLuc activity. Thus, the 
apparent insensitivity associated with the +3A@P44 mutation cannot be attributed to 
masking mRNA changes. Taken together, are consistent with the conclusion that disrupting 
the spacing of the conserved motifs in the uCC interferes with ascorbate control of uCC 
translation.  
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3.4. Ascorbate regulates uCC translation in rabbit reticulocyte lysate (in vitro) 
3.4.1. Significance and rationale for study 
While the experiments in U2OS cells established that ascorbate acts through the uCC 
to regulate GGP synthesis, the cell-based assays limit the ability to test the ascorbate 
specificity of regulation and to monitor ribosome stalling during uCC translation. Both of 
these tests can be more easily performed using in vitro translation extracts. In their studies 
examining the AAP and arginine-mediated regulation of translation, Wang and Sachs 
(1997, 1999) used several different in vitro translation systems including commercial 
wheat germ extracts, and lab-prepared N. crassa and S. cerevisiae extracts. As the GGP 
mRNA is native to plants including wheat, we first considering using wheat germ extracts 
to monitor ascorbate regulation of GGP mRNA translation. However, in preliminary 
experiments, we found that addition of ascorbate dramatically inhibited translational 
activity in the wheat germ extracts (data not shown), rendering them unsuitable for  
studying ascorbate regulation of GGP mRNA translation. In contrast to the wheat germ 
extracts, we found that general translational activity in commercial rabbit reticulocyte 
lysates (RRLs) was maintained upon addition of ascorbate, and therefore chose to study 
GGP mRNA translation in RRLs. There is precedent for studying nascent chain dependent 
stalling in non-native translation systems. AAP, a fungal peptide, has been studied in wheat 
germ extracts as well as rabbit reticulocyte lysates (Wang et al., 1999; Wang and Sachs, 
1997; Wu et al., 2012). In addition, AdoMet-induced translational stalling on the CGS1 
mRNA from A. thaliana has been studied using rabbit reticulocyte lysates (Onouchi et al., 
2008). Despite the fact that mammals do not express cystathionine gamma-synthase, 
  195 
encoded by CGS1, AdoMet induced a sequence-dependent translation elongation arrest in 
rabbit reticulocyte lysate (Onouchi et al., 2008).  
The mRNAs for in vitro translation assays were generated by in vitro transcription. 
The GGP 5’-UTR from the transcription start site up to the stop codon of the uCC was 
cloned downstream of a T7 phage promoter (Fig. 2.2A). Like the in vivo reporters, the uCC 
was modified to remove the internal OF uORF. As preliminary experiments, see below, 
revealed that start codon selection stringency was relaxed in the RRLs, this system would 
not be effective for studying ascorbate stimulation of uCC translation; however, as 
ascorbate impaired AUG-initiated uCC-luciferase expression in cells (Fig. 3.6), we 
hypothesized that a similar response could be examined in vitro. Therefore, the translation 
start site of the uCC was changed to an AUG codon, but kept in its native context. An OF 
control was also constructed by deleting one nucleotide prior to the highly conserved motifs 
and inserting one nucleotide after the last sense codon of the uCC (Fig. 2.1A-C). The uCC 
was fused directly to FLuc, followed by a 22-nt 3’-UTR from the LucPolyA50 vector, a 
Poly(A)55 tail, and a DraI restriction site for linearization of the plasmid (Fig. 2.2A). In 
brief, plasmids were linearized and then T7 RNA polymerase was used to transcribe the 
mRNAs. The mRNAs were capped by incubation with purified recombinant vaccinia virus 
capping enzyme, and the mRNAs were translated in RRLs and translational activity was 
monitored by measuring luciferase activity.  
3.4.2. Optimization of RRLs for in vitro translation  
In order to ensure reproducibility, account for batch-to-batch variation in RRLs, 
and to faithfully monitor regulation of translation, it is critical to ensure that mRNA 
concentrations and incubation times are in the linear range of response. To determine the 
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linear range for time and mRNA concentration, a simple FLuc reporter was used (Fig. 2.3). 
The reporter, under the control of the phage T7 promoter, contained the GGP 5’-UTR from 
the transcription start site up to the start codon of the uCC fused to the AUG start codon of 
FLuc. To ensure that FLuc initiation could only occur at the AUG start codon, nucleotide 
substitutions were used to create stop codons in all three reading frames immediately 
upstream of the start site (Fig. 2.3). As described above for the uCC-FLuc fusions, the FLuc 
stop codon was left intact, followed by a 22-nt 3’-UTR from the LucPolyA50 vector, a 
Poly(A)55 tail, and a DraI restriction site for linearization of the plasmid.  
The FLuc mRNA was translated in RRL and aliquots were removed every 15 minutes up 
to 2 hours and then analyzed for luciferase activity (Fig. 3.9A). FLuc activity was near 
background levels at 15 minutes but reached a plateau by 1 hour, so 30 min was selected 
as the optimal incubation time for the in vitro translation assays. To determine the linear 
range for mRNA concentrations in the assay, 25 ng to 100 ng of the same luciferase mRNA 
preparation was added to RRL and incubated for 30 min before the FLuc activity was 
measured (Fig. 3.9B). Luciferase activity nearly doubled when the mRNA amount was 
increased from 25 ng to 50 ng; however, no further increases in luciferase activity were 
observed when the mRNA level exceeded 50 ng. Therefore, 25 ng was selected as the ideal 
amount of mRNA for the RRL assays.  
 While ascorbate enhanced initiation at the ACG start codon of the uCC in the cell-
based assays (Fig. 3.6), it was unclear whether this could be observed in vitro. Ionic 
strength, particularly the magnesium concentration, is known to dramatically affect start 
codon selection stringency in RRL (Kearse and Wilusz, 2017; Kozak, 1989). To optimize 
the magnesium concentration in the RRL, we generated a set of FLuc reporters with three  























Figure 3.9. Determination of the linear range for incubation time and amount of 
FLuc mRNA translated in RRL
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Figure 3.9. Determination of the linear range for incubation time and amount of 
FLuc mRNA translated in RRL  
(A) 25 ng of FLuc mRNA was translated in RRL, and luciferase activity was measured at 
increasing time points from 15 min to 120 min. (B) FLuc mRNA amounts from 0 ng to 
100 ng were translated in RRL, and luciferase activity was measured at 30 min.  
 
different start codons: AUG, ACG, and AAA (Fig. 2.3). To prevent any luciferase activity 
due to initiation at potential upstream start sites, stop codons were added in all three frames 
within the first 14 nucleotides upstream of the start codon (Fig. 2.3). The FLuc reporter 
mRNAs were transcribed in vitro, capped, and then translated in RRL in the presence of 
increasing concentrations of magnesium. The magnesium concentration in Promega’s 
Flexi RRL in vitro translation assay system varies from lot to lot. The basal magnesium 
concentration in the RRLs used for our studies was 1.8 mM. The ACG-, AAA- and AUG-
initiated luciferase reporter mRNAs were incubated in the RRLs in the presence of 1.8 mM 
to 2.2 mM magnesium (increasing by increments of 0.1 mM). Luciferase activities for all 
three reporters were measured and normalized to the values obtained with the AUG-
initiated luciferase reporter (Fig. 3.10). At 1.8 mM magnesium, translation was impaired 
and the AUG-initiated FLuc activity was low (data not shown); the ACG-initiated 
luciferase activity was even lower at ~10% of the level obtained with the AUG-initiated 
reporter (Fig. 3.10). At 2.0 mM magnesium, the yield of AUG-initiated luciferase reached 
its maximum; however, start codon selection stringency was relaxed and the luciferase 
activity from the ACG-initiated reporter was now ~15% of the level obtained with the 
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AUG-initiated reporter. At magnesium concentrations above 2.0 mM, the luciferase 
activity from the ACG-initiated reporter was over 20% of the value obtained with the wild-
type reporter. According to previous studies, an ACG codon is used at ~12% the efficiency 
of an AUG start codon in mammalian cells (Ivanov et al., 2010b; Kearse and Wilusz, 2017). 
Based on this information and the results of magnesium titration assay, we determined that 
1.9 mM magnesium (Fig. 3.10) was the optimal concentration to obtain acceptable levels 
of translation with normal start site selection stringency.   
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Figure 3.10. Optimization of RRL magnesium concentration 
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Figure. 3.10. Optimization of RRL magnesium concentration  
(A) FLuc transcripts with three start sites (AAA, ACG, or AUG) were translated in RRL 
with increasing concentrations of magnesium acetate. The luciferase activities from the 
ACG- and AAA-initiated mRNAs were normalized to the activity from the AUG-initiated 
transcript (ACG % AUG and AAA % AUG) and then plotted to define the magnesium 
concentration that optimized translational efficiency and  start codon selection stringency 
(n=3).  
 
3.4.3. Ascorbate regulates uCC translation in rabbit reticulocyte lysate (in vitro) 
To test whether ascorbate affects uCC translation in vitro, mRNAs encoding AUG-
initiated wild-type and OF-FLuc fusions (Fig. 3.11A) were translated in RRL in the 
presence and absence of ascorbate. Adding unbuffered ascorbate to RRL disrupted the pH 
of the extract and impaired the translational activity. To avoid this complication, the 
ascorbate was buffered by dissolving ascorbate in 750 mM HEPES. To monitor the impact 
of ascorbate on GGP uCC translation, increasing concentrations of ascorbate were added 
to RRLs and then the wild-type or OF-FLuc mRNA was added to the translation mix. 
Translational activity was determined by measuring FLuc activity (Fig 3.11B). Because 
the translational efficiency of the in vitro transcribed mRNAs varied among different 
preparations and in different translation reactions, the FLuc activity for each reaction was 
normalized to the activity observed with the same mRNA in a reaction lacking ascorbate 
(Fig. 3.11C). With the addition of 5 mM ascorbate, there was a 4-fold decrease in uCC-  














































Figure 3.11. L-AA regulates uCC elongation in RRLFigure 3.11. Ascorbate regulates uCC elongation in RRL 
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Figure 3.11. Ascorbate regulates uCC elongation in RRL 
(A) AUG-initiated in vitro transcribed GGP uCC-FLuc mRNA fusions, or an OF control, 
were (B) translated in RRL in the presence of increasing concentrations of HEPES-
buffered L-ascorbic acid (L-AA). (C) FLuc activity at each L-AA concentration was 
normalized to the level obtained in the absence of L-AA for each mRNA. Error bars 
represent propagation of error, * p < 0.005 (Student’s two-tailed t-test; n=3). 
 
FLuc activity (to 27%; p<0.005), but no decrease with the OF-FLuc control. At 10 mM 
ascorbate, the inhibition of the uCC-FLuc reporter activity was even greater (to 13%); 
however, translation of the OF-FLuc control was also slightly affected (to 83%). At 20 mM 
ascorbate, translation of the uCC-FLuc mRNA was barely detectable, while the OF control 
was reduced by only about 60%. When the ascorbate concentration was increased to 30 
mM, the FLuc activity for both the wild-type and OF fusions was severely inhibited. 
Presumably, at this high concentration of ascorbate, the translational activity of the RRL, 
the stability of the mRNA reporter, or the luciferase enzymatic activity was severely 
impaired. Based on these data, we conclude that 5 mM ascorbate is the optimal 
concentration to monitor uCC-specific inhibition of translation in RRLs. 
 To confirm that the reduction in FLuc activity upon addition of 5 mM ascorbate is 
due to a reduction in translation of the uCC-FLuc mRNA and not due to ascorbate affecting 
FLuc enzymatic activity, we used Western analyses to assess FLuc protein levels (Fig. 
3.12). The wild-type and OF-FLuc mRNAs (Fig. 3.12A) were translated in RRL in the 
presence or absence of 5 mM ascorbate. The reaction products were separated by  
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Figure 3.12. The reduction in FLuc levels in the presence of ascorbate is due to 
a uCC-specific reduction in uCC-FLuc mRNA translation in vitro 
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Figure 3.12. The reduction in FLuc levels in the presence of ascorbate is due to a 
uCC-specific reduction in uCC-FLuc mRNA translation in vitro 
In vitro transcribed and AUG-initiated wild-type or OF GGP uCC-FLuc mRNAs (A) were 
translated in RRL in the absence or presence of 5 mM HEPES buffered L-ascorbic acid (L-
AA). (B) Translation products (5 or 10 µg) were separated on a 4-12% Bis-Tris NuPAGE 
gel, and then transferred to a nitrocellulose membrane. The membrane was then probed 
with anti-FLuc and anti-GAPDH antibodies. The blot is representative of three independent 
experiments. (C) Band intensity on the Western blot was quantified using ImageJ software 
and the reduction in total FLuc protein in the presence of L-AA was calculated by first 
normalizing to GAPDH and then normalizing again to FLuc levels obtained in the absence 
of L-AA. Error bars represent SD, p =0.01 (Student’s two-tailed t-test; n=3). 
 
electrophoresis on a NuPAGE gel, transferred to a nitrocellulose membrane, and the 
membrane was then probed with antibodies that detect FLuc and GAPDH (Fig. 3.12B). 
Addition of ascorbate dramatically decreased the yield of FLuc protein from the 
wild-type, but not the OF reporter (Fig. 3.12B). To quantify the changes in FLuc protein 
levels, the Western signals for FLuc were normalized to the GAPDH signals to correct for 
loading differences between lanes. Next, the corrected FLuc levels from the reactions 
containing 5 mM ascorbate were normalized to the FLuc levels in the reactions lacking 
ascorbate. As shown in Fig. 3.12C, addition of ascorbate significantly lowered uCC-FLuc 
synthesis to around 25% of the level obtained with the OF-FLuc reporter (p=0.01). These 
results are consistent with the luciferase reporter assays and indicate that the reduction in 
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FLuc activity in the in vitro translation assays upon addition of ascorbate is due to a uCC-
specific inhibition of translation. 
3.4.4. The uCC motifs are essential for ascorbate inhibition of  uCC-FLuc 
translation  
In order to examine the role of the conserved uCC motifs in a potential ascorbate 
induced elongation pause, each of the five motifs was disrupted using alanine substitutions 
(Fig. 3.13A). As described above for the mammalian cell reporter assays, the GGRG motif 
was modified to four alanines and the perfectly conserved Arg34 residue was also 
individually mutated to alanine. The conserved PS motif was replaced by two alanine 
residues, as was the GG motif, and three alanine residues were substituted for the PSD 
motif in the middle of the uCC conserved region. The block of the uCC beginning with the 
PS motif and ending with the PSD motif was also mutated to a block of nine alanine 
residues. Finally, the C-terminal glycine repeat was replaced by three alanine residues. 
Like the set of alanine substitutions used for the mammalian cell reporter assays, an S11A 
substitution was included as a control. As Ser11 is upstream of the GGP uCC conserved 
region, we did not expect an alanine substitution at this position to affect ascorbate 
regulation of uCC-FLuc translation. 
The mRNAs containing the alanine substitution mutations, along with mRNAs 
containing the wild-type uCC and the OF control, were translated in RRL in the presence 
or absence of 5 mM ascorbate. Total FLuc activity varied for each reporter, but only the 
wild-type and S11A mutant uCC-FLuc fusions showed a specific reduction in FLuc 
activity in the presence of 5 mM ascorbate (Fig. 3.13B). Like the OF control, every 
substitution targeting a conserved motif resulted in a loss of sensitivity to ascorbate. To 
  207 
account for differences in translation efficiency between the reporters even the in the 
absence of ascorbate, the FLuc activity from each reporter obtained from reactions 
performed in the presence of 5 mM ascorbate was normalized to the activity obtained from 
the same reporter in the absence of ascorbate (Fig. 3.13C). Mirroring the in vivo results, 
only the wild-type and S11A mutant uCC-FLuc fusions showed a significant reduction in 
FLuc activity in the presence of ascorbate (p<0.005). Alanine substitutions at any of the 
conserved motifs abolished sensitivity to ascorbate to the same extent as the OF control. 
These results are nearly identical to the results obtained when the same substitutions were 
made in the reporters for mammalian cell experiments. Taken together, these results further 
support our hypothesis that all of the conserved motifs play a role in reducing uCC-FLuc 
translation in the presence of ascorbate. We hypothesize that the reduction in uCC-FLuc 
activity is due to an elongation pause during translation of the conserved region in the 
presence of ascorbate. 




      uCC: PLPHGGRGALPSEGGSPSDLLFLAGGGSSFNFFSFRF
  GGRG/4A: PLPHAAAAALPSEGGSPSDLLFLAGGGSSFNFFSFRF
     R34A: PLPHGGAGALPSEGGSPSDLLFLAGGGSSFNFFSFRF
    PS/2A: PLPHGGRGALAAEGGSPSDLLFLAGGGSSFNFFSFRF
    GG/2A: PLPHGGRGALPSEAASPSDLLFLAGGGSSFNFFSFRF
   PSD/3A: PLPHGGRGALPSEGGSAAALLFLAGGGSSFNFFSFRF
       9A: PLPHGGRGALAAAAAAAAALLFLAGGGSSFNFFSFRF
   GGG/3A: PLPHGGRGALPSEGGSPSDLLFLAAAASSFNFFSFRF
       OF: PLPQEDVELCRLKAAALPISSFSPVAVPALTSFPLGF
A
S11A














































Figure 3.13. Conservation of the uCC motifs is essential for L-AA control of GGP 
uCC translation in vitro
Figure 3.13. Conservation of the uCC motifs is essential for ascorbate control 
of GGP uCC elo gation in vitro 
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Figure 3.13. Conservation of the uCC motifs is essential for ascorbate control of 
GGP uCC elongation in vitro 
AUG-initiated in vitro transcribed mRNAs with alanine substitutions of conserved motifs 
(A) were translated in RRL in the absence or presence of 5 mM HEPES-buffered L-
ascorbic acid (L-AA). (B) FLuc activity was measured for each sample. (C) Because FLuc 
activity varied by mRNA, the response to L-AA was calculated for each mRNA by 
normalizing the activity obtained in the presence of L-AA to the activity obtained in the 
absence of L-AA (5 mM % 0 mM L-AA). Significance [* p < 0.005 (Student’s two-tailed 
t-test; n=3)] depicts the difference in FLuc activity at 5 mM compared to 0 mM L-AA; 
error bars represent propagation of error. 
 
3.4.5. uCC-FLuc mRNA translation  is inhibited specifically by L-ascorbate  
 In order to examine the specificity of L-ascorbate for translational control of the 
GGP uCC, we tested whether four chemicals related to L-ascorbate could also regulate 
uCC translation (Fig. 3.14A-E). The chemicals tested included the D-isoform of L-ascorbic 
acid, D- isoascorbic acid (D-iso), differing in structure from L-ascorbic acid at one chiral 
center. We also tested dehydroascorbic acid (DHAA), the oxidized form of L-ascorbic acid, 
which is present in cells and likely in the translation reaction mix because L-ascorbic acid 
spontaneously oxidizes to DHAA. In addition, we tested L-Galactono-1,1-lactone (Gal.), 
the precursor one step upstream of L-ascorbic acid in the plant ascorbate biosynthetic 
pathway, and L-Gulono-1,4-lactone (Gul.), the precursor one step upstream of L-ascorbic 
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acid in the animal ascorbate biosynthetic pathway. L-ascorbate is the oxidized product of 
these two precursors that differ from each other at one chiral center. 
To test whether these structurally similar chemicals could also regulate uCC 
translation, the wild-type and OF uCC-FLuc mRNAs (Fig. 3.15A) were translated in RRL 
in the presence or absence of 5 mM ascorbate or the related chemicals. As shown in Fig. 
3.15B, although FLuc activity was lower for the wild-type versus the OF uCC-FLuc 
reporter even in the presence of just the HEPES buffer, both chemical- and reporter-
specific effects were visible before normalization of the data. Addition of ascorbate 
reduced uCC-FLuc activity from the wild-type reporter by about 3-fold, while uCC-FLuc 
activity from the OF reporter was reduced only about 1.5-fold. D-isoascorbic acid had a 
non- specific effect and reduced both wild-type and OF uCC-FLuc translation about 1.5-
fold. The addition of DHAA severely impaired translation in the RRL and almost no 
measurable FLuc activity was observed with either mRNA upon addition of 5 mM DHAA. 
Unlike DHAA, the addition of Gal. or Gul. had little effect on translation of either reporter. 
For both the wild-type and OF uCC-FLuc reporters, the FLuc activity obtained in reactions 
containing each chemical was normalized to the FLuc activity obtained in reactions 
containing an equal volume of HEPES buffer. As shown in Fig. 3.15C, the wild-type uCC 
fusion was twice as sensitive to 5 mM ascorbate as the OF control (p<0.005). In contrast, 
no uCC-specific decrease in FLuc activity was observed in response to 5 mM D-iso, Gal., 
or Gul. These data show that regulation of GGP uCC translation is highly specific to 
ascorbic acid, and that the sensing mechanism can distinguish between the L and D 
isoforms as well as the oxidative state of the molecule. 
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Figure 3.14. Chemical structures of L-AA and chemical analogs Figure 3.14. Chemical structures of L-ascorbic acid and chemical analogs  
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Figure 3.14. Chemical structures of L-ascorbic acid and chemical analogs  
Structures of (A) L-ascorbic acid (L-AA, red label), (B) D-isoascorbic acid (D-iso, green 
label), (C) L-Dehydroascorbic acid (DHAA, purple label), (D) L-Galactono-1,4-lactone 
(Gal., orange label), and (E) L-Gulono-1,4-lactone (Gul., black label).  
 
FLuc activity obtained in reactions containing each chemical was normalized to the 
FLuc activity obtained in reactions containing an equal volume of HEPES buffer for each 
reporter (Fig. 3.15C). Although ascorbate reduced OF-FLuc activity as well as uCC-FLuc 
activity, after normalization the uCC fusion was twice as sensitive to 5 mM ascorbate as 
the OF control (p<0.005). There was no uCC specific decrease in FLuc activity in response 
to 5 mM D-iso, Gal., or Gul, but D-iso appeared to reduce translation to about the same 
extent as ascorbate (note similar decreases in FLuc yield for both the wild-type and OF-
FLuc reporter mRNAs). Gal. and Gul. only modestly impaired translation of both the wild-
type and OF reporters. These data show that regulation of GGP uCC translation is highly 
specific to ascorbic acid and can distinguish between the L and D isoforms of the molecule. 
The regulatory mechanism can also distinguish between the oxidative states of the 
chemicals. 
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Figure 3.15. The uCC-specific reduction in uCC-FLuc translation is unique to L-
ascorbic acid 
AUG-initiated in vitro transcribed wild-type or OF GGP uCC-FLuc mRNA fusions (A) 
were translated in RRL with the following additions: 5 mM HEPES (buffer, blue) or 5 mM 
HEPES-buffered L-AA (red), D-iso (green), DHAA (purple), Gal. (orange), or Gul. 
(black). (B) FLuc activity levels obtained following translation of each mRNA following 
addition of 5 mM of each chemical. C) The response to each chemical was calculated by 
normalizing the FLuc activity obtained in the presence of each chemical versus the buffer 
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3.5. Ascorbate regulation of the uCC is mediated by ribosome pausing during 
translation elongation 
3.5.1. Significance and rationale for study 
In the uCC model developed from the study of AZIN1 mRNA translational control 
by polyamines (Ivanov et al., 2018) and arg-2 mRNA translational control by arginine 
(Freitag et al., 1996; Wang et al., 1998; Wei et al., 2012), inhibition of translation 
elongation on the uCC is mediated in part by conserved residues in the uCC and by 
components of the elongating ribosome, either through inhibition of an elongation factor 
or the PTC by the metabolite. The results of the mammalian cell and in vitro RRL assays 
reported here suggest that ascorbate impairs translation elongation in a GGP uCC-specific 
manner. We performed in vitro and in vivo assays to test the hypothesis that translating 
ribosomes stall while translating the GGP uCC in the presence of ascorbate. 
3.5.2. uCC regulation is due to ribosome pausing during translation 
During translation elongation, the nascent chain is attached to the peptidyl-tRNA 
until a stop codon enters the A site and termination factors release the completed 
polypeptide. If translation stalls during elongation, the nascent chain will remain attached 
to the peptidyl-tRNA. In vitro assays examining the production of completed polypeptides 
and peptidyl-tRNA can be used to assess stalling during translation elongation. Translation 
reaction products can be resolved by SDS-PAGE and then subjected to Western analysis 
to detect the translated peptide. The presence of a tRNA adds approximately 25 kDa to the 
mass of the nascent chain. The presence of peptidyl-tRNA products in the reaction can be 
assessed by RNAse treatment. The tRNA is susceptible to nuclease digestion and will be 
removed from the nascent chain with the addition of RNaseA. The molecular weight of a 
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peptidyl-tRNA product decrease by about 25 kDa following treatment with RNAse. If the 
elongation stall occurs close to the stop codon, the nascent chain released by RNAse 
digestion will co-migrate with the protein produced by authentic translation termination. 
Comparison of the levels of peptidyl-tRNA and free peptide in assays not treated with 
RNAse can provide an estimate of the severity of the elongation defect. Because the 
aminoacyl bond linking the nascent chain to the tRNA is susceptible to high pH, it is 
essential that the sample buffer and SDS-PAGE be at neutral or slightly acidic pH. 
Analysis of peptidyl-tRNA levels has previously been used to demonstrate 
translational stalling during termination at a uORF on the human cytomegalovirus (hCMV) 
UL4 gene encoding the glycopeptide gp48. Before adapting this assay for analysis of GGP 
uCC translation, we examined stalling on the UL4 uORF as a proof of concept. The 5’ 
leader of the hCMV UL4 mRNA contains three AUG-initiated uORFs (Schleiss et al., 
1991). The uORF2, consisting of 22 codons, represses gp48 synthesis during the early 
stages of hCMV infection (Janzen et al., 2002; Schleiss et al., 1991). The repressive nature 
of uORF2 is due to a C-terminal PP-stop motif that impairs translation termination, leading 
to persistence of the uORF2 peptidyl-tRNA linkage with the peptidyl-tRNAPro in the P site 
and the termination codon in the A site (Bhushan et al., 2010; Degnin et al., 1993; Janzen 
et al., 2002). In order to monitor uORF2 translation in vitro, a FLAG epitope was inserted 
at the N-terminus of the uORF (immediately downstream of the AUG start codon). It is 
critical to tag the uCC at the N- versus the C-terminus to ensure that the epitope would be 
synthesized regardless of any elongation defect (Fig. 3.16A). An 130-residue linker peptide 
derived from the human chorionic gonadotropin beta protein was added between the FLAG 
epitope and the uORF to increase the molecular weight of the peptide and to ensure that 
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the FLAG-linker-uORF product would be well-resolved on SDS-PAGE from the abundant 
globin proteins present in the RRL. To conduct the assay, the mRNA encoding the uORF2 
fusion protein was translated in RRL in the presence or absence of 5 mM ascorbate. 
Following translation, the reaction was split into two fractions: one was treated with 
RNaseA to degrade the tRNA and release the nascent chain; while the second was treated 
with water to leave the peptidyl-tRNA intact. Following PAGE, Western analyses using 
anti-FLAG antibodies were used to monitor the levels of the peptidyl-tRNA and the 
released nascent chain peptide. 
As shown in Fig. 3.16B, two prominent products were detected when the FLAG-
linker-uORF2 construct was translated in RRL: an ~39 kDa product and a 25 kDa product 
corresponding to the predicted mass of the FLAG-linker-uORF2 peptide. Treatment of the 
sample with RNAse prior to PAGE results in loss of the 39 kDa product and increased 
amounts of the 25 kDa protein. This behavior is consistent with the notion that the 39 kDa 
product is peptidyl-tRNA stalled at the stop codon and that treatment with RNAse releases 
the full-length peptide. As expected, addition of 5 mM ascorbate to the translation reactions 
did not affect the levels of the peptidyl-tRNA or released peptide (Fig. 3.16B).     
To make a detectable peptidyl-tRNA reporter for the GGP uCC, the same FLAG 
epitope and human chorionic gonadotropin beta peptide linker used in the gp48 uORF2 
experiments was added at the N-terminus of the uCC (immediately downstream of the start 
codon) (Fig. 3.16C). As a control, corresponding constructs were generated using the uCC 
with the same OF mutation as described for the mammalian and in vitro translation 
reporters. In addition to these FLAG-linker-uCC constructs, two additional constructs were  
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Figure 3.16. uCC regulation is due to ribosome pausing during translation
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Figure 3.16. uCC regulation is due to ribosome pausing during translation 
mRNAs encoding AUG-initiated FLAG-linker-gp48 uORF2 fusions (A) were transcribed 
in vitro and then (B) translated in RRL in the absence or presence of 5 mM HEPES-
buffered L-AA. Following translation, the reactions were split into two equal halves, and 
one half was treated with RNaseA to digest the tRNA. The samples were prepared with 
Laemmli buffer, run on a 10% Bis-Tris NuPAGE gel, and then immunoblotted using anti-
FLAG antibodies. FL = Full-length released peptide, diamond = full-length peptidyl-tRNA 
(due to stall at the stop codon). (C) Schematics of  wild-type and OF AUG-initiated FLAG-
linker-uCC and FLAG-linker-uCC-FLuc fusions. (D) The in vitro transcribed mRNAs 
were translated in RRL in the absence or presence of 5 mM HEPES-buffered L-AA. 
Following translation, the reactions were split, and one half was treated with RNaseA to 
digest the tRNA and release the peptide. The samples were prepared with Laemmli buffer, 
run on a 10% Bis-Tris NuPAGE gel, and then immunoblotted using  anti-FLAG antibodies. 
FL= Full-length released peptide; closed arrow = peptidyl-tRNA from stalled elongation 
complex; open arrow = released peptide after RNAse digestion of stalled translation 
products; diamond = peptidyl-tRNA from stalled termination complex; star = unidentified 
product due to elongation stall in the OF control.  
 
made by inserting the FLAG-linker element immediately after the AUG start codon of the 
wild-type and OF uCC-FLuc fusions. These latter constructs were made because, in our 
preliminary experiments, we found that translation termination was inefficient in the RRL, 
and it was difficult to resolve FLAG-linker-uCC products stalled during elongation from 
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those stalled at termination. With the FLAG-linker-uCC-FLuc fusions, the products stalled 
at termination are approximately 50 kDa larger than the products stalled during elongation. 
The translation assays with the FLAG-linker-uCC constructs were performed as described 
above (Fig. 3.16B) for FLAG-linker-uORF2 experiments (Fig. 3.16B).  
Translation of the FLAG-linker-uCC and FLAG-linker-uCC-FLuc mRNAs 
generated multiple products. As shown in Fig. 3.16D, translation of the FLAG-linker-uCC 
mRNA (lane 1) yielded three prominent products. The highest molecular weight (MW) 
product (marked with a diamond) corresponds to peptidyl-tRNA from a complex paused 
at the uCC stop codon. This product was not observed during synthesis of the FLAG-linker-
uCC-FLuc fusion (lane 3); however, it was observed with the FLAG-linker-OF-uCC fusion 
(lane 5). These results are consistent with the notion that termination is slow in the RRL 
and that the largest product in lanes 1 and 5 is due to slow termination when translating the 
FLAG-linker-uCC (wild-type and OF) constructs. Because the termination site is moved 
far downstream in the FLAG-linker-uCC-FLuc construct, the corresponding termination 
product is much larger in lane 3 (diamond). As RNAse treatment eliminates these largest 
products for both the uCC and uCC-FLuc fusions (lanes 2 and 4), we propose that slow 
termination results in accumulation of peptidyl-tRNA containing the full-length nascent 
chain.  
The second largest product observed upon translation of the FLAG-linker-uCC 
fusion is likely the result of an elongation stall during translation of the uCC (Fig. 3.16D, 
lane 1, marked with filled arrow). A product of the same size was observed when 
translating the FLAG-linker-uCC-FLuc fusion (lane 3), but not when translating the OF 
reporters (lanes 5 and 7). Consistent with the notion that this product is peptidyl-tRNA 
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from a stalled elongation complex, treatment with RNaseA eliminated this product (lanes 
2 and 4, black arrow). Notably, RNAse treatment of reactions translating the FLAG-linker-
uCC-FLuc fusion not only eliminated the peptidyl-tRNA stall product (lane 4, black 
arrow), but generated a novel peptide (lane 4, open arrow) that migrated slightly faster than 
the full-length Flag-linker-uCC peptide. We propose that this product is the nascent chain 
released from the stalled elongation complex, suggesting that the elongation stall is near 
the C-terminus of the uCC. As RNAse treatment of the reactions translating the wild-type 
and OF FLAG-linker-uCC-FLuc fusions did not eliminate all of the products between the 
size of the FL FLAG-linker-uCC and FLAG-linker-uCC-FLuc peptides (lanes 4 and 8), we 
propose that ribosomes stall at other non-specific sites when synthesizing the FLAG-linker-
FLuc fusions or that the proteins are subject to proteolysis in the lysates.  
Translation of the OF constructs (lanes 5 and 7) produced a peptidyl-tRNA product 
(marked by asterisk) that migrated close to the size of the stalled FLAG-linker-uCC 
products (black arrow in lanes 1 and 3). As these products do not perfectly co-migrate on 
PAGE, we propose that it may reflect pausing during elongation, perhaps on difficult to 
translate sequences like proline residues. Importantly, the proportion of this unknown 
product (asterisk) in the reactions translating the OF control mRNAs decreases upon 
addition of ascorbate, indicating that the pause is not induced by ascorbate. As the yield of 
all products was higher in the reactions containing 5 mM ascorbate, and the ratio of the 
yields of the termination stall (diamond) and elongation stall (black arrow) products for the 
FLAG-linker-uCC fusions (lane 1) were similar in the reactions containing and lacking 
ascorbate, we cannot confirm that ascorbate triggered more stalling during translation of 
the uCC. 
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3.5.3. Ribosome profiling in plants reveals ribosome pausing on the conserved C-
terminal glycine repeat of the uCC    
Ribosome profiling provides a snapshot of all the translating ribosomes in a cell at 
a particular moment and provides details about the relative levels of translation of particular 
mRNAs and the utilization of specific initiation sites. Ribosome profiling is also used to 
infer elongation rates and identify translation pause sites within the transcriptome. 
Previously published ribosome profiling data from Arabidopsis clearly shows a high 
ribosome density on the GGP uCC (Laing et al., 2015). Using previously published 
ribosome protection data (Juntawong et al., 2014; Liu et al., 2013), Laing et al. (2015) 
analyzed the distribution of ribosomes along the GGP sequence. Their analysis revealed 
that the uCC has a higher ribosome occupancy and density than the mORF.  
Our collaborator Ying Wen Betty Chung at Cambridge University has been using 
ribosome profiling to study translation in plants. Her work has focused on the single-celled 
green algae Chlamydomonas reinhardtii and on the tomato Solanum lycopersicum. The C. 
reinhardtii data was previously published (Chung et al., 2017) using cells grown in Tris-
acetate-phosphate medium under constant illumination with white light as previously 
described (Chung et al., 2015). For S. lycopersicum, the data were generated from seeds 
vernalized at 4 °C in the dark for two weeks. Seedlings were germinated and grown under 
constant light at 23 °C. The two-week old plants were snap frozen with liquid nitrogen 
prior to cryogenic grinding with lysis buffer (20 mM Tris–Cl pH7.5, 140 mM KCl, 5 mM 
MgCl2, 100 µg/mL cycloheximide, 100 µg/mL chloramphenicol, 0.05 mM DTT, 0.1% 
NP40 and 5% sucrose).  
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Although the ascorbate concentration in the plant tissues used for generation of the 
ribosome profiling libraries is unknown, ribosome footprints were readily detected on both 
the uCC and mORFs of the GGP mRNA from C. reinhardtii and S. lycopersicum (Fig. 
3.17A, B). The ribosome footprint reads were higher in the uCC than in the mORF for both 
species, but especially for S. lycopersicum. A very clear stall was observed with the final 
glycine codon of the C-terminal tri-glycine repeat in the P site for both uCCs (lower panels 
in Figs. 3.17A-B). In addition, in the C. reinhardtii profile a second peak is observed 30-
nt or 10 codons upstream of the glycine residue (Fig. 3.17A). As a single ribosome protects 
30-nts, the distance between the two peaks is indicative of 80S ribosome queuing with the 
progress of the upstream ribosome blocked upon collision with the ribosome paused on the 
Gly residue. These data support a model where translating ribosomes stall during 
translation of the final conserved motif leading to a queue of subsequent scanning and 
translating ribosomes.  
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Figure 3.17. Ribosome profiling reveals a ribosome stall at the C-terminal glycine 
of the last conserved motif in the GGP uCC
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Figure 3.17. Ribosome profiling reveals a ribosome stall at the C-terminal glycine 
of the last conserved motif in the GGP uCC
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Figure 3.17. Ribosome profiling reveals a ribosome stall at the C-terminal glycine 
residue of the last conserved motif in the GGP uCC 
(A) Ribosome-protected fragments from C. reinhardtii and (B) S. lycopersicum germinated 
and grown under constant light for 2 weeks were mapped to the GGP mRNA, with the 
uCC (dark blue) and mORF (light blue) depicted as rectangles in the schematic. The data 
were provided by Ying Wen Betty Chung at Cambridge University. The zoomed images 
depict the ribosome footprints over the C-terminal conserved motifs (underlined) in the 
GGP uCC.  
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3.6. Ribosome queuing on the uCC is essential for enhancement of initiation at 
the uCC start site 
3.6.1. Significance and rationale for study 
The third feature of the uCC model, and the hardest to show, is that ribosome 
queuing is responsible for enhanced initiation at the weak start site of the uCC. In the uCC 
model, under the proper conditions (+metabolite) conserved amino acid motifs within the 
uCC trigger an elongation pause. The elongation pause leads to a queue of scanning and 
translating ribosomes. The presence of a ribosome queue causes scanning ribosomes to 
spend more time in the vicinity of the weak start site, leading to increased initiation and 
translation of the uCC and, in turn, decreased translation of the mORF. Ribosome queuing 
cannot reliably be seen using techniques such as ribosome profiling because the queue is 
likely a randomized mix of scanning 40S and translating 80S ribosomes, with only the 
latter detected by standard ribosome profiling approaches. Instead of trying to observe 
queuing directly, a simpler approach is to disrupt queuing or its impact using multiple 
methods and observing whether this leads to a loss of uCC-specific regulation. 
There are multiple ways to interfere with queuing in vivo. One method is to reduce 
ribosome loading on the mRNA. The drug 4EGI-1 blocks the association of the mRNA 
cap-binding factor eIF4E with the scaffolding protein eIF4G within the eIF4F complex 
(Moerke et al., 2007; Sekiyama et al., 2015). As eIF4F is responsible for binding the 
ribosome near the cap of an mRNA, disruption of the eIF4F complex by 4EGI-1 impairs 
ribosome loading onto mRNAs and thereby inhibits general translation. As proof of 
principle, in their studies on the AZIN1 uCC, Ivanov et al. (2018) found that 4EGI-1, at 
concentrations that reduce general translation by 80-95%, impaired uCC translation and 
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derepressed AZIN1 expression in the presence of polyamines. To examine whether 4EGI-
1 has the same effect on the GGP uCC, we examined the impact of 4EGI-1 on ascorbate 
induction of GGP uCC translation. Unfortunately, inconsistent results in these assays, 
including with the transfection control reporter, prevented the use of 4EGI-1 to test whether 
ribosome queuing was important for translational control of the GGP uCC (data not 
shown).  
In an alternate approach to test the importance of ribosome queuing to enhance uCC 
translation, Ivanov et al. (2018) extended the length of the AZIN1 uCC. Based on the 
assumption that the length of the uCC has been optimized to the duration of the elongation 
pause to allow ribosome queuing back to the uCC start codon, extending the uCC would 
prevent the ribosome queue from reaching the weak initiation site and thus would impair 
uCC translation. In their studies on the AZIN1 uCC, Ivanov et al. (2018) used a segment 
from the mouse Trip12 gene that lacks any in-frame near-cognate start codons over a span 
of 65 codons. Inserting the Trip12 sequence immediately downstream of the AUU start 
codon of the AZIN1 uCC resulted in complete loss of regulation in response to spermidine 
(Ivanov et al., 2018). A potential complication of this approach is if the Trip12 extension 
interferes with metabolite sensing by the uCC rather than simply affecting the length of the 
uCC. In light of this possible complication, a third test of the queuing model will be to 
reduce ribosome loading by inserting a stem-loop structure near the 5’ end of the mRNA. 
Secondary structure near the cap of an mRNA impairs ribosome binding and inhibits 
translation (Kozak, 1986a), and stem-loop (SL) structures formed by palindromic 
sequences with a high free energy have been shown to impair ribosome loading and 
scanning (Babendure et al., 2006; Pelletier and Sonenberg, 1985).  
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3.6.2. Lengthening the GGP uCC impairs ascorbate regulation in mammalian cell 
culture (in vivo); however, the extension may interfere with ascorbate sensing 
To test whether lengthening the GGP uCC interferes with regulation in response to 
ascorbate, I doubled the uCC length by adding a 65-codon extension from the mouse 
Trip12 mRNA immediately upstream of the uCC start codon. This natural sequence lacks 
any in-frame near-cognate start codons (Fig. 3.18A). The start codon for the extension was 
either AAA (no initiation) or ACG (near cognate), and the start site for the uCC was either 
the natural near-cognate ACG codon or a non-cognate AAA codon. Three reporters in 
which the uCC as a uORF controls RLuc expression were generated: one with no start 
codon for the extension and the native ACG codon at the uCC start site (AAA ACG), this 
reporter contains the normal uCC; a second with an ACG start codon before the Trip12 
sequences and no uCC start site (ACG AAA), this reporter has the lengthened uCC; and a 
third normalization control with no cognate or near-cognate start codons at either the 
Trip12 or the uCC start sites (AAA AAA) (Fig. 3.18A).  
The three reporters were transfected into U2OS cells, which were then grown in the 
presence or absence of 50 mM ascorbate. The RLuc expression from the reporters was 
normalized to the expression of the FLuc transfection control (Fig. 3.18B). At 0 mM 
ascorbate, RLuc expression was high for all three reporters, but addition of 50 mM 
ascorbate repressed RLuc expression from the normal uCC reporter (AAA ACG). In 
contrast, RLuc expression was not repressed from the reporter with the lengthened uCC 
(ACG AAA).  
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Figure 3.18. Lengthening the GGP uCC leads to a loss of regulation in vivo
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Figure 3.18. Lengthening the GGP uCC leads to a loss of regulation in vivo 
(A) The uCC length was doubled by inserting a 65-codon extension from the mouse Trip12 
gene directly upstream of the uCC start codon. The mouse Trip12 sequence was chosen 
because of its lack of any in-frame near cognate start codons. The start codon for the 
extension was either AAA (no initiation) or ACG (near cognate), and the start site for the 
uCC was either the natural near-cognate ACG codon or a non-cognate AAA codon. This 
generated three reporters 1. AAA ACG, 2. ACG AAA, or 3. AAA AAA. (B) The indicated 
reporters were transfected into U2OS cells and the cells were incubated for 24 hr in DMEM 
in the absence or presence of 50 mM ascorbate-P. RLuc activity was normalized to a co-
transfected FLuc reporter (RLuc/FLuc). (C) L-AA-induced repression of RLuc expression 
was calculated by normalizing the RLuc/FLuc ratios for the normal and extended uCC 
constructs to the ratio for the no uCC control (% AAA AAA). Error bars represent SD, * p 
< 0.005 (Student’s two-tailed t-test; n=6, assayed in duplicate).  
 
The expression of the reporters containing the intact or lengthened uCC were 
normalized to the expression of the reporter lacking start codons (AAA AAA) in order to 
calculate the relative regulation conferred by the native and extended uCC (Fig. 3.18C).  
As expected, the AAA ACG reporter containing the native uCC showed a significant, 4-
fold, inhibition in response to added ascorbate. In contrast, addition of ascorbate did not 
significantly affect expression from the ACG AAA reporter with the extended uCC. These 
results support the notion that the ascorbate-induced ribosome queue on the GGP uCC is 
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sufficient to promote initiation at the native start site, but not when the start site is moved 
further upstream.  
To ensure that the loss of regulation observed upon extending the length of the uCC 
by inserting the Trip12 sequences (ACG AAA reporter) was not due to the Trip12 
sequences interfering with ascorbate sensing, I generated a Trip12-uCC-FLuc fusion in 
which a canonical AUG start codon was inserted upstream of the Trip12 sequences and the 
uCC start codon was replaced by an AAA codon (Fig. 3.19A). Related constructs were 
generated in which the native uCC or the OF mutant, both with an AUG start codon, were 
fused to FLuc.  
Following transfection of the reporters into U2OS cells, the cells were incubated 
with or without 50 mM ascorbate, harvested, and then FLuc expression was normalized to 
the expression of the RLuc transfection control (Fig. 3.19B). Both the uCC-FLuc fusion 
and Trip12-uCC-FLuc fusion showed very low expression compared to the control OF 
uCC-FLuc fusion even in the absence of added ascorbate. Consistent with previous results 
(Fig. 3.6B), addition of 50 mM ascorbate repressed expression of the uCC-FLuc fusion 
(Fig. 3.19B).  
The response to ascorbate was calculated by normalizing the expression of each 
reporter in the presence of 50 mM ascorbate to the expression in the absence of ascorbate 
(Fig. 3.19C). As expected, the expression of the wild-type uCC-FLuc fusion was inhibited 
in the presence of ascorbate; however, unexpectedly, the expression of the Trip12-uCC-
FLuc fusion showed no reduction in the presence of ascorbate. In fact, Trip12-uCC-FLuc 
expression was modestly increased in the presence of ascorbate. These results suggest that 
the Trip12 extension interferes with the ability of the uCC to respond normally in the  
























Figure 3.19. Inserting Trip12 sequences to lengthen the GGP uCC impairs L-AA 
sensing
Figure 3.19. Inserting Trip12 sequences to lengthen the GGP uCC impairs 
ascorbate sensing  
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Figure 3.19. Inserting Trip12 sequences to lengthen the GGP uCC impairs ascorbate 
sensing  
(A) The length of the uCC was doubled by adding a 65-codon extension from the mouse 
Trip12 gene directly upstream of the uCC start codon. The mouse Trip12 gene was chosen 
because it lacks in-frame near-cognate start codons. The Trip12 extension with an AUG 
start codon was fused in-frame to the uCC and FLuc sequences and the start codon for the 
uCC was changed to a non-cognate AAA codon to generate the Trip12-uCC-FLuc fusion. 
The wild-type and OF uCC-FLuc fusions were used as controls. (B) The indicated reporters 
were transfected into U2OS cells and the cells were incubated for 24 hr in DMEM in the 
absence or presence of 50 mM ascorbate-P. FLuc activity was normalized to a co-
transfected RLuc reporter (FLuc/RLuc). (C) To determine how the extension effected L-
AA sensing, repression of FLuc activity was calculated by normalizing the FLuc/RLuc 
ratio obtained in the presence of L-AA to the same ratio obtained in the absence of L-AA 
(50 mM % 0 mM L-AA) for each reporter. The significance of the response was calculated 
in comparison to the wild-type uCC-FLuc reporter. Error bars represent SD, * p < 0.005 
(Student’s two-tailed t-test; n=6, assayed in duplicate). 
 
presence of ascorbate; thus, we cannot rely on these experiments to assess the importance 
of ribosome queuing for translational control by the GGP uCC. 
3.6.3. Reducing ribosome loading with stem loop structures impairs GGP 
regulation in mammalian cell culture (in vivo) 
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As an alternate approach to test the queuing model, stem-loop (SL) structures were 
inserted near the 5’ end of the GGP reporter mRNAs (Fig. 3.20A). The post-translational 
modification was generated from a highly palindromic sequence with a high free energy 
(DG= -41.3 kcal/mol) and was previously used to reduce ribosome scanning (Baird et al., 
2014; Vattem and Wek, 2004). The reporters were generated using the GGP-RLuc 
reporters with the post-translational modification placed 49-nt downstream from the 5’cap, 
impeding scanning (Babendure et al., 2006),  and 325-nt upstream of the uCC start codon 
(Fig. 3.20B). 
Following transfection of the reporters into U2OS cells, the cells were incubated 
with or without 50 mM ascorbate, harvested, and then RLuc expression was normalized to 
the expression of the FLuc transfection control (Fig. 3.20C). As expected, the addition of 
a post-translational modification near the 5’ end of the GGP reporter mRNAs reduced 
RLuc expression. To more easily assess the impact of the post-translational modification 
on regulation of GGP mRNA translation, the RLuc activity for the wild-type uCC reporters 
was normalized to the activity of the corresponding OF reporter. These calculations were 
performed separately for the reporters with and without the post-translational modification 
(Fig. 3.20D). After normalizing to the OF control, addition of ascorbate was found to lower 
RLuc expression from the reporters both lacking and containing the post-translational 
modification.  
Finally, the fold regulation in response to 50 mM ascorbate was calculated for the 
reporters containing or lacking the post-translational modification. As shown in Fig. 3.20E, 
the presence of the post-translational modification did not significantly affect ascorbate 
regulation of GGP mRNA translation. This result was surprising; however, the RLuc  




















































































Figure 3.20. Insertion of a SL into the 5’ leader of a GGP-RLuc reporter in a phRL 
vector (CMV promoter) did not significantly impact ascorbate regulation
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Figure 3.20. Insertion of a SL into the 5’ leader of a GGP-RLuc reporter in a phRL 
vector (CMV promoter) did not significantly impact ascorbate regulation 
(A) A SL was generated from a highly palindromic sequence with a high free energy (DG= 
-41.3 kcal/mol) and (B) inserted 49 nt from the transcription start site and 325 nt upstream 
of the wild-type or OF uCC in a GGP-RLuc reporter. (C) The indicated reporters were 
transfected into U2OS cells and the cells were incubated for 24 hr in DMEM in the absence 
or presence of 50 mM ascorbate-P. RLuc activity was normalized to a co-transfected FLuc 
reporter (RLuc/FLuc). (D) The uCC-specific response to 50 mM ascorbate-P was 
calculated by normalizing the response of the wild-type reporters to the OF control (uCC 
% OF) for reporters without (No SL) or with (+SL) the SL. (E) The impact of the SL on 
the response to ascorbate-P was calculated by normalizing the results from panel D in the 
presence to the absence of L-AA (50 mM L-AA % 0 mM L-AA). Error bars represent SD, 
* p < 0.005 (Student’s two-tailed t-test; n=6, assayed in duplicate). 
 
reporter is based on the vector phRL and expressed under the control of a CMV promoter 
that is known to use alternate transcription start sites. Perhaps the post-translational 
modification imposed even greater heterogeneity in transcription start sites, and the 
apparent lack of impact of the post-translational modification on uCC control might be due 
to the artifacts associated with the reporters. 
Because of the potential issues regarding transcription start site heterogeneity with 
the CMV promoter in the RLuc reporters, the experiment was repeated using FLuc 
reporters which use an SV40-based reporter that has much greater fidelity in using a single 
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transcription start site  (Fig 2.4C, Fig. 3.21A,B). In these reporters, the same post-
translational modification described above was placed only 17 nt from the 5’ cap, which is 
expected to strongly impede ribosome binding (Kozak, 1986a), and 29 nt upstream of the 
uCC start codon. Downstream of the uCC, the 105 nucleotides between the uCC stop codon 
and the GGP start codon were left intact and immediately followed by the AUG start codon 
of FLuc. The reporters were transfected into U2OS cells and following 22 hr incubation in 
the presence or absence of  50 mM ascorbate cells were harvested. The FLuc activity in 
the extracts was normalized to the RLuc activity from the transfection control. As shown 
in Fig. 3.21C, the presence of the post-translational modification substantially reduced 
FLuc expression in the reporters containing the wild-type or OF uCC as well as reporters 
in which the uCC start codon was mutated to AAA.  
As observed above in the assays with the RLuc reporters, the corrected FLuc levels 
were normalized to the OF control for the reporters either containing (+SL) or lacking (No 
SL) the post-translational modification. As observed previously, the reporters lacking the 
post-translational modification showed a significant response to ascorbate, with an 
approximately 2-fold reduction in normalized FLuc activity upon addition of ascorbate 
(p<0.005) (Fig. 3.21D). In contrast, insertion of the post-translational modification, which 
will reduce ribosome loading, blocked ascorbate regulation via the uCC (Fig. 3.21D). In 
the absence of the post-translational modification, we propose that ribosome loading allows 
a queue to develop on the uCC in the presence of ascorbate, which enhances initiation at 
the ACG start codon of the uCC. The increased uCC translation, in turn, blocks GGP (FLuc 
translation). In contrast, insertion of the post-translational modification reduces ribosome 
loading and prevents the ribosome queue from forming despite the translation elongation  






































































Figure 3.21. Insertion of a SL into the 5’ leader of a GGP-FLuc reporter under the 
control of an SV40 promoter impairs ascorbate regulation in vivo
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Figure 3.21. Insertion of a SL into the 5’ leader of a GGP-FLuc reporter under the 
control of an SV40 promoter impairs ascorbate regulation in vivo 
(A) A SL was generated from a highly palindromic sequence with a high free energy (DG= 
-41.3 kcal/mol) and (B) inserted 17 nt from the transcription start site and 29 nt upstream 
of the wild-type, OF, or defective (AAA initiation codon) uCC in a GGP-FLuc reporter. 
(C) The indicated reporters were transfected into U2OS cells and the cells were incubated 
for 24 hr in DMEM in the absence or presence of 50 mM ascorbate-P. FLuc activity was 
normalized to a co-transfected RLuc reporter (FLuc/RLuc). (D) The effect of the SL was 
calculated by normalizing the response of the wild-type reporters to the OF control (ACG 
reporter % OF) for the reporters without (No SL) and with (+SL) the SL. Error bars 
represent SD, * p < 0.005 (Student’s two-tailed t-test; n=6, assayed in duplicate). 
 
pause on the uCC in the presence of ascorbate. In the absence of ribosome queuing, 
scanning ribosomes regularly bypass the ACG start codon of the uCC (leaky scan) and 
initiate translation at the GGP start site, resulting in nearly equivalent expression of the 
FLuc reporter in the presence and absence of ascorbate.  
To quantify how treatment with 50 mM ascorbate affects FLuc mRNA levels, RT-
qPCR was performed as described previously. The FLuc mRNA levels were first 
normalized to the levels of ActB mRNA and then these relative FLuc mRNA levels were  
all normalized to the level of the wild-type (ACG-initiated uCC) reporter. As shown in 
Table 3.7, the fold induction in FLuc mRNA levels in response to 50 mM ascorbate was 
determined for each reporter and displayed along with the fold induction in FLuc activity  
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Table 3.7. Relative reporter mRNA levels – related to Fig. 3.21. 
 
 
Table 3.7. Relative FLuc mRNA levels for experiments in Fig. 3.21 determined by qPCR. 
Standard deviation based on three biological replicates.  
 
(from Fig. 3.21). No clear correlation was observed between FLuc mRNA levels and FLuc 
activity. In cells expressing the wild-type uCC reporter, a modest decrease in mRNA levels 
and FLuc activity was observed after treatment with 50 mM ascorbate; however, this 
correlation was not observed with the OF control or in the reporters containing the post-
translational modification. In fact, in cells expressing the wild-type uCC reporter with the 
post-translational modification, a 5-fold reduction in FLuc mRNA levels was observed 
with no reduction in FLuc activity. The lack of correlation in relative mRNA levels and 
FLuc activity indicates that the changes in FLuc activity are not simply due to alterations 
in mRNA levels. Taken together, these results support the conclusion that impairing 
ribosome loading to dampen queue formation impedes ascorbate and uCC-mediated 
regulation of GGP mRNA translation. 
 
Reporter Description Treatment FLuc mRNA SD FLuc mRNA SD FLuc activity
pC6240 ACG uCC 0 mM 1.00 0.80
pC6240 ACG uCC 50 mM 0.82 0.38 0.82 0.38 0.81
pC6243 SL-ACG uCC 0 mM 1.23 1.26
pC6243 SL-ACG uCC 50 mM 0.20 0.11 0.17 0.09 1.07
pC6241 ACG OF 0 mM 1.15 0.27
pC6241 ACG OF 50 mM 1.30 1.26 1.13 1.09 1.38
pC6244 SL-ACG OF 0 mM 0.90 0.59
pC6244 SL-ACG OF 50 mM 1.48 1.38 1.65 1.54 1.16
(ACG uCC 0 mM set at 1)  (0 mM L-AA / 50 mM L-AA)
Relative mRNA level Fold induction
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4.1. The first described uCC: control of AZIN1 through a polyamine regulated 
uCC 
The 5’ leader is a common target for controlling mRNA translation through 
initiation (Hinnebusch, 2014; Jackson et al., 2010). In addition to the m7G cap, mRNA 
secondary structure, the length of the leader, upstream AUG codons and uORFs affect the 
efficiency of translation (Kozak, 1991b). Furthermore, selection of the translation start site 
by scanning ribosomes is sensitive to the context of the start codon as well as to the use of 
near-cognate start codons. Ivaylo et al. (2018) revealed a mechanism of translational 
control by polyamines that regulates expression of AZIN1 through a uORF initiated with a 
near-cognate start codon. Because of the noncanonical start site, this type of uORF was 
defined as a uCC. A uCC has three defining characteristics: initiation at a weak start site, 
typically a near-cognate start codon; patterns of conservation consistent with coding 
regions, including synonymous rather than non-synonymous substitutions, that are 
essential for regulation through a translational pause; and finally, the translational pause 
leads to ribosome queuing that both blocks downstream scanning, and enhances initiation 
at the weak start site (Ivanov et al., 2018).  
As discussed above, a noncanonical uORF within the AZIN1 mRNA was the first 
described example of a uCC and was used to define the features of a uCC. AZIN1 encodes 
a regulator of cellular polyamine synthesis. Polyamines are essential for a variety of basic 
cellular functions; however, excess polyamines have detrimental effects. Accordingly, the 
key enzymes in the polyamine biosynthetic pathway are tightly regulated, including at the 
translational level, by changes in intracellular polyamine concentrations (Ivanov et al., 
2010a). Elevated polyamine concentrations repress AZIN1 synthesis through translational 
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control and repression is dependent on the uCC encoded in the AZIN1 mRNA (Ivanov et 
al., 2008).  
The AZIN1 uCC initiates at a near-cognate AUU codon that is essential for leaky 
scanning. Introduction of a cognate AUG codon in place of the AUU codon results in 
constitutive repression of AZIN1 synthesis (Ivanov et al., 2008), which is consistent with 
the notion that the 52-codon-long uCC prevents efficient reinitiation at downstream start 
codons. Replacing the near-cognate AUU start codon with a non-cognate UUU codon 
results in constitutive derepression of AZIN1 synthesis (Ivanov et al., 2008). Thus, AZIN1 
expression is inversely correlated with uCC translation, such that ribosomes that translate 
the uCC fail to synthesize AZIN. The coding sequence of the AZIN1 uCC is required for 
polyamine stimulation of uCC translation from the near-cognate AUU start codon (Ivanov 
et al., 2018). In a comparison of AZIN1 orthologs from vertebrates and metazoans, and 
uCC sequences from ODC homologs in invertebrates, Ivanov et al. (2018) identified a 
nearly perfectly conserved PPW motif near the C-terminus of the uCC. Mutations that alter 
the PPW motif abolish polyamine induction of uCC translation. Ribosome profiling of 
HEK293T cells pretreated with DFMO (to deplete polyamines) or with DFMO + 2 mM 
spermidine (high polyamines) revealed that polyamines inversely control ribosome 
occupancy on the uCC and mORF of the AZIN1 mRNA (Ivanov et al., 2018). Under low 
polyamine conditions, ribosome occupancy was high in the mORF and low in the uCC, 
correlating with high AZIN1 expression; however, under high polyamine concentrations, 
the relative ribosome occupancy in the uCC versus the mORF increased 22-fold. The most 
prominent ribosome footprints clustered in three distinct regions of the uCC. The middle 
cluster corresponds to ribosomes pausing during elongation with the Trp codon of the PPW 
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motif in the decoding A site of the ribosome and the two proline residues at the end of the 
nascent chain and linked directly to the P-site tRNA (Ivanov et al., 2018). The other two 
peaks correspond to ribosomes at the termination codon and 10 codons upstream of the 
termination codon. The latter peak is one ribosome width upstream of the termination 
codon and could represent an 80S ribosomes queued behind a ribosome paused during 
termination at the conserved PS-stop motif. The results of the mutational analyses and 
ribosome profiling assays are consistent with a model where the PPW and PS-stop motifs 
confer polyamine-dependent translation elongation and termination pauses, respectively, 
that impede the flow of scanning ribosomes that leaky scan past the near cognate start 
codon of the uCC. Interestingly, PPW motifs were the most prominent pause sites detected 
in bacteria lacking elongation factor (EF) EF-P, an elongation factor known to be important 
for translation of polyproline sequences (Woolstenhulme et al., 2015). The homologous 
eukaryotic translation factor eIF5A (Dever et al., 2014; Saini et al., 2009) has also been 
shown to promote translation of polyproline sequences (Gutierrez et al., 2013; Saini et al., 
2009; Schuller et al., 2017), so Ivanov et al. (2018) hypothesized that eIF5A is required for 
elongation at the PPW motif in the uCC and that polyamines inhibit elongation at the PPW 
motif by inhibiting eIF5A. In a reconstituted yeast in vitro translation system, spermidine 
concentrations of 2 mM or greater inhibited synthesis of a peptide fragment containing a 
PPW motif (Ivanov et al., 2018). Interestingly, the polyamine spermidine was found to 
crosslink to helices H74 and H93 of the 23S rRNA near the PTC of bacterial ribosomes 
(Xaplanteri et al., 2005) and eIF5A interacts with the same region of eukaryotic ribosomes 
(Gutierrez et al., 2013; Ivanov et al., 2018), raising the possibility that polyamines compete 
with eIF5A for a common binding site on the ribosome. In support of this competition 
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model, synthesis of the PPW-containing peptide was maintained at high levels even under 
high polyamine conditions when the eIF5A concentration was increased 100-fold (Ivanov 
et al., 2018).  
In order to test the importance of queuing for translational control of AZIN1 
synthesis, Ivanov et al. (2018) used two methods to impair queuing. The first was to reduce 
the rate of ribosome loading on mRNAs with the drug 4EGI-1, which blocks the function 
of the cap-binding protein that is required for ribosome binding to the mRNA. The addition 
of 4EGI-1 inhibited uCC translation and depressed mORF expression on an mRNA 
containing the 5’ leader from AZIN1 (Ivanov et al., 2018). The second strategy was to 
lengthen the uCC, which was hypothesized to be of optimal length to enable precise control 
of uCC translation in response to varying polyamine levels. Doubling the length of the uCC 
derepressed expression of the mORF of an AZIN1 reporter in the presence of polyamines 
(Ivanov et al., 2018). Presumably, the ribosome queue was of insufficient length to position 
a ribosome in the vicinity of the repositioned uCC start site.  
Having elucidated this novel mechanism of translational control involving 
ribosome queuing on a non-conventional uORF, Ivanov et al. (2018) speculated that the 
translational control of other mRNAs might rely on distinct uCC-like elements that respond 
to different metabolites. 
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4.2. GDP-L galactose phosphorylase (GGP) mRNA was an ideal candidate for 
regulation by a uCC that responds to L-ascorbic acid 
The uCC rules that were established during the study of the AZIN1 uCC apply to 
the GGP uCC making it an ideal candidate for a uCC that responds to ascorbate (Fig. 4.1). 
First, bioinformatics indicated that the GGP noncanonical uORF, or uCC, initiated at a 
weak start site. The GGP mRNA Arabidopsis does not have an in-frame AUG codon 
upstream of the uCC and the uCC is predicted to initiate at an ACG near-cognate codon. 
Here, I showed that mutating the predicted near-cognate uCC start codon (ACG) of the 
Arabidopsis GGP mRNA to a noncognate (AAA) codon reduced expression of a uCC-
FLuc fusion to near-background levels in mammalian cells (Fig. 3.6A,B). This indicates 
that the near-cognate ACG codon is most likely required for initiation of translation on 
GGP uCC. Like the AZIN1 uCC, the GGP uCC has highly conserved motifs that are 
conserved at the amino acid level (Fig. 3.1). I showed that the conserved GGRG and GGG 
motifs are essential for repression of GGP expression in the presence of ascorbate (Fig. 
3.3). In addition, mutation of any of the conserved motifs or alteration of their spacing 
impaired the ability of ascorbate to promote initiation at the ACG start codon of a uCC-
FLuc fusion (Figs. 3.7, 3.8). Finally, like the AZIN1 uCC, under repressing conditions 
ribosomes pause during translation of the GGP uCC and this pause regulates uCC 
translation via a ribosome queuing mechanism. Ribosome profiling of two plant GGP 
mRNAs revealed that ribosomes stall at the final glycine residue of the C-terminal tri-
glycine repeat in both uCCs (lower panels in Figs. 3.17A-B). I proposed that ribosome 
pausing on the uCC leads to queuing of subsequent scanning and translating ribosomes. 
Consistent with this hypothesis, disrupting queuing, by impairing ribosome loading with a  
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Figure 4.1. Proposed model of GGP regulation by the uCC and L-ascorbic acid 
(Upper panel) Under low ascorbate (L-AA) conditions, most scanning ribosomes leaky 
scan over the uCC (dark blue) start codon (red ACG) without initiating and then initiate 
translation at the downstream GGP mORF (light blue). The few ribosomes that initiate 
translation at the uCC ACG start codon, synthesize the uCC peptide, and then disengage 
from the mRNA. As GGP expression increases, L-AA concentrations increase. (Lower 
panel) Under conditions of elevated L-AA concentrations, the occasional ribosome that 
initiates at the ACG start codon of the uCC will translate the conserved motifs at the 3’ end 
of the uCC. L-AA will enter the peptide exit tunnel of the translating ribosome and interact 
with nascent chain and exit tunnel residues causing the ribosome to stall. Subsequent 
scanning ribosomes, which mostly leaky scan over the uCC start codon, and the occasional 
elongating ribosome form a queue behind the paused ribosome. As the queue develops, a 
scanning ribosome will spend an extended time traversing in the vicinity of the uCC start 
codon, providing more opportunities for initiation. The enhanced rate of initiation on the 
uCC reinforces the elongation stall, prevents ribosomes from leaky scanning to the GGP 
mORF, and thus represses GGP synthesis.    
 
post-translational modification inserted near the 5’ end of the mRNA, depressed GGP 
expression in the presence of ascorbate (Fig. 3.21). Based on these and other findings in 
this thesis, I conclude that the GGP noncanonical uORF is in fact a uCC that regulates 
GGP expression in response to ascorbate. 
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We propose that the uCC mechanism of gene regulation is a homeostatic response 
that allows cells to fine tune metabolite concentrations rapidly. As such, the system might 
be optimized to narrowly control GGP expression through a range of ascorbate 
concentrations. In their study, Laing et al. (2015) utilized transient transfection of N. 
benthamiana  leaves to study ascorbate regulation of GGP expression. They generated 
reporters containing the kiwifruit (Actinidia eriantha) GGP promoter including the 5’-
UTR (with the uCC) upstream of FLuc and expressed the gene in N. benthamiana  leaves 
(Laing et al., 2015). To increase leaf ascorbate levels, they co-expressed the coding 
sequence of kiwifruit GGP without the 5’-UTR (or the uCC) under a strong constitutive 
promoter. Overexpression of GGP increased ascorbate levels approximately 2-fold from 
27.3 mg/100 gFW to 49.3 mg/100 gFW. Laing et a. (2015) observed an approximately 5-
fold reduction in FLuc activity in leaves with higher ascorbate levels. This regulation is 
very similar to the approximately 4-fold reduction we observed in the mammalian cell 
culture system when the GGP uCC was placed upstream of RLuc and the cells were 
treated with 50 mm ascorbate (Fig. 3.2B). After normalization to the OF control (Fig. 
3.2C), uCC specific repression is only 2-fold for the GGP reporter, but this level of 
regulation is not too dissimilar from the 7-fold repression of the AZIN1 uCC by 
spermidine observed by Ivanov et a. (2018). In addition, the 3-fold repression of  the 
GGP uCC-FLuc activity that we observe in RRL (Fig. 3.11C, and 3.13C) is similar to the 
1.5-4.0-fold repression of the AAP-FLuc fusions by arginine in translation extracts 
reported by Wang et al. (1999). Taken together, these results indicate that the uCC 
system of translational control likely exerts only moderate levels of regulation under 
physiological conditions; however, the similar levels of regulation seen across different 
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uCCs and translation systems indicates that the uCC system is robust and possibly 
universal in eukaryotes. 
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4.3. How does the GGP uCC detect changes in L-ascorbic acid concentration? 
Although we established that the GGP uCC represses GGP expression in response 
to elevated ascorbate concentrations, we were unable to determine how ascorbate is sensed 
by the translating ribosome or how it induces an elongation pause. The AZIN1 uCC 
contains one highly conserved motif, a PPW sequence near the C-terminus, that requires 
eIF5A for its translation (Ivanov et al., 2018). High polyamine concentrations impair eIF5A 
function (Ivanov et al., 2018), which is especially important for translation of particular 
motifs, including polyproline stretches and PPW (Gutierrez et al., 2013; Ivanov et al., 2018; 
Manjunath et al., 2019). Unlike the AZIN1 uCC, the GGP uCC does not have polyproline 
motifs or motifs that have been identified as requiring eIF5A (Fig. 3.1) (Manjunath et al., 
2019); therefore, there it is unlikely that eIF5A plays a role in regulating GGP expression. 
In addition, the conserved motifs in the GGP uCC, with five perfectly conserved motifs 
spanning exactly 23 codons, are more extensive than the simple PPW motif in the AZIN1 
uCC. Each of the conserved motifs in the GGP uCC, as well as their spacing, plays a role 
in regulation of GGP expression. Substitutions within any of the motifs or inserting even 
a single amino acid within the conserved region, abolished ascorbate-specific induction of 
uCC translation (Figs. 3.7, 3.8). Based on the ribosome profiling data, we were able to 
conclude that the C-terminal tri-glycine repeat serves as a stall site; but how pausing is 
regulated by ascorbate is unknown (lower panels Fig. 3.17A,B).  
We propose that the GGP uCC detects ascorbate through an interaction between 
ascorbate, the uCC nascent chain, and the ribosome exit tunnel in a mechanism similar to 
the well-characterized co-factor mediated translation arrest on the TnaC mRNA in bacteria 
(Fig. 4.2). The TnaC nascent peptide stalls the ribosome in the presence of L-tryptophan to  
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Figure 4.2. GGP uCC and other metabolite-sensing nascent peptides  
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Figure 4.2. GGP uCC and other metabolite-sensing nascent peptides  
(A) Amino acid sequence of the conserved C-terminal portion of the A. thaliana GGP uCC 
nascent peptide aligned from the stalled P-site residue (red) with three other described 
stalling peptides: N. crassa AAP, E. coli TnaC, and the C-terminal portion of E. coli SpeFL. 
Residues reported to interact with a metabolite (Trp for TnaC or ornithine for SpeFL) are 
shown in orange; residues reported to interact with rRNA or ribosomal proteins in the 
ribosome exit tunnel are shown in green. The conserved Asp residues located 8 or 9 
residues before the stall (Asp16 in TnaC and AAP, shown to interact with rRNA A2058 in 
cryo-EM structures, Asp46 in the GGP uCC and Asp27 in SpeFL) are in bold. (B) 
Schematic illustrating the common features of the ribosome stalling peptides shown in A. 
Interactions of the nascent peptide with ribosomal components including the proteins uL4 
and uL22 that form the tunnel constriction trigger allosteric conformational rearrangements 
of PTC nucleotides that, combined with the poorly reactive substrates in the A and P sites, 
results in inhibition of the PTC. The schematic was adapted from Figure 4 in Wilson et al. 
(2016). (C) Ball and stick model of L-ascorbic acid and D-isoascorbic acid with the chiral 
center marked with an asterisk (carbon, gray; oxygen, red; hydrogen, white). 
 
upregulate expression of specific enzymes related to L-tryptophan uptake and catabolism 
(Cruz-Vera et al., 2005; Cruz-Vera and Yanofsky, 2008; Gong and Yanofsky, 2002b). 
TnaC is a 24-amino acid peptide that stalls with the Pro24 codon in the P site and the UGA 
stop codon in the A site. Stalling requires mid-tunnel residues Trp12 (Gollnick and 
Yanofsky, 1990; Gong and Yanofsky, 2002b) and Asp16 (Cruz-Vera and Yanofsky, 2008) 
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as well as the PTC-proximal Pro24 at an exact distance from Trp12/Asp16 (Fig. 4.2A) 
(Gong and Yanofsky, 2002b) for termination arrest. In structural studies, binding of two 
L-tryptophan molecules in pockets formed by TnaC and the ribosome exit tunnel caused 
the PTC to change conformation (Fig. 4.2B) (Bischoff et al., 2014). The pockets were 
formed by TnaC residues between Asn17 and Asp21. The invariant Trp12 and Asp16 
residues interact with the ribosomal proteins uL22 and uL4 that form the central 
constriction, a narrow passage in the ribosome peptide exit tunnel (Bischoff et al., 2014). 
The GGP uCC has a minimum length similar to that of TnaC and my studies showed that 
the conservation of the spacing between motifs is essential for ribosome stalling on the 
GGP uCC in the presence of ascorbate.  
It is possible that the conserved GGP uCC C-terminal region acts together with 
residues in the ribosome exit tunnel to recognize ascorbate. In a recent paper, del Valle et 
al. (2019) elucidated a mechanism whereby polyamine synthesis in bacteria is regulated 
through interactions between ornithine, a specific peptide nascent chain, and residues in 
the ribosome exit tunnel. In addition to being essential in eukaryotes, polyamines play an 
essential role in bacterial cell growth, stress adaptation, and virulence. Pathogenic bacteria 
adjust the expression and activity of polyamine biosynthetic enzymes in response to 
environmental stresses and metabolic cues. In E. coli, the inducible ornithine 
decarboxylase gene speF is present in an operon with potE, an ornithine-putrescine 
antiporter. A regulatory uORF, speFL, is located upstream of speF and controls synthesis 
of the speF-potE mRNA. The 34-amino acid SpeFL peptide acts as an ornithine sensor. In 
a cryo-EM structure of an E. coli ribosome stalled during translation of speFL in the 
presence of ornithine, the ribosome and SpeFL sensor domain form a selective binding 
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pocket that accommodates a single ornithine molecule (Fig. 4.2B) (del Valle et al., 2019). 
Ornithine pre-associates with the ribosome and is then held in place by the SpeFL sensor 
domain, which leads to compaction of the C-terminal SpeFL effector domain, blocking the 
action of release factor RF1. Ribosome stalling on speFL masks a predicted Rho utilization 
site, allowing transcription to proceed and speF and potE to be expressed. Under low 
ornithine conditions, the leading ribosome on speFL terminates efficiently and then 
dissociates from the mRNA, exposing part of the predicted Rho utilization site and leading 
to attenuation of transcription prior to the speF coding region.  
By analogy to SpeFL, we propose that the C-terminal region of the GGP uCC folds 
in ribosome exit tunnel enabling the conserved amino acids to interact with ascorbate 
and/or residues in the ribosome exit tunnel causing the ribosome to a stall during elongation 
at the terminal glycine residue of the tri-glycine repeat. If ascorbate binds low in the exit 
tunnel (near the PTC), the terminal glycine residues could contribute to ascorbate 
recognition. Based on the sequence of the uCC motifs, we hypothesize that multiple motifs 
might interact to sense ascorbate and to induce the elongation pause (Fig. 4.2A). The N-
terminal motifs, the GGRG motif, and possibly the GG motif could serve as ascorbate 
sensors within the ribosome exit tunnel. They could form a pocket for ascorbate along with 
rRNA and ribosomal protein residues in the ribosome exit tunnel. In a further analogy to 
SpeFL, where conserved rare codons in the middle of the peptide are thought to slow 
elongation and allow an N-terminal part of the nascent chain to fold prior to synthesis of 
the C-terminal effector domain, the PxD motif in the GGP uCC might slow elongation to 
allow N-terminal motifs to adopt a conformation necessary for sensing ascorbate. Notably, 
proline, glycine and aspartic acid motifs are known to stall elongation in eIF5A-depleted 
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cells and are thought to represent slowly translated residues (Pelechano and Alepuz, 2017; 
Schuller and Green, 2018; Schuller et al., 2017). As translational control of the GGP uCC 
functions in both plants and mammalian cells, the ribosome peptide exit tunnel residues 
contributing to uCC and ascorbate recognition are likely conserved through evolution. In 
contrast to TnaC and SpeFL, which arrest at termination (Bischoff et al., 2014; del Valle 
et al., 2019), interactions between the uCC nascent chain, ascorbate, and residues in the 
ribosome exit tunnel cause the elongating ribosome to the stall at the C-terminal tri-glycine 
repeat. Consistent with this notion of an elongation rather than termination stall on the GGP 
uCC, the distance between the conserved motifs and the stop codon, which is conserved in 
TnaC and SpeFL, is not conserved among different GGP uCCs (Fig. 3.1).  
Though we do not know the ascorbate concentration in the tissues used for the 
ribosome profiling study, it is conceivable that ribosomes always pause during translation 
of the C-terminal tri-glycine repeat of the GGP uCC. However, we propose that GGP 
regulation is dependent on the duration of the pause and how frequently it occurs. The 
pause would need to last long enough to allow a queue of scanning and translating 
ribosomes to form that positions a scanning ribosome in the vicinity of the weak initiation 
site of the uCC. In theory, interactions between the duration of the pause, the distance 
between the pause site and the uCC start codon (queuing distance), and the ribosome 
loading rate could fine tune GGP expression, and therefore ascorbate concentrations, in 
different plant species or tissues.  
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4.4. Are there other uCCs and what is the advantage of a uCC? 
As discussed in earlier sections, translational regulation via nascent chain-mediated 
ribosome stalling is not rare. In bacteria, nascent chain-mediated ribosome stalling can 
regulate gene expression in multiple ways including transcription antitermination via 
termination stalling (TnaC and SpeFL) (Bischoff et al., 2014; del Valle et al., 2019) and 
translation induction via translation elongation stalling (SecM and ErmCL among others) 
(Arenz et al., 2014; Ito and Chiba, 2013; Sarker and Oliver, 2002; Wilson et al., 2016; 
Zhang et al., 2015). In the case of the bacterial examples described above, gene expression 
is induced rather than repressed by ribosome stalling. In addition to the regulatory 
mechanisms discussed above, riboswitches are a common means of genetic regulation at 
the mRNA level in bacteria (Garst et al., 2011). Riboswitches are most commonly found 
in the 5’-leader of bacterial mRNAs, and through direct interactions with metabolites 
regulate expression of the coding region via a secondary structural switch. A typical 
riboswitch contains two distinct functional domains. An aptamer domain recognizes the 
effector molecule by adopting a compact three-dimensional fold to scaffold the ligand 
binding pocket (Winkler and Breaker, 2003). The RNA receptor is able to discriminate 
between chemically related metabolites with high selectivity. The second domain, the 
expression platform, contains a secondary structural switch that interfaces with the 
transcriptional or translational machinery (Garst et al., 2011). Regulation is achieved by a 
region of overlap between the two domains called the switching sequence, whose pairing 
directs folding of the RNA into one of two mutually exclusive structures in the expression 
platform that represents the on and off states of the mRNA (Garst et al., 2011).  
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One highly conserved group of riboswitches is the thiamine pyrophosphate (TPP)-
binding riboswitches, which have been identified in all kingdoms (Sudarsan et al., 2003). 
In eukaryotes, the TPP riboswitches are in introns or the 5’- or 3’-UTR of their target 
mRNAs. In the case of A. thaliana, the TPP riboswitch AtRs is located in the 3’ region of 
the thiC gene. ThiC catalyzes the conversion of 5-aminoimidazole ribotide to 
hydroxymethyl pyrimidine phosphate in the thiamine-biosynthetic pathway. The TPP 
binding switch is proposed to regulate mRNA processing and stability of thiC in plants 
(Sudarsan et al., 2003). A 2.9 angstrom-resolution crystal structure revealed that the A. 
thaliana TPP riboswitch recognizes TPP via conserved residues located within two parallel 
sensor helices (Thore et al., 2006).  
We believe that the uCC could be an additional mechanism that eukaryotes use to 
directly sense and respond to changes in metabolite concentrations. Currently, only two 
uCCs, the AZIN1 uCC and the GGP uCC, have been formally identified as uCCs, but we 
believe that several well-described uORF-encoded arrest sequences are actually uCCs. 
Although not formally defined as a uCC, we believe that the N. crassa AAP, the well-
described stalling uORF-encoded peptide, is, in fact, a uCC. The N. crassa arg-2 mRNA, 
and the related S. cerevisiae CPA1 mRNA, encode a 23-residue and 24-residue peptide, 
respectively, upstream of the arginine biosynthetic enzyme subunit CPSase A (Luo et al., 
1995; Pierard and Schroter, 1978; Werner et al., 1987; Werner et al., 1985). Acting in cis, 
the AAP represses expression of CPA1 and arg-2 in response to arginine (Delbecq et al., 
1994; Luo et al., 1995; Werner et al., 1987). Unlike the mouse AZIN1 uCC, or the A. 
thaliana GGP uCC, which initiate at near-cognate AUU or ACG start codons, respectively 
(Ivanov et al., 2018; Laing et al., 2015), the CPA1 and arg-2 uORFs (AAPs) initiate at an 
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AUG codon in poor context (Wang et al., 1999; Werner et al., 1987). Of note, some GGP 
uCCs also initiate at AUG codons in poor context (Fig. 3.1). Similar to a near-cognate start 
codon, AUG start codons in poor context allow frequent leaky scanning (Kozak, 1986b). 
The AAP also shows conservation at the amino acid level; four conserved residues in the 
middle of the AAP are necessary for arrest as are two conserved residues near the C-
terminus that are proximal to the PTC in the arrested complex (Delbecq et al., 2000; Hood 
et al., 2007; Ito and Chiba, 2013; Spevak et al., 2010). Finally, there is evidence that AAP 
is regulatory via an elongation pause and ribosome queuing. To test the metabolite 
specificity of uCCs, Ivanov et al. (2018) and I used a reporter that replaced the AZIN1 uCC 
regulatory elements with those from the N. crassa AAP. This fusion uCC contained the 
near-cognate AUU start site and 5’ portion of the mouse AZIN1 uCC linked to the N. crassa 
AAP. Both Ivanov et al. (2018) and I (Fig. 3.4) showed that the chimeric uCC responded 
to Arg, but not to polyamines or ascorbate. These results indicate first, the different uCCs 
specifically respond to distinct metabolites, and second, that the Arg-induced translational 
stall on the AAP, like the polyamine- and ascorbate-induced stalls on the AZIN1 and GGP 
uCCs, respectively, leads to ribosome queuing and enhanced initiation at the weak start site 
of the chimeric uCC and represses translation of the mORF. 
In the case of the AAP, it seems likely that arginine binds in the ribosome exit 
tunnel and interacts with the nascent chain to affect PTC activity, similar to the proposed 
model for regulation of the GGP uCC and bacterial TnaC by ascorbate and Trp, 
respectively (Fig. 4.2B). While Arg induces stalling at the AAP stop codon, the stop codon 
is not a prerequisite for stalling (Wang et al., 1998); therefore, the AAP possesses both 
anti-termination and anti-elongation qualities. Mutation of the AAP residues that lie in the 
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middle of the exit tunnel in the stalled complex abolishes Arg-induced stalling, indicating 
that the peptide interacts with the ribosome exit tunnel (Freitag et al., 1996; Ito and Chiba, 
2013; Wang and Sachs, 1997). Consistent with this idea, in a cryo-EM structure of the 
stalled AAP, the highly conserved residues of the AAP were seen interacting the ribosome 
tunnel constriction (Fig. 4.2A,B) (Bhushan et al., 2010), and mutation of these resides 
abolished translational stalling (Freitag et al., 1996). Similar to TnaC, conserved amino 
acid residues in the AAP arrest sequences interact with conserved rRNA nucleotides 
Ala24/Asn23-U2585/A2062, Asp16-A2058, and Asp12/Gln11-A751 as well as with 
extensions of ribosomal proteins L4 and L17 (Bhushan et al., 2010; Bischoff et al., 2014). 
The rRNA residue A2062, in the vicinity of the PTC, is close to the site of AAP compaction 
in the ribosome exit tunnel, and in the structure of the stalled AAP complex A2062 adopts 
a distinct conformation that is similar to the change in conformation of the corresponding 
bacterial rRNA nucleotide during TnaC stalling that is incompatible with release factor 
action (Bhushan et al., 2010; Bischoff et al., 2014). Intriguingly, the perfectly conserved 
GGP uCC residue Asp46 is located eight residues upstream from the stalling site, the same 
distance as AAP residue Asp16 and the TnaC residue Asp16 that are both described as 
interacting with rRNA in the exit tunnel (Fig. 4.2A,B) (Bhushan et al., 2010; Bischoff et 
al., 2014), raising the possibility that interactions of Asp46 (part of the PxD motif) with the 
exit tunnel contributes to ascorbate-induced stalling during translation of the GGP uCC. In 
addition, the specificity of regulation to L-ascorbate rather than D-isoascorbate also points 
to L-ascorbate binding in the ribosome exit tunnel (Fig. 4.2C).  
In addition to the well-described AAP, we believe that the mRNAs encoding 
growth arrest and DNA damage-inducible protein (GADD34 or PPP1R15A) and DNA 
  263 
damage inducible transcript 3 (also known as C/EBP homologous protein (CHOP)) both 
contain uCCs. GADD34 and CHOP are members of a group of genes whose transcript 
levels are increased by ATF4 in response to the integrated stress response and unfolded 
protein response (Harding et al., 2000). The integrated stress response and unfolded protein 
response lead to increased phosphorylation of eIF2a and inhibition of eIF2B, reducing 
global translation while increasing translation of select transcripts including ATF4. 
GADD34, a protein phosphatase 1 (PP1c) regulatory subunit, binds to PP1 and directs it to 
dephosphorylate eIF2a-P and restore protein synthesis (Brush et al., 2003). 
The 5’ leaders of the Drosophila melanogaster and mouse GADD34 transcripts 
each contain 2 uORFs, with the first being dispensable for regulation (Lee et al., 2009; 
Malzer et al., 2013; Young et al., 2015b). uORF2 in the D. melanogaster GADD34 mRNA 
overlaps out-of-frame with the GADD34 coding sequence and translation of this uORF 
blocks GADD34 production because ribosomes that translated the uORF terminate 3’ of 
the GADD34 coding sequence start codon (Malzer et al., 2013). Mouse uORF2 terminates 
23 nt upstream of the GADD34 coding sequence start codon and is thought to inhibit 
translation through inefficient translation termination (Young et al., 2015b). In their study 
of GADD34, Young et al. (2015) utilized mouse embryonic fibroblast (MEF) cells 
expressing a wild-type version of eIF2a or eIF2a-S51A, a mutant that cannot be 
phosphorylated. To study regulation of GADD34 under ER stress, the cells were treated 
with thapsigargin. Unlike the previously described uCCs, uORF2 initiates at an AUG in 
good, but imperfect, context (GGCGACAUGU) (Palam et al., 2011). The current 
hypothesis for eIF2a-P control of GADD34 expression is that phosphorylation of eIF2 
causes scanning ribosomes to leaky scan over the uORF2 imperfect start codon without 
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initiating. Consistent with this proposal, placing the uORF2 AUG start codon in perfect 
context greatly reduced expression of a GADD34 reporter (Young et al., 2015b). This 
context mutation also decreased stress-induced induction of GADD34 reporter expression 
from 3.3-fold in the reporter with the wild-type context to only 2.7-fold after optimization 
of the start codon context (Young et al., 2015b). Like the other described uCCs, the uORF2 
peptide is necessary for regulation. Mutations that alter the reading frame of uORF2 lead 
to loss of regulation in response to ER stress and increased basal expression 9-fold (Young 
et al., 2015b). The C-terminal PPG* motif appears to be essential for regulation via 
inefficient termination, and replacing this motif with alanine residues, or inserting an 
alanine residue between the PPG motif and the stop codon, increased reporter expression 
although some regulation in response to ER stress was still observed (Young et al., 2015b). 
Consistent with this idea of defective termination, toe-printing experiments demonstrated 
that ribosomes stall at the stop codon (Young et al., 2015b). Intriguingly, uORF2 contains 
a perfectly conserved Asp13 residue that would be in a similar position as the TnaC Asp16 
residue, AAP Asp12 residue, and A. thaliana GGP uCC Asp46 residue and located 
upstream from the stall site. The conservation of residues that would be in the ribosome 
exit tunnel (Ito and Chiba, 2013; Wilson et al., 2016), especially Asp13, and the evidence 
of a termination defect, suggest that GADD34 uORF2 could function in a manner similar 
to TnaC, where an interaction between the nascent chain, the ribosome exit tunnel, and 
perhaps some unknown regulatory molecule, results in a change in the PTC geometry that 
is unfavorable for translation termination. In addition to the imperfect start codon context 
and translation stalling in uORF2 supporting the uCC hypothesis, addition of a post-
translational modification upstream of uORF2 led to a loss of ER stress-dependent 
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regulation of GADD34 reporter expression (Young et al., 2015b), supporting the notion 
that a ribosome queue promotes uORF2 translation and represses GADD34 synthesis. 
CHOP is an ER stress-regulated transcription factor that regulates metabolic genes 
during ER stress (Chikka et al., 2013). Like GADD34, CHOP is regulated by ribosomal 
leaky scanning of a uORF with two in-frame AUG start codons in good, but imperfect, 
context, with the second AUG codon acting as the primary start site (Palam et al., 2011). 
In their study of the CHOP uORF, Young et al. (2016) found that improving the context 
around both AUG codons reduced basal CHOP reporter expression by about 2-fold and 
decreased induction upon ER stress from 2.7-fold to 2.1-fold. Like the GGP uCC and AAP, 
the CHOP uORF contains perfectly conserved residues that would be in the ribosome exit 
tunnel when ribosomes stall near the 3’ end of the uORF. Mutating the three perfectly 
conserved RRK motif, located 9-11 residues upstream of the stop codon, to alanines 
increased CHOP reporter expression 2.4-fold, while mutating the conserved IFI motif, 
located 5-7 residues from the C-terminus, resulted in a 4.9-fold increase in CHOP reporter 
expression, similar to the increase seen with the OF control (Young et al., 2016). Using a 
toe-printing assay, Young et al (2016) observed an elongation stall at the IFI motif; 
however, there are an additional four perfectly conserved residues, HHHT, immediately C-
terminal to the IFI motif. Mutating the histidine residues in this HHHT motif to alanines 
did not significantly affect CHOP reporter expression and the terminal Thr residue was not 
mutated in the study (Young et al., 2016). As it is difficult to understand why residues C-
terminal to the stall would be conserved, it seems likely that the stall could actually occur 
at termination rather than during elongation; however, additional studies will be needed to 
clarify this point.  
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Both the GADD34 uORF2 and the CHOP uORF possess the hallmarks of uCC 
elements: a conserved peptide sequence, evidence of an elongation or termination stall 
(though in this case the stall appears to be constitutive rather than regulated), and a weak 
start codon, though the AUG codon in good but imperfect context is much better than the 
near-cognate start codons of the AZIN1 and GGP uCCs. While increased eIF2a 
phosphorylation under ER stress conditions was proposed to increase leaky scanning and 
enable ribosomes to bypass the inhibitory uORFs due to the imperfect context (Young et 
al., 2016; Young and Wek, 2016; Young et al., 2015b), an alternative possibility is that 
eIF2a phosphorylation impairs ribosome loading. The decreased ribosome loading would 
reduce queue formation on the uORFs and enable more ribosomes to leaky scan over the 
uORFs, thus increasing GADD34 and CHOP expression.  
In addition to the GGP uCC, over 100 different plant genes encode conserved 
peptide uORFs in their 5’ leaders (van der Horst et al., 2020). Besides regulation of GGP 
expression by ascorbate, two other groups of plant uORFs have been described as being 
regulated by metabolites. The first is the AdoMetDC uORF regulated by polyamines that 
was described in the Introduction. The second is the Arabidopsis S1-group bZIP 
transcription factors regulated by sucrose (Kang et al., 2010). The bZIP transcription 
factors are regulators of metabolism and control amino acid and sugar metabolism as well 
as resource allocation (Kang et al., 2010). Translation of the bZIP mORFs is regulated by 
a uORF, uORF2b, in a sucrose-dependent manner (Rahmani et al., 2009). Like the AAP, 
uORF2b initiates translation at an AUG codon in poor context, allowing for leaky scanning 
(Rahmani et al., 2009). In addition, the peptide encoded by uORF2b is highly conserved 
and a frame shift mutation completely abolished sucrose-induced repression of translation 
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(Rahmani et al., 2009). Surprisingly, substituting three Arg residues at the beginning of the 
conserved region with alanines did not abolish regulation (Rahmani et al., 2009; Yamashita 
et al., 2017); however, a different study found that the alanine substitutions also led to 
stalling through changes in the PTC (Yamashita et al., 2017). The C-terminal 10 amino 
acids of uORF2b are critical for sucrose-induced ribosome stalling (Yamashita et al., 
2017). Changing the position of the stop codon also abolished sucrose-induced repression 
of translation, indicating that the stall might occur during termination (Rahmani et al., 
2009; Yamashita et al., 2017). Taken together, the weak start site, conservation of the 
peptide, and regulated stall, indicate that bZIP uORF2b might be uCC regulated by sucrose.  
We believe that with further investigation many of the conserved uORFs identified 
through bioinformatics approaches will be classified as uCCs. Regulated translational stalls 
are used in bacteria to induce downstream gene expression in response to metabolites and 
antibiotics (Ito and Chiba, 2013; Wilson et al., 2016), and the uCC could be the repressive 
eukaryotic equivalent of the bacterial systems. The uCC allows cells to rapidly respond to 
changes in metabolites at the level of translation, rather than synthesizing or degrading 
mRNAs, or degrading excess enzymes. In our uCC model, the interplay between the 
ribosome stall time and ribosome loading determines the development of the ribosome que. 
The distance from the uCC start codon to the stall site is critical because the ribosome stall 
time, and ribosome loading, have to be sufficient for a queue to develop from the stall site 
to the start codon in order to enhance initiation at the weak start site. As evidenced by the 
alignment of GGP uCC sequences (Fig. 3.1), the distance from the start codon to the stall 
site can vary greatly across species for the same uCC. The variation in distance from the 
stall to the start site could be in response to different needs for the particular metabolite or 
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differences in the rate of ribosome loading between species and mRNAs. A species that 
requires higher levels of the metabolite could have a longer distance from the stall site to 
the initiation site to make the uCC less repressive. In addition, stress responses can play a 
role in queuing potential as evidenced by GADD34 and CHOP regulation. Phosphorylation 
of eIF2a derepressed GADD34 and CHOP expression (Young et al., 2016; Young et al., 
2015b), and we propose that initiation at the imperfect uORF start sites is reduced through 
decreased ribosome loading, and a therefore a decrease in queuing. It will be of interest to 
determine if phosphorylation of eIF2a can override the metabolite-induced regulation of 
the AZIN1 and GGP uCCs, perhaps enabling even greater control of metabolite levels 
under certain stress conditions.  
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4.5. What can we learn from the uCC model?  
In addition to being a novel form of gene regulation in eukaryotes, the uCC model 
poses interesting questions about ribosome queuing, translation initiation dynamics, and 
the potential use of uCCs in biotechnology. How does a ribosome queue form and is it a 
mixture of scanning and translating ribosomes? Does the queue affect mRNA turnover and 
further reduce expression of the mORF? How does the queue affect initiation at weak start 
codons?  
Currently, there is no way to monitor ribosome queuing that is not purely 80S 
translating ribosomes. Ribosome profiling of the C. reinhardtii GGP mRNA showed 
evidence of a second peak 30-nt or 10 codons upstream of the stall peak, indicating a 
queued 80S ribosome (Fig. 3.17); however, no further peaks consistent with further 
queuing could be resolved. The crosslinking-dependent 40S ribosome profiling technique 
(Archer et al., 2016)might provide insights into how the ribosome queue forms . In our 
study, we measured reporter mRNA levels in cells after treatment with ascorbate, but we 
did not measure the native mRNA under conditions that lead to ribosome queue formation. 
Kinetic traps such as hairpins or truncations that prevent further translation are known to 
trigger the no-go mRNA decay pathway as a quality control mechanism (Doma and Parker, 
2006). Finally, the enhancement of initiation at weak start codons by ribosome queuing has 
been described for uCCs and for drug-induced ribosome queuing (Ivanov et al., 2018; 
Kearse et al., 2019). Aberrant translation initiation at non-AUG start codons is associated 
with multiple cancers and neurodegenerative diseases, so how it is regulated and induced 
is of interest to biomedical researchers. In a study of initiation at non-AUG start codons, 
Kearse et al (2019) used reporters with distinct start codons and ribosome profiling to 
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examine how translation from non-AUG start codons responds to protein synthesis 
inhibitors in human cells. Expression from multiple reporters with non-AUG start codons 
was resistant to cycloheximide (CHX), a protein synthesis inhibitor that severely slows but 
does not completely abrogate elongation (Kearse et al., 2019). The resistance of these 
reporters initiated at non-AUG start codons to CHX suggests that slowly elongating 
ribosomes can trigger queuing or stacking of subsequent scanning PICs and/or translating 
ribosomes, enabling preferential enhancement of recognition of weak non-AUG start 
codons. Similar to findings with the AZIN1 (Ivanov et al., 2018) and GGP (Fig. 3.21) uCCs, 
Kearse et al. (2019) also found that limiting PIC formation or scanning sensitizes non-
AUG-initiated translation to CHX, probably by reducing queuing potential. The Kearse 
study supports the uCC queuing model where a stalled, or slowed elongating ribosome, 
leads to queuing of subsequent scanning and translating ribosomes to enhance initiation at 
the weak start codon (Fig. 4.1) (Ivanov et al., 2018; Kearse et al., 2019).  
The uCC represents an interesting target for modifying gene expression. In plant 
biology, control of GGP expression is widely studied as a mechanism to increase vitamin 
C production in agricultural products such as grains, fruits, and vegetables (Broad et al., 
2019; Zhang et al., 2018; Zhang, 2013). In a study of four different plant mRNAs 
containing uORFs: AtBRI1, A. thaliana phytohormone brassinosteroid receptor; AtVCT2, 
A. thaliana GGP; LsGGP1, lettuce GGP; and LsGGP2, a second lettuce GGP, deleting the 
5’ portion of the uORF/uCC resulted in dramatically increased production of the mORF-
encoded protein, either phytohormone brassinosteroid receptor or GGP (Zhang et al., 
2018), presumably by impeding the uCC mechanism of regulation. Notably, editing the 
AtVCT2 or LsGGP1 uCC to prevent its translation increased ascorbate concentrations by 
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almost 2-fold in plant leaves(Zhang et al., 2018). Removing the uCC from other mRNAs 
could be used to increase metabolite concentrations; however, in some cases the loss of 
regulation might impair fitness or survival.  
In addition to removing uCCs to derepress enzyme expression in the presence of 
the regulatory metabolite, uCCs could be used to repress target gene expression. The GGP 
uCC and AZIN1 uCC repress the native downstream mORF and also function in 
heterologous mRNAs to control mORF translation. A uCC could be inserted upstream of 
different target genes to regulate expression in the presence of the metabolite sensed by the 
uCC. In this scenario, the gene of interest would be expressed at some high level by default 
but could be turned off by increasing the concentration of a metabolite. Increasing the 
concentration of a metabolite could be complicated in a whole organism if the metabolite 
is essential, so finding complementary pairs of novel metabolites (drugs) and uCCs 
translation would be useful. In bacteria, macrolide antibiotics are known to cause peptide-
specific stalls (Ito and Chiba, 2013; Wilson et al., 2016). One example is the ErmCL leader 
peptide where translating ribosomes stall in the presence of erythromycin; however, it is 
unclear whether the macrolide antibiotic-dependent stalling of ErmCL leader peptide 
translation would function with eukaryotic ribosomes. However, the ribosome PTC and 
exit tunnel are highly conserved, and eukaryotic arrest peptides have been shown to 
function in multiple systems. For example, the ascorbate regulation of the GGP uCC 
functions in mammalian cells and the RRL in vitro translation system even though the GGP 
uCC is only naturally present in plants (Figs 3.2, 3.4 and 3.11). Likewise, the fungal and 
mammalian AZIN1 uCCs (Ivanov et al., 2018), the fungal AAP (Fig. 3.4) (Fang et al., 2004; 
Ivanov et al., 2018; Spevak et al., 2010), and the human viral gp48/UL4 uORF2 (Fig 
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3.16A) (Bhushan et al., 2010) function in various mammalian and fungal systems. Many 
of the eukaryotic uCC/uORF-encoded peptides had similar stalling motifs to their bacterial 
counterparts and interacted with homologous rRNA and ribosomal proteins in the peptide 
exit tunnel, so it is possible that bacterial stalling peptides could work with eukaryotic 
ribosomes (Bhushan et al., 2010; Bischoff et al., 2014; Ito and Chiba, 2013; Wilson et al., 
2016). Finally, small molecules have been found to induce stalling during translation of 
specific peptides (Li et al., 2019; Liaud et al., 2019). The drug-like molecule PF846 blocks 
production of the proprotein convertase subtilisin/kexin type 9 (PCSK9), an important 
target for regulating plasma low-density lipoprotein cholesterol levels, by interfering with 
translation elongation (Li et al., 2019; Lintner et al., 2017; Petersen et al., 2016). Early 
studies of PF846 showed that the drug-like molecule selectively stalled ribosomes 
translating specific peptide sequences (Lintner et al., 2017). A cryo-EM structure of a 
PR846-stalled human ribosome nascent chain complex showed that PF846 binds in the 
ribosome exit tunnel in a eukaryotic-specific pocket formed by the 28S rRNA and alters 
the path of the nascent chain (Li et al., 2019). PF846 can also block termination when 
proline-rich sequences occur immediately adjacent to the stop codon (Li et al., 2019). 
Unfortunately, both PF846 and its similar sister compound 8503 have toxic effects due to 
off-target effects (Liaud et al., 2019); however, this type of drug-like molecule could be 
optimized to be more specific. The structural studies on these metabolite-induced stalling 
events leads to questions about how ascorbate and L-Arg trigger translational stalling on 
the GGP uCC and the AAP, and how the sequence of these uCCs confers metabolite 
specificity.  
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 In summary, my studies on GGP translation control, combined with the previous 
studies on AZIN1 and arg-2 regulation, establishes a new paradigm for translational control 
involving an elongation pause and ribosome queuing to stimulate initiation at an upstream 
weak translation start site. The uCC has common features with the well-described bacterial 
leader peptides where ribosome stalling in response to specific metabolites or cellular 
conditions controls transcript levels or downstream mORF translation. Similar amino acid 
motifs in the arrest peptides and similar interactions of the nascent chains with the ribosome 
exit tunnel suggest that they share a common mechanism of translational stalling. Finally, 
the uCC system poses interesting questions for future studies on how the metabolites are 
sensed, how ribosome queuing occurs, how ribosome queuing affects mRNA stability, how 
the ribosome queue enhances initiation at the upstream weak start site, and whether this 
system can be exploited to manipulate gene expression for biotechnology applications. 
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5.1. Introduction to the role of eIF2g in translation 
eIF2 is a heterotrimeric eukaryotic translation initiation factor, which is formed by 
the subunits: eIF2a, eIF2b, and eIF2g. eIF2 forms a stable ternary complex with GTP and 
the initiator methionyl-tRNA (Met-tRNAiMet). The ternary complex along with eIFs 1, 1A, 
3, and 5 bind to the 40S ribosomal subunit to form the 43S preinitiation complex (PIC) 
(Fig. 5.1A)(Hussain et al., 2014; Llacer et al., 2015). In the scanning model of translation 
initiation, the 43S PIC attaches to an mRNA near the 5’ cap and then linearly scans the 
mRNA leader in a 3’ direction in search of an AUG start codon in a suitable context 
(Hinnebusch, 2011). Base pairing interactions between the anticodon loop of tRNAiMet in 
the 43S complex and an AUG codon signals the end of scanning and triggers the eIF5-
dependent irreversible hydrolysis of the GTP bound to eIF2 (Hinnebusch, 2011). 
Following GTP hydrolysis, eIF2-GDP and many of the other initiation factors are released 
from the 43S complex. Subsequent binding of the GTPase eIF5B promotes joining of the 
large 60S ribosomal subunit to form the 80S initiation complex, where Met-tRNAiMet is 
base paired to the AUG start codon in the P site. After GTP hydrolysis by eIF5B, this 
terminal 80S complex is ready to begin the elongation phase of protein synthesis 
(Hinnebusch, 2014).  
 Active eIF2-GTP is regenerated from eIF2-GDP by the guanine exchange 
nucleotide exchange factor eIF2B, and this recycling reaction is a key regulatory point for 
eukaryotic translation. Phosphorylation of the eIF2a subunit converts eIF2 into a 
competitive inhibitor of eIF2B, limiting the availability of eIF2-GTP for ternary complex 
formation (Hinnebusch, 2005). This inhibition of eIF2B results in impaired general 
translation but enhanced translation of a specific subset of mRNAs in a process known as 
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the integrated stress response (Baird and Wek, 2012; Harding et al., 2000). In mammalian 
cells four distinct protein kinases share a common eIF2a kinase domain linked to different 
regulatory domains that trigger activation of the kinases in response to different stress 
signals. PERK, one of these four eIF2a kinases, feeds into the integrated stress response 
by sensing ER stress and triggering the translational branch of the unfolded protein 
response to reduce the burden of misfolded protein accumulation. The decrease in ternary 
complex levels that accompanies eIF2a phosphorylation impairs global translation, 
providing time for the cell to cope with the stressor, while increasing the translation of 
select mRNAs containing regulatory uORFs including the mRNA encoding the 
transcription factor ATF4. The yeast S. cerevisiae contains only a single eIF2a kinase, 
GCN2, and phosphorylation of eIF2a derepresses translation of the mRNA encoding the 
transcription factor GCN4 (Hinnebusch, 2014). The integrated stress response and 
translational control of GCN4 are useful in vivo reporters of eIF2 function in mammalian 
and yeast cells, respectively (Alone et al., 2008; Baird and Wek, 2012; Borck et al., 2012; 
Dever et al., 1995; Erickson et al., 1997; Harding et al., 2003; Hinnebusch, 1985; Shin et 
al., 2011).  
As there are no protein structures available for human eIF2 or the isolated eIF2g 
subunit, cryo-EM images of the yeast 48S PIC give the most insight into the structure of 
eIF2 and interactions with other PIC components (Hussain et al., 2014; Llacer et al., 2015). 
As shown in Figure 5.1A and B, eIF2 ternary complex interacts with the intersubunit face 
of the 40S subunit. The g subunit consists of three domains: an N-terminal GTP binding 
domain (G) and two b-barrel domains DII and DIII (Fig. 5.1B and C). The g subunit is the 
center of the eIF2 complex and ternary complex, and eIF2g has binding sites for eIF2𝛼, 
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eIF2𝛽, Met-tRNAiMet, and GTP. The eIF2b subunit binds to the G domain on the face 
opposite the side that contacts GTP (shown in dark blue in Fig. 5.1B). Domain DII of eIF2g 
provides the binding site for  
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Figure 5.1. Putative MEHMO mutation S108R maps to an unstructured loop in 
eIF2γ
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Figure 5.1. Putative MEHMO mutation S108R maps to an unstructured loop in 
eIF2g  
(A) Ribbons representation of the yeast 48S preinitiation complex (PIC; PDB 3JAP). 
Only the 18S rRNA of the 40S subunit (grey), Met-tRNAiMet (green), eIF2a (N-terminal 
domains, light yellow; C-terminal domain, yellow), eIF2b (helix a1, blue; C-terminal 
domain, slate), and eIF2g (cyan) are shown. (B) The image from panel A rotated and 
zoomed to highlight the eIF2g subunit. The sites of two mutations identified in patients 
are highlighted: Homo sapiens (Hs) S108 (corresponding to S. cerevisiae Sc D167; red) 
and Hs I222 (Sc V281; purple). (C) Zoom and rotation of eIF2g from panel B. The other 
eIF2 subunits and components of the 48S complex have been removed for clarity. The 
sites of the eIF2g mutations are colored as in panel B and labeled.  
 
eIF2a (light yellow), and the acceptor arm of Met-tRNAiMet binds in a groove of eIF2g 
between the G domain and domains DII and DIII.  
In 2012, Borck et al. reported a case where three male family members (two 
brothers and a maternal uncle) were affected with an X-linked intellectual disability 
(XLID) (Borck et al., 2012). The patients exhibited a variety of clinical features including 
moderate to severe intellectual disability, microcephaly, short stature, and facial 
dysmorphic features. In addition, one brother had seizures and the uncle had 
microgenitalism and obesity. A single variant, c.665T>C, was detected in the X-
chromosome gene EIF2S3 that encodes humans eIF2g. The gene variant was reported to 
result in an isoleucine-to-threonine missense substitution, p.Ile222Thr (eIF2g-I222T). 
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Yeast structural data (Fig. 5.1 B and C, I222 shown in purple) and biochemical studies of 
human cells overexpressing eIF2g-I222T and of yeast with the analogous mutation showed 
a disruption in eIF2b binding to eIF2g (Borck et al., 2012). The yeast eIF2g mutation 
impaired translation and reduced the stringency of translation start site selection in vivo in 
a manner that was suppressed by overexpressing eIF2b. These results thus link intellectual 
disability to impaired translation initiation through the partial loss of eIF2 function.  
The clinical manifestation of the family studied by Borck et al. is very similar to 
MEHMO syndrome (Borck et al., 2012; Steinmuller et al., 1998). MEHMO syndrome is a 
rare severe X-linked neurodevelopmental disorder (MIM#300148), characterized by 
intellectual disability and clinical symptoms including epileptic seizures, hypogonadism, 
hypogenitalism, microcephaly, and obesity. Steinmuller et al. (1998) coined the term 
MEHMO in a study of a large family with five affected boys and identified the disease 
locus as the short arm of chromosome X (Xp11.3-22.13). Though Steinmuller et al. (1998) 
were not able to determine the genetic cause of the condition, based on the X linkage and 
clinical similarities with the family described by Borck et al. (2012), we suspected that 
MEHMO syndrome is caused by mutations in eIF2g. 
Rare diseases can be hard to study in humans, so model organisms are commonly 
used. Yeast are an advantageous model organism for rare disease studies because they are 
simple to genetically manipulate (Smith and Snyder, 2006; Yang et al., 2017). In yeast, 
eIF2g is essential for viability and is encoded by GCD11 (Hannig et al., 1993). Mutations 
in GCD11 alter translational regulation of GCN4 and the selection of the start site for 
protein synthesis (Dorris et al., 1995). In this study, I utilized yeast functional assays to 
assess a novel maternally inherited missense EIF2S3 variant (c.324T>A). The substitution 
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changes a conserved serine codon to arginine (p.Ser108Arg or eIF2g-S108R). The serine 
residue is conserved in human, rat, mouse, chicken, frog, and D. melanogaster, but is not 
conserved in budding yeast (Skopkova et al., 2017). The analogous residue to S108 in 
human eIF2g is D167 in the yeast factor. This residue is located in a flexible loop that is 
part of a zinc-binding ribbon in the G domain (Fig. 5.1 C, shown in red) (Hussain et al., 
2014; Llacer et al., 2015; Roll-Mecak et al., 2004). 
 
  282 
5.2. Materials and methods 
5.2.1. GCD11 mutant plasmids 
The plasmid pC2860, a derivative of the single copy LEU2 vector YCplac111 and 
encoding a His8-tagged derivative of yeast eIF2𝛾 (GCD11) under control of the native 
promoter (Alone et al., 2008) served as the starting point for all mutant constructs. The 
His8 tag was inserted between codons 2 and 3 of the GCD11 open reading frame. Site 
directed mutagenesis, conducted by Joo-Ran Kim, was used to generate various mutant 
constructs (Table 5.1). A series of four mutations were made at GCD11 residue D167 to 
generate: a GCD11 mutant with the wild-type human amino acid residue eIF2g-D167S; the 
human mutation eIF2g-D167R; and eIF2g-D167K and eIF2g-D167W, two mutations that 
were predicted to generate a more severe phenotype based on the size and charge of their 
side-chains. The residues flanking D167 in yeast eIF2g are not homologous to human 
eIF2g, so a series of mutants were made where GCD11 residues 164-173 were swapped for 
their corresponding human eIF2g residues, generating His8-GCD11-(human 164-173), 
referred to as ‘swap’ for simplicity. The plasmid pC5346 (swap) was used to generate three 
mutations; the eIF2g-human164-173-S167R (swap-S167R) mutation that corresponds to the 
patient mutation; and the eIF2g-human164-173-S167K (swap-S167K) and eIF2g-human164-
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Table 5.1. The yeast GCD11 plasmids used in this study 
Description Plasmid ID Source 
His8-GCD11, LEU2 pC2860 Alone et al., 2008 
His8-GCD11-D167S  pC5342 This study 
His8-GCD11-D167R pC5343 This study 
His8-GCD11-D167K  pC5344 This study 
His8-GCD11-D167W pC5345 This study 
His8-GCD11-human164-173 
(swap)**  
pC5346 This study 
His8-GCD11-human164-173**-
S167W  
pC5347 This study 
His8-GCD11-human164-173 
**-S167K 
pC5348 This study 
His8-GCD11-human164-173 
**-S167R 
pC5349 This study 
His8-GCD11-V281K pC4187 Borck et al., 2012 
His8-GCD11-V281T pC4188 Borck et al., 2012 
 
 
Table 5.1. ** For simplicity the yeast to human 164-173 substitutions are referred to as 
‘swap’ in the figures. 
 
5.2.2. Yeast transformation 
S. cerevisiae cells were transformed using the lithium acetate (LiOAc)/single-
stranded carrier DNA/PEG method (Gietz and Schiestl, 2007). Briefly, stock solutions of 






  284 
Table 5.2. Stock 10X LiOAc solution 
1 M LiOAc/TE (10X) 
Lithium acetate 10.2 g 
1X TE pH 7.5 100 ml 
 
Table 5.2. Filter sterilize the 10X solution before storage. To make the 1X (0.1M) working 
solution, dilute the 10X stock solution in 1X TE pH 7.5 and filter sterilize.  
 
Table 5.3. The 44% PEG stock solution 
44% PEG 
PEG 3350 220 g 
1X TE pH 7.5 310 ml 
 
Table 5.3. To sterilize, autoclave the 44% PEG stock solution. To make the 40% PEG 
working stock, mix 45 ml of 44% PEG with 5 ml of 10X lithium acetate in TE.  
 
 The day prior to transformation, inoculate the yeast strain(s) in three ml of yeast 
extract peptone dextrose (YPD) medium and incubate overnight at 30°C. The next day, 
dilute the overnight culture 1:50 in fresh YPD medium (1 ml culture in 49 ml YPD in a 
250 ml flask). Incubate at 30°C with shaking for three to five hr until OD600 is 0.5-0.8. 
Pellet the cells in a 50 ml Falcon tube by centrifugation for 5 min at 1462 x g, and then 
discard the supernatant. Wash the cell pellet with five to ten ml of 1X LiOAc/TE, re-pellet 
the cells by centrifugation for five min at 1462 x g, and then discard the supernatant. 
Resuspend the cells in one ml 1X LiOAc/TE, then transfer the cells to a microcentrifuge 
tube and incubate at 30°C for 30 min. While the cells are incubating, prepare the DNA for 
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transformation by mixing 5-10 µl of calf thymus DNA, 25-50 ng of plasmid DNA, and 350 
µl of 40% PEG in a microcentrifuge tube. Following the incubation, pellet the cells at 
13,000 x g for 30 s in a microcentrifuge and resuspend the pellet in 1/100 of the original 
yeast culture volume in 1X LiOAc/TE (e.g. use 500 µl 1X LiOAc/TE for the pellet from a 
50 ml culture). Add 50 µl of the competent cells to each of the tubes containing DNA and 
then mix by vortexing. Incubate the DNA and competent cell mixture at RT for 30 min. 
Then, mix the samples on a vortex, heat shock by incubating at 42°C for 15 min, and then 
spin down the cells and resuspend the pellet in 200 µl synthetic minimal medium. Finally, 
spread the cells on YPD plates to recover overnight at 30°C. The next day, replica plate 
onto restrictive plates to select for transformants.  
5.2.3. Generation of GCD11 mutant yeast strains 
As GCD11 is essential for yeast viability, plasmid shuffling (Boeke et al., 1987) 
was used to introduce mutant forms of eIF2g into a yeast strain lacking chromosomal 
GCD11. The gcd11D strain J292 (MATa, leu2-3, leu2-112, ura3-52, his3, gcn2D::loxP, 
gcd11D::KanMX, p[GCD11, URA3]) was used for all studies. J292 contains GCD11 on a 
plasmid with a URA3 marker that allows for negative selection after the introduction of a 
second copy of GCD11 on a different (LEU2) plasmid. Following introduction of a GCD11 
mutant on a LEU2 plasmid, plasmid shuffling was used to select for cells that lost the wild-
type GCD11, URA3 plasmid (Boeke et al., 1987). In short, yeast strain J292 was 
transformed with each of the 13 gcd11 mutant plasmids. Clonally purified transformants 
were patched on synthetic minimal plates supplemented with histidine, and then replica 
printed to medium containing 5-fluororotic acid (5-FOA). Cells that have lost the GCD11, 
URA3 plasmid will grow on the 5-FOA medium. The 5-FOA-resistant colonies were 
  286 
clonally purified by streaking on synthetic minimal plates supplemented with uracil and 
histidine. The purified strains carrying a mutant GCD11, LEU2 plasmid and lacking the 
wild-type GCD11, URA3 plasmid were used for subsequent studies (Table 5.4). The 
resulting strains were colony purified and then patched on plates. For growth assays, the 
strains were streaked on synthetic minimal plates supplemented with uracil and histidine 
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Table 5.4. The yeast strains generated in this study 
Yeast genotypes Strain ID Source 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[GCD11, 
URA3] 
J292 (Borck et al., 2012) 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11, LEU2] 
J1440 This study 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11-D167S, LEU2] 
J1441 This study 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11-D167R, LEU2] 
J1442 This study 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11-D167K,LEU2] 
J1443 This study 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11-D167W,LEU2] 
J1444 This study 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11-(human164-173), LEU2] 
J1445 This study 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11-human164-173-S167W, LEU2] 
J1446 This study 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11-human164-173-S167K,LEU2] 
J1447 This study 
Matα leu2-3, leu2-112,  ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11-human164-173-S167R,LEU2] 
J1448 This study 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11-V281K,LEU2] 
J1449 This study 
Matα leu2-3, leu2-112, ura3-52, his3, 
gcn2Δ, gcd11Δ::KanMax p[His8-
GCD11-V281T,LEU2] 
J1450 This study 
 
Table 5.4. For simplicity, the yeast to human 164-173 substitutions are referred to as 
‘swap’ in the figures.  
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5.2.4. b-galactosidase assay 
For the measurement of GCN4-lacZ expression, derivatives of yeast strain J292 
expressing wild-type or mutated forms of GCD11 were transformed with the plasmid p180 
(Table 5.5). Transformants were grown in synthetic minimal medium supplemented with 
histidine to OD ~ 0.8, and b-galactosidase activities were determined as described below. 
To measure translation start site selection stringency, the derivatives of yeast strain J292 
were transformed with the plasmids p3989 (His4(AUG)-lacZ) or p3990 (His4(UUG)-lacZ) 
(Table 5.5). Transformants were grown to OD ~ 0.8, and b-galactosidase activities were 
determined as described below.  
Table 5.5. b-galactosidase assay lacZ reporters 
Reporter Plasmid ID Source 
GCN4-lacZ, URA3 p180 (Hinnebusch, 1985) 
His4(AUG)-lacZ, URA3 p3989 (Cigan et al., 1988b) 
His4(UUG)-lacZ, URA3 p3990 (Cigan et al., 1988b) 
 
To initiate b-galactosidase assays, triplicate five ml pre-cultures in synthetic 
minimal medium supplemented with histidine were incubated overnight at 30°C with 
shaking. The next day, the pre-cultures were used to inoculate 5 ml cultures of synthetic 
minimal plus histidine medium at an OD of 0.5 in 14 ml round bottom plastic Falcon tubes. 
The cultures were incubated for six hr at 30°C with shaking at 250 rpm, then the cells were 
pelleted at 1462 x g, transferred to a 1.5 ml microcentrifuge tube, and the cell pellets stored 
at -80 °C overnight.  
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The breaking buffer (Table 5.6) was chilled on ice, and chilled Z-buffer (Table 5.7) 
was prepared by adding 0.75 g of ortho-Nitrophenyl-𝛽-galactoside (ONPG) per liter of Z-
buffer. The frozen cells were resuspended in 200 µl breaking buffer (Table 5.6) and lysed 
using two-thirds volume glass beads. The cell suspension was mixed on a vortex for 10 
min at 4°C. The supernatant was transferred to a clean chilled microcentrifuge tube and the 
solution was clarified by centrifugation at maximum speed for 15 min at 4°C. The 
supernatant was transferred to a cold 1.5 ml microcentrifuge tube.  
Total protein concentration was measured using a Bradford assay. Bradford 
Reagent (BIO-RAD) was prepared by mixing one-part 5X reagent with four parts water 
and filtering. Each sample was then prepared by adding one ml of 1x Bradford reagent and 
1 µl of sample and then mixed on a vortex. The samples were incubated for five min at RT 
and then the absorbance was measured at 595 nm. To calculate the protein concentration, 
a set of protein standards containing 0.2 mg/ml, 0.4 mg/ml, 0.6 mg/ml, 0.8 mg/ml and 1 
mg/ml BSA were used to create a standard curve.  
Two hours before beginning the b-galactosidase assays, an ortho-Nitrophenyl-b-
galactoside (ONPG) solution was prepared by mixing 0.2 g of ONPG in 50 ml Z-buffer 
(Table 5.7). For the b-galactosidase assays, 950 µl of Z-buffer was added to a 5 ml round 
bottom falcon tube and then 50 µl of sample was added. The samples were incubated for 
five minutes at 28 °C and then 200 µl ONPG solution was added to each sample and the 
start time for each sample was recorded. The samples were incubated at 28 °C until pale 
yellow, the time was recorded, and the reaction was terminated by adding 500 µl Na2Co3 
stock solution (5.3 g Na2Co3 in 50 ml water). The absorbance was measured at 420 nm. 
The b-galactosidase concentration was calculated using the following formula: 
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(absorbance at 420 nm*1.7)/(0.0045*protein concentration*volume(ml)*time(min)) 
protein concentration = absorbance at 595 nm/0.069, where 0.069 is the slope generated 
by the BSA standard curve.  
Table 5.6. Composition of the b-galactosidase assay breaking buffer 
Breaking Buffer 
Reagent Volume (40 mls) 
ddH20 28 ml 
1 M Tris pH 8.0  4 ml 
20% Glycerol 8 ml 
BME 2.88 µl 
40 mM AEBSF** 400 µl 
 
Table 5.6. **(2-aminoethyl)benzenesulfonyl fluoride hydrochloride serine protease 
inhibitor 
 
Table 5.7. Composition of the b-galactosidase assay Z-buffer 
Z-Buffer 
Reagent Volume (250 mls) 
Na2HPO4 4.03 g 
NaH2PO4 1.38 g 
2 M KCl  1.25 ml 
MgSO4 0.062 g 




  291 
5.3. Results  
A male patient displaying microcephaly, hypospadia and cryptochordism, 
developmental delay and obesity was given a probably diagnosis of MEHMO syndrome 
by Dr. Clesson Turner, M.D. at Walter Reed National Military Medical Center (Skopkova 
et al., 2017). While the patient did not have all the clinical features of MEHMO syndrome, 
having intellectual disability, hypogonadism, microcephaly, and obesity, but not epilepsy, 
whole exome sequencing revealed that he had a novel maternally inherited missense 
EIF2S3 variant (c.324T>A). The substitution changes a conserved serine codon to arginine 
(p.Ser108Arg). The serine residue is conserved in human, rat, mouse, chicken, frog, and  
D. melanogaster but is not conserved in budding yeast (Skopkova et al., 2017). The 
analogous residue to S108 in human eIF2g is D167 in the yeast factor. This residue is 
located in a flexible loop that is part of a zinc-binding ribbon in the G domain (Fig. 5.1 C, 
shown in red) (Hussain et al., 2014; Llacer et al., 2015; Roll-Mecak et al., 2004). This 
region is not fully resolved in the yeast cryo-EM structure, but it does not appear to interact 
with other components of the 48S PIC (Fig. 5.1 B), and the function of the Zn2+-binding 
element in eIF2g is unknown.  
To test the impact of the eIF2g-S108R substitution on eIF2 function, a yeast/human 
(Sc/Hs) chimeric form of eIF2g was generated by replacing yeast eIF2g amino acid residues 
164-173 with the corresponding residues from human eIF2g (Fig. 5.2). In this chimeric 
protein, S167 corresponds to the native human eIF2g residue S108. The S167 residue was 
mutated to Arg to correspond with the patient S108R mutation or to Trp or Lys. The latter 
mutations, which are anticipated to be more severe than the Arg substitution, were 
generated in case the eIF2g-S167R mutation does not confer a phenotype in yeast. In 























Figure 5.2. Schematic of the eIF2γ (yeast GCD11) mutations generated for this 
study
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Figure 5.2. Schematic of the eIF2g (yeast GCD11) mutations generated for this study 
To study the impact of S108 mutations in human eIF2g, mutations were made at the 
corresponding D167 residue in yeast eIF2g (GCD11) and in a human-yeast chimera. 
(Upper) GCD11 is displayed as a rectangle with the targeted region highlighted in blue. 
The wild-type yeast sequence for residues 164-173 is depicted in black and amino acid 
substitutions (red) were made at residue D167 to generate the normal human residue S108 
(D167S), and the mutations D167R, D167K, and D167W. A chimeric (swap) mutant was 
made by substituting the human residues 105-114 in place of the corresponding yeast 
residues 164-173 (Swap). The same S167 amino acid substitutions (blue) were made in 
this chimeric allele.  
 
addition to mutating the yeast-human chimeric allele, the D167 residue in the native yeast 
GCD11 gene, which corresponds to S108 in the human protein, was mutated to Ser, the 
native human residue, as well as to Arg, the patient’s mutation, and to Trp and Lys. The 
yeast strain J292 was transformed with the plasmids containing wild-type or mutant forms 
of GCD11, followed by loss of the original plasmid-borne GCD11 plasmid, so that only 
the introduced eIF2g was expressed (Tables 5.1 and 5.4). In addition to the yeast mutants 
corresponding to the human eIF2g-S108R mutant, mutant strains expressing two other 
previously described eIF2g mutants were also generated, eIF2g-V281K and eIF2g-V281T, 
which correspond to mutations at human eIF2g residue I222 (Borck et al., 2012). The 
eIF2g-V281K and eIF2g-V281T mutants were included as controls because the mutations 
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were previously shown to affect growth, GCN4-lacZ reporter expression, and translation 
start site selection stringency (Borck et al., 2012). 
Yeast expressing the eIF2g-D167S or the eIF2g-human164-173 (swap) as the sole 
form of eIF2g grew like yeast expressing wild-type yeast eIF2g with no discernable growth 
defect at 30°C (Fig. 5.3). Similarly, yeast expressing the eIF2g-D167R and the eIF2g-
human164-173-S167R mutants, corresponding to the patient mutation, had no discernable 
growth defect. Yeast expressing the eIF2g-D167K and eIF2g-D167W mutations also had 
no discernable growth defect. Finally, like the other mutations at residue 167, the eIF2g-
human164-173-S167W and eIF2g- human164-173-S167K mutants also conferred no 
discernable growth defect when expressed as the sole form of eIF2g in yeast. As a positive 
control in this growth assay, I tested the yeast eIF2g-V281T and eIF2g-V281K mutants, 
corresponding to the human eIF2g-I222T mutation identified in the previously described 
patients with XLID (Borck et al., 2012). As described previously, the eIF2g-V281K 
showed a striking slow growth phenotype at 30°C (Fig. 5.3).  
  To further assess the impact of the human eIF2g-S108R mutation on eIF2g 
function, a GCN4-lacZ reporter was introduced into isogenic yeast strains expressing: 
wild-type-eIF2g; the yeast eIF2g-D167S, eIF2g-D167R, eIF2g-D167K, and eIF2g-D167W 
mutations; the eIF2g-human164-173(swap), eIF2g-human164-173-S167R, eIF2g-human164-173-
S167K, and eIF2g-human164-173-S167W; or as a positive control, yeast eIF2g-V281T and 
eIF2g-V281K, which were previously shown to impair eIF2 function and cause 
derepression of GCN4 expression (Borck et al., 2012). The GCN4-lacZ reporter system is 
a useful tool to measure eIF2 function. In yeast, phosphorylation of eIF2a by the protein 










Figure 5.3. Mutations at residue D167 of yeast eIF2γ do not impair cell growth
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Figure 5.3. Mutations at residue D167 of yeast eIF2g do not impair cell growth  
Yeast expressing the indicated eIF2g mutants, as the sole source of eIF2g, were streaked 
on synthetic minimal medium and incubated at 30 °C for 3 days.  
 
kinase GCN2 mediates translational control of the transcriptional activator GCN4 (Dever 
et al., 1992). The GCN4 mRNA contains four short uORFs prior to the GCN4 mORF. 
Regulated reinitiation on the uORFs, which is sensitive to eIF2 function, controls 
synthesis of GCN4. Ribosomes bind near the 5’ cap of the mRNA, scan down and 
translate uORF1 (Fig. 5.4A). Following translation of uORF1, the post-termination 40S 
subunit remains attached to the mRNA and resumes scanning (Hinnebusch, 2011). If 
ternary complex levels are high, indicating normal eIF2 function, nearly all of the 
scanning 40S subunits will re-acquire a ternary complex, which enables the scanning 
ribosome to recognize subsequent start codons and re-initiate translation at uORF2, 
uORF3, or uORF4. Following translation of these latter uORFs, especially uORF3 and 
uORF4, the ribosome dissociates from the mRNA and fails to translate the GCN4 mORF. 
However, if ternary complex levels are low or ternary complex binding to the ribosome is 
impaired, the 40S subunits scanning down the mRNA after translating uORF1 are more 
likely to scan past uORFs 2-4 without reinitiating translation. If these scanning 40S 
subunits acquire a ternary complex after scanning past uORF4, the ribosomes can then re-
initiate translation at the GCN4 start codon. Thus, mutations that lower ternary complex 
levels or impair eIF2 function will induce the expression of a GCN4-lacZ reporter.  
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Figure 5.4. Mutations at residue D167 of yeast eIF2γ do not affect GCN4 
expression
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Figure 5.4. Mutations at residue D167 of yeast eIF2g do not affect GCN4 expression 
(A) Schematic of GCN4-lacZ reporter construct containing the four uORFs that control 
GCN4 mRNA translation. (B) Yeast expressing the indicated eIF2g mutants, as the sole-
source of eIF2g, were transformed with the GCN4-lacZ reporter. b-Galactosidase activities 
and standard deviations were determined from three independent transformants. Error bars 
represent SD, * p < 0.005 (Student’s two-tailed t-test; n=3, assayed in duplicate, assessed 
against wild-type). 
 
As expected, GCN4-lacZ expression was low in yeast expressing wild-type eIF2g 
or the eIF2g-D167S mutant in which the wild-type human residue was substituted for the 
native yeast residue (Fig. 5.4B). Likewise, the eIF2g-D167R mutant, which mimics the 
human mutation, did not increase GCN4-lacZ expression. Notably, this lack of impact of 
the patient mutation on GCN4-lacZ expression was previously observed for the yeast 
eIF2g-V281T mutation that mimics the human eIF2g-I222T mutation that causes MEHMO 
syndrome. Like the eIF2g-D167R mutation, the eIF2g-V281T mutation conferred only a 
mild growth defect and did not increase GCN4-lacZ expression (Fig. 5.3 and Fig. 5.4B). 
As neither of these mutations is lethal in humans, where alterations in translation are 
expected to be more impactful than in single-celled yeast, perhaps it is not surprising that 
these patient mutations do not confer a phenotype in yeast. Unexpectedly, the eIF2g-
D167K and eIF2g-D167W mutations, which were chosen with the notion that they might 
more substantially impair eIF2 function, did not impact GCN4-lacZ expression. Similar 
results were observed when the mutations were introduced into the yeast-human eIF2g 
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chimera. As expected, the wild-type yeast-human chimera (referred to as the Swap mutant) 
showed wild-type levels of GCN4-lacZ expression. Moreover, consistent with the results 
obtained when mutating native yeast eIF2g, the mutations Swap-S167W, Swap-S167K, 
and Swap-S167R did not impact GCN4-lacZ expression. Taken together, these results 
indicate that mutations at residue D167 in yeast eIF2g have minimal or no impact on eIF2 
function. 
Mutations that impair eIF2 function can also lower translation initiation fidelity 
and allow ribosomes to initiate translation at non-AUG codons (Hinnebusch, 2011). 
Translation is normally stringently restricted to initiate at an AUG codon; however, 
mutations that weaken Met-tRNAiMet binding to eIF2, enhance eIF2 GTPase activity, or 
disrupt eIF2 integrity, enhance initiation at non-AUG codons and confer a suppressor of 
initiation (Sui-) phenotype in yeast (Huang et al., 1997). Yeast Sui- mutations were first 
identified through the restoration of the expression of his4 alleles with a non-AUG start 
codon. Sui- mutations enable translation to initiate more efficiently at the third, UUG 
codon of the his4 open reading frame, reestablishing growth in histidine-free medium 
(Yoon and Donahue, 1992). To assess stringency of translation start codon selection, 
His4-lacZ reporter constructs with either an AUG or UUG start codon (Fig. 5.5A) were 
transformed into yeast strains expressing: wild-type-eIF2g; the yeast eIF2g-D167S, 
eIF2g-D167R, eIF2g-D167K, and eIF2g-D167W mutants; the eIF2g-human164-173 (swap), 
eIF2g-human164-173-S167R, eIF2g-human164-173-S167K, and eIF2g-human164-173-S167W 
mutants; or as positive controls, the yeast eIF2g-V281T and eIF2g-V281K mutants, 
which were previously shown to impair eIF2 function and decrease the stringency of 
translation start codon selection (Borck et al., 2012). 

















































































































Figure 5.5. Mutations at residue D167 of yeast eIF2γ do not alter translation start 
site fidelity
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Figure 5.5. Mutations at residue D167 of yeast eIF2g do not alter translation start 
site fidelity 
(A) Schematics of HIS4(AUG)- and HIS4(UUG)-lacZ reporter constructs. (B) The 
HIS4(AUG)- and HIS4(UUG)-lacZ reporter constructs were introduced into yeast 
expressing the indicated eIF2g mutants, as the sole-source of eIF2g. b-galactosidase 
activities (B) and mean ratios of the activities (C) were determined. Error bars represent 
SD, * p < 0.005 (Student’s two-tailed t-test; n=3, assayed in duplicate, assessed against 
wild-type (Sc)). 
 
Consistent with previous reports, expression of the His4(UUG)-lacZ reporter was 
substantially poorer than expression of the His4(AUG)-lacZ reporter in cells expressing 
wild-type eIF2g, as well as in cells expressing yeast eIF2g-D167S and eIF2g-human164-173 
(swap) (Donahue and Cigan, 1988), leading to a low UUG/AUG initiation ratio of less than 
0.02 (Fig. 5.5C). Similarly, expression of the His4(UUG)-lacZ was substantially poorer 
than expression of the His4(AUG)-lacZ reporter in cells expressing the eIF2g-D167R, 
eIF2g-D167K, and eIF2g-D167W mutants, also leading to a low UUG/AUG ratio of less 
than 0.02. Poor expression of the His4(UUG)-lacZ compared to the His4(AUG)-lacZ 
reporter was also seen in cells expressing eIF2g-human164-173-S167R (swap-S167R), eIF2g-
human164-173-S167K (swap-S167K), and eIF2g-human164-173-S167W (swap-S167W). In 
contrast, expression of the His4(UUG)-lacZ reporter was substantially increased along 
with expression of the His4(AUG)-lacZ reporter in cells expressing the previously 
described eIF2g-V281K mutant. His4(UUG)-lacZ expression was approximately 10-times 
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higher in yeast expressing eIF2g-V281K compared to yeast expressing wild-type 
eIF2g, leading to an increase in the UUG/AUG initiation ratio from 0.02 in the wild-type 
to 0.06 in the cells expressing eIF2g-V281K, a greater than 3-fold increase. The 3-fold 
increase in the UUG/AUG ratio in cells expressing eIF2g-V281K is consistent with 
previous findings (Borck et al., 2012); however, unlike as in the previous study, 
His4(UUG)-lacZ expression was not elevated in cells expressing eIF2g-V281T. The 
UUG/AUG ratio remained below 0.02, at a similar level to cells expressing wild-type 
eIF2g. In contrast, the eIF2g-V281T mutation was previously shown to increase the 
UUG/AUG ratio approximately 2-fold (Borck et al., 2012), perhaps reflecting a difference 
in growth conditions or assay sensitivity in this assay compared to the previous study. 
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5.4. Discussion and conclusions  
Our lab, together with collaborators, recently demonstrated that mutations in eIF2 
cause MEHMO syndrome (Skopkova et al., 2017). While the original MEHMO patient 
exhibited intellectual disability, epilepsy, hypogonadism, microcephaly, and obesity 
(Steinmuller et al., 1998), the male patient with the c.324T>A (p.Ser108Arg) mutation in 
EIF2S3, the mutation examined in this thesis, has not experienced seizures and has not 
been diagnosed with epilepsy. The eIF2g-S108R mutation described is one of five different 
mutations in EIF2S3 that has been linked to MEHMO syndrome to date. In 2017, our 
collaborators described a 4 bp deletion in the EIF2S3 gene (c.1394_1397delTCAA) in two 
families with sons exhibiting MEHMO syndrome phenotypes (Skopkova et al., 2017). 
Moreover, a separate family in which four males were afflicted with an XLID that was 
associated with the same 4 bp deletion in EIF2S3 was reported (Moortgat et al., 2016). 
Definitive linkage of mutations in EIF2S3 to MEHMO syndrome was provided when our 
collaborators obtained archival DNA samples from the index patient. Sequencing of the 
EIF2S3 gene from this patient (Steinmuller et al., 1998) revealed the same 4 bp deletion 
that is predicted to cause a frameshift and premature stop codon (p.Ile465Serfs*4) that 
impacts the C-terminal eight residues of eIF2g (Skopkova et al., 2017). The eIF2g-fs 
mutation decreases eIF2 heterotrimer formation by impairing binding of eIF2a to 
eIF2g (Young-Baird et al., 2020). The impaired interaction is not due to an alteration in the 
site on eIF2g where eIF2a binds, because the mutation affects the C-terminal residues of 
eIF2g which are far from the loop in Domain II that was previously shown to interact with 
eIF2a (Hussain et al., 2014; Roll-Mecak et al., 2004; Yatime et al., 2007; Young-Baird et 
al., 2019a){Young-Baird, 2020 #405}. Instead, Young-Baird et al. (2019) propose that the 
  304 
eIF2g-fs mutation alters the interaction of eIF2g with the chaperone CDC123, consistent 
with structural studies that map the CDC123 interaction site to the C-terminus of eIF2g 
(Bieganowski et al., 2004; Perzlmaier et al., 2013). As CDC123 was previously shown to 
facilitate eIF2a binding to eIF2g (Perzlmaier et al., 2013), the altered interaction with 
CDC123 likely accounts for defective eIF2a binding to the eIF2g-fs mutant.  
In their 2012 paper, Borck et al. described three patients with XLID who carried a 
c.665T>C mutation in EIF2S3 that caused the missense mutation eIF2g-I222T (Borck et 
al., 2012). The I222T mutation lies in a hydrophobic cleft on the backside of the GTP 
binding domain (Fig. 5.1B and C, purple) that forms the binding site for helix a1 of the 
eIF2b subunit and disrupts eIF2b binding to eIF2g (Borck et al., 2012). The disruption in 
eIF2b binding is consistent with the homologous archaeal aIF2 complex crystal structures 
available at the time (Stolboushkina et al., 2008; Yatime et al., 2007), and the subsequent 
yeast high resolution cryo-EM structures (Hussain et al., 2014; Llacer et al., 2015). 
In addition to the family in which four males carried the eIF2g-fs mutation, 
Moortgat et al. (2016) also described a family where two male siblings exhibited severe 
microcephaly, growth retardation, seizures, and intellectual disability, some of the features 
of MEHMO syndrome. The family had a  c.777T>G mutation causing a p.Ile259Met 
missense mutation in the domain DII Met-tRNAiMet binding pocket of eIF2g (Moortgat et 
al., 2016; Young-Baird et al., 2019b). In a study to examine how the 
eIF2g-I259M mutation impairs eIF2 function, Young-Baird et al. (2019b) generated the 
corresponding mutation in yeast, eIF2g-I318M. In yeast, the eIF2g-I318M mutation 
caused derepression of GCN4 expression and relaxed the stringency of translation start site 
selection. The eIF2g-I318M mutation impairs Met-tRNAiMet binding to eIF2 (Young-Baird 
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et al., 2019b). The impairment in Met-tRNAiMet binding is likely due to an indirect effect 
because I318 does not directly contact the Met-tRNAiMet. However, the I318 residue is 
adjacent to R319, which is part of the Met-tRNAiMet binding pocket. The eIF2g-R319D 
mutation is lethal in yeast (Roll-Mecak et al., 2004) and Young-Baird et al. (2019 propose 
that the eIF2g-I318M mutation impacts the position of R319 in the binding pocket.  
The most recently described mutation in EIF2S3 was reported in a family with three 
affected male children, a cousin and twin brothers (Gregory et al., 2019). The children had 
hypoglycemia, short stature with growth hormone and thyroid stimulating hormone 
deficiencies, and a pancreatic phenotype. Their phenotype was linked to a c.1294C>T 
EIF2S3 mutation (p.Pro432Ser) that alters a highly conserved residue in domain III of 
eIF2g (Gregory et al., 2019). To date, the impact of this mutation on eIF2 function has not 
been determined, but the corresponding mutation in yeast, eIF2g-P490S, resulted in a 
modest 1.7-fold increase in GCN4-LacZ expression and a modestly relaxed stringency of 
translation start site selection (Gregory et al., 2019).  
All five EIF2S3 mutations that have been linked to ID or MEHMO syndrome have 
been introduced into the yeast gene to examine the impact on cell growth, GCN4 expression 
and the stringency of translation start site. Of the five mutations, only the eIF2g-S108R 
(yeast eIF2g-D167R) had no phenotype in any of the yeast assays. The eIF2g-I222T (yeast 
eIF2g-V281T) mutation conferred a mild growth defect in yeast, but substituting lysine for 
the valine residue (V281K) resulted in a severe growth defect (Borck et al., 2012). The C-
terminal I465Sfs*4 mutation, eIF2g-fs, introduced into a yeast-human chimeric allele in 
which the C-terminal thirteen residues of yeast eIF2g were replaced by the corresponding 
sixteen residues of human eIF2g, caused no growth phenotype at 30 °C but conferred a 
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mild slow-growth phenotype at 37 °C (Skopkova et al., 2017). The eIF2g-I259M mutation 
(yeast eIF2g-I318M mutation) caused a pronounced slow growth phenotype at 30 °C that 
was nearly as severe as the eIF2g-V281K mutation (Young-Baird et al., 2019b). Finally, 
like the eIF2g-D167R mutation, the P432S (yeast eIF2g-P490S) mutation did not impact 
yeast cell growth (Gregory et al., 2019). Thus, despite all five of the EIF2S3 mutations 
conferring a phenotype in the patients, the less severe human EIF2S3 mutations do not 
have a corresponding slow growth phenotype in yeast.  
 The GCN4-lacZ and UUG/AUG His4-lacZ reporter assays are much more sensitive 
to disturbances in eIF2 function than yeast cell growth. The eIF2g-V281T (human eIF2g-
I222T) mutation lead to over a 2-fold increase in GCN4-lacZ expression while the lysine 
substitution led to a nearly 40-fold increase in GCN4-lacZ expression (Borck et al., 2012). 
The eIF2g-V281T mutation also affected translation start site selection stringency with a 
two-fold increase in the UUG to AUG initiation ratio, while the lysine mutation caused a 
three-fold increase in the UUG to AUG initiation ratio. Like the eIF2g-V281K mutation, 
the eIF2g-fs mutation in the yeast-human chimeric allele caused an approximately two-fold 
increase in GCN4-lacZ expression and also increased the UUG to AUG initiation ratio by 
about 2-fold (Skopkova et al., 2017). The eIF2g-I318M mutation that impairs Met-tRNA 
binding led to a dramatic 16-fold increase in GCN4-lacZ expression that mirrored the effect 
seen with the V281K mutation (Young-Baird et al., 2019b). The eIF2g-I318M mutation 
also substantially increased the UUG to AUG initiation ratio, indicating that weakened 
Met-tRNAiMet binding to eIF2 both decreases ternary complex levels and enables initiation 
at non-AUG codons. While neither the D167R mutation nor the P490S mutation in eIF2g 
affected yeast cell growth, the P490S mutation caused modest increases in both GCN4-
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lacZ expression and the UUG to AUG initiation ratio (Gregory et al., 2019). Taken 
together, these results reveal that of all of the yeast models of human eIF2g mutations, the 
D167R mutation has the least effect on eIF2 function. However, I make this conclusion 
cautiously because in my assays the eIF2g-V281T mutation, which previously was shown 
to modestly affect the yeast reporter assays (Borck et al., 2012; Skopkova et al., 2017), also 
failed to impact GCN4-lacZ expression or UUG to AUG initiation ratios (data not shown). 
This lack of impact of the V281T mutation in my assays might reflect subtle differences in 
experimental technique that mask the effects of the mild V281K and D167R mutations in 
eIF2g. At odds with this simple explanation, the fact that more extreme amino acid changes 
at D167, substituting with oppositely charged lysine or bulky tryptophan, likewise had no 
impact indicates that the residue D167 of yeast eIF2g is not as sensitive to amino acid 
changes as the residues altered by the other eIF2g mutations. Due to the fact that the yeast 
eIF2g-D167 mutations do not confer a phenotype, we have no evidence that the human 
eIF2g-S108R mutation is pathogenic. Therefore, we cannot, at this time, definitively 
conclude that the eIF2g-S108R mutation is the cause of the patient’s disease.  
Mutations in EIF2S3 affect eIF2 function and may cause pathology through the 
integrated stress response (Skopkova et al., 2017; Young-Baird et al., 2019a). Induced 
pluripotent stem cells (iPSCs) derived from a patient with eIF2g-fs mutation showed 
impaired general translation and cell growth (Young-Baird et al., 2019a). Western blot 
analyses revealed elevated levels of ATF4, CHOP, and GADD34, key components of the 
integrated stress response pathway, but no increase in eIF2a-P, indicating that the 
integrated stress response is induced independently of eIF2a phosphorylation, likely due 
to decreased eIF2 activity (Young-Baird et al., 2019a).   As described previously, 
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translational regulation of ATF4, CHOP and GADD34 is mediated, in part, by uORFs in 
the 5’ leaders of the transcripts that couple expression to the level of eIF2a-P and eIF2 
activity (Wek, 2018; Young and Wek, 2016). Translational control of ATF4 is mediated by 
two uORFs (Harding et al., 2000; Lu et al., 2004; Vattem and Wek, 2004). As in the GCN4 
mRNA, the ATF4 uORF1 acts as a positive element by enabling downstream translational 
re-initiation. When eIF2 ternary complex levels are high, ribosomes that resume scanning 
after translation of uORF1 quickly reacquire a new eIF2 ternary complex and reinitiate 
translation at uORF2; however, uORF2 overlaps out-of-frame with the ATF4 coding 
sequence, and termination at the uORF2 stop codon is 3’ of the ATF4 coding sequence start 
codon. Translation of uORF2 precludes the ribosome from initiating translation at the 
ATF4 coding sequence, resulting in low ATF4 expression when eIF2 ternary complex 
levels are high. Under conditions that lower eIF2 ternary complex levels, ribosomes that 
resume scanning after translating uORF1 take a longer time to acquire a new eIF2 ternary 
complex. This additional time allows the ribosome to scan past the inhibitory uORF2 start 
codon and initiate translation at the ATF4 coding sequence start codon, increasing ATF4 
expression when eIF2 ternary complex concentrations are low. Similarly, as described 
above, decreased eIF2 ternary complex concentrations increase expression of CHOP and 
GADD34 by increasing the bypass of the inhibitory uORF (uCC) (Young et al., 2016; 
Young and Wek, 2016; Young et al., 2015b). 
The eIF2g-fs mutation impairs eIF2 function, mimicking constitutive 
eIF2a phosphorylation and leading to chronic activation of the integrated stress response. 
The mutation also leads to hyperactivation of the integrated stress response and apoptosis 
under stress conditions (Young-Baird et al., 2019a), which could contribute to the 
  309 
symptoms of MEHMO syndrome. ATF4 induction via eIF2a phosphorylation has also 
been linked to regulation of learning and memory in mice , which could explain the ID 
phenotype seen in MEHMO patients (Young-Baird et al., 2019a). ATF4 is a transcription 
factor that triggers a program of gene expression to alleviate stress (Walter and Ron, 2011); 
however, prolonged or pronounced expression of ATF4 prompts maladaptive responses 
including induction of apoptosis (Matsumoto et al., 2013). Among the ATF4 
transcriptional targets is the pro-apoptotic transcription factor CHOP (Zinszner et al., 
1998), whose expression was shown to be elevated in eIF2g-fs iPSCs (Young-Baird et al., 
2019a). 
 The S108R mutation exists in a flexible loop of eIF2g (Fig 5.1) (Hussain et al., 
2014; Llacer et al., 2015). The flexible loop is part of a zinc-binding ribbon within the G 
domain, but it is unclear whether the human zinc-binding ribbon actually binds zinc. The 
eIF2g proteins from diverse species including the archaeon Methanococcus jannaschii, S. 
cerevisiae, and D. melanogaster have four cysteine residues within the loop that could be 
involved in coordinating a zinc ion (Roll-Mecak et al., 2004). Mutation of the single 
invariant cysteine residue in yeast eIF2g results in a severe slow growth phenotype 
(Erickson et al., 1997; Roll-Mecak et al., 2004); however, it is not known if the mutation 
affects zinc binding. Of the four cysteine residues conserved among M. jannaschii , S. 
cerevisiae, and D. melanogaster, mammals have lost three, replacing them with leucine or 
threonine. Loss of zinc binding during evolution was observed in zinc-binding ribosomal 
proteins, such as ribosomal protein L33 (Krishna et al., 2003). In the case of these 
ribosomal proteins, the integrity of the structure is preserved through main chain hydrogen 
bonds and van der Waals interactions among the hydrophobic amino acids replacing the 
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zinc-binding cysteines (Krishna et al., 2003; Roll-Mecak et al., 2004). The human eIF2g-
S108R mutation is in the middle of a region of the zinc ribbon that is not highly conserved 
outside animals. The loop is absent in archaea and the serine is replaced by an aspartate in 
S. cerevisiae and by an asparagine in S. pombe. It is possible that the human eIF2g-S108R 
mutation, which introduces a positively charged amino acid side chain, slightly destabilizes 
the region and leads to lower levels of eIF2g. The fact that mutating the residue to 
tryptophan or lysine also did not interfere with eIF2 function in yeast indicates that the 
residue is not extremely sensitive to changes in charge or structure.  
 Rare human diseases such as MEHMO syndrome affect fewer than 1 person in 
100,000, but over 8,000 rare diseases have been identified to date; therefore, although each 
disease only affects a small number of people, in total, rare diseases affect a significant 
percentage of the population (Hmeljak and Justice, 2019). Rare diseases can be hard to 
study in humans, so model organisms are commonly used. For MEHMO syndrome, 
patient-derived cell lines and budding yeast (S. cerevisiae) have been used to understand 
how EIF2S3 mutations affect eIF2 activity. Yeast are advantageous for these studies 
because they are simple to genetically manipulate (Smith and Snyder, 2006; Yang et al., 
2017). Although the GCD11 gene encoding eIF2g is essential for yeast viability, we were 
easily able to introduce mutant forms of eIF2g using plasmid shuffling. The majority of the 
EIF2S3 mutations examined to date conferred a phenotype in yeast, indicating that the 
corresponding human mutation is likely pathogenic due to eIF2g dysfunction. The 
limitations of the yeast model system were illustrated by the yeast eIF2g-D167 mutations. 
Whereas the human eIF2g-S108R mutation is likely pathogenic in the patient, the 
corresponding yeast mutation, eIF2g-D167R, did not confer any phenotypes. This lack of 
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phenotype could be because the residues flanking eIF2g-D167 are not highly conserved 
from humans to yeast and, thus, are permissive to substitutions. Alternatively, the putative 
zinc binding ribbon might have distinct functions in humans and yeast, and the mutation 
specifically impairs the mammalian function of this element. While we cannot rule out the 
possibility that the lack of phenotype in yeast is because the mutation is not pathogenic and 
not the cause of the patients’ symptoms, we favor the notion that eIF2 function is slightly 
compromised in yeast but our assays lack the sensitivity to detect the defects and that 
modest impairments in eIF2 function will have greater impacts in developing humans than 
in single-celled yeast.  
 Although the X-chromosome comprises only about five percent of the human 
genome, it accounts for about 15 percent of the genes currently associated with intellectual 
disability (Neri et al., 2018). As of 2017, 141 genes have been linked to XLID and 
geneticists expect that as many as 80 other X-chromosomally encoded genes could also 
contribute to XLIDs (Neri et al., 2018). With the introduction of cheap genome sequencing, 
it is likely that more XLID syndromes will be attributed to mutations in EIF2S3. Although, 
to date, only the eIF2g-I465Sfs*4 (eIF2g-fs) mutation has been linked to activation of the 
integrated stress response, it seems likely that other eIF2g mutations will also induce the 
integrated stress response (Skopkova et al., 2017; Young-Baird et al., 2019a). Out of the 
five eIF2g mutations that have been studied in yeast, four were found to derepress 
expression of GCN4, the yeast homolog of ATF4 (Borck et al., 2012; Gregory et al., 2019; 
Skopkova et al., 2017; Young-Baird et al., 2019b). Patient derived iPSCs with eIF2g-fs 
were shown to have elevated integrated stress response associated factors including ATF4, 
CHOP, and GADD34 (Young-Baird et al., 2019a). The small molecule drug ISRIB was 
  312 
identified as an inhibitor of the integrated stress response (Sidrauski et al., 2013; Sidrauski 
et al., 2015a) and activator of the eIF2 guanine nucleotide exchange factor eIF2B (Sekine 
et al., 2015; Sidrauski et al., 2015b; Zyryanova et al., 2018). In light of these properties of 
ISRIB, Young-Baird et al. (2019a) tested whether ISRIB could suppress the effects of the 
eIF2g-fs mutation in patient-derived iPSCs. Treatment with ISRIB rescued the cell growth 
defect and restored global translation and blocked the basal depression of ATF4, CHOP, 
and GADD34 expression in the mutant cells (Young-Baird et al., 2019a). The current 
model is that treatment with ISRIB enhances eIF2B activity, increasing the fraction of 
GTP-bound eIF2 complexes, and thereby restoring translational activity in the mutant 
iPSCs (Young-Baird et al., 2019a). While studies in mouse models of MEHMO syndrome 
are needed to further assess the efficacy of ISRIB, these studies raise the possibility that 
the integrated stress response might represent a druggable target for reducing MEHMO 
symptoms in these patients.  
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6.1. Appendix: Glossary of abbreviations 
3’-UTR: 3’ untranslated region 
4EGI-1: eIF4E/eIF4G interaction inhibitor 1 
5-FOA: 5-fluoroorotic acid 
5’-UTR: 5’ untranslated region 
A site: aminoacyl site 
AEBSF: 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride 
Amp: ampicillin 
AREs: AU-rich elements 
ASL: anticodon stem loop 
ATP: adenosine triphosphate 
BME: 2-mercaptoethanol 
BSA: bovine serum albumin 
C-terminal: carboxy terminal 
CDS: coding sequence 
CHX: cycloheximide 
CoA: coenzyme A 
Cryo-EM: cryogenic electron microscopy 
Ct: threshold cycle 
D-iso: D-isoascorbic acid 
DFMO: difluoromethylornithine 
DHAA: L-Dehydroascorbic acid 
DI: deionized  
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DMEM: Dulbecco’s Modified Eagle Medium 
DNA: deoxyribonucleic acid 
dNTPs: deoxyribonucleotide triphosphates 
dsRNA: double stranded RNA 
DTT: Dithiothreitrol 
E site: exit site 
E1: ubiquitin activating enzyme 
E2: ubiquitin conjugating enzyme 
E3: ubiquitin ligase 
ECL: enhanced chemiluminescence 
EDTA: Ethylenediaminetetraacetic acid 
eEF: eukaryotic elongation factor 
EF: bacterial elongation factor 
EGTA: ethylene glycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid 
eIF: eukaryotic initiation factor 
ER: endoplasmic reticulum 
eRF: eukaryotic release factor 
EST: expressed sequence tag 
FBS: fetal bovine serum 
FL: full-length  
Gal.: L-Galactono-1,4-lactone 
GDP: guanosine-5’-diphosphate 
GEF: guanine nucleotide exchange factor 
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GTP: guanosine -5’-triphosphate 
Gul.: L-Gulono-1,4-lactone 
HEK293T cells: human embryonic kidney 293 cells with T antigen 
HEPES: 4(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
ISR: integrated stress response 
L-AA: L-ascorbic acid 
LB: Luria broth 
LDS: lithium dodecyl sulfate 
MEF: mouse embryonic fibroblast cells 
Met-tRNAMeti: initiator tRNAMet 
miRNA: micro RNA 
MOPS: 3-(N-morpholino)propanesulfonic acid buffer 
mORF: main open reading frame 
mRNA: messenger RNA 
mRNP: messenger ribonucleoprotein 
MW: molecular weight 
MYA: million years ago 
N-terminal: amino terminal 
NC: nascent chain 
NCBI: National Center for Biotechnology Information 
NEB: New England Biolab 
NMD: nonsense-mediated decay 
nt: nucleotide 
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NTPs: ribonucleotide triphosphates 
OD: optical density 
OF: out-of-frame 
ONPG: ortho-Nitrophenyl-β-galactoside 
ORF: open reading frame 
P Site: peptidyl site 
PBS: phosphate-buffered saline 
PCR: polymerase chain reaction 
PEG: polyethylene glycol 
Pi: inorganic phosphate 
PIC: translation preinitiation complex 
Pol II: RNA polymerase II 
poly(A): polyadenylation 
Post-TC: post-termination ribosomal complex 
PTC: peptidyl transferase center 
PTM: post-translational modification 
RIPA: radioimmunoprecipitation assay 
RNA: ribonucleic acid 
RRL: rabbit reticulocyte lysate 
rRNA: ribosomal RNA 
RT-qPCR: Quantitative reverse transcription polymerase chain reaction 
RT: room temperature 
SAM: S-adenosyl methionine 
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SD: standard deviation 
SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
SDS: sodium dodecyl sulfate 
siRNA: small interfering RNA 
stem-loop: stem-loop 
SOC: super optimal broth 
TBS-T: tris-buffered saline and polysorbate 20 (Tween 20) 
TC: ternary complex 
TE: tris EDTA buffer 
tRNA: transfer RNA 
TSA: transcriptome shotgun assembly 
TSS: transcription start site 
U2OS cells: human bone osteosarcoma epithelial cells 
uAUG: upstream AUG 
uCC: upstream conserved coding region 
uORF: upstream open reading frame 
UPR: unfolded protein response 
XLID: X-linked intellectual disability 
YIPP: pyrophosphatase, inorganic (yeast) 




  319 
6.2. Bibliography  
Abastado, J.P., Miller, P.F., Jackson, B.M., and Hinnebusch, A.G. (1991). Suppression of 
ribosomal reinitiation at upstream open reading frames in amino acid-starved cells 
forms the basis for GCN4 translational control. Mol Cell Biol 11, 486-496. 
Agius, F., Gonzalez-Lamothe, R., Caballero, J.L., Munoz-Blanco, J., Botella, M.A., and 
Valpuesta, V. (2003). Engineering increased vitamin C levels in plants by overexpression 
of a D-galacturonic acid reductase. Nat Biotechnol 21, 177-181. 
Algire, M.A., Maag, D., and Lorsch, J.R. (2005). Pi release from eIF2, not GTP hydrolysis, 
is the step controlled by start-site selection during eukaryotic translation initiation. Mol 
Cell 20, 251-262. 
Alone, P.V., Cao, C., and Dever, T.E. (2008). Translation initiation factor 2gamma mutant 
alters start codon selection independent of Met-tRNA binding. Mol Cell Biol 28, 6877-
6888. 
Alves, R., and Savageau, M.A. (2000). Effect of overall feedback inhibition in unbranched 
biosynthetic pathways. Biophys J 79, 2290-2304. 
Amrani, N., Ganesan, R., Kervestin, S., Mangus, D.A., Ghosh, S., and Jacobson, A. (2004). 
A faux 3'-UTR promotes aberrant termination and triggers nonsense-mediated mRNA 
decay. Nature 432, 112-118. 
Archer, S.K., Shirokikh, N.E., Beilharz, T.H., and Preiss, T. (2016). Dynamics of ribosome 
scanning and recycling revealed by translation complex profiling. Nature 535, 570-574. 
  320 
Arenz, S., Meydan, S., Starosta, A.L., Berninghausen, O., Beckmann, R., Vazquez-Laslop, 
N., and Wilson, D.N. (2014). Drug sensing by the ribosome induces translational arrest 
via active site perturbation. Mol Cell 56, 446-452. 
Babendure, J.R., Babendure, J.L., Ding, J.H., and Tsien, R.Y. (2006). Control of 
mammalian translation by mRNA structure near caps. RNA 12, 851-861. 
Baird, T.D., Palam, L.R., Fusakio, M.E., Willy, J.A., Davis, C.M., McClintick, J.N., Anthony, 
T.G., and Wek, R.C. (2014). Selective mRNA translation during eIF2 phosphorylation 
induces expression of IBTKalpha. Mol Biol Cell 25, 1686-1697. 
Baird, T.D., and Wek, R.C. (2012). Eukaryotic initiation factor 2 phosphorylation and 
translational control in metabolism. Adv Nutr 3, 307-321. 
Bartoli, C.G., Yu, J., Gomez, F., Fernandez, L., McIntosh, L., and Foyer, C.H. (2006). Inter-
relationships between light and respiration in the control of ascorbic acid synthesis and 
accumulation in Arabidopsis thaliana leaves. J Exp Bot 57, 1621-1631. 
Behrmann, E., Loerke, J., Budkevich, T.V., Yamamoto, K., Schmidt, A., Penczek, P.A., Vos, 
M.R., Burger, J., Mielke, T., Scheerer, P., et al. (2015). Structural snapshots of actively 
translating human ribosomes. Cell 161, 845-857. 
Benne, R., and Hershey, J.W. (1978). The mechanism of action of protein synthesis 
initiation factors from rabbit reticulocytes. The Journal of biological chemistry 253, 
3078-3087. 
  321 
Berthelot, K., Muldoon, M., Rajkowitsch, L., Hughes, J., and McCarthy, J.E. (2004). 
Dynamics and processivity of 40S ribosome scanning on mRNA in yeast. Mol Microbiol 
51, 987-1001. 
Bertolotti, A., Zhang, Y., Hendershot, L.M., Harding, H.P., and Ron, D. (2000). Dynamic 
interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell 
Biol 2, 326-332. 
Bhushan, S., Meyer, H., Starosta, A.L., Becker, T., Mielke, T., Berninghausen, O., Sattler, 
M., Wilson, D.N., and Beckmann, R. (2010). Structural basis for translational stalling by 
human cytomegalovirus and fungal arginine attenuator peptide. Mol Cell 40, 138-146. 
Bieganowski, P., Shilinski, K., Tsichlis, P.N., and Brenner, C. (2004). Cdc123 and 
checkpoint forkhead associated with RING proteins control the cell cycle by controlling 
eIF2gamma abundance. The Journal of biological chemistry 279, 44656-44666. 
Bischoff, L., Berninghausen, O., and Beckmann, R. (2014). Molecular basis for the 
ribosome functioning as an L-tryptophan sensor. Cell Rep 9, 469-475. 
Boeke, J.D., Trueheart, J., Natsoulis, G., and Fink, G.R. (1987). 5-Fluoroorotic acid as a 
selective agent in yeast molecular genetics. Methods Enzymol 154, 164-175. 
Bohlen, J., Fenzi, K., Kramer, G., Bukau, B., and Teleman, A. (2019). Selective 40S 
footprinting reveals that scanning ribosomes remain cap-tethered in human cells. 
bioRxiv Preprint. 
  322 
Borck, G., Shin, B.S., Stiller, B., Mimouni-Bloch, A., Thiele, H., Kim, J.R., Thakur, M., 
Skinner, C., Aschenbach, L., Smirin-Yosef, P., et al. (2012). eIF2gamma mutation that 
disrupts eIF2 complex integrity links intellectual disability to impaired translation 
initiation. Mol Cell 48, 641-646. 
Broad, R.C., Bonneau, J.P., Beasley, J.T., Roden, S., Philips, J.G., Baumann, U., Hellens, 
R.P., and Johnson, A.A.T. (2019). Genome-wide identification and characterization of the 
GDP-L-galactose phosphorylase gene family in bread wheat. BMC Plant Biol 19, 515. 
Brush, M.H., Weiser, D.C., and Shenolikar, S. (2003). Growth arrest and DNA damage-
inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic 
reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic 
translation initiation factor 2. Mol Cell Biol 23, 1292-1303. 
Budkevich, T., Giesebrecht, J., Altman, R.B., Munro, J.B., Mielke, T., Nierhaus, K.H., 
Blanchard, S.C., and Spahn, C.M. (2011). Structure and dynamics of the mammalian 
ribosomal pretranslocation complex. Mol Cell 44, 214-224. 
Bulley, S., Wright, M., Rommens, C., Yan, H., Rassam, M., Lin-Wang, K., Andre, C., 
Brewster, D., Karunairetnam, S., Allan, A.C., et al. (2012). Enhancing ascorbate in fruits 
and tubers through over-expression of the L-galactose pathway gene GDP-L-galactose 
phosphorylase. Plant Biotechnol J 10, 390-397. 
Bulley, S.M., Rassam, M., Hoser, D., Otto, W., Schunemann, N., Wright, M., MacRae, E., 
Gleave, A., and Laing, W. (2009). Gene expression studies in kiwifruit and gene over-
  323 
expression in Arabidopsis indicates that GDP-L-galactose guanyltransferase is a major 
control point of vitamin C biosynthesis. J Exp Bot 60, 765-778. 
Burns, J.J. (1957). Missing Step in Man, Monkey and Guinea Pig required for the 
Biosynthesis of L-Ascorbic Acid. Nature 180, 553-553. 
Calvo, S.E., Pagliarini, D.J., and Mootha, V.K. (2009). Upstream open reading frames 
cause widespread reduction of protein expression and are polymorphic among humans. 
Proc Natl Acad Sci U S A 106, 7507-7512. 
Cao, J., and Geballe, A.P. (1995). Translational inhibition by a human cytomegalovirus 
upstream open reading frame despite inefficient utilization of its AUG codon. J Virol 69, 
1030-1036. 
Carmody, S.R., and Wente, S.R. (2009). mRNA nuclear export at a glance. J Cell Sci 122, 
1933-1937. 
Cavener, D.R., and Ray, S.C. (1991). Eukaryotic start and stop translation sites. Nucleic 
Acids Res 19, 3185-3192. 
Chang, C.P., Vesole, D.H., Nelson, J., Oldstone, M.B., and Stinski, M.F. (1989). 
Identification and expression of a human cytomegalovirus early glycoprotein. J Virol 63, 
3330-3337. 
Chen, J.J., and London, I.M. (1995). Regulation of protein synthesis by heme-regulated 
eIF-2 alpha kinase. Trends Biochem Sci 20, 105-108. 
  324 
Chen, J.J., Throop, M.S., Gehrke, L., Kuo, I., Pal, J.K., Brodsky, M., and London, I.M. 
(1991). Cloning of the cDNA of the heme-regulated eukaryotic initiation factor 2 alpha 
(eIF-2 alpha) kinase of rabbit reticulocytes: homology to yeast GCN2 protein kinase and 
human double-stranded-RNA-dependent eIF-2 alpha kinase. Proc Natl Acad Sci U S A 88, 
7729-7733. 
Cheng, H., Dufu, K., Lee, C.S., Hsu, J.L., Dias, A., and Reed, R. (2006). Human mRNA 
export machinery recruited to the 5' end of mRNA. Cell 127, 1389-1400. 
Chiabudini, M., Tais, A., Zhang, Y., Hayashi, S., Wolfle, T., Fitzke, E., and Rospert, S. 
(2014). Release factor eRF3 mediates premature translation termination on polylysine-
stalled ribosomes in Saccharomyces cerevisiae. Mol Cell Biol 34, 4062-4076. 
Chikka, M.R., McCabe, D.D., Tyra, H.M., and Rutkowski, D.T. (2013). C/EBP homologous 
protein (CHOP) contributes to suppression of metabolic genes during endoplasmic 
reticulum stress in the liver. The Journal of biological chemistry 288, 4405-4415. 
Chu, D., Barnes, D.J., and von der Haar, T. (2011). The role of tRNA and ribosome 
competition in coupling the expression of different mRNAs in Saccharomyces cerevisiae. 
Nucleic Acids Res 39, 6705-6714. 
Chung, B.Y., Deery, M.J., Groen, A.J., Howard, J., and Baulcombe, D.C. (2017). 
Endogenous miRNA in the green alga Chlamydomonas regulates gene expression 
through CDS-targeting. Nat Plants 3, 787-794. 
  325 
Chung, B.Y., Hardcastle, T.J., Jones, J.D., Irigoyen, N., Firth, A.E., Baulcombe, D.C., and 
Brierley, I. (2015). The use of duplex-specific nuclease in ribosome profiling and a user-
friendly software package for Ribo-seq data analysis. RNA 21, 1731-1745. 
Cigan, A.M., Feng, L., and Donahue, T.F. (1988a). tRNAi(met) functions in directing the 
scanning ribosome to the start site of translation. Science 242, 93-97. 
Cigan, A.M., Pabich, E.K., and Donahue, T.F. (1988b). Mutational analysis of the HIS4 
translational initiator region in Saccharomyces cerevisiae. Mol Cell Biol 8, 2964-2975. 
Clements, J.M., Laz, T.M., and Sherman, F. (1988). Efficiency of translation initiation by 
non-AUG codons in Saccharomyces cerevisiae. Mol Cell Biol 8, 4533-4536. 
Colgan, D.F., and Manley, J.L. (1997). Mechanism and regulation of mRNA 
polyadenylation. Genes Dev 11, 2755-2766. 
Coller, J., and Parker, R. (2005). General translational repression by activators of mRNA 
decapping. Cell 122, 875-886. 
Cruz-Rus, E., Amaya, I., Sanchez-Sevilla, J.F., Botella, M.A., and Valpuesta, V. (2011). 
Regulation of L-ascorbic acid content in strawberry fruits. J Exp Bot 62, 4191-4201. 
Cruz-Rus, E., Amaya, I., and Valpuesta, V. (2012). The challenge of increasing vitamin C 
content in plant foods. Biotechnol J 7, 1110-1121. 
  326 
Cruz-Vera, L.R., Rajagopal, S., Squires, C., and Yanofsky, C. (2005). Features of ribosome-
peptidyl-tRNA interactions essential for tryptophan induction of tna operon expression. 
Mol Cell 19, 333-343. 
Cruz-Vera, L.R., and Yanofsky, C. (2008). Conserved residues Asp16 and Pro24 of TnaC-
tRNAPro participate in tryptophan induction of Tna operon expression. J Bacteriol 190, 
4791-4797. 
Degnin, C.R., Schleiss, M.R., Cao, J., and Geballe, A.P. (1993). Translational inhibition 
mediated by a short upstream open reading frame in the human cytomegalovirus gpUL4 
(gp48) transcript. J Virol 67, 5514-5521. 
del Valle, A.H., Seip, B., Cervera-Marzal, I., Sacheau, G., Seefeldt, A.C., and Innis, C.A. 
(2019). Ornithine capture by a translating ribosome controls bacterial polyamine 
synthesis. bioRxiv, 604074. 
Delbecq, P., Calvo, O., Filipkowski, R.K., Pierard, A., and Messenguy, F. (2000). Functional 
analysis of the leader peptide of the yeast gene CPA1 and heterologous regulation by 
other fungal peptides. Curr Genet 38, 105-112. 
Delbecq, P., Werner, M., Feller, A., Filipkowski, R.K., Messenguy, F., and Pierard, A. 
(1994). A segment of mRNA encoding the leader peptide of the CPA1 gene confers 
repression by arginine on a heterologous yeast gene transcript. Mol Cell Biol 14, 2378-
2390. 
  327 
Dever, T.E., Dinman, J.D., and Green, R. (2018). Translation Elongation and Recoding in 
Eukaryotes. Cold Spring Harb Perspect Biol 10. 
Dever, T.E., Feng, L., Wek, R.C., Cigan, A.M., Donahue, T.F., and Hinnebusch, A.G. (1992). 
Phosphorylation of initiation factor 2 alpha by protein kinase GCN2 mediates gene-
specific translational control of GCN4 in yeast. Cell 68, 585-596. 
Dever, T.E., and Green, R. (2012). The elongation, termination, and recycling phases of 
translation in eukaryotes. Cold Spring Harb Perspect Biol 4, a013706. 
Dever, T.E., Gutierrez, E., and Shin, B.S. (2014). The hypusine-containing translation 
factor eIF5A. Crit Rev Biochem Mol Biol 49, 413-425. 
Dever, T.E., Yang, W., Astrom, S., Bystrom, A.S., and Hinnebusch, A.G. (1995). 
Modulation of tRNA(iMet), eIF-2, and eIF-2B expression shows that GCN4 translation is 
inversely coupled to the level of eIF-2.GTP.Met-tRNA(iMet) ternary complexes. Mol Cell 
Biol 15, 6351-6363. 
Dittmar, K.A., Sorensen, M.A., Elf, J., Ehrenberg, M., and Pan, T. (2005). Selective 
charging of tRNA isoacceptors induced by amino-acid starvation. EMBO Rep 6, 151-157. 
Doma, M.K., and Parker, R. (2006). Endonucleolytic cleavage of eukaryotic mRNAs with 
stalls in translation elongation. Nature 440, 561-564. 
  328 
Donahue, T.F., and Cigan, A.M. (1988). Genetic selection for mutations that reduce or 
abolish ribosomal recognition of the HIS4 translational initiator region. Mol Cell Biol 8, 
2955-2963. 
Dong, J., Lai, R., Nielsen, K., Fekete, C.A., Qiu, H., and Hinnebusch, A.G. (2004). The 
essential ATP-binding cassette protein RLI1 functions in translation by promoting 
preinitiation complex assembly. The Journal of biological chemistry 279, 42157-42168. 
Dorris, D.R., Erickson, F.L., and Hannig, E.M. (1995). Mutations in GCD11, the structural 
gene for eIF-2 gamma in yeast, alter translational regulation of GCN4 and the selection 
of the start site for protein synthesis. EMBO J 14, 2239-2249. 
Dowdle, J., Ishikawa, T., Gatzek, S., Rolinski, S., and Smirnoff, N. (2007). Two genes in 
Arabidopsis thaliana encoding GDP-L-galactose phosphorylase are required for 
ascorbate biosynthesis and seedling viability. Plant J 52, 673-689. 
Duan, G., and Walther, D. (2015). The roles of post-translational modifications in the 
context of protein interaction networks. PLoS Comput Biol 11, e1004049. 
Dziembowski, A., Lorentzen, E., Conti, E., and Seraphin, B. (2007). A single subunit, Dis3, 
is essentially responsible for yeast exosome core activity. Nature structural & molecular 
biology 14, 15-22. 
Elf, J., Nilsson, D., Tenson, T., and Ehrenberg, M. (2003). Selective charging of tRNA 
isoacceptors explains patterns of codon usage. Science 300, 1718-1722. 
  329 
Erickson, F.L., Harding, L.D., Dorris, D.R., and Hannig, E.M. (1997). Functional analysis of 
homologs of translation initiation factor 2gamma in yeast. Mol Gen Genet 253, 711-719. 
Fang, P., Spevak, C.C., Wu, C., and Sachs, M.S. (2004). A nascent polypeptide domain 
that can regulate translation elongation. Proc Natl Acad Sci U S A 101, 4059-4064. 
Fang, P., Wang, Z., and Sachs, M.S. (2000). Evolutionarily conserved features of the 
arginine attenuator peptide provide the necessary requirements for its function in 
translational regulation. The Journal of biological chemistry 275, 26710-26719. 
Flaherty, S.M., Fortes, P., Izaurralde, E., Mattaj, I.W., and Gilmartin, G.M. (1997). 
Participation of the nuclear cap binding complex in pre-mRNA 3' processing. Proc Natl 
Acad Sci U S A 94, 11893-11898. 
Franks, T.M., and Lykke-Andersen, J. (2008). The control of mRNA decapping and P-body 
formation. Mol Cell 32, 605-615. 
Freitag, M., Dighde, N., and Sachs, M.S. (1996). A UV-induced mutation in neurospora 
that affects translational regulation in response to arginine. Genetics 142, 117-127. 
Fresco, L.D., and Buratowski, S. (1996). Conditional mutants of the yeast mRNA capping 
enzyme show that the cap enhances, but is not required for, mRNA splicing. RNA 2, 584-
596. 
  330 
Frischmeyer, P.A., van Hoof, A., O'Donnell, K., Guerrerio, A.L., Parker, R., and Dietz, H.C. 
(2002). An mRNA surveillance mechanism that eliminates transcripts lacking termination 
codons. Science 295, 2258-2261. 
Gaba, A., Jacobson, A., and Sachs, M.S. (2005). Ribosome occupancy of the yeast CPA1 
upstream open reading frame termination codon modulates nonsense-mediated mRNA 
decay. Mol Cell 20, 449-460. 
Gao, Y., Badejo, A.A., Shibata, H., Sawa, Y., Maruta, T., Shigeoka, S., Page, M., Smirnoff, 
N., and Ishikawa, T. (2011). Expression analysis of the VTC2 and VTC5 genes encoding 
GDP-L-galactose phosphorylase, an enzyme involved in ascorbate biosynthesis, in 
Arabidopsis thaliana. Biosci Biotechnol Biochem 75, 1783-1788. 
Garst, A.D., Edwards, A.L., and Batey, R.T. (2011). Riboswitches: structures and 
mechanisms. Cold Spring Harb Perspect Biol 3. 
Gietz, R.D., and Schiestl, R.H. (2007). Quick and easy yeast transformation using the 
LiAc/SS carrier DNA/PEG method. Nat Protoc 2, 35-37. 
Gillman, E.C., Slusher, L.B., Martin, N.C., and Hopper, A.K. (1991). MOD5 translation 
initiation sites determine N6-isopentenyladenosine modification of mitochondrial and 
cytoplasmic tRNA. Mol Cell Biol 11, 2382-2390. 
Gollnick, P., and Yanofsky, C. (1990). tRNA(Trp) translation of leader peptide codon 12 
and other factors that regulate expression of the tryptophanase operon. J Bacteriol 172, 
3100-3107. 
  331 
Gong, F., and Yanofsky, C. (2002a). Analysis of tryptophanase operon expression in vitro: 
accumulation of TnaC-peptidyl-tRNA in a release factor 2-depleted S-30 extract prevents 
Rho factor action, simulating induction. The Journal of biological chemistry 277, 17095-
17100. 
Gong, F., and Yanofsky, C. (2002b). Instruction of translating ribosome by nascent 
peptide. Science 297, 1864-1867. 
Gregory, L.C., Ferreira, C.B., Young-Baird, S.K., Williams, H.J., Harakalova, M., van 
Haaften, G., Rahman, S.A., Gaston-Massuet, C., Kelberman, D., Gosgene, et al. (2019). 
Impaired EIF2S3 function associated with a novel phenotype of X-linked hypopituitarism 
with glucose dysregulation. EBioMedicine 42, 470-480. 
Grentzmann, G., Ingram, J.A., Kelly, P.J., Gesteland, R.F., and Atkins, J.F. (1998). A dual-
luciferase reporter system for studying recoding signals. RNA 4, 479-486. 
Guhaniyogi, J., and Brewer, G. (2001). Regulation of mRNA stability in mammalian cells. 
Gene 265, 11-23. 
Gutierrez, E., Shin, B.S., Woolstenhulme, C.J., Kim, J.R., Saini, P., Buskirk, A.R., and Dever, 
T.E. (2013). eIF5A promotes translation of polyproline motifs. Mol Cell 51, 35-45. 
Hancock, R.D., Galpin, J.R., and Viola, R. (2000). Biosynthesis of L-ascorbic acid (vitamin 
C) by Saccharomyces cerevisiae. FEMS Microbiol Lett 186, 245-250. 
  332 
Hannig, E.M., Cigan, A.M., Freeman, B.A., and Kinzy, T.G. (1993). GCD11, a negative 
regulator of GCN4 expression, encodes the gamma subunit of eIF-2 in Saccharomyces 
cerevisiae. Mol Cell Biol 13, 506-520. 
Hanson, G., and Coller, J. (2018). Codon optimality, bias and usage in translation and 
mRNA decay. Nat Rev Mol Cell Biol 19, 20-30. 
Harding, H.P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., and Ron, D. (2000). 
Regulated translation initiation controls stress-induced gene expression in mammalian 
cells. Mol Cell 6, 1099-1108. 
Harding, H.P., Zhang, Y., and Ron, D. (1999). Protein translation and folding are coupled 
by an endoplasmic-reticulum-resident kinase. Nature 397, 271-274. 
Harding, H.P., Zhang, Y., Zeng, H., Novoa, I., Lu, P.D., Calfon, M., Sadri, N., Yun, C., Popko, 
B., Paules, R., et al. (2003). An integrated stress response regulates amino acid 
metabolism and resistance to oxidative stress. Mol Cell 11, 619-633. 
Hata, R., and Senoo, H. (1989). L-ascorbic acid 2-phosphate stimulates collagen 
accumulation, cell proliferation, and formation of a three-dimensional tissuelike 
substance by skin fibroblasts. J Cell Physiol 138, 8-16. 
Hayden, C.A., and Jorgensen, R.A. (2007). Identification of novel conserved peptide 
uORF homology groups in Arabidopsis and rice reveals ancient eukaryotic origin of 
select groups and preferential association with transcription factor-encoding genes. 
BMC Biol 5, 32. 
  333 
Herold, A., Suyama, M., Rodrigues, J.P., Braun, I.C., Kutay, U., Carmo-Fonseca, M., Bork, 
P., and Izaurralde, E. (2000). TAP (NXF1) belongs to a multigene family of putative RNA 
export factors with a conserved modular architecture. Mol Cell Biol 20, 8996-9008. 
Hershey, J.W., Sonenberg, N., and Mathews, M.B. (2012). Principles of translational 
control: an overview. Cold Spring Harb Perspect Biol 4. 
Hershko, A., Heller, H., Elias, S., and Ciechanover, A. (1983). Components of ubiquitin-
protein ligase system. Resolution, affinity purification, and role in protein breakdown. 
The Journal of biological chemistry 258, 8206-8214. 
Hinnebusch, A.G. (1984). Evidence for translational regulation of the activator of general 
amino acid control in yeast. Proc Natl Acad Sci U S A 81, 6442-6446. 
Hinnebusch, A.G. (1985). A hierarchy of trans-acting factors modulates translation of an 
activator of amino acid biosynthetic genes in Saccharomyces cerevisiae. Mol Cell Biol 5, 
2349-2360. 
Hinnebusch, A.G. (1997). Translational regulation of yeast GCN4. A window on factors 
that control initiator-trna binding to the ribosome. The Journal of biological chemistry 
272, 21661-21664. 
Hinnebusch, A.G. (2005). Translational regulation of GCN4 and the general amino acid 
control of yeast. Annu Rev Microbiol 59, 407-450. 
  334 
Hinnebusch, A.G. (2011). Molecular mechanism of scanning and start codon selection in 
eukaryotes. Microbiol Mol Biol Rev 75, 434-467, first page of table of contents. 
Hinnebusch, A.G. (2014). The scanning mechanism of eukaryotic translation initiation. 
Annu Rev Biochem 83, 779-812. 
Hinton, T.M., Coldwell, M.J., Carpenter, G.A., Morley, S.J., and Pain, V.M. (2007). 
Functional analysis of individual binding activities of the scaffold protein eIF4G. The 
Journal of biological chemistry 282, 1695-1708. 
Hmeljak, J., and Justice, M.J. (2019). From gene to treatment: supporting rare disease 
translational research through model systems. Dis Model Mech 12. 
Hood, H.M., Spevak, C.C., and Sachs, M.S. (2007). Evolutionary changes in the fungal 
carbamoyl-phosphate synthetase small subunit gene and its associated upstream open 
reading frame. Fungal Genet Biol 44, 93-104. 
Horikami, S.M., De Ferra, F., and Moyer, S.A. (1984). Characterization of the infections of 
permissive and nonpermissive cells by host range mutants of vesicular stomatitis virus 
defective in RNA methylation. Virology 138, 1-15. 
Horinouchi, S., and Weisblum, B. (1980). Posttranscriptional modification of mRNA 
conformation: mechanism that regulates erythromycin-induced resistance. Proc Natl 
Acad Sci U S A 77, 7079-7083. 
  335 
Houseley, J., and Tollervey, D. (2009). The many pathways of RNA degradation. Cell 136, 
763-776. 
Huang, H.K., Yoon, H., Hannig, E.M., and Donahue, T.F. (1997). GTP hydrolysis controls 
stringent selection of the AUG start codon during translation initiation in Saccharomyces 
cerevisiae. Genes Dev 11, 2396-2413. 
Hussain, T., Llacer, J.L., Fernandez, I.S., Munoz, A., Martin-Marcos, P., Savva, C.G., 
Lorsch, J.R., Hinnebusch, A.G., and Ramakrishnan, V. (2014). Structural changes enable 
start codon recognition by the eukaryotic translation initiation complex. Cell 159, 597-
607. 
Ibba, M., and Soll, D. (2004). Aminoacyl-tRNAs: setting the limits of the genetic code. 
Genes Dev 18, 731-738. 
Ingolia, N.T., Ghaemmaghami, S., Newman, J.R., and Weissman, J.S. (2009). Genome-
wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. 
Science 324, 218-223. 
Inoue, K., Ohno, M., Sakamoto, H., and Shimura, Y. (1989). Effect of the cap structure on 
pre-mRNA splicing in Xenopus oocyte nuclei. Genes Dev 3, 1472-1479. 
Ishii, E., Chiba, S., Hashimoto, N., Kojima, S., Homma, M., Ito, K., Akiyama, Y., and Mori, 
H. (2015). Nascent chain-monitored remodeling of the Sec machinery for salinity 
adaptation of marine bacteria. Proc Natl Acad Sci U S A 112, E5513-5522. 
  336 
Ito, K., and Chiba, S. (2013). Arrest peptides: cis-acting modulators of translation. Annu 
Rev Biochem 82, 171-202. 
Ivanov, I.P., Atkins, J.F., and Michael, A.J. (2010a). A profusion of upstream open reading 
frame mechanisms in polyamine-responsive translational regulation. Nucleic Acids Res 
38, 353-359. 
Ivanov, I.P., Loughran, G., and Atkins, J.F. (2008). uORFs with unusual translational start 
codons autoregulate expression of eukaryotic ornithine decarboxylase homologs. Proc 
Natl Acad Sci U S A 105, 10079-10084. 
Ivanov, I.P., Loughran, G., Sachs, M.S., and Atkins, J.F. (2010b). Initiation context 
modulates autoregulation of eukaryotic translation initiation factor 1 (eIF1). Proc Natl 
Acad Sci U S A 107, 18056-18060. 
Ivanov, I.P., Shin, B.S., Loughran, G., Tzani, I., Young-Baird, S.K., Cao, C., Atkins, J.F., and 
Dever, T.E. (2018). Polyamine Control of Translation Elongation Regulates Start Site 
Selection on Antizyme Inhibitor mRNA via Ribosome Queuing. Mol Cell 70, 254-264 
e256. 
Jackson, R.J., Hellen, C.U., and Pestova, T.V. (2010). The mechanism of eukaryotic 
translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 11, 113-127. 
Jackson, R.J., Hellen, C.U., and Pestova, T.V. (2012). Termination and post-termination 
events in eukaryotic translation. Adv Protein Chem Struct Biol 86, 45-93. 
  337 
Janzen, D.M., Frolova, L., and Geballe, A.P. (2002). Inhibition of translation termination 
mediated by an interaction of eukaryotic release factor 1 with a nascent peptidyl-tRNA. 
Mol Cell Biol 22, 8562-8570. 
Jiang, H.Y., Wek, S.A., McGrath, B.C., Lu, D., Hai, T., Harding, H.P., Wang, X., Ron, D., 
Cavener, D.R., and Wek, R.C. (2004). Activating transcription factor 3 is integral to the 
eukaryotic initiation factor 2 kinase stress response. Mol Cell Biol 24, 1365-1377. 
Jiao, X., Chang, J.H., Kilic, T., Tong, L., and Kiledjian, M. (2013). A mammalian pre-mRNA 
5' end capping quality control mechanism and an unexpected link of capping to pre-
mRNA processing. Mol Cell 50, 104-115. 
Johansson, M., Ieong, K.W., Trobro, S., Strazewski, P., Aqvist, J., Pavlov, M.Y., and 
Ehrenberg, M. (2011). pH-sensitivity of the ribosomal peptidyl transfer reaction 
dependent on the identity of the A-site aminoacyl-tRNA. Proc Natl Acad Sci U S A 108, 
79-84. 
Joshi, C.P., Zhou, H., Huang, X., and Chiang, V.L. (1997). Context sequences of translation 
initiation codon in plants. Plant Mol Biol 35, 993-1001. 
Juntawong, P., Girke, T., Bazin, J., and Bailey-Serres, J. (2014). Translational dynamics 
revealed by genome-wide profiling of ribosome footprints in Arabidopsis. Proc Natl Acad 
Sci U S A 111, E203-212. 
  338 
Kang, S.G., Price, J., Lin, P.C., Hong, J.C., and Jang, J.C. (2010). The arabidopsis bZIP1 
transcription factor is involved in sugar signaling, protein networking, and DNA binding. 
Mol Plant 3, 361-373. 
Karim, M.M., Svitkin, Y.V., Kahvejian, A., De Crescenzo, G., Costa-Mattioli, M., and 
Sonenberg, N. (2006). A mechanism of translational repression by competition of Paip2 
with eIF4G for poly(A) binding protein (PABP) binding. Proc Natl Acad Sci U S A 103, 
9494-9499. 
Kearse, M.G., Goldman, D.H., Choi, J., Nwaezeapu, C., Liang, D., Green, K.M., 
Goldstrohm, A.C., Todd, P.K., Green, R., and Wilusz, J.E. (2019). Ribosome queuing 
enables non-AUG translation to be resistant to multiple protein synthesis inhibitors. 
Genes Dev 33, 871-885. 
Kearse, M.G., and Wilusz, J.E. (2017). Non-AUG translation: a new start for protein 
synthesis in eukaryotes. Genes Dev 31, 1717-1731. 
Kemper, W.M., Berry, K.W., and Merrick, W.C. (1976). Purification and properties of 
rabbit reticulocyte protein synthesis initiation factors M2Balpha and M2Bbeta. The 
Journal of biological chemistry 251, 5551-5557. 
King, C.G., and Waugh, W.A. (1932). The Chemical Nature of Vitamin C. Science 75, 357-
358. 
Kiser, K.B., and Schmidt, M.G. (1999). Regulation of the Escherichia coli secA gene is 
mediated by two distinct RNA structural conformations. Curr Microbiol 38, 113-121. 
  339 
Kohler, A., and Hurt, E. (2007). Exporting RNA from the nucleus to the cytoplasm. Nat 
Rev Mol Cell Biol 8, 761-773. 
Kolitz, S.E., Takacs, J.E., and Lorsch, J.R. (2009). Kinetic and thermodynamic analysis of 
the role of start codon/anticodon base pairing during eukaryotic translation initiation. 
RNA 15, 138-152. 
Kornberg, R.D. (1974). Chromatin structure: a repeating unit of histones and DNA. 
Science 184, 868-871. 
Korostelev, A., Asahara, H., Lancaster, L., Laurberg, M., Hirschi, A., Zhu, J., Trakhanov, S., 
Scott, W.G., and Noller, H.F. (2008). Crystal structure of a translation termination 
complex formed with release factor RF2. Proc Natl Acad Sci U S A 105, 19684-19689. 
Koutmou, K.S., Radhakrishnan, A., and Green, R. (2015). Synthesis at the Speed of 
Codons. Trends Biochem Sci 40, 717-718. 
Kozak, M. (1978). How do eucaryotic ribosomes select initiation regions in messenger 
RNA? Cell 15, 1109-1123. 
Kozak, M. (1984). Compilation and analysis of sequences upstream from the 
translational start site in eukaryotic mRNAs. Nucleic Acids Res 12, 857-872. 
Kozak, M. (1986a). Influences of mRNA secondary structure on initiation by eukaryotic 
ribosomes. Proc Natl Acad Sci U S A 83, 2850-2854. 
  340 
Kozak, M. (1986b). Point mutations define a sequence flanking the AUG initiator codon 
that modulates translation by eukaryotic ribosomes. Cell 44, 283-292. 
Kozak, M. (1987). Effects of intercistronic length on the efficiency of reinitiation by 
eucaryotic ribosomes. Mol Cell Biol 7, 3438-3445. 
Kozak, M. (1989). Context effects and inefficient initiation at non-AUG codons in 
eucaryotic cell-free translation systems. Mol Cell Biol 9, 5073-5080. 
Kozak, M. (1991a). A short leader sequence impairs the fidelity of initiation by 
eukaryotic ribosomes. Gene Expr 1, 111-115. 
Kozak, M. (1991b). Structural features in eukaryotic mRNAs that modulate the initiation 
of translation. The Journal of biological chemistry 266, 19867-19870. 
Kozak, M. (1992). Regulation of translation in eukaryotic systems. Annu Rev Cell Biol 8, 
197-225. 
Kozak, M. (2001). Constraints on reinitiation of translation in mammals. Nucleic Acids 
Res 29, 5226-5232. 
Krishna, S.S., Majumdar, I., and Grishin, N.V. (2003). Structural classification of zinc 
fingers: survey and summary. Nucleic Acids Res 31, 532-550. 
Laing, W.A., Martinez-Sanchez, M., Wright, M.A., Bulley, S.M., Brewster, D., Dare, A.P., 
Rassam, M., Wang, D., Storey, R., Macknight, R.C., et al. (2015). An upstream open 
  341 
reading frame is essential for feedback regulation of ascorbate biosynthesis in 
Arabidopsis. Plant Cell 27, 772-786. 
Lanker, S., Bushman, J.L., Hinnebusch, A.G., Trachsel, H., and Mueller, P.P. (1992). 
Autoregulation of the yeast lysyl-tRNA synthetase gene GCD5/KRS1 by translational and 
transcriptional control mechanisms. Cell 70, 647-657. 
Laurberg, M., Asahara, H., Korostelev, A., Zhu, J., Trakhanov, S., and Noller, H.F. (2008). 
Structural basis for translation termination on the 70S ribosome. Nature 454, 852-857. 
Law, G.L., Raney, A., Heusner, C., and Morris, D.R. (2001). Polyamine regulation of 
ribosome pausing at the upstream open reading frame of S-adenosylmethionine 
decarboxylase. The Journal of biological chemistry 276, 38036-38043. 
Lawless, C., Pearson, R.D., Selley, J.N., Smirnova, J.B., Grant, C.M., Ashe, M.P., Pavitt, 
G.D., and Hubbard, S.J. (2009). Upstream sequence elements direct post-transcriptional 
regulation of gene expression under stress conditions in yeast. BMC Genomics 10, 7. 
Le Quesne, J.P., Spriggs, K.A., Bushell, M., and Willis, A.E. (2010). Dysregulation of 
protein synthesis and disease. J Pathol 220, 140-151. 
Lebreton, A., Tomecki, R., Dziembowski, A., and Seraphin, B. (2008). Endonucleolytic 
RNA cleavage by a eukaryotic exosome. Nature 456, 993-996. 
  342 
Lee, Y.Y., Cevallos, R.C., and Jan, E. (2009). An upstream open reading frame regulates 
translation of GADD34 during cellular stresses that induce eIF2alpha phosphorylation. 
The Journal of biological chemistry 284, 6661-6673. 
Levin, D.H., Petryshyn, R., and London, I.M. (1980). Characterization of double-stranded-
RNA-activated kinase that phosphorylates alpha subunit of eukaryotic initiation factor 2 
(eIF-2 alpha) in reticulocyte lysates. Proc Natl Acad Sci U S A 77, 832-836. 
Li, W., Ward, F.R., McClure, K.F., Chang, S.T., Montabana, E., Liras, S., Dullea, R.G., and 
Cate, J.H.D. (2019). Structural basis for selective stalling of human ribosome nascent 
chain complexes by a drug-like molecule. Nature structural & molecular biology 26, 501-
509. 
Li, X., and Coffino, P. (1992). Regulated degradation of ornithine decarboxylase requires 
interaction with the polyamine-inducible protein antizyme. Mol Cell Biol 12, 3556-3562. 
Liaud, N., Horlbeck, M.A., Gilbert, L.A., Gjoni, K., Weissman, J.S., and Cate, J.H.D. (2019). 
Cellular response to small molecules that selectively stall protein synthesis by the 
ribosome. PLoS Genet 15, e1008057. 
Lind, J. (1953). Lind’s treatise on scurvy. In The diagnostics, or signs, G. Stewart CP, eds., 
ed. (Edinburgh: Edinburgh University Press), pp. 113–132. 
Linster, C.L., and Van Schaftingen, E. (2007). Vitamin C. Biosynthesis, recycling and 
degradation in mammals. FEBS J 274, 1-22. 
  343 
Lintner, N.G., McClure, K.F., Petersen, D., Londregan, A.T., Piotrowski, D.W., Wei, L., 
Xiao, J., Bolt, M., Loria, P.M., Maguire, B., et al. (2017). Selective stalling of human 
translation through small-molecule engagement of the ribosome nascent chain. PLoS 
Biol 15, e2001882. 
Liu, M.J., Wu, S.H., Wu, J.F., Lin, W.D., Wu, Y.C., Tsai, T.Y., Tsai, H.L., and Wu, S.H. (2013). 
Translational landscape of photomorphogenic Arabidopsis. Plant Cell 25, 3699-3710. 
Liu, Q., Greimann, J.C., and Lima, C.D. (2006). Reconstitution, activities, and structure of 
the eukaryotic RNA exosome. Cell 127, 1223-1237. 
Llacer, J.L., Hussain, T., Marler, L., Aitken, C.E., Thakur, A., Lorsch, J.R., Hinnebusch, A.G., 
and Ramakrishnan, V. (2015). Conformational Differences between Open and Closed 
States of the Eukaryotic Translation Initiation Complex. Mol Cell 59, 399-412. 
Lopatin, A.N., Makhina, E.N., and Nichols, C.G. (1995). The mechanism of inward 
rectification of potassium channels: "long-pore plugging" by cytoplasmic polyamines. J 
Gen Physiol 106, 923-955. 
Lorence, A., Chevone, B.I., Mendes, P., and Nessler, C.L. (2004). myo-inositol oxygenase 
offers a possible entry point into plant ascorbate biosynthesis. Plant Physiol 134, 1200-
1205. 
Lu, J., and Deutsch, C. (2008). Electrostatics in the ribosomal tunnel modulate chain 
elongation rates. J Mol Biol 384, 73-86. 
  344 
Lu, P.D., Harding, H.P., and Ron, D. (2004). Translation reinitiation at alternative open 
reading frames regulates gene expression in an integrated stress response. J Cell Biol 
167, 27-33. 
Luo, Z., Freitag, M., and Sachs, M.S. (1995). Translational regulation in response to 
changes in amino acid availability in Neurospora crassa. Mol Cell Biol 15, 5235-5245. 
Luukkonen, B.G., Tan, W., and Schwartz, S. (1995). Efficiency of reinitiation of translation 
on human immunodeficiency virus type 1 mRNAs is determined by the length of the 
upstream open reading frame and by intercistronic distance. J Virol 69, 4086-4094. 
Machida, K., Shigeta, T., Yamamoto, Y., Ito, T., Svitkin, Y., Sonenberg, N., and Imataka, H. 
(2018). Dynamic interaction of poly(A)-binding protein with the ribosome. Sci Rep 8, 
17435. 
Malkin, L.I., and Rich, A. (1967). Partial resistance of nascent polypeptide chains to 
proteolytic digestion due to ribosomal shielding. J Mol Biol 26, 329-346. 
Malzer, E., Szajewska-Skuta, M., Dalton, L.E., Thomas, S.E., Hu, N., Skaer, H., Lomas, 
D.A., Crowther, D.C., and Marciniak, S.J. (2013). Coordinate regulation of eIF2alpha 
phosphorylation by PPP1R15 and GCN2 is required during Drosophila development. J 
Cell Sci 126, 1406-1415. 
Manjunath, H., Zhang, H., Rehfeld, F., Han, J., Chang, T.C., and Mendell, J.T. (2019). 
Suppression of Ribosomal Pausing by eIF5A Is Necessary to Maintain the Fidelity of Start 
Codon Selection. Cell Rep 29, 3134-3146 e3136. 
  345 
Masuda, S., Das, R., Cheng, H., Hurt, E., Dorman, N., and Reed, R. (2005). Recruitment of 
the human TREX complex to mRNA during splicing. Genes Dev 19, 1512-1517. 
Matsufuji, S., Matsufuji, T., Miyazaki, Y., Murakami, Y., Atkins, J.F., Gesteland, R.F., and 
Hayashi, S. (1995). Autoregulatory frameshifting in decoding mammalian ornithine 
decarboxylase antizyme. Cell 80, 51-60. 
Matsufuji, S., Miyazaki, Y., Kanamoto, R., Kameji, T., Murakami, Y., Baby, T.G., Fujita, K., 
Ohno, T., and Hayashi, S. (1990). Analyses of ornithine decarboxylase antizyme mRNA 
with a cDNA cloned from rat liver. J Biochem 108, 365-371. 
Matsui, T., Segall, J., Weil, P.A., and Roeder, R.G. (1980). Multiple factors required for 
accurate initiation of transcription by purified RNA polymerase II. The Journal of 
biological chemistry 255, 11992-11996. 
Matsumoto, H., Miyazaki, S., Matsuyama, S., Takeda, M., Kawano, M., Nakagawa, H., 
Nishimura, K., and Matsuo, S. (2013). Selection of autophagy or apoptosis in cells 
exposed to ER-stress depends on ATF4 expression pattern with or without CHOP 
expression. Biol Open 2, 1084-1090. 
McEwen, E., Kedersha, N., Song, B., Scheuner, D., Gilks, N., Han, A., Chen, J.J., Anderson, 
P., and Kaufman, R.J. (2005). Heme-regulated inhibitor kinase-mediated 
phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces 
stress granule formation, and mediates survival upon arsenite exposure. The Journal of 
biological chemistry 280, 16925-16933. 
  346 
McNicholas, P., Salavati, R., and Oliver, D. (1997). Dual regulation of Escherichia coli 
secA translation by distinct upstream elements. J Mol Biol 265, 128-141. 
Meurs, E., Chong, K., Galabru, J., Thomas, N.S., Kerr, I.M., Williams, B.R., and 
Hovanessian, A.G. (1990). Molecular cloning and characterization of the human double-
stranded RNA-activated protein kinase induced by interferon. Cell 62, 379-390. 
Minois, N., Carmona-Gutierrez, D., and Madeo, F. (2011). Polyamines in aging and 
disease. Aging (Albany NY) 3, 716-732. 
Mittal, N., Guimaraes, J.C., Gross, T., Schmidt, A., Vina-Vilaseca, A., Nedialkova, D.D., 
Aeschimann, F., Leidel, S.A., Spang, A., and Zavolan, M. (2017). The Gcn4 transcription 
factor reduces protein synthesis capacity and extends yeast lifespan. Nat Commun 8, 
457. 
Moazed, D., and Noller, H.F. (1989). Intermediate states in the movement of transfer 
RNA in the ribosome. Nature 342, 142-148. 
Moerke, N.J., Aktas, H., Chen, H., Cantel, S., Reibarkh, M.Y., Fahmy, A., Gross, J.D., 
Degterev, A., Yuan, J., Chorev, M., et al. (2007). Small-molecule inhibition of the 
interaction between the translation initiation factors eIF4E and eIF4G. Cell 128, 257-267. 
Moortgat, S., Desir, J., Benoit, V., Boulanger, S., Pendeville, H., Nassogne, M.C., Lederer, 
D., and Maystadt, I. (2016). Two novel EIF2S3 mutations associated with syndromic 
intellectual disability with severe microcephaly, growth retardation, and epilepsy. Am J 
Med Genet A 170, 2927-2933. 
  347 
Mueller, P.P., and Hinnebusch, A.G. (1986). Multiple upstream AUG codons mediate 
translational control of GCN4. Cell 45, 201-207. 
Muller-Moule, P. (2008). An expression analysis of the ascorbate biosynthesis enzyme 
VTC2. Plant Mol Biol 68, 31-41. 
Murakami, Y., Ichiba, T., Matsufuji, S., and Hayashi, S. (1996). Cloning of antizyme 
inhibitor, a highly homologous protein to ornithine decarboxylase. The Journal of 
biological chemistry 271, 3340-3342. 
Murakami, Y., Matsufuji, S., Kameji, T., Hayashi, S., Igarashi, K., Tamura, T., Tanaka, K., 
and Ichihara, A. (1992). Ornithine decarboxylase is degraded by the 26S proteasome 
without ubiquitination. Nature 360, 597-599. 
Naidu, K.A. (2003). Vitamin C in human health and disease is still a mystery? An 
overview. Nutr J 2, 7. 
Najarian, D., Dihanich, M.E., Martin, N.C., and Hopper, A.K. (1987). DNA sequence and 
transcript mapping of MOD5: features of the 5' region which suggest two translational 
starts. Mol Cell Biol 7, 185-191. 
Nakagawa, S., Niimura, Y., Gojobori, T., Tanaka, H., and Miura, K. (2008). Diversity of 
preferred nucleotide sequences around the translation initiation codon in eukaryote 
genomes. Nucleic Acids Res 36, 861-871. 
  348 
Neri, G., Schwartz, C.E., Lubs, H.A., and Stevenson, R.E. (2018). X-linked intellectual 
disability update 2017. Am J Med Genet A 176, 1375-1388. 
Niederberger, P., Miozzari, G., and Hutter, R. (1981). Biological role of the general 
control of amino acid biosynthesis in Saccharomyces cerevisiae. Mol Cell Biol 1, 584-593. 
Nika, J., Rippel, S., and Hannig, E.M. (2001). Biochemical analysis of the eIF2beta gamma 
complex reveals a structural function for eIF2alpha in catalyzed nucleotide exchange. 
The Journal of biological chemistry 276, 1051-1056. 
Nishikimi, M., and Yagi, K. (1991). Molecular basis for the deficiency in humans of 
gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. Am J Clin Nutr 54, 
1203S-1208S. 
Nojima, T., Hirose, T., Kimura, H., and Hagiwara, M. (2007). The interaction between 
cap-binding complex and RNA export factor is required for intronless mRNA export. The 
Journal of biological chemistry 282, 15645-15651. 
Nurenberg, E., and Tampe, R. (2013). Tying up loose ends: ribosome recycling in 
eukaryotes and archaea. Trends Biochem Sci 38, 64-74. 
Onouchi, H., Haraguchi, Y., Nakamoto, M., Kawasaki, D., Nagami-Yamashita, Y., Murota, 
K., Kezuka-Hosomi, A., Chiba, Y., and Naito, S. (2008). Nascent peptide-mediated 
translation elongation arrest of Arabidopsis thaliana CGS1 mRNA occurs autonomously. 
Plant Cell Physiol 49, 549-556. 
  349 
Padayatty, S.J., and Levine, M. (2016). Vitamin C: the known and the unknown and 
Goldilocks. Oral Dis 22, 463-493. 
Pain, V.M. (1986). Initiation of protein synthesis in mammalian cells. Biochem J 235, 
625-637. 
Palam, L.R., Baird, T.D., and Wek, R.C. (2011). Phosphorylation of eIF2 facilitates 
ribosomal bypass of an inhibitory upstream ORF to enhance CHOP translation. The 
Journal of biological chemistry 286, 10939-10949. 
Park, M.H., Cooper, H.L., and Folk, J.E. (1981). Identification of hypusine, an unusual 
amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic 
precursor. Proc Natl Acad Sci U S A 78, 2869-2873. 
Passmore, L.A., Schmeing, T.M., Maag, D., Applefield, D.J., Acker, M.G., Algire, M.A., 
Lorsch, J.R., and Ramakrishnan, V. (2007). The eukaryotic translation initiation factors 
eIF1 and eIF1A induce an open conformation of the 40S ribosome. Mol Cell 26, 41-50. 
Pavlov, M.Y., Watts, R.E., Tan, Z., Cornish, V.W., Ehrenberg, M., and Forster, A.C. (2009). 
Slow peptide bond formation by proline and other N-alkylamino acids in translation. 
Proc Natl Acad Sci U S A 106, 50-54. 
Peabody, D.S. (1987). Translation initiation at an ACG triplet in mammalian cells. The 
Journal of biological chemistry 262, 11847-11851. 
  350 
Peabody, D.S. (1989). Translation initiation at non-AUG triplets in mammalian cells. The 
Journal of biological chemistry 264, 5031-5035. 
Pegg, A.E. (2009). Mammalian polyamine metabolism and function. IUBMB Life 61, 880-
894. 
Pelechano, V., and Alepuz, P. (2017). eIF5A facilitates translation termination globally 
and promotes the elongation of many non polyproline-specific tripeptide sequences. 
Nucleic Acids Res 45, 7326-7338. 
Pelletier, J., and Sonenberg, N. (1985). Insertion mutagenesis to increase secondary 
structure within the 5' noncoding region of a eukaryotic mRNA reduces translational 
efficiency. Cell 40, 515-526. 
Perzlmaier, A.F., Richter, F., and Seufert, W. (2013). Translation initiation requires cell 
division cycle 123 (Cdc123) to facilitate biogenesis of the eukaryotic initiation factor 2 
(eIF2). The Journal of biological chemistry 288, 21537-21546. 
Pesole, G., Gissi, C., Grillo, G., Licciulli, F., Liuni, S., and Saccone, C. (2000). Analysis of 
oligonucleotide AUG start codon context in eukariotic mRNAs. Gene 261, 85-91. 
Pestova, T.V., and Kolupaeva, V.G. (2002). The roles of individual eukaryotic translation 
initiation factors in ribosomal scanning and initiation codon selection. Genes Dev 16, 
2906-2922. 
  351 
Petersen, D.N., Hawkins, J., Ruangsiriluk, W., Stevens, K.A., Maguire, B.A., O'Connell, 
T.N., Rocke, B.N., Boehm, M., Ruggeri, R.B., Rolph, T., et al. (2016). A Small-Molecule 
Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein 
Translation. Cell Chem Biol 23, 1362-1371. 
Pierard, A., and Schroter, B. (1978). Structure-function relationships in the arginine 
pathway carbamoylphosphate synthase of Saccharomyces cerevisiae. J Bacteriol 134, 
167-176. 
Pisarev, A.V., Hellen, C.U., and Pestova, T.V. (2007). Recycling of eukaryotic 
posttermination ribosomal complexes. Cell 131, 286-299. 
Pisarev, A.V., Skabkin, M.A., Pisareva, V.P., Skabkina, O.V., Rakotondrafara, A.M., 
Hentze, M.W., Hellen, C.U., and Pestova, T.V. (2010). The role of ABCE1 in eukaryotic 
posttermination ribosomal recycling. Mol Cell 37, 196-210. 
Porrua, O., Boudvillain, M., and Libri, D. (2016). Transcription Termination: Variations on 
Common Themes. Trends Genet 32, 508-522. 
Poyry, T.A., Kaminski, A., and Jackson, R.J. (2004). What determines whether 
mammalian ribosomes resume scanning after translation of a short upstream open 
reading frame? Genes Dev 18, 62-75. 
Proudfoot, N.J., Furger, A., and Dye, M.J. (2002). Integrating mRNA processing with 
transcription. Cell 108, 501-512. 
  352 
Purvis, I.J., Bettany, A.J., Santiago, T.C., Coggins, J.R., Duncan, K., Eason, R., and Brown, 
A.J. (1987). The efficiency of folding of some proteins is increased by controlled rates of 
translation in vivo. A hypothesis. J Mol Biol 193, 413-417. 
Radhakrishnan, A., Chen, Y.H., Martin, S., Alhusaini, N., Green, R., and Coller, J. (2016). 
The DEAD-Box Protein Dhh1p Couples mRNA Decay and Translation by Monitoring 
Codon Optimality. Cell 167, 122-132 e129. 
Radhakrishnan, A., and Green, R. (2016). Connections Underlying Translation and mRNA 
Stability. J Mol Biol 428, 3558-3564. 
Raghavan, A., Ogilvie, R.L., Reilly, C., Abelson, M.L., Raghavan, S., Vasdewani, J., 
Krathwohl, M., and Bohjanen, P.R. (2002). Genome-wide analysis of mRNA decay in 
resting and activated primary human T lymphocytes. Nucleic Acids Res 30, 5529-5538. 
Rahmani, F., Hummel, M., Schuurmans, J., Wiese-Klinkenberg, A., Smeekens, S., and 
Hanson, J. (2009). Sucrose control of translation mediated by an upstream open reading 
frame-encoded peptide. Plant Physiol 150, 1356-1367. 
Ramanathan, A., Robb, G.B., and Chan, S.H. (2016). mRNA capping: biological functions 
and applications. Nucleic Acids Res 44, 7511-7526. 
Rasanu, N.M., V.; Matei, Nicoleta; Soceanu, Alina. (2005). Determination of Vitamin C in 
different stages of fruits growing. Analele UniversităŃii din Bucureşti I-II, 167-172. 
  353 
Ravid, T., and Hochstrasser, M. (2008). Diversity of degradation signals in the ubiquitin-
proteasome system. Nat Rev Mol Cell Biol 9, 679-690. 
Resch, A.M., Ogurtsov, A.Y., Rogozin, I.B., Shabalina, S.A., and Koonin, E.V. (2009). 
Evolution of alternative and constitutive regions of mammalian 5'UTRs. BMC Genomics 
10, 162. 
Richter, J.D., and Lasko, P. (2011). Translational control in oocyte development. Cold 
Spring Harb Perspect Biol 3, a002758. 
Rodnina, M.V. (2013). The ribosome as a versatile catalyst: reactions at the peptidyl 
transferase center. Curr Opin Struct Biol 23, 595-602. 
Roeder, R.G. (1996). The role of general initiation factors in transcription by RNA 
polymerase II. Trends Biochem Sci 21, 327-335. 
Roll-Mecak, A., Alone, P., Cao, C., Dever, T.E., and Burley, S.K. (2004). X-ray structure of 
translation initiation factor eIF2gamma: implications for tRNA and eIF2alpha binding. 
The Journal of biological chemistry 279, 10634-10642. 
Roth, A.C. (2012). Decoding properties of tRNA leave a detectable signal in codon usage 
bias. Bioinformatics 28, i340-i348. 
Rowlands, A.G., Panniers, R., and Henshaw, E.C. (1988). The catalytic mechanism of 
guanine nucleotide exchange factor action and competitive inhibition by 
  354 
phosphorylated eukaryotic initiation factor 2. The Journal of biological chemistry 263, 
5526-5533. 
Ruan, H., Shantz, L.M., Pegg, A.E., and Morris, D.R. (1996). The upstream open reading 
frame of the mRNA encoding S-adenosylmethionine decarboxylase is a polyamine-
responsive translational control element. The Journal of biological chemistry 271, 
29576-29582. 
Sabatini, D.D., and Blobel, G. (1970). Controlled proteolysis of nascent polypeptides in 
rat liver cell fractions. II. Location of the polypeptides in rough microsomes. J Cell Biol 
45, 146-157. 
Sabi, R., and Tuller, T. (2014). Modelling the efficiency of codon-tRNA interactions based 
on codon usage bias. DNA Res 21, 511-526. 
Safaee, N., Kozlov, G., Noronha, A.M., Xie, J., Wilds, C.J., and Gehring, K. (2012). 
Interdomain allostery promotes assembly of the poly(A) mRNA complex with PABP and 
eIF4G. Mol Cell 48, 375-386. 
Saikia, M., Wang, X., Mao, Y., Wan, J., Pan, T., and Qian, S.B. (2016). Codon optimality 
controls differential mRNA translation during amino acid starvation. RNA 22, 1719-1727. 
Saini, A.K., Nanda, J.S., Lorsch, J.R., and Hinnebusch, A.G. (2010). Regulatory elements in 
eIF1A control the fidelity of start codon selection by modulating tRNA(i)(Met) binding to 
the ribosome. Genes Dev 24, 97-110. 
  355 
Saini, P., Eyler, D.E., Green, R., and Dever, T.E. (2009). Hypusine-containing protein 
eIF5A promotes translation elongation. Nature 459, 118-121. 
Salzberg, S.L. (2018). Open questions: How many genes do we have? BMC Biol 16, 94. 
Sarker, S., and Oliver, D. (2002). Critical regions of secM that control its translation and 
secretion and promote secretion-specific secA regulation. J Bacteriol 184, 2360-2369. 
Schleiss, M.R., Degnin, C.R., and Geballe, A.P. (1991). Translational control of human 
cytomegalovirus gp48 expression. J Virol 65, 6782-6789. 
Schuller, A.P., and Green, R. (2018). Roadblocks and resolutions in eukaryotic 
translation. Nat Rev Mol Cell Biol 19, 526-541. 
Schuller, A.P., Wu, C.C., Dever, T.E., Buskirk, A.R., and Green, R. (2017). eIF5A Functions 
Globally in Translation Elongation and Termination. Mol Cell 66, 194-205 e195. 
Schwartz, S., Felber, B.K., Benko, D.M., Fenyo, E.M., and Pavlakis, G.N. (1990). Cloning 
and functional analysis of multiply spliced mRNA species of human immunodeficiency 
virus type 1. J Virol 64, 2519-2529. 
Schwartz, S., Felber, B.K., and Pavlakis, G.N. (1992). Mechanism of translation of 
monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs. Mol 
Cell Biol 12, 207-219. 
  356 
Sekine, Y., Zyryanova, A., Crespillo-Casado, A., Fischer, P.M., Harding, H.P., and Ron, D. 
(2015). Stress responses. Mutations in a translation initiation factor identify the target 
of a memory-enhancing compound. Science 348, 1027-1030. 
Sekiyama, N., Arthanari, H., Papadopoulos, E., Rodriguez-Mias, R.A., Wagner, G., and 
Leger-Abraham, M. (2015). Molecular mechanism of the dual activity of 4EGI-1: 
Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1. 
Proc Natl Acad Sci U S A 112, E4036-4045. 
Shin, B.S., Kim, J.R., Walker, S.E., Dong, J., Lorsch, J.R., and Dever, T.E. (2011). Initiation 
factor eIF2gamma promotes eIF2-GTP-Met-tRNAi(Met) ternary complex binding to the 
40S ribosome. Nature structural & molecular biology 18, 1227-1234. 
Shoemaker, C.J., and Green, R. (2011). Kinetic analysis reveals the ordered coupling of 
translation termination and ribosome recycling in yeast. Proc Natl Acad Sci U S A 108, 
E1392-1398. 
Shoemaker, C.J., and Green, R. (2012). Translation drives mRNA quality control. Nature 
structural & molecular biology 19, 594-601. 
Sidrauski, C., Acosta-Alvear, D., Khoutorsky, A., Vedantham, P., Hearn, B.R., Li, H., 
Gamache, K., Gallagher, C.M., Ang, K.K., Wilson, C., et al. (2013). Pharmacological brake-
release of mRNA translation enhances cognitive memory. Elife 2, e00498. 
  357 
Sidrauski, C., McGeachy, A.M., Ingolia, N.T., and Walter, P. (2015a). The small molecule 
ISRIB reverses the effects of eIF2alpha phosphorylation on translation and stress granule 
assembly. Elife 4. 
Sidrauski, C., Tsai, J.C., Kampmann, M., Hearn, B.R., Vedantham, P., Jaishankar, P., 
Sokabe, M., Mendez, A.S., Newton, B.W., Tang, E.L., et al. (2015b). Pharmacological 
dimerization and activation of the exchange factor eIF2B antagonizes the integrated 
stress response. Elife 4, e07314. 
Simonovic, M., and Steitz, T.A. (2009). A structural view on the mechanism of the 
ribosome-catalyzed peptide bond formation. Biochim Biophys Acta 1789, 612-623. 
Skabkin, M.A., Skabkina, O.V., Dhote, V., Komar, A.A., Hellen, C.U., and Pestova, T.V. 
(2010). Activities of Ligatin and MCT-1/DENR in eukaryotic translation initiation and 
ribosomal recycling. Genes Dev 24, 1787-1801. 
Skopkova, M., Hennig, F., Shin, B.-S., Turner, C.E., Stanikova, D., Brennerova, K., Stanik, 
J., Fischer, U., Henden, L., Müller, U., et al. (2017). EIF2S3 Mutations Associated with 
Severe X-Linked Intellectual Disability Syndrome MEHMO.  38, 409-425. 
Slusher, L.B., Gillman, E.C., Martin, N.C., and Hopper, A.K. (1991). mRNA leader length 
and initiation codon context determine alternative AUG selection for the yeast gene 
MOD5. Proc Natl Acad Sci U S A 88, 9789-9793. 
Smith, M.G., and Snyder, M. (2006). Yeast as a model for human disease. Curr Protoc 
Hum Genet Chapter 15, Unit 15 16. 
  358 
Sonenberg, N., and Hinnebusch, A.G. (2009). Regulation of translation initiation in 
eukaryotes: mechanisms and biological targets. Cell 136, 731-745. 
Song, H., Mugnier, P., Das, A.K., Webb, H.M., Evans, D.R., Tuite, M.F., Hemmings, B.A., 
and Barford, D. (2000). The crystal structure of human eukaryotic release factor eRF1--
mechanism of stop codon recognition and peptidyl-tRNA hydrolysis. Cell 100, 311-321. 
Sorensen, M.A., and Pedersen, S. (1991). Absolute in vivo translation rates of individual 
codons in Escherichia coli. The two glutamic acid codons GAA and GAG are translated 
with a threefold difference in rate. J Mol Biol 222, 265-280. 
Sothiselvam, S., Liu, B., Han, W., Ramu, H., Klepacki, D., Atkinson, G.C., Brauer, A., 
Remm, M., Tenson, T., Schulten, K., et al. (2014). Macrolide antibiotics allosterically 
predispose the ribosome for translation arrest. Proc Natl Acad Sci U S A 111, 9804-9809. 
Spevak, C.C., Ivanov, I.P., and Sachs, M.S. (2010). Sequence requirements for ribosome 
stalling by the arginine attenuator peptide. The Journal of biological chemistry 285, 
40933-40942. 
Steinmuller, R., Steinberger, D., and Muller, U. (1998). MEHMO (mental retardation, 
epileptic seizures, hypogonadism and -genitalism, microcephaly, obesity), a novel 
syndrome: assignment of disease locus to xp21.1-p22.13. Eur J Hum Genet 6, 201-206. 
Stewart, M. (2019). Polyadenylation and nuclear export of mRNAs. The Journal of 
biological chemistry 294, 2977-2987. 
  359 
Stoecklin, G., Mayo, T., and Anderson, P. (2006). ARE-mRNA degradation requires the 5'-
3' decay pathway. EMBO Rep 7, 72-77. 
Stoecklin, G., and Muhlemann, O. (2013). RNA decay mechanisms: specificity through 
diversity. Biochim Biophys Acta 1829, 487-490. 
Stolboushkina, E., Nikonov, S., Nikulin, A., Blasi, U., Manstein, D.J., Fedorov, R., Garber, 
M., and Nikonov, O. (2008). Crystal structure of the intact archaeal translation initiation 
factor 2 demonstrates very high conformational flexibility in the alpha- and beta-
subunits. J Mol Biol 382, 680-691. 
Sudarsan, N., Barrick, J.E., and Breaker, R.R. (2003). Metabolite-binding RNA domains 
are present in the genes of eukaryotes. RNA 9, 644-647. 
Svirbely, J.L., and Szent-Gyorgyi, A. (1932). The chemical nature of vitamin C. Biochem J 
26, 865-870. 
Svirbely, J.L., and Szent-Gyorgyi, A. (1933). The chemical nature of vitamin C. Biochem J 
27, 279-285. 
Takamizawa, S., Maehata, Y., Imai, K., Senoo, H., Sato, S., and Hata, R. (2004). Effects of 
ascorbic acid and ascorbic acid 2-phosphate, a long-acting vitamin C derivative, on the 
proliferation and differentiation of human osteoblast-like cells. Cell Biol Int 28, 255-265. 
  360 
Taniuchi, S., Miyake, M., Tsugawa, K., Oyadomari, M., and Oyadomari, S. (2016). 
Integrated stress response of vertebrates is regulated by four eIF2alpha kinases. Sci Rep 
6, 32886. 
Thanaraj, T.A., and Argos, P. (1996). Protein secondary structural types are differentially 
coded on messenger RNA. Protein Sci 5, 1973-1983. 
Thore, S., Leibundgut, M., and Ban, N. (2006). Structure of the eukaryotic thiamine 
pyrophosphate riboswitch with its regulatory ligand. Science 312, 1208-1211. 
Ulvskov, P., Paiva, D.S., Domozych, D., and Harholt, J. (2013). Classification, naming and 
evolutionary history of glycosyltransferases from sequenced green and red algal 
genomes. PLoS One 8, e76511. 
Unbehaun, A., Borukhov, S.I., Hellen, C.U., and Pestova, T.V. (2004). Release of initiation 
factors from 48S complexes during ribosomal subunit joining and the link between 
establishment of codon-anticodon base-pairing and hydrolysis of eIF2-bound GTP. 
Genes Dev 18, 3078-3093. 
van den Heuvel, J.J., Bergkamp, R.J., Planta, R.J., and Raue, H.A. (1989). Effect of 
deletions in the 5'-noncoding region on the translational efficiency of phosphoglycerate 
kinase mRNA in yeast. Gene 79, 83-95. 
van der Horst, S., Filipovska, T., Hanson, J., and Smeekens, S. (2020). Metabolite Control 
of Translation by Conserved Peptide uORFs: The Ribosome as a Metabolite Multisensor. 
Plant Physiol 182, 110-122. 
  361 
Varshavsky, A. (2005). Regulated protein degradation. Trends Biochem Sci 30, 283-286. 
Vassilenko, K.S., Alekhina, O.M., Dmitriev, S.E., Shatsky, I.N., and Spirin, A.S. (2011). 
Unidirectional constant rate motion of the ribosomal scanning particle during eukaryotic 
translation initiation. Nucleic Acids Res 39, 5555-5567. 
Vattem, K.M., and Wek, R.C. (2004). Reinitiation involving upstream ORFs regulates 
ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A 101, 11269-11274. 
Venters, B.J., and Pugh, B.F. (2009). How eukaryotic genes are transcribed. Crit Rev 
Biochem Mol Biol 44, 117-141. 
Wahle, E., and Winkler, G.S. (2013). RNA decay machines: deadenylation by the Ccr4-not 
and Pan2-Pan3 complexes. Biochim Biophys Acta 1829, 561-570. 
Walsh, D., Mathews, M.B., and Mohr, I. (2013). Tinkering with translation: protein 
synthesis in virus-infected cells. Cold Spring Harb Perspect Biol 5, a012351. 
Walter, P., and Ron, D. (2011). The unfolded protein response: from stress pathway to 
homeostatic regulation. Science 334, 1081-1086. 
Wang, Y., and Casero, R.A., Jr. (2006). Mammalian polyamine catabolism: a therapeutic 
target, a pathological problem, or both? J Biochem 139, 17-25. 
Wang, Z., Fang, P., and Sachs, M.S. (1998). The evolutionarily conserved eukaryotic 
arginine attenuator peptide regulates the movement of ribosomes that have translated 
it. Mol Cell Biol 18, 7528-7536. 
  362 
Wang, Z., Gaba, A., and Sachs, M.S. (1999). A highly conserved mechanism of regulated 
ribosome stalling mediated by fungal arginine attenuator peptides that appears 
independent of the charging status of arginyl-tRNAs. The Journal of biological chemistry 
274, 37565-37574. 
Wang, Z., and Sachs, M.S. (1997). Ribosome stalling is responsible for arginine-specific 
translational attenuation in Neurospora crassa. Mol Cell Biol 17, 4904-4913. 
Wei, J., Wu, C., and Sachs, M.S. (2012). The arginine attenuator peptide interferes with 
the ribosome peptidyl transferase center. Mol Cell Biol 32, 2396-2406. 
Wei, J., Zhang, Y., Ivanov, I.P., and Sachs, M.S. (2013). The stringency of start codon 
selection in the filamentous fungus Neurospora crassa. The Journal of biological 
chemistry 288, 9549-9562. 
Wek, R.C. (2018). Role of eIF2alpha Kinases in Translational Control and Adaptation to 
Cellular Stress. Cold Spring Harb Perspect Biol 10. 
Wek, S.A., Zhu, S., and Wek, R.C. (1995). The histidyl-tRNA synthetase-related sequence 
in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation 
in response to starvation for different amino acids. Mol Cell Biol 15, 4497-4506. 
Werner, M., Feller, A., Messenguy, F., and Pierard, A. (1987). The leader peptide of yeast 
gene CPA1 is essential for the translational repression of its expression. Cell 49, 805-813. 
  363 
Werner, M., Feller, A., and Pierard, A. (1985). Nucleotide sequence of yeast gene CP A1 
encoding the small subunit of arginine-pathway carbamoyl-phosphate synthetase. 
Homology of the deduced amino acid sequence to other glutamine amidotransferases. 
Eur J Biochem 146, 371-381. 
West, S., Proudfoot, N.J., and Dye, M.J. (2008). Molecular dissection of mammalian RNA 
polymerase II transcriptional termination. Mol Cell 29, 600-610. 
Wheeler, G.L., Jones, M.A., and Smirnoff, N. (1998). The biosynthetic pathway of vitamin 
C in higher plants. Nature 393, 365-369. 
Wilson, D.N., Arenz, S., and Beckmann, R. (2016). Translation regulation via nascent 
polypeptide-mediated ribosome stalling. Curr Opin Struct Biol 37, 123-133. 
Wilson, D.N., and Beckmann, R. (2011). The ribosomal tunnel as a functional 
environment for nascent polypeptide folding and translational stalling. Curr Opin Struct 
Biol 21, 274-282. 
Winkler, W.C., and Breaker, R.R. (2003). Genetic control by metabolite-binding 
riboswitches. Chembiochem 4, 1024-1032. 
Wohlgemuth, I., Brenner, S., Beringer, M., and Rodnina, M.V. (2008). Modulation of the 
rate of peptidyl transfer on the ribosome by the nature of substrates. The Journal of 
biological chemistry 283, 32229-32235. 
  364 
Wolucka, B.A., and Van Montagu, M. (2003). GDP-mannose 3',5'-epimerase forms GDP-
L-gulose, a putative intermediate for the de novo biosynthesis of vitamin C in plants. The 
Journal of biological chemistry 278, 47483-47490. 
Woolstenhulme, C.J., Guydosh, N.R., Green, R., and Buskirk, A.R. (2015). High-precision 
analysis of translational pausing by ribosome profiling in bacteria lacking EFP. Cell Rep 
11, 13-21. 
Wu, C., Wei, J., Lin, P.J., Tu, L., Deutsch, C., Johnson, A.E., and Sachs, M.S. (2012). 
Arginine changes the conformation of the arginine attenuator peptide relative to the 
ribosome tunnel. J Mol Biol 416, 518-533. 
Xaplanteri, M.A., Petropoulos, A.D., Dinos, G.P., and Kalpaxis, D.L. (2005). Localization of 
spermine binding sites in 23S rRNA by photoaffinity labeling: parsing the spermine 
contribution to ribosomal 50S subunit functions. Nucleic Acids Res 33, 2792-2805. 
Yabuta, Y., Mieda, T., Rapolu, M., Nakamura, A., Motoki, T., Maruta, T., Yoshimura, K., 
Ishikawa, T., and Shigeoka, S. (2007). Light regulation of ascorbate biosynthesis is 
dependent on the photosynthetic electron transport chain but independent of sugars in 
Arabidopsis. J Exp Bot 58, 2661-2671. 
Yamashita, Y., Takamatsu, S., Glasbrenner, M., Becker, T., Naito, S., and Beckmann, R. 
(2017). Sucrose sensing through nascent peptide-meditated ribosome stalling at the 
stop codon of Arabidopsis bZIP11 uORF2. FEBS Lett 591, 1266-1277. 
  365 
Yang, F., Sun, S., Tan, G., Costanzo, M., Hill, D.E., Vidal, M., Andrews, B.J., Boone, C., and 
Roth, F.P. (2017). Identifying pathogenicity of human variants via paralog-based yeast 
complementation. PLoS Genet 13, e1006779. 
Yatime, L., Mechulam, Y., Blanquet, S., and Schmitt, E. (2007). Structure of an archaeal 
heterotrimeric initiation factor 2 reveals a nucleotide state between the GTP and the 
GDP states. Proc Natl Acad Sci U S A 104, 18445-18450. 
Yoon, H.J., and Donahue, T.F. (1992). The suil suppressor locus in Saccharomyces 
cerevisiae encodes a translation factor that functions during tRNA(iMet) recognition of 
the start codon. Mol Cell Biol 12, 248-260. 
Young, D.J., Guydosh, N.R., Zhang, F., Hinnebusch, A.G., and Green, R. (2015a). 
Rli1/ABCE1 Recycles Terminating Ribosomes and Controls Translation Reinitiation in 
3'UTRs In Vivo. Cell 162, 872-884. 
Young, S.K., Palam, L.R., Wu, C., Sachs, M.S., and Wek, R.C. (2016). Ribosome Elongation 
Stall Directs Gene-specific Translation in the Integrated Stress Response. The Journal of 
biological chemistry 291, 6546-6558. 
Young, S.K., and Wek, R.C. (2016). Upstream Open Reading Frames Differentially 
Regulate Gene-specific Translation in the Integrated Stress Response. The Journal of 
biological chemistry 291, 16927-16935. 
  366 
Young, S.K., Willy, J.A., Wu, C., Sachs, M.S., and Wek, R.C. (2015b). Ribosome 
Reinitiation Directs Gene-specific Translation and Regulates the Integrated Stress 
Response. The Journal of biological chemistry 290, 28257-28271. 
Young-Baird, S.K., Lourenco, M.B., Elder, M.K., Klann, E., Liebau, S., and Dever, T.E. 
(2019a). Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB. 
Mol Cell. 
Young-Baird, S.K., Lourenco, M.B., Elder, M.K., Klann, E., Liebau, S., and Dever, T.E. 
(2020). Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB. 
Mol Cell 77, 875-886 e877. 
Young-Baird, S.K., Shin, B.S., and Dever, T.E. (2019b). MEHMO syndrome mutation 
EIF2S3-I259M impairs initiator Met-tRNAiMet binding to eukaryotic translation initiation 
factor eIF2. Nucleic Acids Res 47, 855-867. 
Yu, C.H., Dang, Y., Zhou, Z., Wu, C., Zhao, F., Sachs, M.S., and Liu, Y. (2015). Codon Usage 
Influences the Local Rate of Translation Elongation to Regulate Co-translational Protein 
Folding. Mol Cell 59, 744-754. 
Zhang, G., Hubalewska, M., and Ignatova, Z. (2009). Transient ribosomal attenuation 
coordinates protein synthesis and co-translational folding. Nature structural & 
molecular biology 16, 274-280. 
  367 
Zhang, H., Si, X., Ji, X., Fan, R., Liu, J., Chen, K., Wang, D., and Gao, C. (2018). Genome 
editing of upstream open reading frames enables translational control in plants. Nat 
Biotechnol 36, 894-898. 
Zhang, J., Pan, X., Yan, K., Sun, S., Gao, N., and Sui, S.F. (2015). Mechanisms of ribosome 
stalling by SecM at multiple elongation steps. Elife 4. 
Zhang, P., McGrath, B.C., Reinert, J., Olsen, D.S., Lei, L., Gill, S., Wek, S.A., Vattem, K.M., 
Wek, R.C., Kimball, S.R., et al. (2002). The GCN2 eIF2alpha kinase is required for 
adaptation to amino acid deprivation in mice. Mol Cell Biol 22, 6681-6688. 
Zhang, Y. (2013). Ascorbic Acid in Plants (Springer). 
Zhou, Z., Luo, M.J., Straesser, K., Katahira, J., Hurt, E., and Reed, R. (2000). The protein 
Aly links pre-messenger-RNA splicing to nuclear export in metazoans. Nature 407, 401-
405. 
Zinder, J.C., and Lima, C.D. (2017). Targeting RNA for processing or destruction by the 
eukaryotic RNA exosome and its cofactors. Genes Dev 31, 88-100. 
Zinszner, H., Kuroda, M., Wang, X., Batchvarova, N., Lightfoot, R.T., Remotti, H., Stevens, 
J.L., and Ron, D. (1998). CHOP is implicated in programmed cell death in response to 
impaired function of the endoplasmic reticulum. Genes Dev 12, 982-995. 
Zitomer, R.S., Walthall, D.A., Rymond, B.C., and Hollenberg, C.P. (1984). Saccharomyces 
cerevisiae ribosomes recognize non-AUG initiation codons. Mol Cell Biol 4, 1191-1197. 
  368 
Zyryanova, A.F., Weis, F., Faille, A., Alard, A.A., Crespillo-Casado, A., Sekine, Y., Harding, 
H.P., Allen, F., Parts, L., Fromont, C., et al. (2018). Binding of ISRIB reveals a regulatory 
site in the nucleotide exchange factor eIF2B. Science 359, 1533-1536. 






















  370 
Leda Eleanor Lotspeich-Cole 
 
Education 
Johns Hopkins University-National Institutes of Health Graduate 




Johns Hopkins University Bloomberg School of Public Health, 
Baltimore, MD, Sc.M., Molecular Microbiology and Immunology 





University of Alaska Fairbanks, Fairbanks, AK, B.S. magna cum 




National Institutes of Health, Eunice Kennedy Shriver National 
Institute of Child Health and Human Development, Bethesda, MD 
Predoctoral Fellow, Principle Investigator: Thomas Dever, Ph.D. 
2014-present 
  
National Institutes of Health, National Institutes of Allergy and 
Infectious Diseases, Bethesda, MD 
Predoctoral Fellow, Principle Investigator: Stefan Muljo, Ph.D. 
2013-2014 
  
  371 
United States Food and Drug Administration, Center for Biologics 
Evaluation and Research, Bethesda, MD 
ORISE Fellow, Principle Investigator: Sheldon Morris, Ph.D. 
2011-2012 
  
The Johns Hopkins University Bloomberg School of Public Health, 
Baltimore, MD 
Graduate Student, Principle Investigator: Egbert Hoicyk, Ph.D. 
2009-2011 
  
University of Alaska Fairbanks, Institute of Arctic Biology, Fairbanks, 
AK 
Undergraduate Research Assistant, Principle Investigator: Karsten 




1. EIF2S3 mutations associated with severe X-linked intellectual disability 
syndrome MEHMO. Skopkova M, Hennig F, Shin BS, Turner CE, Stanikova D, 
Brennerova K, Stanik J, Fischer U, Henden L, Müller U, Steinberger D, 
Kurdiova T, Ukropec J, Nyitrayova O, Kolníkova K, Klimes I, Borck G, Bahlo 
M, Haas SA, Kim JR, Lotspeich-Cole LE, Gasperikova D, Dever TE, 
Kalscheuer VM. Hum Mutat, 2017. 
2. T-bet modulates the antibody response and immune protection during murine 
malaria. Oakley MS, Sahu B, Lotspeich-Cole L, Majam V, Pham PT, 
  372 
Sengupta Banerjee A, Kozakai Y, Morris SL, and Kumar S. Eur J Immunol, 
2014.  
3. The transcription factor T-bet regulated parasite and promotes pathogenesis 
during Plasmodium berghei ANKA murine malaria. Oakley MS, Sahu B, 
Lotspeich-Cole L, Solanki N, Majam V, Pham PT, Banerjee R, Kozaki Y, 
Derrick SC, Kumar S, and Morris SL. Journal Immunol., 2013.  
4. Oakley MS, Gerald N, Anantharaman V, Gao Y, Majam V, Mahajan B, Pham 
PT, Lotspeich-Cole L, Meyers TG, McCutchan TF, Morris SL, Aravind L, 
Kumar S. Radiation Induced Cellular and Molecular Alterations in Asexual 
Intraerythrocytic Plasmodium falciparum Parasites. J Infect Dis., 2013. 
5. Detection of Francisella tularensis in Alaskan mosquitoes (Diptera: Culicidae) 
and assessment of a laboratory model for transmission. Triebenbach AN, Vogl 
SJ, Lotspeich-Cole L, Sikes DS, Happ GM, Hueffer K. J Med Entomol, 2010. 
 
